symbol,publishedDate,title,image,site,text,url,title_compound,text_compound
PFE,2020-12-31,Pfizer Criticizes Sudden Change in Coronavirus Vaccine Dosing Regime in the U.K.,https://cdn.snapi.dev/images/v1/b/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6068172fa-syringe-being-filled-with-a-vaccine-from-a-vialjpgw700opresize.jpg,The Motley Fool,The company sounded alarm bells about the widening gap between the initial shot and booster of BNT162b2.,https://www.fool.com/investing/2020/12/31/pfizer-criticizes-sudden-change-in-coronavirus-dos/,-0.34,-0.34
PFE,2020-12-31,Why Pfizer is the Cheapest Coronavirus Vaccine Play,https://cdn.snapi.dev/images/v1/u/p/biotech3---j2lywpuo13.jpg,InvestorPlace,PFE stock does not include any value to the Pfizer-BioNTech partnership and the developments of a game-changing Covid-19 vaccine. The post Why Pfizer is the Cheapest Coronavirus Vaccine Play appeared first on InvestorPlace.,https://investorplace.com/2020/12/pfe-stock-pfizer-does-not-include-value-biontech-and-vaccine/,0.34,0.0936
PFE,2020-12-31,Top ETF Stories of Fourth-Quarter 2020,https://cdn.snapi.dev/images/v1/f/q/drugs7.jpg,Zacks Investment Research,The year 2020 as a whole could easily be attributed to the COVID-19 outbreak.,https://www.zacks.com/stock/news/1239976/top-etf-stories-of-fourth-quarter-2020,0.2023,0.34
PFE,2020-12-31,5 Big ETF Stories of 2020 Worth Watching in 2021,https://cdn.snapi.dev/images/v1/2/e/computer-electronic4.jpg,Zacks Investment Research,We discuss some of the events that dominated the headlines in 2020 and are worth watching in 2021.,https://www.zacks.com/stock/news/1239830/5-big-etf-stories-of-2020-worth-watching-in-2021,0.2263,0.2263
PFE,2020-12-31,U.K. health service pushes back interval for delivering second Pfizer coronavirus vaccine to a duration company says is untested,https://cdn.snapi.dev/images/v1/o/d/im-279638width620size15005861664712778.jpg,Market Watch,The U.K. National Health Service has pushed back the window for people to receive the second dose of the coronavirus vaccine made by Pfizer and BioNTech — to a duration the companies tested on only a small percentage of patients.,https://www.marketwatch.com/story/u-k-health-service-pushes-back-interval-for-delivering-second-pfizer-coronavirus-vaccine-to-a-duration-company-says-is-untested-11609424175,0.0,0.0
PFE,2020-12-30,4 Best Performing Sector ETFs of December,https://cdn.snapi.dev/images/v1/8/o/etf5.jpg,Zacks Investment Research,"Despite the surge in coronavirus cases, December has been kind for the U.S. stock market with the major indices enjoying a historic rally.",https://www.zacks.com/stock/news/1235929/4-best-performing-sector-etfs-of-december,0.6369,0.7783
PFE,2020-12-30,Why the New Covid-19 Strain Matters for Pfizer Stakeholders,https://cdn.snapi.dev/images/v1/m/h/201209123827-pfizer-biontech-coronavirus-vaccine-wales-1208-super-169.jpg,InvestorPlace,"With Pfizer delivering Covid-19 vaccines, PFE stock appears to be the pandemic's winner. However, a new strain of SARS-CoV-2 and fresh competition may apply some pressure.",https://investorplace.com/2020/12/pfe-stock-why-new-coronavirus-strain-matters/,-0.0258,0.5719
PFE,2020-12-30,Wall Street Stories That Hit Headlines in 2020,https://cdn.snapi.dev/images/v1/w/m/computer-electronic31.jpg,Zacks Investment Research,"With super-easy policies and vaccination, small-cap stocks like Liquidity Services (LQDT) and cyclical stocks like Nexstar Media (NXST), Deere & Company (DE) and BHP Billiton (BBL) are expected to benefit the most.",https://www.zacks.com/stock/news/1235105/wall-street-stories-that-hit-headlines-in-2020,0.0,0.7906
PFE,2020-12-30,5 Factors Indicating That Oil is Poised for a Run-Up in 2021,https://cdn.snapi.dev/images/v1/x/h/oil5.jpg,Zacks Investment Research,"As a proof of the improving energy environment, refining biggies like Marathon Petroleum (MPC) and Phillips 66 (PSX) experienced sequential increase in utilization during the third quarter.",https://www.zacks.com/stock/news/1235183/5-factors-indicating-that-oil-is-poised-for-a-run-up-in-2021,0.25,0.8271
PFE,2020-12-30,The 3 Safest Stocks to Buy With Your Stimulus Money,https://cdn.snapi.dev/images/v1/p/6/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5938142fgettyimages-1194732144jpgw700opresize.jpg,The Motley Fool,"These companies are heavyweights, and they're only getting stronger.",https://www.fool.com/investing/2020/12/30/the-3-safest-stocks-to-buy-with-600-in-stimulus-mo/,0.4019,0.3818
PFE,2020-12-30,2 Top Picks - Safe High Dividend Biotechs For 2021,https://cdn.snapi.dev/images/v1/i/d/drugs8.jpg,Seeking Alpha,2 Top Picks - Safe High Dividend Biotechs For 2021,https://seekingalpha.com/article/4396693-2-top-picks-safe-high-dividend-biotechs-for-2021,0.5719,0.5719
PFE,2020-12-29,Pfizer and BioNTech Supplying 100 Million Additional Doses of Coronavirus Vaccine to European Union,https://cdn.snapi.dev/images/v1/9/e/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6066262fgettyimages-1266494637jpgw700opresize.jpg,The Motley Fool,The EU's total order now stands at 300 million.,https://www.fool.com/investing/2020/12/29/pfizer-and-biontech-supplying-100-million-addition/,0.0,0.0
PFE,2020-12-29,Undervalued Pharmaceutical Dividends For The New Year,https://cdn.snapi.dev/images/v1/w/1/euh22.jpg,Seeking Alpha,"AbbVie and Bristol-Myers Squibb are major pharmaceuticals that have recently made large acquisitions that have significantly increased their total debt. However, both AbbVie and Bristol-Myers Squibb have robust drug pipelines and are actively expanding indications of key therapeutics to drive strong growth going forward.",https://seekingalpha.com/article/4396667-undervalued-pharmaceutical-dividends-for-new-year,0.0,0.8481
PFE,2020-12-29,Pfizer (PFE) Gains As Market Dips: What You Should Know,https://cdn.snapi.dev/images/v1/p/f/drugs2.jpg,Zacks Investment Research,"In the latest trading session, Pfizer (PFE) closed at $37.05, marking a +0.62% move from the previous day.",https://www.zacks.com/stock/news/1232103/pfizer-pfe-gains-as-market-dips-what-you-should-know,0.34,0.0
PFE,2020-12-29,Arcturus Reports Results From Early-Stage Testing of Its Coronavirus Vaccine,https://cdn.snapi.dev/images/v1/w/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6065922fa-syringe-being-filled-with-a-vaccine-from-a-vialjpgw700opresize.jpg,The Motley Fool,"Investors obviously considered these to be underwhelming, however.",https://www.fool.com/investing/2020/12/29/arcturus-reports-results-from-early-stage-testing/,0.0,0.0
PFE,2020-12-29,European Union Set To Purchase 100M More Doses Of Pfizer COVID-19 Vaccine,https://cdn.snapi.dev/images/v1/l/q/medicine-5103043-1920-28.jpg,Benzinga,"European Commission President Ursula von der Leyen took to Twitter to announce Tuesday that the European Union will purchase an additional 100 million doses of the Pfizer (NYSE: PFE)-BioNTech (NASDAQ: BNTX) coronavirus vaccine.  We decided to take an additional 100 million doses of the #BioNTech /@Pfizer vaccine, which is already being used to vaccinate people across the EU.",https://www.benzinga.com/general/biotech/20/12/18954761/european-union-set-to-purchase-100m-more-doses-of-pfizer-covid-19-vaccine,0.0,0.0
PFE,2020-12-29,Pfizer and BioNTech to supply additional 100 million COVID vaccine doses to EU in 2021,https://cdn.snapi.dev/images/v1/w/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998182fbntx-stock-biontech-stock-why-bntx-stock-up-today-monday-covid-vaccinejpgw700opresize.jpg,Market Watch,"Pfizer Inc. and its German partner BioNTech SE will supply an additional 100 million doses of their COVID-19 vaccine to the 27 member states of the European Union, the companies said in a joint statement. The move comes after the European Commission exercised an option to purchase the extra doses that was granted as part of an agreement signed in November.",https://www.marketwatch.com/story/pfizer-and-biontech-to-supply-additional-100-million-covid-vaccine-doses-to-eu-in-2021-2020-12-29,0.0,0.6369
PFE,2020-12-29,Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®,https://cdn.snapi.dev/images/v1/c/c/press7---sg6hddejwr.jpg,Business Wire,"NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies' COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission's decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on November 11, 2020. This agreement brings the total",https://www.businesswire.com/news/home/20201229005380/en/Pfizer-and-BioNTech-to-Supply-the-European-Union-with-100-Million-Additional-Doses-of-COMIRNATY%C2%AE/,0.0,0.8126
PFE,2020-12-29,Myovant (MYOV) Up on Collaboration With Pfizer for Relugolix,https://cdn.snapi.dev/images/v1/d/u/biotech35---evzqrysgbv.jpg,Zacks Investment Research,"Myovant Sciences (MYOV) and Pfizer enter collaboration agreement to develop and commercialize relugolix monotherapy and combination regimen for prostate cancer and uterine fibroids, respectively.",https://www.zacks.com/stock/news/1230385/myovant-myov-up-on-collaboration-with-pfizer-for-relugolix,0.0,0.0516
PFE,2020-12-29,Why Betting Against the S&P 500 Makes Little Sense in 2021,https://cdn.snapi.dev/images/v1/v/m/computer-electronic19.jpg,InvestorPlace,"It has defied the odds -- or at least Covid-19's wrath -- in 2020, and conditions continue to shape up for a strong year ahead in SPY stock. The post Why Betting Against the S&P 500 Makes Little Sense in 2021 appeared first on InvestorPlace.",https://investorplace.com/2020/12/why-betting-against-the-sp-500-makes-little-sense-in-2021/,0.0,0.5106
PFE,2020-12-29,Pfizer Stock Is Too Hot but It's Definitely Safe to Handle Here,https://cdn.snapi.dev/images/v1/g/0/heres-why-pfizer-stock-looks-inviting-at-39-levels.jpg,InvestorPlace,PFE stock has had 2 recent mega rallies and it could have another one. But it's best asset is the support below and the dividend yield.,https://investorplace.com/2020/12/pfe-stock-is-too-hot-but-its-definitely-safe-to-handle-here/,0.8126,0.8555
PFE,2020-12-29,Pfizer (PFE) Lorbrena First-Line sNDA Gets FDA Priority Review,https://cdn.snapi.dev/images/v1/v/g/drugs45.jpg,Zacks Investment Research,Pfizer's (PFE) label expansion application for Lorbrena as first-line treatment for metastatic lung cancer gets priority review from the FDA.,https://www.zacks.com/stock/news/1230258/pfizer-pfe-lorbrena-first-line-snda-gets-fda-priority-review,0.0,-0.6597
PFE,2020-12-29,"My Favorite Stocks for 2021: Pfizer, Disney, 8 Others",https://cdn.snapi.dev/images/v1/y/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5790832fwall-street-signjpgw700opresize.jpg,GuruFocus,"Pfizer (NYSE:PFE), Walt Disney (NYSE:DIS) and D.R. Horton (NYSE:DHI) are among my favorite stocks for the coming year.",https://www.gurufocus.com/news/1319877/my-favorite-stocks-for-2021-pfizer-disney-8-others,0.4588,0.4588
PFE,2020-12-29,3 Stocks Set for Huge Returns In 2021,https://cdn.snapi.dev/images/v1/m/8/aaai22.jpg,InvestorPlace,A new year comes with new opportunities and challenges for investors looking to make a smart bet. Here are the top stocks set for huge returns in 2021.,https://investorplace.com/2020/12/3-stocks-set-for-huge-returns-in-2021/,0.3182,0.8271
PFE,2020-12-29,Why New Coronavirus Strains Could Boost Pfizer and Moderna's Fortunes,https://cdn.snapi.dev/images/v1/2/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6063542fman-looking-at-coronavirus-and-chart-imagesjpgw700opresize.jpg,The Motley Fool,Mutations could mean more money for the two drugmakers.,https://www.fool.com/investing/2020/12/29/why-new-coronavirus-strains-could-boost-pfizer-and/,0.128,0.0
PFE,2020-12-29,Pfizer's All-in Costs Show Vaccine Probably Won't Move the Needle Much,https://cdn.snapi.dev/images/v1/d/m/biotech29.jpg,InvestorPlace,"For all the hoopla, PFE stock has already seen the benefit of the Covid-19 vaccine and needs new catalysts. Still, long-term investors may want it's healthy dividend.",https://investorplace.com/2020/12/vaccine-probably-wont-move-the-pfe-stock-needle-much/,0.0,0.7184
PFE,2020-12-28,Shares of Startup Biotechs Soar on Cancer Study Results,https://cdn.snapi.dev/images/v1/e/g/drugs40---xmaegx6y3t.jpg,GuruFocus,"Breast cancer is the second leading cause of death of women in the U.S. alone. Given the prevalence of the disease, it's no surprise that numerous pharmaceutical and biotech companies are searching for effective treatments.",https://www.gurufocus.com/news/1319538/shares-of-startup-biotechs-soar-on-cancer-study-results,-0.4939,-0.8074
PFE,2020-12-28,LORBRENA® (lorlatinib) sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA,https://cdn.snapi.dev/images/v1/v/j/press7---x5mh08thog.jpg,Business Wire,NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug Application (sNDA) for LORBRENA ® (lorlatinib) as a first-line treatment for people with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC). The sNDA is based on data from the pivotal CROWN study and is being reviewed by the FDA under its Real-Time Oncology Review (RTOR) pilot program. T,https://www.businesswire.com/news/home/20201228005232/en/LORBRENA%C2%AE-lorlatinib-sNDA-in-Previously-Untreated-ALK-Positive-Lung-Cancer-Accepted-for-Priority-Review-by-U.S.-FDA/,-0.5106,-0.5106
PFE,2020-12-28,7 Hot Stocks That Are Cheering on Vaccine Approvals,https://cdn.snapi.dev/images/v1/j/7/biotech26.jpg,InvestorPlace,"The recent vaccine approvals could turn these names into hot stocks to buy now, despite them hailing from some of this year's most beleaguered sectors. The post 7 Hot Stocks That Are Cheering on Vaccine Approvals appeared first on InvestorPlace.",https://investorplace.com/2020/12/7-hot-stocks-to-buy-now-that-are-cheering-vaccine-approvals/,0.5106,0.5106
PFE,2020-12-28,4 Transportation Stocks Likely to Keep Flying High in 2021,https://cdn.snapi.dev/images/v1/j/k/air5---vadzkwo0x1.jpg,Zacks Investment Research,"Robust advancement in e-commerce and an uptick in freight conditions make transportation stocks attractive investment bets. Evidently, the likes of UPS, Knight-Swift (KNX), Atlas Air (AAWW) and ArcBest (ARCB) should grace one's portfolio.",https://www.zacks.com/stock/news/1225865/4-transportation-stocks-likely-to-keep-flying-high-in-2021,0.0,0.872
PFE,2020-12-28,Myovant leaps 35% on Pfizer partnership for development of prostate-cancer drug,https://cdn.snapi.dev/images/v1/m/y/myovant-leaps-35-on-pfizer-partnership-for-development-of-prostate-cancer-drug.jpg,Business Insider,"Shares of Myovant surged as much as 35% to $30 on Monday after the biopharmaceutical company announced a partnership with Pfizer to develop and commercialize a drug for the treatment of prostate cancer patients. The drug, called Orgovyx, was approved by the FDA on December 18 for the treatment of adult patients with advanced prostate cancer. Myovant is also working on a relugolix combination tablet that could treat patients with endometriosis and uterine fibroids. That tablet is still awaiting FDA approval. ""We are thrilled to partner with Pfizer to unlock the full potential of ORGOVYX in advanced prostate cancer and relugolix combination tablet in uterine fibroids and endometriosis, advancing our mission to redefine care for women and for men,"" said Lynn Seely, Myovant CEO, in an announcement. ""This transformative collaboration will significantly strengthen the upcoming launch of ORGOVYX and the potential launches of relugolix combination tablet in women's health, while substantially enhancing our financial position and enabling us to expand our pipeline of potential new medicines."" Read more: Wall Street's biggest firms are warning that these 8 things could crash the stock market's party in 2021",https://www.businessinsider.com/myovant-stock-price-pfizer-partnership-develop-prostate-cancer-drug-endrometriosis-2020-12,0.0,0.7096
PFE,2020-12-28,Myovant shares soar 27% on news of Pfizer prostate cancer drug collaboration worth up to $4.2 billion,https://cdn.snapi.dev/images/v1/j/2/biotech24.jpg,Market Watch,"Shares of Myovant Sciences soared 27% Monday, after its parent Sumitovant Biopharma unveiled an agreement with Pfizer Inc. to jointly develop a treatment for prostate cancer and women's health in a deal worth up to $4.2 billion in upfront and potential milestone payments.",https://www.marketwatch.com/story/myovant-shares-soar-27-on-news-of-pfizer-prostate-cancer-drug-collaboration-worth-up-to-42-billion-2020-12-28,-0.3182,0.2263
PFE,2020-12-28,5 Sector ETFs That Beat the Market in 2020,https://cdn.snapi.dev/images/v1/q/k/etf8.jpg,Zacks Investment Research,"With historic twists and turns, 2020 has turned out to be a banner year.",https://www.zacks.com/stock/news/1225238/5-sector-etfs-that-beat-the-market-in-2020,0.0,0.0
PFE,2020-12-28,"Coronavirus vaccine: Moderna, Pfizer trials were the ‘highest of quality,' expert explains",https://cdn.snapi.dev/images/v1/b/y/coronavirus-vaccine-moderna-pfizer-trials-were-the-highest-of-quality-expert-explains.jpg,Yahoo Finance,"Yahoo Finance's Julie Hyman, Brian Sozzi, and Myles Udland discuss the COVID-19 vaccine rollout with Dr. Reynold Panettieri, Robert Wood Johnson Medical School Professor of Medicine and advisor to the GERM ETF. Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.",https://www.youtube.com/watch?v=KMG5JoWMd6w,0.0,0.7184
PFE,2020-12-28,Why This Recently Approved Prostate Cancer Treatment Could Be Huge for Myovant,https://cdn.snapi.dev/images/v1/b/p/biotech21.jpg,24/7 Wall Street,Myovant Sciences Ltd. (NYSE: MYOV) shares shot up on Monday after the company announced a new collaboration with the pharmaceutical giant Pfizer Inc.,https://247wallst.com/healthcare-business/2020/12/28/why-this-recently-approved-prostate-cancer-treatment-could-be-huge-for-myovant/,-0.0772,0.296
PFE,2020-12-28,Deal With Pfizer Sends Myovant Shares Higher: What Investors Need To Know,https://cdn.snapi.dev/images/v1/v/g/pill-1884775-1920-62.jpg,Benzinga,Myovant Sciences Ltd (NYSE: MYOV) stock is adding about one-fourth of its market capitalization Monday following a licensing deal with Pfizer Inc. (NYSE: PFE). What Happened: Myovant announced a collaboration with Pfizer to develop and commercialize relugolix for oncology indications and women's health in the U.S. and Canada.,https://www.benzinga.com/general/biotech/20/12/18938649/deal-with-pfizer-sends-myovant-shares-higher-what-investors-need-to-know,0.296,0.0
PFE,2020-12-28,Biopharmaceutical Stock Surges Thanks to Pfizer Partnership,https://cdn.snapi.dev/images/v1/e/o/drugs37.jpg,Schaeffers Research,"The shares of Myovant Sciences Ltd (NYSE:MYOV) are up 27.2% at $29.08 at last check, gapping to record highs, after the biopharmaceutical concern announced a collaboration with Pfizer (PFE) to develop and commercialize cancer treatment relugolix in both the U.S. and Canada.",https://www.schaeffersresearch.com/content/news/2020/12/28/biopharmaceutical-stock-surges-thanks-to-pfizer-partnership,0.4404,-0.4939
PFE,2020-12-28,3 Restaurant Stocks to Gain Big With the Vaccine Rollout,https://cdn.snapi.dev/images/v1/p/d/drugs35.jpg,Zacks Investment Research,"Restaurant industry is likely to benefit from the vaccine rollout. Following the vaccine rollout, dine-in option should become safe and traffic is likely to increase.",https://www.zacks.com/stock/news/1225207/3-restaurant-stocks-to-gain-big-with-the-vaccine-rollout,0.5267,0.802
PFE,2020-12-28,UPDATE - Sumitovant Biopharma Announces Myovant Sciences and Pfizer Enter Collaboration to Develop and Commercialize Relugolix in Oncology and Women's Health,https://cdn.snapi.dev/images/v1/p/r/press10---dr7pd6i9ac.jpg,GlobeNewsWire,Myovant and Pfizer to jointly develop and commercialize ORGOVYX™ (relugolix) and relugolix combination tablet and share profits and expenses in the U.S. and Canada,https://www.globenewswire.com/news-release/2020/12/28/2150911/0/en/UPDATE-Sumitovant-Biopharma-Announces-Myovant-Sciences-and-Pfizer-Enter-Collaboration-to-Develop-and-Commercialize-Relugolix-in-Oncology-and-Women-s-Health.html,0.0,0.6249
PFE,2020-12-28,5 Stocks That Could Directly Gain From Pfizer's Vaccine Success,https://cdn.snapi.dev/images/v1/g/p/biotech11.jpg,Zacks Investment Research,"As vaccine rollout picks up in the United States, companies directly involved in the distribution process stand to benefit, making it wise to keep an eye on names like FedEx (FDX) and Linde (LIN)",https://www.zacks.com/stock/news/1224655/5-stocks-that-could-directly-gain-from-pfizers-vaccine-success,0.7964,0.886
PFE,2020-12-28,Dividend Bumps and Buybacks Give Pfizer Stock 20% Upside,https://cdn.snapi.dev/images/v1/v/q/drugs34.jpg,InvestorPlace,Pfizer's dividend yield and other value metrics imply good upside for PFE stock. PFE stock is still at least 22% undervalued based on its dividend yield and other valuation metrics.,https://investorplace.com/2020/12/dividend-bumps-and-buybacks-give-pfizer-stock-20-upside/,0.0,0.6486
PFE,2020-12-28,Myovant shares soar 16% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion,https://cdn.snapi.dev/images/v1/m/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5489222fdrugs-and-pills-on-top-of-hundred-dollar-billsjpgw700opresize.jpg,Market Watch,"Shares of Myovant Sciences soared 16% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant will work with Pfizer Inc. to jointly develop a treatment for men's and women's cancer in a deal worth up to $4.2 billion in upfront and potential milestone payments. Myovant will receive an upfront payment of $650 million to develop relugolix, a once-daily, oral gonadotropin-releasing hormone receptor antagonist for use in oncology and women's health in the U.S. and Canada.",https://www.marketwatch.com/story/myovant-shares-soar-16-premarket-on-news-of-pfizer-cancer-drug-deal-worth-up-to-42-billion-2020-12-28,-0.3182,-0.6369
PFE,2020-12-28,Sumitovant Biopharma Announces Myovant Sciences and Pfizer Enter Collaboration to Develop and Commercialize Relugolix in Oncology and Women's Health,https://cdn.snapi.dev/images/v1/p/r/press20---0byqjdmsgi.jpg,GlobeNewsWire,Myovant and Pfizer to jointly develop and commercialize ORGOVYXTM (relugolix) and relugolix combination tablet and share profits and expenses in the U.S. and CanadaMyovant to receive an upfront payment of $650 million in addition to potential regulatory and sales milestones for a total payment of up to $4.2 billionORGOVYX(relugolix) is the first approved therapy in the Sumitovant Biopharma family of companies Myovant and Pfizer to jointly develop and commercialize ORGOVYXTM (relugolix) and relugolix combination tablet and share profits and expenses in the U.S. and CanadaMyovant to receive an upfront payment of $650 million in addition to potential regulatory and sales milestones for a total payment of up to $4.2 billionORGOVYX(relugolix) is the first approved therapy in the Sumitovant Biopharma family of companies,https://www.globenewswire.com/news-release/2020/12/28/2150827/0/en/Sumitovant-Biopharma-Announces-Myovant-Sciences-and-Pfizer-Enter-Collaboration-to-Develop-and-Commercialize-Relugolix-in-Oncology-and-Women-s-Health.html,0.0,0.93
PFE,2020-12-28,"As Vaccine Excitement Fades, Buy the Pullback in Pfizer",https://cdn.snapi.dev/images/v1/u/c/biotech5.jpg,InvestorPlace,"With its solid dividend yield and reasonable valuation, there's more to like about PFE stock than just Pfizer's pandemic catalyst. The post As Vaccine Excitement Fades, Buy the Pullback in Pfizer appeared first on InvestorPlace.",https://investorplace.com/2020/12/vaccine-excitement-fades-buy-pullback-pfizer-pfe-stock/,0.4939,0.7635
PFE,2020-12-28,Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women's Health,https://cdn.snapi.dev/images/v1/1/k/press20---0ab9ktfyt2.jpg,GlobeNewsWire,"BASEL, Switzerland and NEW YORK, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced a collaboration to develop and commercialize relugolix – a once-daily, oral gonadotropin-releasing hormone (GnRH) receptor antagonist – in oncology and women's health in the U.S. and Canada. Pfizer will also receive an exclusive option to commercialize relugolix in oncology outside the U.S. and Canada, excluding certain Asian countries.",https://www.globenewswire.com/news-release/2020/12/28/2150813/0/en/Myovant-Sciences-and-Pfizer-Announce-Collaboration-to-Develop-and-Commercialize-Relugolix-in-Oncology-and-Women-s-Health.html,0.0,-0.0772
PFE,2020-12-28,Moderna or Pfizer? Which Company Stands to Gain the Most From Vaccine Rollout,https://cdn.snapi.dev/images/v1/g/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6059132fgettyimages-1215824553jpgw700opresize.jpg,The Motley Fool,Cost and logistics will determine the ultimate winner.,https://www.fool.com/investing/2020/12/27/moderna-or-pfizer-which-company-stands-to-gain-the/,0.5267,0.5859
PFE,2020-12-28,4 Reasons the Stock Market Could Crash in January,https://cdn.snapi.dev/images/v1/8/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6062052fstock-market-crash-plunge-dollar-newspaper-invest-dow-sp-500-gettyjpgw700opresize.jpg,The Motley Fool,The New Year might begin on a sour note if one of more of these events comes to fruition.,https://www.fool.com/investing/2020/12/27/4-reasons-the-stock-market-could-crash-in-january/,-0.4019,0.0
PFE,2020-12-28,Should Investors Be Stashing Cash for 2021?,https://cdn.snapi.dev/images/v1/i/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6056432f2021-and-moneyjpgw700opresize.jpg,The Motley Fool,"As effective coronavirus vaccines pave the way for an economic recovery, cash-rich investors will be at an advantage.",https://www.fool.com/investing/2020/12/27/should-investors-be-stashing-cash-for-2021/,0.0,0.6249
PFE,2020-12-28,3 COVID Vaccine Stocks Smart Investors Are Buying for 2021,https://cdn.snapi.dev/images/v1/i/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6056812f2021-with-syringejpgw700opresize.jpg,The Motley Fool,"Should you consider these stocks, too?",https://www.fool.com/investing/2020/12/27/3-covid-vaccine-stocks-smart-investors-are-buying/,0.4019,0.0
PFE,2020-12-28,What's Behind the Vaccine Feud Between Pfizer and the Feds?,https://cdn.snapi.dev/images/v1/p/o/podc3---fcfyzwqwaw.jpg,The Motley Fool,There's more bark than bite.,https://www.fool.com/investing/2020/12/26/whats-behind-the-vaccine-feud-between-pfizer-and-t/,-0.34,0.0
PFE,2020-12-28,Pfizer's Pipeline Candidate That Could Be a Bigger Winner Than Its COVID Vaccine,https://cdn.snapi.dev/images/v1/n/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6056782fvaccine-vials-with-stacks-of-cashjpgw700opresize.jpg,The Motley Fool,The drugmaker has another experimental vaccine that should generate billions of dollars in sales annually.,https://www.fool.com/investing/2020/12/26/pfizers-pipeline-candidate-that-could-be-a-bigger/,0.5859,0.0
PFE,2020-12-25,3 Undervalued Dividend Stocks For Christmas: Lanny's Christmas List,https://cdn.snapi.dev/images/v1/s/k/stocks1234-epfiv9fteo.jpg,Seeking Alpha,"Intel is going to be the dominant player in the industry, as many other industries and companies in and outside of technology rely on its chips.",https://seekingalpha.com/article/4396177-3-undervalued-dividend-stocks-for-christmas-lannys-christmas-list,0.0,0.0
PFE,2020-12-24,Evergreen Tree of ETFs to Lighten Your Christmas,https://cdn.snapi.dev/images/v1/5/x/etf43.jpg,Zacks Investment Research,The Christmas tree of top-ranked ETFs to brighten 2021 is now ready for investors. May it spread cheer!,https://www.zacks.com/stock/news/1205906/evergreen-tree-of-etfs-to-lighten-your-christmas,0.0,0.8398
PFE,2020-12-24,Pfizer/BioNTech to Sell More COVID-19 Vaccine Doses to U.S.,https://cdn.snapi.dev/images/v1/g/d/biotech25---3rjhevqkvj.jpg,Zacks Investment Research,Pfizer (PFE)/BioNTech(BNTX) won a deal for 100 million more doses of its COVID-19 vaccine in the United States.,https://www.zacks.com/stock/news/1206080/pfizer-biontech-to-sell-more-covid-19-vaccine-doses-to-us,0.0,0.7579
PFE,2020-12-24,2 Must-Own Stocks in 2021,https://cdn.snapi.dev/images/v1/m/o/us-market-movers-as-economic-data-outweighs-the-pandemic.jpg,The Motley Fool,American Airlines and Pfizer should both perform far better than expected in 2021.,https://www.fool.com/investing/2020/12/24/2-must-own-stocks-in-2021/,0.0,0.4404
PFE,2020-12-24,5 Bank Stocks Set to Rebound With Vaccine-Driven Economic Recovery,https://cdn.snapi.dev/images/v1/k/k/biotech22.jpg,Zacks Investment Research,"Improving lending scenarios and restoration of normal activities in 2021, with the help of coronavirus vaccines rollout, will likely help banks like JPMorgan (JPM), Bank of Hawaii (BOH), Bank OZK (OZK), UMB Financial (UMBF) and Synovus (SNV) witness a rebound.",https://www.zacks.com/stock/news/1205586/5-bank-stocks-set-to-rebound-with-vaccine-driven-economic-recovery,0.0,0.8658
PFE,2020-12-24,Better Coronavirus Stock: Moderna or Pfizer?,https://cdn.snapi.dev/images/v1/e/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6057862fcoronavirus-vaccinejpgw700opresize.jpg,The Motley Fool,Both biotech companies' vaccines have received approval for emergency use in the U.S. -- but which is a better coronavirus stock?,https://www.fool.com/investing/2020/12/24/better-coronavirus-stock-moderna-or-pfizer/,0.4404,0.6249
PFE,2020-12-24,"3 Red-Hot Stocks to Buy With Just $1,000",https://cdn.snapi.dev/images/v1/0/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6058872fgettyimages-1273207450jpgw700opresize.jpg,The Motley Fool,Investing doesn't have to be complicated. These three stocks are premium buys for the new year and beyond.,https://www.fool.com/investing/2020/12/24/3-red-hot-stocks-to-buy-with-just-1000/,0.0,0.0
PFE,2020-12-24,10 Dividend Growth Stocks For December 2020,https://cdn.snapi.dev/images/v1/i/q/the-mirage-within-the-market-a-current-snapshot.jpg,Seeking Alpha,"In my monthly series of 10 Dividend Growth Stocks, I rank a selection of dividend growth stocks in Dividend Radar and present the 10 top-ranked stocks for consideration. To rank stocks, I use DVK Quality Snapshots to get quality scores and sort them in descending order, breaking ties with additional metrics.",https://seekingalpha.com/article/4396091-10-dividend-growth-stocks-for-december-2020,0.3818,0.6369
PFE,2020-12-23,Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know,https://cdn.snapi.dev/images/v1/r/q/drugs21.jpg,Zacks Investment Research,"Pfizer (PFE) closed the most recent trading day at $37.44, moving +1.91% from the previous trading session.",https://www.zacks.com/stock/news/1202463/pfizer-pfe-outpaces-stock-market-gains-what-you-should-know,0.34,0.0
PFE,2020-12-23,More than 1M Americans have been vaccinated; U.S. to buy 100M more vaccines from Pfizer,https://cdn.snapi.dev/images/v1/x/9/more-than-1m-americans-have-been-vaccinated-us-to-buy-100m-more-vaccines-from-pfizer.jpg,Yahoo Finance,"Yahoo Finance's Anjalee Khemlani reports the latest news on the coronavirus vaccine distribution, and the new strain of COVID-19. For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.",https://www.youtube.com/watch?v=milJbnGw0AQ,0.0,0.7964
PFE,2020-12-23,ETFs to Shine as Pfizer's COVID-19 Vaccine Gets a Nod in Europe,https://cdn.snapi.dev/images/v1/m/n/biotech16---mqykzixgjr.jpg,Zacks Investment Research,Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development.,https://www.zacks.com/stock/news/1201995/etfs-to-shine-as-pfizers-covid-19-vaccine-gets-a-nod-in-europe,0.0,0.9001
PFE,2020-12-23,"Vaccine Stocks Rebound On Pfizer's U.S. Deal, Moderna OK In Canada",https://cdn.snapi.dev/images/v1/w/h/biotech28.jpg,Investors Business Daily,"Coronavirus vaccine stocks yo-yoed Wednesday as Pfizer won a deal for 100 million more doses in the U.S. and Moderna snagged authorization in Canada for people ages 18 and older. The post Vaccine Stocks Rebound On Pfizer's U.S. Deal, Moderna OK In Canada appeared first on Investor's Business Daily.",https://www.investors.com/news/technology/coronavirus-vaccine-stocks-rebound-pfizer-us-deal-moderna-ok-canada/,0.4466,0.7672
PFE,2020-12-23,Pfizer and BioNTech to Supply Feds With 100 Million Additional Doses of Coronavirus Vaccine,https://cdn.snapi.dev/images/v1/y/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6061712fchild-getting-a-jab-from-a-medical-professionaljpgw700opresize.jpg,The Motley Fool,The government still holds an option to get as many as 400 million more.,https://www.fool.com/investing/2020/12/23/pfizer-and-biontech-to-supply-feds-with-100-millio/,0.0,0.0
PFE,2020-12-23,Here's Why Wells Fargo Was Rising on Wednesday,https://cdn.snapi.dev/images/v1/l/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6061792fwfc-mediajpgw700opresize.jpg,The Motley Fool,"The financial sector was performing well, but Wells Fargo was a big standout.",https://www.fool.com/investing/2020/12/23/heres-why-wells-fargo-was-rising-on-wednesday/,0.25,0.4678
PFE,2020-12-23,"U.S. government, Pfizer reach deal for more vaccine doses",https://cdn.snapi.dev/images/v1/d/l/us-government-pfizer-reach-deal-for-more-vaccine-doses.jpg,CNBC Television,CNBC's Meg Tirrell reports that Pfizer and the U.S. government have reached a deal to supply more doses of the coronavirus vaccine.,https://www.youtube.com/watch?v=yOivzBNQvAk,0.0258,0.1027
PFE,2020-12-23,Pfizer to deliver 100 million additional doses of its COVID-19 vaccine to the U.S. government,https://cdn.snapi.dev/images/v1/f/o/104685035-s-740x416.jpg,Invezz,Pfizer Inc. (NYSE: PFE) said on Wednesday that it struck a £1.48 billion deal with the U.S. government under which it will now deliver an additional 100 million doses of its COVID-19 vaccine by the end of July. The ongoing pandemic has so far infected more than 18 million people in the United States and caused over 332 thousand deaths.,https://invezz.com/news/2020/12/23/pfizer-to-deliver-100-million-additional-doses-of-its-covid-19-vaccine-to-the-u-s-government/,0.0,-0.3976
PFE,2020-12-23,Why Pfizer Stock Deserves a Spot In Your Portfolio,https://cdn.snapi.dev/images/v1/n/c/vaccine-4.jpeg,InvestorPlace,"Pfizer has received its share of ""no respect"" treatment in 2020, but investors should be able to use that to their advantage going forward The post Why Pfizer Stock Deserves a Spot In Your Portfolio appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets",https://investorplace.com/2020/12/why-pfizer-stock-deserves-a-spot-in-your-portfolio/,0.0,0.6908
PFE,2020-12-23,"COVID News Flow: Pfizer-BioNTech's US Vaccine Supply Deal, Merck Strikes $356M Contract, Sorrento Files For EUA Of Rapid Test",https://cdn.snapi.dev/images/v1/b/f/lab-217041-1280-38.jpg,Benzinga,"COVID-19-related developments headlined biotech news flow on Wednesday, with announcements of a couple of federal deals and a filing for emergency use authorization. Pfizer-BioNTech to Supply U.S. 100M Incremental Doses: Pfizer Inc. (NYSE: PFE)-BioNTech SE (NASDAQ: BNTX) announced the U.S. government has firmed up commitment to purchase an incremental 100 million doses of the companies' investigational vaccine – BNT162b2, confirming earlier reports.",https://www.benzinga.com/general/biotech/20/12/18912070/covid-news-flow-pfizer-biontechs-us-vaccine-supply-deal-merck-strikes-356m-contract-sorrento-file,-0.3612,0.0
PFE,2020-12-23,Coronavirus vaccine: US to secure an additional 100 million doses of COVID-19 vaccine from Pfizer,https://cdn.snapi.dev/images/v1/h/n/106809695-1607644402725-vac.jpg,Yahoo Finance,"Yahoo Finance's Anjalee Khemlani reports on the United States purchasing an additional 100 million doses of the coronavirus vaccine with a delivery date of July 2021. For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.",https://www.youtube.com/watch?v=VvgaGGLrHeQ,0.34,0.8779
PFE,2020-12-23,Top Stocks To Buy Today As Markets Trade Higher Despite Stimulus Criticism,https://cdn.snapi.dev/images/v1/t/o/top-stocks-to-buy-today-as-markets-trade-higher-despite-stimulus-criticism.jpg,Forbes,"Markets rose slightly despite President Donald Trump slamming the stimulus package in a late night video. For investors looking to make the most of this market, our deep learning algorithms have crunched the data to give you a set of Top Buys.",https://www.forbes.com/sites/qai/2020/12/23/top-stocks-to-buy-today-as-markets-trade-higher-despite-stimulus-criticism/,0.4949,0.2023
PFE,2020-12-23,Coronavirus vaccine: US to purchase additional 100 million doses of COVID-19 vaccines,https://cdn.snapi.dev/images/v1/m/q/coronavirus-vaccine-us-to-purchase-additional-100-million-doses-of-covid-19-vaccines.jpg,Yahoo Finance,"Yahoo Finance's Anjalee Khemlani reports on the United States purchasing an additional 100 million doses of the COVID-19 Pfizer- Biontech vaccine. For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.",https://www.youtube.com/watch?v=79ELBUAiT6U,0.0,0.8779
PFE,2020-12-23,Pfizer Stock Surges After Vaccine Deal with U.S. Government,https://cdn.snapi.dev/images/v1/a/m/biotech1---5ubqvpavxx.jpg,Schaeffers Research,"The shares of Pfizer Inc. (NYSE:PFE) are up 1.9% at $37.48 at last check, after the pharmaceutical company announced a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion.",https://www.schaeffersresearch.com/content/news/2020/12/23/pfizer-stock-surges-after-vaccine-deal-with-us-government,0.0,0.6597
PFE,2020-12-23,Dubai is offering the Pfizer vaccine to residents for free in addition to China's Sinopharm shot,https://cdn.snapi.dev/images/v1/u/b/106551552-1590481334887gettyimages-1048780340.jpeg,CNBC,The emirate's first batch of the Pfizer vaccines landed at Dubai International Airport late Tuesday night from Brussels.,https://www.cnbc.com/2020/12/23/dubai-offering-pfizer-sinopharm-covid-vaccines-to-residents-for-free.html,0.5106,0.0
PFE,2020-12-23,How Effective Will Vaccines be Against New Coronavirus Strain?,https://cdn.snapi.dev/images/v1/j/u/drugs16.jpg,Zacks Investment Research,"Pfizer (PFE) and Moderna (MRNA), the companies whose coronavirus vaccines have been approved for emergency use, are evaluating their vaccines against the fast-spreading new strain of coronavirus found in the United Kingdom.",https://www.zacks.com/stock/news/1200531/how-effective-will-vaccines-be-against-new-coronavirus-strain,0.4404,0.4215
PFE,2020-12-23,Pfizer Stock Just Can't Seem to Find a Cure for Investor Apathy,https://cdn.snapi.dev/images/v1/5/0/drugs15.jpg,InvestorPlace,"Here's my investor math: Huge medical breakthrough, plus huge PR and reputation breakthrough, plus insatiable demand for new product equals (or should equal) ... something.",https://investorplace.com/2020/12/pfizer-stock-just-cant-seem-to-find-a-cure-for-investor-apathy/,-0.296,0.4767
PFE,2020-12-23,Pfizer to Supply an Additional 100 Million Doses of Covid-19 Vaccine to U.S.,https://cdn.snapi.dev/images/v1/w/s/im-277327.jpg,Barrons,Here's what you need to know about the impact of Covid-19 to navigate the markets today.,https://www.barrons.com/articles/news-updates-51608736667,0.0,0.0
PFE,2020-12-23,Trump Administration Reaches Deal For 100 Million Additional Doses Of Pfizer's Vaccine,https://cdn.snapi.dev/images/v1/b/9/trump-administration-reaches-deal-for-100-million-additional-doses-of-pfizers-vaccine.jpg,Forbes,The deal doubles the nation's Pfizer vaccine doses.,https://www.forbes.com/sites/elanagross/2020/12/23/trump-administration-reaches-deal-for-100-million-additional-doses-of-pfizers-vaccine/,0.0516,0.0
PFE,2020-12-23,Pfizer Stock Was a Long-Term Place Before Covid and Will Stay One After,https://cdn.snapi.dev/images/v1/g/6/m02d20201111t2i1540849465w940fhfwllplsqrlynxmpegaa13p.jpg,InvestorPlace,"The Covid-19 vaccine isn't a game-changer for Pfizer's valuation. That said, PFE stock was already cheap, and remains a strong buy.",https://investorplace.com/2020/12/pfizer-stock-long-term-before-covid-stay-one/,0.0,0.5106
PFE,2020-12-23,3 High-Yield Dividend Stocks I'd Buy Right Now,https://cdn.snapi.dev/images/v1/q/9/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5745282fbank-account-1-gettyimages-841087530jpgw700opresize.jpg,The Motley Fool,"If you're looking for a top notch payout, look no further than these stocks.",https://www.fool.com/investing/2020/12/23/3-high-yield-dividend-stocks-id-buy-right-now/,0.0,-0.1027
PFE,2020-12-23,White House and Pfizer strike deal for 100 million more vaccine doses,https://cdn.snapi.dev/images/v1/c/r/white-house-and-pfizer-strike-deal-for-100-million-more-vaccine-doses.jpg,CNBC Television,"Pfizer will supply the United States with 100 million additional doses of its Covid-19 vaccine by July next year, the U.S. drugmaker said on Wednesday. CNBC's Becky Quick and Joe Kernen discuss.",https://www.youtube.com/watch?v=2PvC9zaKsSA,-0.128,0.4215
PFE,2020-12-23,"Pfizer, BioNTech to supply U.S. with an additional 100 million doses of COVID-19 vaccine for about $2 billion",https://cdn.snapi.dev/images/v1/t/j/pfizer-covid-19-vaccines-five-big-unknowns.jpg,Market Watch,Pfizer Inc. and BioNTech SE announced Wednesday a second agreement with the U.S. government to supply an additional 100 million doses of its COVID-19 vaccine for $1.95 billion. That brings the total doses for the U.S. to 200 million.,https://www.marketwatch.com/story/pfizer-biontech-to-supply-us-with-an-additional-100-million-doses-of-covid-19-vaccine-for-about-2-billion-2020-12-23,0.0,0.4939
PFE,2020-12-23,Pfizer to supply U.S. with 100 million more COVID-19 shots by July,https://cdn.snapi.dev/images/v1/2/l/m02d20201223t2i1545553758w940fhfwllplsqrlynxmpegbm0sx.jpg,Reuters,"Pfizer Inc will supply the United States with 100 million additional doses of its COVID-19 vaccine by July next year, the U.S. drugmaker said on Wednesday.",https://www.reuters.com/article/us-health-coronavirus-usa-pfizer/pfizer-to-supply-u-s-with-100-million-more-covid-19-shots-by-july-idUSKBN28X1GC,0.0,0.4215
PFE,2020-12-23,Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine,https://cdn.snapi.dev/images/v1/u/i/press3---ne6mfgpa1l.jpg,Business Wire,"NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies' COVID-19 Vaccine from production facilities in the U.S. This agreement brings the total number of doses to be delivered to the U.S. to 200 million. The companies expect to deliver the full 200 million doses to Operation Warp Speed (OWS) by July 31, 2021. Consistent with the origi",https://www.businesswire.com/news/home/20201223005185/en/Pfizer-and-BioNTech-to-Supply-the-U.S.-with-100-Million-Additional-Doses-of-COVID-19-Vaccine/,0.0,0.7717
PFE,2020-12-23,Pfizer and the Trump administration are reportedly close to agreeing 70 million extra vaccine doses for next year to plug a potentially massive shortfall in the US,https://cdn.snapi.dev/images/v1/p/f/pfizer-and-the-trump-administration-are-reportedly-close-to-agreeing-70-million-extra-vaccine-doses-for-next-year-to-plug-a-potentially-massive-shortfall-in-the-us.jpg,Business Insider,"Pfizer is reportedly close to striking a deal with the Trump administration to supply tens of million more doses of its COVID-19 vaccine to the US in 2021, people familiar with the discussions told The New York Times Tuesday. The US government wants 100 million additional doses of Pfizer and its German partner BioNTech's vaccine between April to June, the Times reported. The drugmaker has said it could supply 70 million doses, the people said, provided it gets better access to manufacturing supplies through the Defense Production Act.",https://www.businessinsider.com/pfizer-vaccine-trump-administration-extra-doses-2020-12,0.34,0.5267
PFE,2020-12-23,Should You Worry About This Side Effect to Moderna's and Pfizer's COVID Vaccines?,https://cdn.snapi.dev/images/v1/p/o/podc1---ajbypxgi8m.jpg,The Motley Fool,"The short answer is ""no.""",https://www.fool.com/investing/2020/12/23/should-you-worry-about-this-side-effect-to-moderna/,-0.4404,0.0
PFE,2020-12-23,Throw Growth Aside and See Pfizer Stock as Top Dividend and Cash Flow Play,https://cdn.snapi.dev/images/v1/u/v/drugs7.jpg,InvestorPlace,Forget growth. Pfizer is an income play.,https://investorplace.com/2020/12/pfe-stock-is-a-top-dividend-and-cash-flow-play/,0.7003,0.4767
PFE,2020-12-22,US close on deal with Pfizer for millions more vaccine doses,https://cdn.snapi.dev/images/v1/j/c/biotech26---yw0adtdmps.jpg,Fox Business,Another deal with Pfizer would move the nation closer to the goal of vaccinating all Americans.,https://www.foxbusiness.com/markets/us-close-on-deal-with-pfizer-for-millions-more-vaccine-doses,0.0,0.0
PFE,2020-12-22,BioInvent receives $3 million payment related to selection of antibodies under collaboration with Pfizer Inc.,https://cdn.snapi.dev/images/v1/v/k/press2---j3dufz2358.jpg,PRNewsWire,"LUND, Sweden, Dec. 23, 2020 /PRNewswire/ -- BioInvent International AB (OMXS: BINV ), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, today announced that Pfizer Inc. (""Pfizer"") (NYSE: PFE) has...",https://www.prnewswire.com/news-releases/bioinvent-receives-3-million-payment-related-to-selection-of-antibodies-under-collaboration-with-pfizer-inc-301197924.html,0.0,-0.128
PFE,2020-12-22,Pfizer Nears Deal To Supply Another 100M COVID-19 Vaccine Doses To US By July,https://cdn.snapi.dev/images/v1/i/n/cdc-9mvmgp2zhgs-unsplash.jpg,Benzinga,"Pfizer Inc (NYSE: PFE) is nearing a deal with the outgoing President Donald Trump's administration to supply 100 million doses of its coronavirus vaccine to the United States, the Wall Street Journal reported Tuesday. What Happened: The U.S. government would pay Pfizer $2 billion as per the terms of the deal, under consideration, and the drugmaker would provide the vaccine doses by July, people familiar with the matter told the Journal.",https://www.benzinga.com/general/biotech/20/12/18904942/pfizer-nears-deal-to-supply-another-100m-covid-19-vaccine-doses-to-us-by-july,0.0,0.5719
PFE,2020-12-22,Las Vegas: COVID Winter,https://cdn.snapi.dev/images/v1/u/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6059782fvegas-strip-during-winter-editjpgw700opresize.jpg,The Motley Fool,"Amidst an unchecked surge that has left Nevada with the highest per capita COVID hospitalizations in the nation, Governor Steve Sisolak (D) has chosen a novel approach to containing the spread of the virus: Do absolutely nothing.",https://www.fool.com/investing/2020/12/22/las-vegas-covid-winter/,0.0,0.3182
PFE,2020-12-22,Pfizer and the U.S. is nearing deal to deliver 100M more vaccines,https://cdn.snapi.dev/images/v1/u/c/pfizer-and-the-us-is-nearing-deal-to-deliver-100m-more-vaccines.jpg,CNBC Television,"CNBC's senior health and science reporter Meg Tirrell reports the U.S. is nearing a deal with Pfizer to deliver an additional 100 million doses of the coronavirus vaccine. The first 70 million will be split across April, May and June.",https://www.youtube.com/watch?v=8B98NGnvmwA,0.0,0.0
PFE,2020-12-22,Report: Trump Administration Nears Deal For Additional Pfizer Vaccine Doses,https://cdn.snapi.dev/images/v1/w/9/report-trump-administration-nears-deal-for-additional-pfizer-vaccine-doses.jpg,Forbes,The government had the opportunity to secure 600 million doses under an agreement signed in July.,https://www.forbes.com/sites/elanagross/2020/12/22/report-trump-administration-nears-deal-for-additional-pfizer-vaccine-doses/,0.0,0.8126
PFE,2020-12-22,"Pfizer nears deal with U.S. government for more Covid vaccine doses, source says",https://cdn.snapi.dev/images/v1/b/s/106814531-16085762092020-12-21t182006z-1140774493-rc2urk9pi75l-rtrmadp-0-health-coronavirus-vaccines.jpeg,CNBC,"The U.S. government is close to a deal with Pfizer for up to an additional 100 million doses of its coronavirus vaccine, a source told CNBC's Meg Tirrell on Tuesday.",https://www.cnbc.com/2020/12/22/covid-vaccine-pfizer-nears-deal-with-us-government-for-more-doses-.html,0.0,0.0
PFE,2020-12-22,Top Stocks To Buy Today As Markets Trade Mixed After Yesterday's Session,https://cdn.snapi.dev/images/v1/t/o/top-stocks-to-buy-today-as-markets-trade-mixed-after-yesterdays-session.jpg,Forbes,"Markets sharply reversed during yesterday's trading session. However, the indices ended the day largely mixed.",https://www.forbes.com/sites/qai/2020/12/22/top-stocks-to-buy-today-as-markets-trade-mixed-after-yesterdays-session/,0.2023,0.0
PFE,2020-12-22,5 High Beta & Momentum ETFs to Tap the Santa Rally,https://cdn.snapi.dev/images/v1/h/e/bank43---ekca46iumh.jpg,Zacks Investment Research,These ETFs are expected to outperform in the seven-day period and are intriguing choices for a short spell.,https://www.zacks.com/stock/news/1196100/5-high-beta-momentum-etfs-to-tap-the-santa-rally,0.0,0.0
PFE,2020-12-22,"Moderna, Pfizer Testing Coronavirus Vaccine Against New Strain",https://cdn.snapi.dev/images/v1/9/l/syringe-1884758-1920-80.jpg,Benzinga,"Even with the relief brought by the conditional approval of two coronavirus vaccines, a more virulent and contagious variant of the virus in the U.K. has emerged.  Pfizer Inc. (NYSE: PFE), with its German partner BioNTech SE – ADR (NASDAQ: BNTX), and Moderna Inc (NASDAQ: MRNA) are the two companies that have received approval for emergency use of their respective investigational vaccines.",https://www.benzinga.com/general/biotech/20/12/18895061/moderna-pfizer-testing-coronavirus-vaccine-against-new-strain,-0.0516,0.4297
PFE,2020-12-22,3 Large Drugmakers Set to Rule the Sector in 2021,https://cdn.snapi.dev/images/v1/w/h/drugs48.jpg,Zacks Investment Research,3 Large Drugmakers Set to Rule the Sector in 2021,https://www.zacks.com/commentary/1194839/3-large-drugmakers-set-to-rule-the-sector-in-2021,0.0,0.0
PFE,2020-12-22,Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts,https://cdn.snapi.dev/images/v1/e/h/conf8---wldmcx8qsv.jpg,Business Wire,"NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, February 2, 2021. The purpose of the call is to provide an update on Pfizer's results, as reflected in the company's Fourth Quarter and Full Year 2020 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/",https://www.businesswire.com/news/home/20201222005012/en/Pfizer-Invites-Public-to-View-and-Listen-to-Webcast-of-February-2-Conference-Call-with-Analysts/,0.0,0.0
PFE,2020-12-22,4 Restaurant Stocks to Play a Likely Turnaround in 2021,https://cdn.snapi.dev/images/v1/l/a/drugs44.jpg,Zacks Investment Research,"Although the restaurant industry is grappling with the coronavirus outbreak, restaurant stocks like JACK, RUTH, FAT and STKS have impressive 2021 earnings growth projections.",https://www.zacks.com/stock/news/1195324/4-restaurant-stocks-to-play-a-likely-turnaround-in-2021,0.34,0.8126
PFE,2020-12-22,Do These Coronavirus Vaccine Companies Have a Place in an ESG Portfolio?,https://cdn.snapi.dev/images/v1/7/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6053342fgettyimages-1218143963jpgw700opresize.jpg,The Motley Fool,"They might, especially if you consider vaccines to be good for society.",https://www.fool.com/investing/2020/12/22/do-these-coronavirus-vaccine-companies-have-place-/,0.0,0.4404
PFE,2020-12-22,Pfizer/BioNTech COVID-19 Vaccine Gets Authorization in Europe,https://cdn.snapi.dev/images/v1/a/w/biotech34.jpg,Zacks Investment Research,Pfizer (PFE)/BioNTech's (BNTX) COVID-19 vaccine candidate is the first COVID-19 vaccine to be granted conditional authorization in Europe.,https://www.zacks.com/stock/news/1195067/pfizer-biontech-covid-19-vaccine-gets-authorization-in-europe,0.0,0.25
PFE,2020-12-22,"Pfizer-BioNTech, Moderna Test Vaccines Against New Covid-19 Variant Spreading Across U.K.",https://cdn.snapi.dev/images/v1/y/q/pfizer-biontech-moderna-test-vaccines-against-new-covid-19-variant-spreading-across-uk.jpg,Forbes,"BioNTech's CEO said on Tuesday that while it is currently unclear whether the vaccine can protect against the new U.K. strain, it is “highly likely” the shot can protect against new variants.",https://www.forbes.com/sites/roberthart/2020/12/22/pfizer-biontech-moderna-test-vaccines-against-new-covid-19-variant-spreading-across-uk/,0.0,0.4588
PFE,2020-12-22,5 Huge Investing Lessons We All Re-Learned in 2020,https://cdn.snapi.dev/images/v1/b/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6056632fgettyimages-1063612540jpgw700opresize.jpg,The Motley Fool,It was a crazy year that reinforced time-tested investing principles.,https://www.fool.com/investing/2020/12/22/5-huge-investing-lessons-we-all-re-learned-in-2020/,0.3182,-0.34
PFE,2020-12-22,Is Pfizer's COVID Vaccine Growth Story Already Over?,https://cdn.snapi.dev/images/v1/s/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6056732fend-of-story-typewriterjpgw700opresize.jpg,The Motley Fool,"It might seem like it, based on the stock's recent performance.",https://www.fool.com/investing/2020/12/22/is-pfizers-covid-vaccine-growth-story-already-over/,0.3818,0.3612
PFE,2020-12-22,Dividend Stock Purchase: Lanny's November 2020 Summary,https://cdn.snapi.dev/images/v1/j/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5219362ftd-ameritrade-apps-and-web-sites.jpg,Seeking Alpha,"My dividend stock portfolio was burnt by dividend cuts and lost over $800+ in forward dividend income. Therefore, I was ready to get back to basics and acquire more shares in the best quality dividend stocks out there. My dividend stock purchases of VYM totaled $1,307.79, acquiring 15 total shares. This added $41.10 in forward dividend income. I will continue this going forward, 3 shares per week.",https://seekingalpha.com/article/4395776-dividend-stock-purchase-lannys-november-2020-summary,0.0,0.8651
PFE,2020-12-22,Singapore is first Asian country to receive batch of Pfizer's Covid-19 vaccine,https://cdn.snapi.dev/images/v1/8/y/006-syringe-glove-mask-covid-coronavirus-vaccine-pfizer-moderna-astrazenica-race-stock-prices-biosecurity.jpg,CNET,The Pfizer-BioNTech vaccine has landed in the tiny-island nation after it was approved for distribution last week.,https://www.cnet.com/health/singapore-becomes-first-asian-country-to-receive-batches-of-pfizer-vaccine/,0.0,0.4215
PFE,2020-12-21,Pfizer Partner BioNTech Confident Vaccine Effective Against UK Mutant COVID-19 Strain,https://cdn.snapi.dev/images/v1/q/b/satheesh-sankaran-yxtna6yccls-unsplash-1.jpg,Benzinga,"Ugur Sahin, CEO of BioNTech SE (NASDAQ: BNTX) — the German partner of Pfizer Inc (NYSE: PFE) — expressed confidence that two companies' jointly-developed vaccine is effective against a new mutation of COVID-19, Reuters reported Monday.  What Happened: Sahin told Germany's Bild TV that BioNTech would look into the mutation that has emerged out of the United Kingdom in the coming days and viewed the matter “with a degree of soberness,” as per Reuters.",https://www.benzinga.com/general/biotech/20/12/18887340/pfizer-partner-biontech-confident-vaccine-effective-against-uk-mutant-covid-19-strain,0.7269,0.8519
PFE,2020-12-21,Pfizer and BioNTech's Coronavirus Vaccine Approved in Europe,https://cdn.snapi.dev/images/v1/b/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6058702fgloved-hands-holding-a-vial-of-medicinejpgw700opresize.jpg,The Motley Fool,BNT162b2 gets another green light from a top healthcare regulator.,https://www.fool.com/investing/2020/12/21/pfizer-and-biontechs-coronavirus-vaccine-approved/,0.4215,0.2023
PFE,2020-12-21,U.S. plans to study allergic reactions from Pfizer's Covid vaccine,https://cdn.snapi.dev/images/v1/p/d/106814522-16085755612020-12-18t013420z-1275281663-rc2dpk9hqxno-rtrmadp-0-health-coronavirus-usa.jpeg,CNBC,"The U.S. is planning a study to find out why some people have suffered from allergic reactions after receiving a Covid vaccine, an NIAID official told CNBC.",https://www.cnbc.com/2020/12/21/covid-vaccine-us-plans-to-study-allergic-reactions-from-pfizer-shots.html,-0.296,-0.6597
PFE,2020-12-21,E.U. committee recommends authorization of BioNTech and Pfizer's coronavirus vaccine,https://cdn.snapi.dev/images/v1/a/x/004-syringe-glove-mask-covid-coronavirus-vaccine-pfizer-moderna-astrazenica-race-stock-prices-biosecurity.jpg,Market Watch,"Shares of Pfizer Inc. were down 1.1% and BioNTech SE shares were up 1.2% in trading on Monday after the companies said their COVID-19 vaccine has been recommended for authorization in the European Union. The Committee for Medicinal Products for Human Use made the recommendation, and the European Commission is expected to review it and make a final decision in the ""near future.",https://www.marketwatch.com/story/eu-committee-recommends-authorization-of-biontech-and-pfizers-coronavirus-vaccine-2020-12-21,0.2263,0.6369
PFE,2020-12-21,Trending Stocks For This Week As Markets Remain Sensitive To News,https://cdn.snapi.dev/images/v1/t/r/trending-stocks-for-this-week-as-markets-remain-sensitive-to-news.jpg,Forbes,"Mixed sentiment is once again the theme. On one hand, a stimulus package finally passed and a second coronavirus vaccine is on its way.",https://www.forbes.com/sites/qai/2020/12/21/trending-stocks-for-this-week-as-markets-remain-sensitive-to-news/,0.0,0.4939
PFE,2020-12-21,Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine,https://cdn.snapi.dev/images/v1/i/2/press11---j2glzpg5p9.jpg,Business Wire,"NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer and BioNTech for COMIRNATY® (also known as BNT162b2), for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus, in individuals 16 years of age and older. This follows the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) positive op",https://www.businesswire.com/news/home/20201221005672/en/Pfizer-and-BioNTech-Receive-Authorization-in-the-European-Union-for-COVID-19-Vaccine/,0.0,0.8126
PFE,2020-12-21,Trump Covid vaccine czar says 'extremely low' chance Pfizer and Moderna shots won't work against new strain,https://cdn.snapi.dev/images/v1/j/n/106811374-1608036473344-gettyimages-1291313833-tdp-l-covid19-vaccines-1408.jpeg,CNBC,resident Donald Trump's coronavirus vaccine czar said Monday that he expects Pfizer's and Moderna's Covid-19 shots will be effective against a new mutation of the virus found in the U.K.,https://www.cnbc.com/2020/12/21/trump-covid-vaccine-czar-says-extremely-low-chance-pfizer-and-moderna-shots-wont-work-against-new-strain.html,-0.081,0.4767
PFE,2020-12-21,European Commission gives final approval to Pfizer/BioNTech vaccine,https://cdn.snapi.dev/images/v1/p/m/m02d20201221t2i1545335695w940fhfwllplsqrlynxmpegbk1cq.jpg,Reuters,"The European Commission gave approval on Monday for the use of the COVID-19 vaccine jointly developed by U.S. company Pfizer and its German partner BioNTech, the final step to allowing Europe to start inoculations within a week.",https://www.reuters.com/article/us-health-coronavirus-vaccine-eu/european-commission-gives-final-approval-to-pfizer-biontech-vaccine-idUSKBN28V2ED,0.4767,0.4767
PFE,2020-12-21,Pfizer/BioNTech Covid vaccine approved by European regulator,https://cdn.snapi.dev/images/v1/0/h/4660jpgwidth460quality85autoformatfitmaxs13aede3c6ff836eab80a61758ff31a36.jpg,The Guardian,EMA's move paves way for inoculations to begin across Europe within next few days,https://www.theguardian.com/society/2020/dec/21/pfizer-biontech-covid-vaccine-approved-by-european-regulator,0.4215,0.0
PFE,2020-12-21,5 Small-Cap ETFs Set to Explode on COVID-19 Vaccines,https://cdn.snapi.dev/images/v1/q/u/biotech20.jpg,Zacks Investment Research,"As the economy seems on track for strong growth, a small-cap rally is expected to strengthen in the New Year.",https://www.zacks.com/stock/news/1191922/5-small-cap-etfs-set-to-explode-on-covid-19-vaccines,0.0,0.802
PFE,2020-12-21,Top 5 S&P 500 Stocks That Helped the Index Gain in 2020,https://cdn.snapi.dev/images/v1/c/p/computer-electronic28.jpg,Zacks Investment Research,"Here we pick five S&P 500 stocks -- NVDA, ETSY, AAPL, MSFT & AMZN -- that have helped the index deliver solid returns this year.",https://www.zacks.com/stock/news/1191709/top-5-sp-500-stocks-that-helped-the-index-gain-in-2020,0.6369,0.1531
PFE,2020-12-21,Pre-Markets Down to Start Christmas Week,https://cdn.snapi.dev/images/v1/m/x/aero3.jpg,Zacks Investment Research,"Though already off the lows we saw a couple hours before today's opening bell, the Dow is down 400 points, the S&P 500 -55 and the Nasdaq -140.",https://www.zacks.com/stock/news/1191729/pre-markets-down-to-start-christmas-week,0.0,-0.2023
PFE,2020-12-21,Christmas Week Begins With Pre-market Sell-off,https://cdn.snapi.dev/images/v1/e/w/aero2.jpg,Zacks Investment Research,Christmas Week Begins With Pre-market Sell-off,https://www.zacks.com/stock/news/1191805/christmas-week-begins-with-pre-market-sell-off,0.0,0.0
PFE,2020-12-21,EMA Committee Recommends Conditional Approval Of Pfizer-BioNTech Vaccine In Europe,https://cdn.snapi.dev/images/v1/f/q/vaccine-4892017-1920-8.jpg,Benzinga,"Pfizer Inc. (NYSE: PFE)-BioNTech SE's – ADR (NASDAQ: BNTX) coronavirus vaccine candidate – BNT162b2 – is inching closer to getting conditional approval in European Union, after similar approvals in the U.S., U.K., Bahrain Saudi Arabia, Canada, Mexico and Switzerland. What Happened: Following a rigorous evaluation of BNT162b2, which is to go by the trade name Comirnaty in Europe, the European Medicines Agency's Committee For Medicinal Products For Human Use concluded by consensus that sufficiently robust data on the safety and efficacy of the vaccine are now available to recommend a formal conditional marketing authorization.",https://www.benzinga.com/general/biotech/20/12/18877575/ema-committee-recommends-conditional-approval-of-pfizer-biontech-vaccine-in-europe,0.6124,0.8271
PFE,2020-12-21,7 Healthcare Stocks to Buy With the Sector Under Scrutiny,https://cdn.snapi.dev/images/v1/w/b/reit9.jpg,InvestorPlace,"True, there are political risks in the industry. But there are also lots of growth opportunities for investors in healthcare stocks.",https://investorplace.com/2020/12/7-healthcare-stocks-to-buy-with-the-sector-under-scrutiny/,0.0,0.7096
PFE,2020-12-21,European Union Approves Pfizer-BioNTech Covid Vaccine,https://cdn.snapi.dev/images/v1/v/a/im-276070.jpg,Barrons,"The European Union has authorized its first vaccine against Covid-19, joining the U.S. and the U.K. in allowing the shots developed by Pfizer and BioNTech.",https://www.barrons.com/articles/european-union-approves-pfizer-biontech-covid-vaccine-51608565816,0.4019,0.0
PFE,2020-12-21,EU Drug Regulator Approves Pfizer-BioNTech Covid-19 Vaccine For Emergency Use,https://cdn.snapi.dev/images/v1/n/w/eu-drug-regulator-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use.jpg,Forbes,The European Union has so far managed to secure 2 billion doses of various Covid-19 vaccines.,https://www.forbes.com/sites/siladityaray/2020/12/21/eu-drug-regulator-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use/,0.0258,0.34
PFE,2020-12-21,European Regulators Clear Pfizer's Covid-19 Vaccine,https://cdn.snapi.dev/images/v1/6/t/im-276103.jpg,Barrons,Here's what you need to know about the impact of Covid-19 to navigate the markets today.,https://www.barrons.com/articles/news-updates-51608563362,0.3818,0.0
PFE,2020-12-21,EU drug regulator: Pfizer-BioNTech vaccine should be on case by case for pregnant women,https://cdn.snapi.dev/images/v1/m/r/m02d20201221t2i1545315607w940fhfwllplsqrlynxmpegbk12x.jpg,Reuters,The European drug regulator said on Monday the use of the COVID-19 vaccine jointly developed by U.S. company Pfizer and its German partner BioNTech on pregnant women should be done on a case by case basis.,https://www.reuters.com/article/us-health-coronavirus-vaccine-ema-pregna/eu-drug-regulator-pfizer-biontech-vaccine-should-be-on-case-by-case-for-pregnant-women-idUSKBN28V1VV,0.0,0.0
PFE,2020-12-21,European Medicines Agency just recommended the Pfizer and BioNtech COVID-19 vaccine for use in EU,https://cdn.snapi.dev/images/v1/e/u/european-medicines-agency-just-recommended-the-pfizer-and-biontech-covid-19-vaccine-for-use-in-eu.jpg,Business Insider,The European Union drug regulator recommended the EU authorize the Pfizer and BioNtech COVID-19 vaccine on Monday. Experts on the European Medicines Agency's human medicines committee concluded the Pfizer vaccine was safe and effective for people 16-years-old and older using available data. The decision will lead the way for a EU-wide authorization of the vaccine.,https://www.businessinsider.com/pfizer-covid-vaccine-use-european-medicines-agency-eu-2020-12,0.2023,0.7783
PFE,2020-12-21,European Medicines Agency authorizes Pfizer vaccine for use in the EU,https://cdn.snapi.dev/images/v1/h/h/106801456-1606219164685-gettyimages-1229640665-boy2020.jpeg,CNBC,The European Medicines Agency said it had recommended granting conditional marketing authorization for the vaccine in people aged 16 and over.,https://www.cnbc.com/2020/12/21/european-medicines-agency-authorizes-pfizer-vaccine-for-use-in-the-eu.html,0.0,0.4767
PFE,2020-12-21,Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine,https://cdn.snapi.dev/images/v1/h/s/press19---ikxkcpxpjn.jpg,Business Wire,"NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion to recommend the conditional marketing authorization (CMA) of the Pfizer-BioNTech COVID-19 Vaccine (also known as BNT162b2), for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus, in individuals 16 years of age and older. The purpose of a",https://www.businesswire.com/news/home/20201221005471/en/Pfizer-and-BioNTech-Receive-CHMP-Positive-Opinion-for-their-COVID-19-Vaccine/,0.5574,0.836
PFE,2020-12-21,Vaccines to Fuel Santa Claus Rally: 5 Stock Picks,https://cdn.snapi.dev/images/v1/i/0/steel21.jpg,Zacks Investment Research,"With only eight trading days left this year, markets are bracing for the so-called Santa Claus rally.",https://www.zacks.com/stock/news/1191264/vaccines-to-fuel-santa-claus-rally-5-stock-picks,0.0,0.0
PFE,2020-12-21,4 Restaurant Stocks to Watch as Vaccine Rollout Begins,https://cdn.snapi.dev/images/v1/f/f/biotech6.jpg,Zacks Investment Research,"Vaccine rollout should allow dine-in to resume in restaurants with online delivery expected to sustain, making it prudent to keep an eye on names like Brinker International (EAT) and McDonald's (MCD)",https://www.zacks.com/stock/news/1191291/4-restaurant-stocks-to-watch-as-vaccine-rollout-begins,0.0,0.5267
PFE,2020-12-21,3 Mega-Cap Stocks for Safe Dividends,https://cdn.snapi.dev/images/v1/s/t/stcu22---ndweqtz8d7.jpg,InvestorPlace,"Thanks to their safe dividends, you can rely on these mega-cap stocks to not only survive tough times, but pay you while you wait. The post 3 Mega-Cap Stocks for Safe Dividends appeared first on InvestorPlace.",https://investorplace.com/2020/12/3-mega-cap-stocks-for-safe-dividends/,0.4404,0.7457
PFE,2020-12-21,Shippers prepare to move both Pfizer and Moderna vaccines simultaneously,https://cdn.snapi.dev/images/v1/n/n/shippers-prepare-to-move-both-pfizer-and-moderna-vaccines-simultaneously.jpg,CNBC Television,The first doses of Moderna's coronavirus vaccine are being shipped around the U.S. after the FDA approved it for emergency use late Friday. CNBC's Frank Holland reports how this rollout will be much different than that of Pfizer's vaccine and how FedEx is playing a key role in its distribution.,https://www.youtube.com/watch?v=2e6FP8iydXo,0.0,0.25
PFE,2020-12-21,Stocks Set to Confront the Virus in 2021 (NASDAQ: MRNA) (OTC: HALB) (NYSE: PFE),https://cdn.snapi.dev/images/v1/d/p/biotech3.jpg,OTC PR Wire,Stocks Set to Confront the Virus in 2021 (NASDAQ: MRNA) (OTC: HALB) (NYSE: PFE),https://otcprwire.com/stocks-set-to-confront-the-virus-in-2021-nasdaq-mrna-otc-halb-nyse-pfe/,-0.1779,-0.1779
PFE,2020-12-21,"CDC Says Over 556,208 Pfizer/BioNTech COVID-19 Shots Administered In Week 1 Of Inoculation Drive",https://cdn.snapi.dev/images/v1/w/b/dimitri-houtteman-qbhppxw3ess-unsplash-4-0.jpg,Benzinga,"A week into the COVID-19 mass vaccination efforts, the U.S. Centers For Disease Control and Prevention reports that — of the 2,838,225 doses distributed around the country — over 556,208 doses had been administered as of Sunday. What Happened: The U.S. Food and Drug Administration has approved two vaccine candidates so far.",https://www.benzinga.com/general/biotech/20/12/18869562/cdc-says-over-556-208-pfizerbiontech-covid-19-shots-administered-in-week-1-of-inoculation-drive,0.0,0.4215
PFE,2020-12-21,3 Top Breakout Stocks to Watch in 2021,https://cdn.snapi.dev/images/v1/k/1/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6045752fgettyimages-851045746jpgw700opresize.jpg,The Motley Fool,"These companies have already delivered handsome profits to their shareholders in 2020, but their growth prospects mean they remain solid buys.",https://www.fool.com/investing/2020/12/20/3-top-breakout-stocks-to-watch-in-2021/,0.2023,0.8793
PFE,2020-12-21,4 Reasons You Should Buy Pfizer Stock Right Now,https://cdn.snapi.dev/images/v1/w/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6052752fsciency-scientists-with-lab-equipment-gettyjpgw700opresize.jpg,The Motley Fool,You're not the only one wondering if this dividend-paying pharma stock deserves a place in a portfolio.,https://www.fool.com/investing/2020/12/20/reasons-to-buy-pfizer-stock-right-now/,0.0,0.0
PFE,2020-12-21,$40 Billion Per Year for COVID Vaccine Makers Hinges on This 1 Unanswered Question,https://cdn.snapi.dev/images/v1/6/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6047842fquestion-mark-made-of-cashjpgw700opresize.jpg,The Motley Fool,And it could be a long time before we know the answer.,https://www.fool.com/investing/2020/12/20/40-billion-per-year-for-covid-vaccine-makers-hinge/,0.0,0.0
PFE,2020-12-21,Pfizer-BioNTech And Moderna Covid-19 Vaccines: Here Are 5 Differences,https://cdn.snapi.dev/images/v1/d/c/pfizer-biontech-and-moderna-covid-19-vaccines-here-are-5-differences.jpg,Forbes,Now there are two. The Moderna Covid-19 coronavirus vaccine received emergency use authorization from the U.S. FDA to join the Pfizer/BioNTech vaccine.,https://www.forbes.com/sites/brucelee/2020/12/19/pfizer-biontech-and-moderna-covid-19-vaccines-here-are-5-differences/,0.0,-0.1027
PFE,2020-12-21,Here's What Investors Need to Know About Pfizer and BioNTech's Vaccine Launch,https://cdn.snapi.dev/images/v1/p/o/podc11---a7lalanm24.jpg,The Motley Fool,Manufacturing is a black box for investors.,https://www.fool.com/investing/2020/12/19/heres-what-investors-need-to-know-about-pfizer-and/,0.0,0.0
PFE,2020-12-21,Here's Why Pfizer's Vaccine Is So Important,https://cdn.snapi.dev/images/v1/p/o/podc8---eoytkzmqaf.jpg,The Motley Fool,It could be the beginning of the end for the pandemic.,https://www.fool.com/investing/2020/12/19/heres-why-pfizers-vaccine-is-so-important/,0.2716,0.0
PFE,2020-12-21,Better Coronavirus Stock: Pfizer vs. BioNTech,https://cdn.snapi.dev/images/v1/6/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6050762fgettyimages-1219401083jpgw700opresize.jpg,The Motley Fool,One healthcare company is confident about its future while the other tries to recapture its former glory.,https://www.fool.com/investing/2020/12/19/better-coronavirus-stock-pfizer-vs-biontech/,0.4404,0.7717
PFE,2020-12-21,Moderna Finishes The Vaccine Race Close Behind Pfizer as FDA Authorizes Its Coronavirus Vaccine For Emergency Use,https://cdn.snapi.dev/images/v1/b/c/virus-4030721-1920-1-1.jpg,Benzinga,"A week after Pfizer Inc. (NYSE: PFE) received the greenlight for its vaccine against the coronavirus, the Food and Drug Administration cleared a similar vaccine candidate, mRNA-1273, from Moderna Inc (NASDAQ: MRNA). What Happened: The FDA authorized the emergency use of mRNA-1273 against COVID-19 in individuals 18 years and older, the Cambridge, Massachusetts-based biopharma said in a late Friday statement.",https://www.benzinga.com/general/biotech/20/12/18864205/moderna-finishes-the-vaccine-race-close-behind-pfizer-as-fda-authorizes-its-coronavirus-vaccine-f,-0.3818,-0.296
PFE,2020-12-21,Is Pfizer Stock a Good Bet on Coronavirus Vaccines?,https://cdn.snapi.dev/images/v1/3/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6048762fvaccinejpgw700opresize.jpg,The Motley Fool,"The FDA gave this pharmaceutical company's COVID-19 vaccine the green light for emergency use, but does that make it a sound investment?",https://www.fool.com/investing/2020/12/19/is-pfizer-stock-a-good-bet-on-coronavirus-vaccines/,0.4404,-0.2023
PFE,2020-12-18,"Dr. Scott Gottlieb on the Pfizer, Moderna vaccine rollouts",https://cdn.snapi.dev/images/v1/i/c/dr-scott-gottlieb-on-the-pfizer-moderna-vaccine-rollouts.jpg,CNBC Television,"The FDA advisory panel recommended Moderna vaccine for emergency use authorization. The Pfizer vaccine has been distributed across the U.S. and delivered to health-care workers, but some states said they haven't received enough vaccines.",https://www.youtube.com/watch?v=QRiE_aAQXoQ,0.0,-0.1027
PFE,2020-12-18,Pfizer Stock and the Modern-Day Apollo Program,https://cdn.snapi.dev/images/v1/a/x/drugs25.jpg,InvestorPlace,"Much like the effort to put a man on the moon, the Covid-19 vaccine is historic. But there are other drivers for Pfizer stock as well.",https://investorplace.com/2020/12/pfizer-stock-and-the-modern-day-apollo-program/,0.0,0.5574
PFE,2020-12-18,"Markets, Covid Deaths at New All-Time Highs",https://cdn.snapi.dev/images/v1/u/j/biotech25.jpg,Zacks Investment Research,"The coronavirus posted a new one-day high in both cases -- 241,620 -- and fatalities -- 3,438 -- on Thursday.",https://www.zacks.com/stock/news/1180622/markets-covid-deaths-at-new-all-time-highs,0.0,-0.5994
PFE,2020-12-18,4 Small COVID-19 Vaccine Makers to Look Out for in 2021,https://cdn.snapi.dev/images/v1/s/l/biotech16.jpg,Zacks Investment Research,"Here we discuss four small biotech companies, NVAX, CVAC, VXRT and ARCT, that are making COVID-19 vaccine candidates, which may be approved in 2021, if successfully developed, and bring profits.",https://www.zacks.com/stock/news/1179956/4-small-covid-19-vaccine-makers-to-look-out-for-in-2021,0.0,0.836
PFE,2020-12-18,A leading vaccine researcher on the key differences between the Moderna and Pfizer vaccines,https://cdn.snapi.dev/images/v1/z/7/a-leading-vaccine-researcher-on-the-key-differences-between-the-moderna-and-pfizer-vaccines.jpg,CNBC Television,"Padmini Pillai, an immunoengineer at MIT, discusses the main issues with both the Moderna and Pfizer-BioNTech COVID vaccines, including why one must be stored at much colder temperatures than the other.",https://www.youtube.com/watch?v=OtQdRNY22UM,0.0,0.0
PFE,2020-12-18,Pfizer said it has millions of doses of vaccine sitting in a warehouse because the federal government hasn't told it where to send them,https://cdn.snapi.dev/images/v1/p/f/pfizer-said-it-has-millions-of-doses-of-vaccine-sitting-in-a-warehouse-because-the-federal-government-hasnt-told-it-where-to-send-them.jpg,Business Insider,"Pfizer said Thursday that millions of COVID-19 vaccines are sitting in storage because the US government hasn't given it directions on where to send them yet.  The statement was released a day after Health and Human Services Secretary Alex Azar suggested at a press conference that the drug company was having ""manufacturing challenges,"" The Hill reported. ",https://www.businessinsider.com/pfizer-waiting-on-government-to-ship-millions-of-coronavirus-shots-2020-12,0.0,0.0
PFE,2020-12-18,Should You Sell Pfizer Stock Now?,https://cdn.snapi.dev/images/v1/8/4/heres-why-pfizer-stock-looks-inviting-at-39-levels.jpg,The Motley Fool,Think long and hard about it first.,https://www.fool.com/investing/2020/12/18/should-you-sell-pfizer-stock-now/,0.0,-0.1027
PFE,2020-12-17,Pfizer (PFE) Gains But Lags Market: What You Should Know,https://cdn.snapi.dev/images/v1/g/q/drugs16.jpg,Zacks Investment Research,"Pfizer (PFE) closed the most recent trading day at $38.03, moving +0.5% from the previous trading session.",https://www.zacks.com/stock/news/1177828/pfizer-pfe-gains-but-lags-market-what-you-should-know,-0.0258,0.0
PFE,2020-12-17,TIPS ETFs to Buy for 2021 on Inflation Trade,https://cdn.snapi.dev/images/v1/r/y/drugs12.jpg,Zacks Investment Research,The COVID-19 vaccines and their availability have raised the prospect of inflation as we move ahead into the next year.,https://www.zacks.com/stock/news/1177239/tips-etfs-to-buy-for-2021-on-inflation-trade,0.0,0.296
PFE,2020-12-17,PreMarket Prep Stock Of The Day: Pfizer,https://cdn.snapi.dev/images/v1/2/z/new-york-city-pfizer-world-headquarters-01-2.jpg,Benzinga,"Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session.",https://www.benzinga.com/general/health-care/20/12/18841503/premarket-prep-stock-of-the-day-pfizer,0.0,0.0
PFE,2020-12-17,Pfizer says it's not having problems with vaccine distribution,https://cdn.snapi.dev/images/v1/2/p/pfizer-says-its-not-having-problems-with-vaccine-distribution.jpg,CNBC Television,"CNBC's senior health and science reporter Meg Tirrell reports Pfizer says it doesn't have any problems with vaccine distribution. However, there are also millions of doses that are currently awaiting further instruction for distribution.",https://www.youtube.com/watch?v=BDPSzkr5GF4,0.3089,0.3089
PFE,2020-12-17,10 Best Performing Leveraged ETFs of 2020,https://cdn.snapi.dev/images/v1/n/q/biotech8.jpg,Zacks Investment Research,"This year has witnessed historic twists and turns with the largest bull market turning into a bear market in March on the coronavirus outbreak, and then marking the fastest-ever recovery.",https://www.zacks.com/stock/news/1176737/10-best-performing-leveraged-etfs-of-2020,0.6369,0.0
PFE,2020-12-17,HHS Secretary Azar says Pfizer keeps government at 'arm's length' on Covid vaccine manufacturing,https://cdn.snapi.dev/images/v1/u/m/106812877-1608217991766-gettyimages-1230127960-hhs-vaccination.jpeg,CNBC,"Health and Human Services Secretary Alex Azar said Thursday he'd like “more visibility” into Pfizer's Covid vaccine manufacturing, adding Pfizer has kept the federal government at “arm's length.”",https://www.cnbc.com/2020/12/17/covid-vaccine-hhs-secretary-azar-says-pfizer-keeps-us-at-arms-length-on-manufacturing.html,0.0,0.3612
PFE,2020-12-17,Why Didn't Pfizer Stock Jump More After Winning Authorization for Its COVID Vaccine?,https://cdn.snapi.dev/images/v1/p/o/podc5---evhg8sfxei.jpg,The Motley Fool,The failure to launch really isn't all that surprising.,https://www.fool.com/investing/2020/12/17/why-didnt-pfizer-stock-jump-more-after-winning-aut/,0.5688,-0.6266
PFE,2020-12-17,These Stocks Could Be Your Secret Santa This Christmas,https://cdn.snapi.dev/images/v1/t/f/specialty14.jpg,Zacks Investment Research,"Looking for a surprise this Christmas? Bet on these stocks - BJs Wholesale (BJ), Gogo (GOGO), TRI Pointe (TPH), Penske Automotive (PAG), and Santander Consumer (SC) - for big returns.",https://www.zacks.com/stock/news/1176251/these-stocks-could-be-your-secret-santa-this-christmas,0.0,0.2732
PFE,2020-12-17,HHS Sec. Azar says he'd like more visibility into Pfizer's manufacturing,https://cdn.snapi.dev/images/v1/g/f/hhs-sec-azar-says-hed-like-more-visibility-into-pfizers-manufacturing.jpg,CNBC Television,"""Pfizer has got a different relationship with us. They're part of Operation Warp Speed.",https://www.youtube.com/watch?v=iJdeK5HaAYQ,0.3612,0.0
PFE,2020-12-17,You can't sue Pfizer or Moderna if you have severe Covid vaccine side effects. The government likely won't compensate you for damages either,https://cdn.snapi.dev/images/v1/g/o/106811150-1607984220234-2020-12-14t213737z-738443905-rc29nk9yvgvs-rtrmadp-3-health-coronavirus-usa.jpg,CNBC,Companies like Pfizer and Moderna have total immunity from legal liability if something unintentionally goes wrong with their Covid vaccines.,https://www.cnbc.com/2020/12/16/covid-vaccine-side-effects-compensation-lawsuit.html,-0.6705,-0.2263
PFE,2020-12-17,The Coronavirus Vaccine Number No One Is Talking About (but Should Be),https://cdn.snapi.dev/images/v1/m/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6049532fcoronavirus-vaccine-doctor-patient-healthcare-gettyjpgw700opresize.jpg,The Motley Fool,Hint: It has nothing to do with efficacy.,https://www.fool.com/investing/2020/12/17/the-coronavirus-vaccine-number-no-one-is-talking-a/,-0.2263,0.0
PFE,2020-12-17,Pfizer COVID-19 Vaccine US Supply Could Rise 40% As FDA Clears Use Of Extra Doses In Vials,https://cdn.snapi.dev/images/v1/y/t/national-cancer-institute-kmvohcb-w5g-unsplash-0.jpg,Benzinga,"Extra doses contained in the vials of Pfizer Inc's (NYSE: PFE) COVID-19 vaccine do not need to be discarded, according to the United States Food and Drug Administration, Reuters reported Wednesday.  What Happened: Labeling confusion had led to hospital pharmacists discarding one in every six doses of the vaccine made jointly by Pfizer and its German partner BioNTech SE (NASDAQ: BNTX), Stat News had reported earlier.",https://www.benzinga.com/general/biotech/20/12/18828445/pfizer-covid-19-vaccine-us-supply-could-rise-40-as-fda-clears-use-of-extra-doses-in-vials,0.0772,-0.3612
PFE,2020-12-16,Pfizer vaccine doses thrown away in US after labelling confusion,https://cdn.snapi.dev/images/v1/v/w/2372012150224604507-5208056jpg20201215140859.jpg,Skynews,Hospital pharmacists in the US have been throwing out extra COVID-19 vaccine doses as the country battles with record numbers of infections and deaths.,https://news.sky.com/story/covid-19-fda-says-extra-doses-of-pfizer-vaccine-can-be-used-after-labelling-confusion-12165102,-0.296,-0.3818
PFE,2020-12-16,Could Trillium Fall Below $10 in 2021?,https://cdn.snapi.dev/images/v1/g/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6052342fgettyimages-949947192jpgw700opresize.jpg,The Motley Fool,A decline in the stock price plus positive clinical data equals opportunity.,https://www.fool.com/investing/2020/12/16/could-trillium-fall-below-10-in-2021/,0.0,0.7506
PFE,2020-12-16,New report shows label confusion led to wasted doses of Pfizer vaccine,https://cdn.snapi.dev/images/v1/y/x/new-report-shows-label-confusion-led-to-wasted-doses-of-pfizer-vaccine.jpg,CNBC Television,"CNBC's senior health and science correspondent Meg Tirrell joins Shep Smith to report hospitals found that once the Covid vaccine was diluted there might be more doses than were previously calculated, leading to some waste. She also reports Dr. Anthony Fauci expects everyone to receive the vaccine by early spring of 2021 if the current speed of distributing vaccines continues.",https://www.youtube.com/watch?v=DH5ps_D2L8A,-0.6597,-0.4215
PFE,2020-12-16,Report: Pfizer Vaccine Vials Hold Extra Doses—Increasing U.S. Supply By Up To 40%,https://cdn.snapi.dev/images/v1/u/u/report-pfizer-vaccine-vials-hold-extra-dosesincreasing-us-supply-by-up-to-40.jpg,Forbes,But some doses may have already been thrown away.,https://www.forbes.com/sites/nicholasreimann/2020/12/16/report-pfizer-vaccine-vials-hold-extra-doses-increasing-us-supply-by-up-to-40/,0.0,0.0
PFE,2020-12-16,Delta Air Lines moves Pfizer vaccine on passenger flights (with video),https://cdn.snapi.dev/images/v1/u/f/delta-air-canada-vaccine-shipments-2.jpg,FreightWaves,"Delta Air Lines (NYSE: DAL) said it has delivered two shipments of Pfizer Inc.'s COVID-19 vaccine, joining American Airlines (NASDQ: AAL) and United Airlines in supporting distribution of the initial wave of doses to the American public. Delta said it transported the shipments from Detroit to Atlanta and San Francisco on regularly scheduled passenger flights.",https://www.freightwaves.com/news/delta-air-lines-moves-pfizer-vaccine-on-passenger-flights-with-video,0.0,0.6908
PFE,2020-12-16,Alaska health worker has serious allergic reaction to Pfizer vaccine: NYT,https://cdn.snapi.dev/images/v1/d/y/alaska-health-worker-has-serious-allergic-reaction-to-pfizer-vaccine-nyt.jpg,CNBC Television,CNBC's Meg Tirrell breaks down The New York Times report about a health worker in Alaska who suffered an allergic reaction to the Pfizer vaccine. The patient is now in stable condition and it is not known if the person has a history of allergic reactions to vaccines.,https://www.youtube.com/watch?v=fJ0ImR-K-hU,-0.3612,-0.6597
PFE,2020-12-16,Top Stocks To Buy Today As Markets Respond To Mixed Sentiment,https://cdn.snapi.dev/images/v1/t/o/top-stocks-to-buy-today-as-markets-respond-to-mixed-sentiment.jpg,Forbes,"Although stocks surged yesterday on stimulus hopes, the indices showed some signs of weakness this morning reflecting the mixed bag of news being thrown at investors on a daily basis. For investors looking to make the most of this market, our AI has crunched the data to give you a set of Top Buys.",https://www.forbes.com/sites/qai/2020/12/16/top-stocks-to-buy-today-markets-respond-to-mixed-sentiment/,0.2023,0.2023
PFE,2020-12-16,U.S. quarantines Pfizer vaccine shipments in California and Alabama after transit 'anomaly' left vials too cold,https://cdn.snapi.dev/images/v1/f/a/106812050-1608123664721-gettyimages-1230147221-afp-8x88h6.jpeg,CNBC,Doses of Pfizer's vaccine were quarantined in California and Alabama after an “anomaly” in the transportation process caused the storage temperature to get too cold.,https://www.cnbc.com/2020/12/16/covid-vaccine-us-quarantines-pfizer-shipments-in-california-alabama-after-transit-anomaly.html,0.0,0.0
PFE,2020-12-16,Pfizer And Moderna's Vaccines Could Be More Profitable Than You Think,https://cdn.snapi.dev/images/v1/j/b/pfizer-and-modernas-vaccines-could-be-more-profitable-than-you-think.jpg,Forbes,"Moderna and Pfizer have quickly developed highly effective vaccines that should help to end the Covid-19 pandemic. With Pfizer's vaccine already rolling out in the U.K, and the U.S. in limited quantities, and Moderna's likely to follow suit in the coming weeks, investors are likely trying to.",https://www.forbes.com/sites/greatspeculations/2020/12/16/pfizer-and-modernas-vaccines-could-be-more-profitable-than-you-think/,0.4927,0.6361
PFE,2020-12-16,Earn 7% Plus Yield With These ETFs,https://cdn.snapi.dev/images/v1/c/3/etf25---3pad5ag8gm.jpg,Zacks Investment Research,These ETFs offer at least 7% in annual yield.,https://www.zacks.com/stock/news/1172044/earn-7-plus-yield-with-these-etfs,0.0,0.0
PFE,2020-12-16,2 REITs To Buy Before The Vaccine Changes Everything,https://cdn.snapi.dev/images/v1/z/q/entertainment-diversified13.jpg,Seeking Alpha,The vaccine is now approved and we have a clear end in sight to this crisis. This is very good news for the most covid-sensitive businesses.,https://seekingalpha.com/article/4394487-2-reits-to-buy-vaccine-changes-everything,0.0,0.4055
PFE,2020-12-16,3 COVID-19 Vaccine Stocks That Could Be the Biggest Winners in a Post-Pandemic World,https://cdn.snapi.dev/images/v1/x/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6047752fthrowing-mask-into-a-trash-canjpgw700opresize.jpg,The Motley Fool,They each have a key competitive edge that could set them apart.,https://www.fool.com/investing/2020/12/16/3-covid-19-vaccine-stocks-that-could-be-the-bigges/,0.4767,0.1779
PFE,2020-12-16,What Pfizer's Vaccine Authorization Means for Moderna,https://cdn.snapi.dev/images/v1/p/o/podc3---wakaxmh6nr.jpg,The Motley Fool,The Moderna and Pfizer vaccines have one key similarity.,https://www.fool.com/investing/2020/12/16/what-pfizers-vaccine-authorization-means-for-moder/,0.0,0.0
PFE,2020-12-16,Why AstraZeneca's and Sanofi's Bad News Could Be Great News for Pfizer and Moderna,https://cdn.snapi.dev/images/v1/d/2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6047732fgloved-hands-holding-2-covid-vaccine-bottlesjpgw700opresize.jpg,The Motley Fool,The challenges for two big drugmakers could translate to opportunities for their rivals in the COVID-19 vaccine race.,https://www.fool.com/investing/2020/12/16/why-astrazenecas-and-sanofis-bad-news-could-be-gre/,0.1531,0.4404
PFE,2020-12-16,China Secures 100M Doses Of Pfizer-BioNTech COVID-19 Vaccine For 2021,https://cdn.snapi.dev/images/v1/1/z/dimitri-houtteman-qbhppxw3ess-unsplash-3-0.jpg,Benzinga,"Millions of doses of Pfizer Inc (NYSE: PFE) and BioNTech SE's  (NASDAQ: BNTX) COVID-19 vaccine will be administered in China alongside home-made options, Bloomberg reported Tuesday. What Happened: Local pharmaceutical firm Shanghai Fosun Pharmaceutical (Group) Co, Ltd (OTC: SFOSF) —  which signed an agreement with BioNTech in March — will pay the German company $300 million (EUR 250 million) for an initial 50 million doses, according to Bloomberg.",https://www.benzinga.com/general/biotech/20/12/18809547/china-secures-100m-doses-of-pfizer-biontech-covid-19-vaccine-for-2021,0.3182,0.4215
PFE,2020-12-15,Piper Sandler analyst discusses Pfizer and Moderna's respective vaccine rollouts,https://cdn.snapi.dev/images/v1/x/e/piper-sandler-analyst-discusses-pfizer-and-modernas-respective-vaccine-rollouts.jpg,CNBC Television,"Ted Tenthoff, Piper Sandler Senior Analyst, says Moderna has risen to the challenge by creating its own Covid-19 vaccine. He joins 'Closing Bell' to discuss the vaccine rollouts by Pfizer and Moderna.",https://www.youtube.com/watch?v=fJwBMs5fB_I,0.4215,0.3612
PFE,2020-12-15,The 8 Best Long-Term Stocks with Plenty of Potential,https://cdn.snapi.dev/images/v1/x/k/d22edfff-hfr4nxtl0b.jpg,InvestorPlace,These best long-term stocks can help boost any diversified portfolio. Here are eight picks with particularly strong potential for the years to come.,https://investorplace.com/2020/12/the-8-best-long-term-stocks-with-plenty-of-potential/,0.6369,0.9216
PFE,2020-12-15,"One health-care stock looks like a buy as Pfizer begins Covid vaccine rollout, market analyst says",https://cdn.snapi.dev/images/v1/e/f/106811524-1608047971885-gettyimages-1230137377-afp-8x77pk.jpeg,CNBC,Health-care stocks are in focus after Pfizer began shipments in the U.S. of its Covid vaccine and the first vaccinations were given this week.,https://www.cnbc.com/2020/12/15/health-care-stocks-on-watch-as-pfizer-begins-covid-vaccine-rollout.html,0.3612,0.0
PFE,2020-12-15,5 Small-Cap Sector ETFs Beating the Russell 2000,https://cdn.snapi.dev/images/v1/2/x/biotech5.jpg,Zacks Investment Research,We have presented five ETFs that have easily crushed the Russell 2000 Index over the past three months.,https://www.zacks.com/stock/news/1168817/5-small-cap-sector-etfs-beating-the-russell-2000,-0.4588,-0.1027
PFE,2020-12-15,Sector ETFs to Gain the Most on COVID-19 Vaccine Rollout,https://cdn.snapi.dev/images/v1/q/g/etf6.jpg,Zacks Investment Research,The United States has geared up for the largest-ever immunization with the rollout of the COVID-19 vaccine.,https://www.zacks.com/stock/news/1168617/sector-etfs-to-gain-the-most-on-covid-19-vaccine-rollout,0.5267,0.4215
PFE,2020-12-15,Why One Analyst Sees Big Upside in This COVID-19 Vaccine Stock,https://cdn.snapi.dev/images/v1/x/5/biotech40---u5rsqmuvj8.jpg,24/7 Wall Street,BioNTech S.E. (NASDAQ: BNTX) was in the spotlight on Tuesday after it received a sizable price target hike from one key analyst.,https://247wallst.com/healthcare-business/2020/12/15/why-one-analyst-sees-big-upside-in-this-covid-19-vaccine-stock/,0.0,0.0
PFE,2020-12-15,Pfizer coronavirus vaccine arrives in Louisiana,https://cdn.snapi.dev/images/v1/f/a/pfizer-coronavirus-vaccine-arrives-in-louisiana.jpg,CNBC Television,CNBC's Brian Sullivan reports on the arrival of the Pfizer vaccine in Louisiana as workers prepare the coronavirus vaccine for distribution.,https://www.youtube.com/watch?v=jv_pXC5FqrU,0.0,0.0
PFE,2020-12-15,Here's How To Bull Trade The Dip In Pfizer Stock With Finesse,https://cdn.snapi.dev/images/v1/e/p/im-270120width620size15005861664712778.jpg,InvestorPlace,"Sellers are striking Pfizer stock , even as it rolls out its novel coronavirus vaccine. Ignore the weakness, and buy with short puts.",https://investorplace.com/2020/12/heres-how-to-bull-trade-the-dip-in-pfizer-stock-with-finesse/,0.0,-0.4588
PFE,2020-12-15,FDA staff recommends watching for Bell's palsy in Moderna and Pfizer vaccine recipients,https://cdn.snapi.dev/images/v1/z/j/106799008-1605725497031-gettyimages-1229670584-afp-8vf9bn.jpeg,CNBC,"The FDA said that there were four reported cases of Bell's palsy among Moderna's 30,000 trial participants, including three who got the vaccine.",https://www.cnbc.com/2020/12/15/fda-staff-recommends-watching-for-bells-palsy-in-moderna-and-pfizer-vaccine-recipients.html,0.2263,0.0
PFE,2020-12-15,US Starts COVID-19 Vaccine Drive: 5 Consumer Discretionary Picks,https://cdn.snapi.dev/images/v1/t/c/biotech27.jpg,Zacks Investment Research,"The COVID-19 vaccine comes as a relief, indicating that the economy might bounce back in the coming days helping stocks like WilliamsSonoma (WSM), Reynolds Consumer Products (REYN) and Spectrum Brands Holdings (SPB).",https://www.zacks.com/stock/news/1167917/us-starts-covid-19-vaccine-drive-5-consumer-discretionary-picks,0.0,0.7783
PFE,2020-12-15,5 Stocks to Win Big as Coronavirus Vaccine Rollout Begins,https://cdn.snapi.dev/images/v1/m/a/us-market-movers-as-economic-data-outweighs-the-pandemic.jpg,Zacks Investment Research,"Emergency approval of COVID-19 vaccines is a boon for stocks such as Trane Technologies (TT), United Parcel Service (UPS), FedEx (FDX), Pfizer (PFE) and Moderna (MRNA). Here's why -",https://www.zacks.com/stock/news/1167984/5-stocks-to-win-big-as-coronavirus-vaccine-rollout-begins,0.5859,0.5106
PFE,2020-12-15,Pfizer vaccine expected to land in 425 locations across the U.S.,https://cdn.snapi.dev/images/v1/1/f/pfizer-vaccine-expected-to-land-in-425-locations-across-the-us.jpg,CNBC Television,"The first shots of Pfizer-BioNTech's Covid-19 vaccine are being administered to healthcare workers, marking a pivotal moment in the country's long march to bring the virus under control. CNBC's Meg Tirrell reports the latest on the operation to distribute the vaccine around the country.",https://www.youtube.com/watch?v=6kBWL6KoT1Q,0.0,0.0
PFE,2020-12-15,"Could the S&P 500 Hit 4,000 in 2021?",https://cdn.snapi.dev/images/v1/v/8/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6047552fstock-market-ticker-symbol-digital-quote-board-nyse-sp-500-nasdaq-gettyjpgw700opresize.jpg,The Motley Fool,A handful of catalysts will dictate how the benchmark stock index performs next year.,https://www.fool.com/investing/2020/12/15/could-the-sp-500-hit-4000-in-2021/,0.0,0.0
PFE,2020-12-15,"WHO sees ""strong commitment"" from Pfizer on affordable COVID vaccine",https://cdn.snapi.dev/images/v1/f/p/m02d20201215t2i1544617194w940fhfwllplsqrlynxmpegbe0qh.jpg,Reuters,A World Health Organization senior official said on Tuesday that the agency was in talks with Pfizer to include its COVID-19 vaccine as part of an early global roll out.,https://www.reuters.com/article/health-coronavirus-who-pfizer/who-sees-strong-commitment-from-pfizer-on-affordable-covid-vaccine-idUSKBN28P1AT,0.7096,0.0
PFE,2020-12-15,"Which Is the Best COVID Vaccine Stock Now: Pfizer, BioNTech, or Moderna?",https://cdn.snapi.dev/images/v1/p/o/podc10---z8oxfgrl8k.jpg,The Motley Fool,Hint: There isn't just one answer.,https://www.fool.com/investing/2020/12/15/which-is-the-best-covid-vaccine-stock-now-pfizer-b/,0.6369,0.0
PFE,2020-12-15,7 Christmas Stocks to Buy for 2020's Atypical Holidays,https://cdn.snapi.dev/images/v1/k/i/asset-management42.jpg,InvestorPlace,This year's holiday season is anything but typical due to Covid-19. Here are seven Christmas stocks to buy that are atypical from past years.,https://investorplace.com/2020/12/7-christmas-stocks-to-buy-for-2020s-atypical-holidays/,0.3818,0.2144
PFE,2020-12-14,"After Pfizer, Moderna's COVID-19 Vaccine Data Comprised In Cyberattack",https://cdn.snapi.dev/images/v1/7/g/markus-spiske-iar-afb0qqw-unsplash-1.jpg,Benzinga,"Moderna Inc (NASDAQ: MRNA) said documents related to its COVID-19 vaccine were targeted by hackers in an attack on the European Medicines Agency (EMA), Reuters reported Monday. What Happened: The Cambridge, Massachusetts-based vaccine maker said its submissions to the EMA didn't contain any information pertaining to the identity of its vaccine study participants.",https://www.benzinga.com/general/biotech/20/12/18787354/after-pfizer-modernas-covid-19-vaccine-data-comprised-in-cyberattack,0.0,-0.4767
PFE,2020-12-14,"Warren Buffett's Berkshire Hathaway has new stakes in AbbVie, Pfizer, Merck, Bristol-Myers Squibb",https://cdn.snapi.dev/images/v1/y/e/warren-buffetts-berkshire-hathaway-has-new-stakes-in-abbvie-pfizer-merck-bristol-myers-squibb.jpg,Yahoo Finance,Warren Buffett's Berkshire Hathaway released its newest holdings worth more than $1.8 billion with notable investments in some big pharma stocks like Merck and Pfizer. Yahoo Finance's Jared Blikre breaks it all down.,https://www.youtube.com/watch?v=2YDnF3BMX7w,0.0,0.5267
PFE,2020-12-14,"Vaccine distribution, peak-season climax spawn parcel delivery storm",https://cdn.snapi.dev/images/v1/w/d/will-vaccine-distribution-1.jpg,FreightWaves,"A tumultuous year for the parcel-delivery business has been taken to another level as parcel shippers find themselves competing with the most precious of cargoes for peak holiday season air and surface capacity.  To the amazement of many, the first of what are expected to be several vaccines to crush the novel coronavirus has been approved by federal regulators and shipped out before the end of 2020.",https://www.freightwaves.com/news/vaccine-distribution-peak-season-climax-spawn-parcel-delivery-storm,0.0,0.9286
PFE,2020-12-14,Coronavirus vaccine: First doses of COVID-19 Pfizer vaccine are administered on the East Coast,https://cdn.snapi.dev/images/v1/b/j/coronavirus-vaccine-first-doses-of-covid-19-pfizer-vaccine-are-administered-on-the-east-coast.jpg,Yahoo Finance,"Yahoo Finance's Anjalee Khemlani reports on the distribution of the first COVID-19 vaccine. #coronavirusvaccine #COVID19vaccine #Pfizer For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.",https://www.youtube.com/watch?v=blDQfY0kP5M,0.0,0.8074
PFE,2020-12-14,"The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF",https://cdn.snapi.dev/images/v1/n/h/medical14.jpg,InvestorPlace,One aspect of the ANEW ETF is focused on the bleeding edge of medical advances. Here's what you need to know if you're considering investing.,https://investorplace.com/genomics-telehealth-and-the-future-of-healthcare-with-the-anew-etf/,0.0,0.3818
PFE,2020-12-14,Pfizer Rated Top Buy This Week As Vaccine Distribution Kicks Off,https://cdn.snapi.dev/images/v1/w/e/pfizer-rated-top-buy-this-week-as-vaccine-distribution-kicks-off.jpg,Forbes,"Although December has largely kept November's election and vaccine rally moving, markets fell for the first week in three last week. Among all the news and data spurring on the markets, our deep learning algorithms have used AI technology to rate the Top Trending Stocks for this week.",https://www.forbes.com/sites/qai/2020/12/14/pfizer-rated-top-buy-this-week-as-vaccine-distribution-kicks-off/,0.2023,0.2023
PFE,2020-12-14,3 Health Care Companies That Recently Raised Dividends,https://cdn.snapi.dev/images/v1/h/k/drugs14.jpg,GuruFocus,Dividend increase announcements continue to pile up as 2020 draws to a close. The health care sector remains one of my favorite places to find stocks offering solid yields and lengthy track records of dividend growth.,https://www.gurufocus.com/news/1310730/3-health-care-companies-that-recently-raised-dividends,0.4939,0.8934
PFE,2020-12-14,"U.S. administers first shots of Pfizer's Covid vaccine, launching a historic rollout",https://cdn.snapi.dev/images/v1/k/o/106810931-1607968510591-gettyimages-1230125351-virus-vaccine-us.jpeg,CNBC,"""There is not one part of this country that's not being touched today through Wednesday,"" Gen. Gustave Perna, who's in charge of logistics for Operation Warp Speed, said.",https://www.cnbc.com/2020/12/14/us-administers-first-shots-of-pfizers-covid-vaccine-launching-a-historic-rollout.html,0.0,0.0
PFE,2020-12-14,Pfizer and Biontech have a significant commercial opportunity: Analyst,https://cdn.snapi.dev/images/v1/x/f/pfizer-and-biontech-have-a-significant-commercial-opportunity-analyst.jpg,Yahoo Finance,"Senior research analyst for healthcare at ClearBridge Investments Marshall Gordon, joins Yahoo Finance Live to discuss the commercial opportunity COVID-19 vaccine developers such as Pfizer and BioNTech have over the next couple of months, and the genera… #Pfizer #Biontech #ClearBridgeinvestments For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. About Yahoo Finance Premium: With a subscription to Yahoo Finance Premium, get the tools you need to invest with confidence.",https://www.youtube.com/watch?v=_u2sdpP2Xic,0.5574,0.9246
PFE,2020-12-14,"Pfizer negotiating with U.S. to provide additional 100 million Covid vaccine doses, CEO says",https://cdn.snapi.dev/images/v1/y/5/pfizer-negotiating-with-us-to-provide-additional-100-million-covid-vaccine-doses-ceo-says.jpg,CNBC Television,Pfizer CEO Dr. Albert Bourla said the company is negotiating with the federal government to provide an additional 100 million Covid-19 vaccine doses next year as Americans will receive some of the first shots Monday.,https://www.youtube.com/watch?v=Dm0xnZEaVD0,0.0,0.0
PFE,2020-12-14,The Margin: WATCH: Relieved Americans applaud as the Pfizer-BioNTech COVID-19 vaccine rolls out across the country,https://cdn.snapi.dev/images/v1/5/e/mw-iw132-pfizer-20201214105526-zqjpguuidc86fdc14-3e24-11eb-8b79-9c8e992d421e.jpg,Market Watch,"Queens, N.Y., nurse Sandra Lindsay received the first COVID-19 vaccine in the U.S. on Monday morning",https://www.marketwatch.com/story/watch-relieved-americans-applaud-as-the-pfizer-biontech-covid-19-vaccine-rolls-out-across-the-country-2020-12-14,0.6808,0.0
PFE,2020-12-14,5 Potential Thematic Rotations That I Expect To Take Place In 2021,https://cdn.snapi.dev/images/v1/a/y/sdw212w-2.jpg,Seeking Alpha,2020 has already featured a number of short-term leadership shifts. I expect that trend to continue in 2021.,https://seekingalpha.com/article/4394610-5-potential-thematic-rotations-i-expect-to-take-place-in-2021,0.0,0.0772
PFE,2020-12-14,"Historic Day for Pfizer (PFE), Covid-19 Vaccine",https://cdn.snapi.dev/images/v1/v/8/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5955382fsyringe-and-needle-on-top-of-calendarjpgw700opresize.jpg,Zacks Investment Research,"With more than 180K daily reported cases as of yesterday, with more than 109K hospitalizations and nearly 1500 deaths on Sunday alone, this vaccine availability is not just historic, it's momentous.",https://www.zacks.com/stock/news/1164542/historic-day-for-pfizer-pfe-covid-19-vaccine,0.0,-0.25
PFE,2020-12-14,Jim Cramer on the Pfizer vaccine rollout: 'This is a historic moment',https://cdn.snapi.dev/images/v1/z/e/jim-cramer-on-the-pfizer-vaccine-rollout-this-is-a-historic-moment.jpg,CNBC Television,"After months of research and clinical trials, the Pfizer-BioNTech vaccine delivery is underway, with millions of doses being distributed across the country. CNBC's Jim Cramer, Carl Quintanilla and David Faber discuss what the vaccine means for the country.",https://www.youtube.com/watch?v=B6dDCmUFw64,0.0,0.0
PFE,2020-12-14,TPG's Jim Coulter on the business impact of Pfizer's vaccine rollout,https://cdn.snapi.dev/images/v1/l/w/tpgs-jim-coulter-on-the-business-impact-of-pfizers-vaccine-rollout.jpg,CNBC Television,"Jim Coulter, co-founder and co-CEO of TPG, which oversees $85 billion in assets under management, joined ""Squawk Box"" on Monday to discuss what he thinks a working vaccine could mean for the markets and investors.",https://www.youtube.com/watch?v=jaP0TE3ggUo,0.0,0.1779
PFE,2020-12-14,Pfizer in talks to supply US with another 100 million vaccine doses,https://cdn.snapi.dev/images/v1/9/r/health-coronavirus-usa-pfizerjpgquality90stripall.jpg,New York Post,"Pfizer is in talks to supply the US government with another 100 million doses of the company's coronavirus vaccine, CEO Albert Bourla said Monday. That would add to the 100 million doses Pfizer plans to deliver by the end of March under an order the Trump administration placed in July, Bourla told CNN.",https://nypost.com/2020/12/14/pfizer-in-talks-to-give-us-another-100-million-vaccine-doses/,0.0,0.0
PFE,2020-12-14,Contingency planning guides Pfizer vaccine distribution flow,https://cdn.snapi.dev/images/v1/b/q/operation-warp-speed-timeline-1.jpg,FreightWaves,"With lifesaving COVID-19 vaccines finally en route to state administration sites, the guiding principles for officials in charge of managing the supply chain are adaptability and maintaining a consistent flow of doses to health care facilities.   Army Gen.",https://www.freightwaves.com/news/contingency-planning-guides-pfizer-vaccine-distribution-flow,0.0,0.4939
PFE,2020-12-14,"Pfizer's CEO hasn't gotten his Covid vaccine yet, saying he doesn't want to cut in line",https://cdn.snapi.dev/images/v1/t/a/105687507-1547831143627bourla.jpg,CNBC,"""This is a vaccine that was developed without cutting corners from a company with 171 years of credentials,"" Pfizer CEO Albert Bourla said.",https://www.cnbc.com/2020/12/14/pfizers-ceo-hasnt-gotten-his-covid-vaccine-yet-saying-he-doesnt-want-to-cut-in-line.html,0.1511,0.0951
PFE,2020-12-14,"Pfizer negotiating with U.S. to provide an additional 100 million Covid vaccine doses, CEO says",https://cdn.snapi.dev/images/v1/e/s/106810481-1607869242560-106810481-1607868621351-gettyimages-1230101981-afp-8x2884.jpg,CNBC,"Pfizer and the U.S. are working out details on timing, CEO Albert Bourla told CNBC's ""Squawk Box"" in an interview.",https://www.cnbc.com/2020/12/14/covid-vaccine-pfizer-negotiating-with-us-to-provide-an-additional-100-million-doses-ceo-says.html,0.0,0.0
PFE,2020-12-14,"U.S. could have bought additional Pfizer vaccines in November but passed, says Pfizer board member",https://cdn.snapi.dev/images/v1/6/i/105764881-1551816622419scott.jpg,CNBC,"""This has been a challenging process because there have been multiple conversations happening as recently as November,"" Dr. Scott Gottlieb told CNBC.",https://www.cnbc.com/2020/12/14/covid-vaccine-us-passed-on-more-pfizer-doses-in-november-says-board-member-gottlieb.html,0.0,0.1531
PFE,2020-12-14,Pfizer CEO Albert Bourla on vaccine hesitancy: 'Trust science',https://cdn.snapi.dev/images/v1/4/8/pfizer-ceo-albert-bourla-on-vaccine-hesitancy-trust-science.jpg,CNBC Television,"""The decision not to vaccinate will not affect only your health or your life,"" Pfizer Chairman and CEO Albert Bourla told CNBC's ""Squawk Box"" Monday when asked about individuals who may be hesitant to take the vaccine. ""Unfortunately it will affect the lives of others, and likely the lives of the people you love the most, which are the people that usually you are in contact with.",https://www.youtube.com/watch?v=P6O6FqYYImk,0.34,0.2023
PFE,2020-12-14,U.S. turned down more Covid vaccines as recently as Nov. 2020: Pfizer board member,https://cdn.snapi.dev/images/v1/2/b/us-turned-down-more-covid-vaccines-as-recently-as-nov-2020-pfizer-board-member.jpg,CNBC Television,"Pfizer board member and former FDA Commissioner Dr. Scott Gottlieb told CNBC's ""Squawk Box"" that the U.S. government turned down additional doses of Pfizer's vaccine as recently as November 2020.",https://www.youtube.com/watch?v=lOmzpR8JCx8,0.0,0.0
PFE,2020-12-14,COVID-19 Vaccine Race Heats Up as Pfizer Gets Emergency Nod,https://cdn.snapi.dev/images/v1/q/v/biotech23.jpg,Zacks Investment Research,FDA grants emergency use approval to Pfizer (PFE)/BioNTech's (BNTX) COVID-19 vaccine candidate.,https://www.zacks.com/stock/news/1163938/covid-19-vaccine-race-heats-up-as-pfizer-gets-emergency-nod,-0.3818,0.34
PFE,2020-12-14,How UPS is shipping the Pfizer Covid vaccine around the U.S.,https://cdn.snapi.dev/images/v1/w/n/how-ups-is-shipping-the-pfizer-covid-vaccine-around-the-us.jpg,CNBC Television,Months of planning and investment to update cold chain capabilities has all lead up to this: the first shipments of Pfizer's Covid vaccine across the country. CNBC's Frank Holland reports from the heart of UPS's World Port air operations.,https://www.youtube.com/watch?v=VzK3ZDUWLRA,0.0,0.0
PFE,2020-12-14,Pfizer and Moderna could earn $32 billion in revenues from their COVID-19 vaccines in 2021,https://cdn.snapi.dev/images/v1/p/o/poster-moderna-fda-application-emergency-use.jpg,Business Insider,"US drugmakers Pfizer and Moderna could rake in around $32 billion in revenues from their COVID-19 vaccines in 2021, according to Wall Street estimates. Pfizer and its German partner BioNTech will bring in roughly $19 billion from global sales of its COVID-19 vaccine in 2021, according to Morgan Stanley estimates first reported by CNN on Friday.",https://www.businessinsider.com/pfizer-moderna-biontech-vaccine-sales-revenue-covid-19-shot-2021-2020-12,0.0,0.0
PFE,2020-12-14,Pfizer-BioNTech Covid vaccine distribution begins around the United States,https://cdn.snapi.dev/images/v1/k/6/pfizer-biontech-covid-vaccine-distribution-begins-around-the-united-states.jpg,CNBC Television,"After months of research and clinical trials, the Pfizer-BioNTech vaccine delivery is underway, with millions of doses being distributed across the country. CNBC's Meg Tirrell reports.",https://www.youtube.com/watch?v=2U5KEGw6pg4,0.4215,0.0
PFE,2020-12-14,Head of trucking company transporting Pfizer vaccine discusses the first day of distribution,https://cdn.snapi.dev/images/v1/9/m/head-of-trucking-company-transporting-pfizer-vaccine-discusses-the-first-day-of-distribution.jpg,CNBC Television,"Andrew Boyle, Co-President of Boyle Transportation which is working with UPS to distribute the Pfizer/Biontech Covid-19 vaccine, joins Worldwide Exchange with an inside look at the rollout process.",https://www.youtube.com/watch?v=ZnE4KXsTE_U,0.0,0.0
PFE,2020-12-14,Pfizer CEO says still negotiating with U.S. on more coronavirus vaccines,https://cdn.snapi.dev/images/v1/x/i/m02d20201214t2i1544495089w940fhfwllplsqrlynxmpegbd0sx.jpg,Reuters,"Pfizer CEO Albert Bourla on Monday said the company has not signed an agreement yet with the United States on providing 100 million more coronavirus vaccine doses in 2021, telling CNN it is still negotiating whether to deliver the drug in the second or third quarter of the year.",https://www.reuters.com/article/health-coronavirus-usa-pfizer/pfizer-ceo-says-still-negotiating-with-u-s-on-more-coronavirus-vaccines-idUSKBN28O1GI,0.0,0.0444
PFE,2020-12-14,"Pfizer, BioNTech COVID-19 vaccine candidate study in Germany support safety profile",https://cdn.snapi.dev/images/v1/g/s/biotech20---k0hzq4jhpu.jpg,Market Watch,"Pfizer Inc. and its Germany-based partner BioNTech SE said overall results of a Phase 1/2 study in Germany of its COVID-19 vaccine candidate, BNT162b2, mirrored those from the U.S. study. The companies said the results supported ""the favorable safety profile and robust induction of virus-specific antibody responses.",https://www.marketwatch.com/story/pfizer-biontech-covid-19-vaccine-candidate-study-in-germany-support-safety-profile-2020-12-14,0.6705,0.8625
PFE,2020-12-14,3 COVID Stocks That Are Screaming Buys,https://cdn.snapi.dev/images/v1/y/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038422fdollar-sign-in-the-midst-of-coronavirusjpgw700opresize.jpg,The Motley Fool,These coronavirus leaders are great picks for different reasons.,https://www.fool.com/investing/2020/12/14/3-covid-stocks-that-are-screaming-buys/,-0.3818,0.6249
PFE,2020-12-14,Pfizer Plans To Offer COVID-19 Vaccine To Placebo Group Trial Volunteers: Report,https://cdn.snapi.dev/images/v1/i/o/syringe-417786-1920-11.jpg,Benzinga,"Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) plan to allow the participants in the COVID-19 vaccine trials to learn if they were part of the placebo group and offer them free shots, Bloomberg reports. What Happened: Pfizer, in an emailed statement to Bloomberg, said that both companies are providing voluntary options to COVID-19 vaccine clinical trial volunteers, who were part of the placebo group, to receive the vaccine at scheduled time points.",https://www.benzinga.com/general/biotech/20/12/18767922/pfizer-plans-to-offer-covid-19-vaccine-to-placebo-group-trial-volunteers-report,0.0,0.6369
PFE,2020-12-14,Former FDA director says Pfizer's coronavirus vaccine approval was speedy but thorough,https://cdn.snapi.dev/images/v1/v/g/former-fda-director-says-pfizers-coronavirus-vaccine-approval-was-speedy-but-thorough.jpg,CNBC International TV,"Norman Baylor of Biologics Consulting and former U.S. FDA Director says the agency took no shortcuts in approving Pfizer's vaccine, despite political pressure.",https://www.youtube.com/watch?v=XGXPAIvbbj4,0.2617,-0.0803
PFE,2020-12-14,Michigan airports support airlift of Pfizer vaccine (with video),https://cdn.snapi.dev/images/v1/6/d/gerald-ford-airport-1.jpg,FreightWaves,"Gerald R. Ford International Airport in Grand Rapids, Michigan, could play an active role in the U.S. and worldwide distribution of COVID-19 vaccine because it is the closest commercial airport to Pfizer Inc.'s Kalamazoo manufacturing plant. On Sunday, an Airbus A300 cargo jet operated by FedEx Express (NYSE: F D X) left Ford airport for the 90- minute flight to FedEx's global air hub in Memphis, Tennessee, carrying the first air shipment of the life-saving vaccine.",https://www.freightwaves.com/news/michigan-airports-support-airlift-of-pfizer-vaccine-with-video,0.4019,0.7964
PFE,2020-12-14,Boyle Transportation helps UPS air network move COVID vaccine,https://cdn.snapi.dev/images/v1/2/u/121320-boyle-transportation-vaccines.jpg,FreightWaves,"Heavy-duty Freightliner Cascadias operated by Billerica, Massachusetts-based Boyle Transportation rumbled from a Pfizer (NYSE: PFE) plant in Michigan on Sunday, hauling the first doses of a vaccine critical to ending the coronavirus pandemic. Boyle is an experienced transporter of vaccines.",https://www.freightwaves.com/news/boyle-transportion-helps-ups-air-network-move-covid-vaccine,0.3818,-0.3182
PFE,2020-12-14,How Many COVID Vaccine Doses Will Pfizer and Moderna Distribute by Year-End?,https://cdn.snapi.dev/images/v1/p/o/podc11---imo4wulepw.jpg,The Motley Fool,Hint: It's a big number -- but not nearly big enough.,https://www.fool.com/investing/2020/12/13/how-many-covid-vaccine-doses-will-pfizer-and-moder/,0.0,0.0387
PFE,2020-12-14,CDC's Redfield officially recommends Pfizer coronavirus vaccine,https://cdn.snapi.dev/images/v1/8/f/biotech15.jpg,Fox Business,"Centers for Disease Control and Prevention Director Dr. Robert Redfield said Sunday that he signed the CDC's official recommendation for Americans 16 and older to use the Pfizer-BioNTech coronavirus vaccine and applauded the vaccine as a step to ""help restore some normalcy to our lives and our country."".",https://www.foxbusiness.com/markets/cdc-redfield-pfizer-biontech-coronavirus-vaccine-recommendation,0.2263,0.7506
PFE,2020-12-14,"FedEX, UPS trucks depart with first Pfizer COVID vaccines",https://cdn.snapi.dev/images/v1/m/g/interview-with-ait-1-1.jpg,FreightWaves,"FedEx Express (NYSE: FDX)  and UPS (NYSE: UPS) trucks departed Pfizer Inc.'s (NYSE: PFE) sprawling manufacturing facility in Portage, Michigan, on Sunday morning loaded with COVID-19 vaccines packed in dry ice to maintain them at ultra-cold temperatures. The express delivery companies have roughly divided the nation in two, with FedEx supplying the western states and UPS those in the east, based on plans developed in coordination with the federal government's Operation Warp Speed.",https://www.freightwaves.com/news/fedex-ups-trucks-depart-with-first-pfizer-covid-vaccines,0.0,0.0
PFE,2020-12-14,These 2 Early-Stage COVID Vaccines Could Be Game-Changers,https://cdn.snapi.dev/images/v1/p/o/podc9---ahhpxguzjt.jpg,The Motley Fool,The first to market won't necessarily dominate the market over the long run.,https://www.fool.com/investing/2020/12/13/these-2-early-stage-covid-vaccines-could-be-game-c/,0.0,0.0951
PFE,2020-12-14,COVID Vaccine Stock Ideas for Different Investors,https://cdn.snapi.dev/images/v1/p/o/podc5---6e5g2cfdua.jpg,The Motley Fool,"Whether you're aggressive, risk-averse, or somewhere in between, here are some coronavirus vaccine stocks you might want to consider.",https://www.fool.com/investing/2020/12/13/covid-vaccine-stock-ideas-for-different-investor/,0.0,-0.0772
PFE,2020-12-14,How Soon Will COVID Vaccines Be Available After FDA Authorization?,https://cdn.snapi.dev/images/v1/p/o/podc4---eh9z719kph.jpg,The Motley Fool,Faster than you might think.,https://www.fool.com/investing/2020/12/13/how-soon-will-covid-vaccines-be-available-after-fd/,0.0,0.0
PFE,2020-12-14,Pfizer begins packing coronavirus vaccine shipments at Michigan facility,https://cdn.snapi.dev/images/v1/z/e/biotech13.jpg,Fox Business,The first trucks carrying a COVID-19 vaccine for widespread use in the United States are set to pull out of a Michigan manufacturing plant Sunday.,https://www.foxbusiness.com/markets/pfizer-biontech-coronavirus-vaccine-ships-to-states,0.0,0.4215
PFE,2020-12-14,3 Easy Retirement Investing Resolutions for 2021,https://cdn.snapi.dev/images/v1/h/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6043182fyounger-man-holding-money-laptopjpgw700opresize.jpg,The Motley Fool,"Start the year off right with these easy, money-making resolutions.",https://www.fool.com/retirement/2020/12/13/3-easy-retirement-investing-resolutions-for-2021/,0.4404,0.4404
PFE,2020-12-14,The Most Popular Coronavirus Stock May Lose Half Its Value by 2023,https://cdn.snapi.dev/images/v1/w/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6044342fcoronavirus-vaccine-doctor-patient-healthcare-gettyjpgw700opresize.jpg,The Motley Fool,This as-of-now unstoppable COVID-19 stock might be one of the worst investments going forward.,https://www.fool.com/investing/2020/12/13/the-most-popular-coronavirus-stock-may-lose-half-i/,0.4201,-0.7096
PFE,2020-12-14,3 Top Coronavirus Stocks to Buy in December,https://cdn.snapi.dev/images/v1/v/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038402fgift-box-with-vaccinejpgw700opresize.jpg,The Motley Fool,There's something for every kind of investor with this list.,https://www.fool.com/investing/2020/12/13/3-top-coronavirus-stocks-to-buy-in-december/,0.2023,0.0
PFE,2020-12-14,Coronavirus vaccine: This is one of the safest vaccines we've seen: Physician on Pfizer vaccine,https://cdn.snapi.dev/images/v1/3/g/coronavirus-vaccine-this-is-one-of-the-safest-vaccines-weve-seen-physician-on-pfizer-vaccine.jpg,Yahoo Finance,"Dr. Heather Yeo, SurvivorNet Medical Advisor & Associate Professor of Surgery and Population Health Sciences at Weill Cornell Medical College joins Yahoo Finance's Kristin Myers to break down the latest coronavirus developments. #Pfizer #coronavirus #COVID-19vaccine #coronavirusvaccine For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.",https://www.youtube.com/watch?v=PyLE3K7wuLU,0.4019,0.8074
PFE,2020-12-14,FAA clears pilots to receive Pfizer COVID-19 vaccine,https://cdn.snapi.dev/images/v1/j/v/faa-issues-pilot-1.jpg,FreightWaves,"The Federal Aviation Administration on Saturday determined that commercial pilots and air traffic controllers subject to FAA medical clearance may receive Pfizer Inc.'s (NYSE: PFE) newly approved COVID-19 vaccine. The Food and Drug Administration Friday night authorized the vaccine's public use on an emergency basis after an extensive review of its safety and ability to protect against the virus, which has claimed nearly 300,000 lives in the U.S. The Air Line Pilots Association earlier this week urged the FAA to quickly approve the vaccine for pilots so they don't violate medical certifications by taking the drug.",https://www.freightwaves.com/news/faa-clears-pilots-to-receive-pfizer-covid-19-vaccine,0.0772,0.904
PFE,2020-12-14,U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older,https://cdn.snapi.dev/images/v1/e/l/press1---l0frnjdhbb.jpg,Business Wire,"NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted today to recommend the use of the Pfizer-BioNTech COVID-19 vaccine in people 16 years of age and older under the Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Administration (FDA). This ACIP vote follows the December 1, 2020, ACIP recommend",https://www.businesswire.com/news/home/20201212005026/en/U.S.-CDC-Committee-of-Independent-Health-Experts-Recommends-Vaccination-with-Pfizer-and-BioNTech-COVID-19-Vaccine-for-Persons-Ages-16-Years-and-Older/,0.2263,0.34
PFE,2020-12-14,Trucks to play key role in vaccine distribution,https://cdn.snapi.dev/images/v1/p/r/interview-with-ait-1.jpg,FreightWaves,"The biggest and most important civilian logistics project in American history is under way, and trucks are likely to be at the center of it. Trucks operated by UPS Inc. (NYSE:UPS) and FedEx Express, the air express unit of FedEx Corp. (NYSE:FDX) hit the road Saturday to begin distributing hundreds of millions of COVID-19 vaccine shipments designed to end the scourge that has claimed more than 290,000 American lives, just hours after the Food and Drug Administration authorized the emergency use of a vaccine from U.S. drug giant Pfizer Inc. (NYSE:PFE) and its German partner BioNTech.",https://www.freightwaves.com/news/trucks-to-play-key-role-in-vaccine-distribution,0.34,-0.1298
PFE,2020-12-14,A CDC panel just voted to recommend Pfizer's COVID-19 shot for people 16 years and older,https://cdn.snapi.dev/images/v1/a/-/a-cdc-panel-just-voted-to-recommend-pfizers-covid-19-shot-for-people-16-years-and-older.jpg,Business Insider,"The Advisory Committee on Immunization Practices, part of the Centers for Disease Control and Prevention, just voted to recommend Pfizer's coronavirus vaccine for everyone over age 16. The move further paves the way for the shots to be rolled out in the US, although CDC Director Robert Redfield still must accept the panel's recommendation.",https://www.businessinsider.com/cdc-acip-recommend-coronavirus-vaccine-paving-way-to-be-covered-2020-12,0.3612,0.6249
PFE,2020-12-14,Pfizer's Covid vaccine ships within hours. Here's how the U.S. plans to get it to everyone,https://cdn.snapi.dev/images/v1/o/1/106810439-1607797641738-assets-img-media-freezer-13.jpg,CNBC,"The FDA just cleared the first Covid vaccine for emergency use. Within hours, FedEx and UPS will begin shipping 2.9 million doses across the country.",https://www.cnbc.com/2020/12/12/how-fedex-ups-plan-to-distribute-fda-approved-covid-vaccine-when-will-you-get-the-coronavirus-vaccine.html,0.0,-0.296
PFE,2020-12-14,"CDC panel clears Pfizer Covid vaccine for people 16 years and older, clearing another pivotal hurdle",https://cdn.snapi.dev/images/v1/k/x/106544019-1589903717399gettyimages-1207345881.jpeg,CNBC,A key U.S. Centers for Disease Control and Prevention panel voted unanimously to recommend Pfizer-BioNTech's Covid-19 vaccine for people 16 years and older on Saturday.,https://www.cnbc.com/2020/12/12/cdc-panel-clears-pfizer-covid-vaccine-for-people-over-age-of-16.html,0.0772,0.3612
PFE,2020-12-14,Pfizer Covid Vaccine Expected To Arrive In All 50 States By Monday,https://cdn.snapi.dev/images/v1/i/r/pfizer-covid-vaccine-expected-to-arrive-in-all-50-states-by-monday.jpg,Forbes,"The vaccines are already being packaged, an official said.",https://www.forbes.com/sites/nicholasreimann/2020/12/12/pfizer-covid-vaccine-expected-to-arrive-in-all-50-states-by-monday/,0.0,0.0
PFE,2020-12-14,Why the U.K. Beat the U.S. in Authorizing a COVID Vaccine,https://cdn.snapi.dev/images/v1/p/o/podc13---xohicasui1.jpg,The Motley Fool,Hint: It's all about the process.,https://www.fool.com/investing/2020/12/12/why-the-uk-beat-the-us-in-authorizing-a-covid-vacc/,0.0,0.0
PFE,2020-12-14,"FedEx, UPS activate delivery networks after FDA approves Pfizer vaccine",https://cdn.snapi.dev/images/v1/q/m/fedex-and-ups-1.jpg,FreightWaves,"FedEx (NYSE: FDX) and UPS (NYSE: UPS) refrigerated trucks are expected to roll out of Pfizer's (NYSE: PFE) pharmaceutical facilities Saturday, carrying the first 3.2 million-dose batch of COVID-19 vaccines to designated drop facilities in each state and to airports for longer trips. The Food and Drug Administration on Friday night gave the go-ahead for the drug's emergency public use.",https://www.freightwaves.com/news/fedex-ups-activate-delivery-networks-after-fda-approves-pfizer-vaccine,0.4019,-0.5719
PFE,2020-12-14,"Most people with allergies should get Pfizer's coronavirus shot, according to the FDA",https://cdn.snapi.dev/images/v1/m/o/most-people-with-allergies-should-get-pfizers-coronavirus-shot-according-to-the-fda.jpg,Business Insider,"People with common allergies to foods or to things in the environment like pollen or dust probably don't have to worry about having a serious reaction to the just-authorized Pfizer coronavirus vaccine, the US Food and Drug Administration said during a press conference on Saturday.  Even people who've had a severe allergic reaction to food or to something in the environment in the past should be OK to get the shot, Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said during the briefing. FDA said that people who are allergic to the shot itself or to one of its ingredients shouldn't get it.",https://www.businessinsider.com/fda-people-allergies-can-take-pfizer-coronavirus-vaccine-2020-12,0.0,0.1378
PFE,2020-12-14,FDA Authorizes Pfizer and BioNTech's Coronavirus Vaccine,https://cdn.snapi.dev/images/v1/7/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6047292fvaccination-5jpgw700opresize.jpg,The Motley Fool,Don't call it an approval -- yet.,https://www.fool.com/investing/2020/12/12/fda-authorizes-pfizer-and-biontechs-coronavirus-va/,0.0,0.4767
PFE,2020-12-14,Pfizer's COVID-19 vaccine wins emergency use authorisation from the U.S. FDA,https://cdn.snapi.dev/images/v1/t/o/56848336-s-740x416.jpg,Invezz,Pfizer Inc. (NYSE: PFE) received emergency use authorisation from the U.S. Food and Drug Administration (FDA) for its COVID-19 vaccine that it developed in collaboration with Germany's BioNTech on Friday. The first round of vaccination comprising 2.9 million doses will begin in the upcoming week and focus primarily on elderly patients and healthcare workers this month.,https://invezz.com/news/2020/12/12/pfizers-covid-19-vaccine-wins-emergency-use-authorisation-from-the-u-s-fda/,0.2732,-0.3818
PFE,2020-12-14,Pfizer-BioNTech Gets FDA Nod For Emergency Use Of Coronavirus Vaccine; Deliveries To Begin Immediately,https://cdn.snapi.dev/images/v1/c/o/virus-4937553-1920-1-1.jpg,Benzinga,"The U.S. became the fifth nation behind the U.K., Bahrain, Canada and Saudi Arabia to approve a coronavirus vaccine candidate for emergency use. The verdict from the drug regulator came swifter than even the rapid timeline expected by many.",https://www.benzinga.com/general/biotech/20/12/18762366/pfizer-biontech-gets-fda-nod-for-emergency-use-of-coronavirus-vaccine-deliveries-to-begin-immedia,-0.3818,-0.25
PFE,2020-12-14,"How Pfizer delivered a COVID vaccine in record time: Crazy deadlines, a pushy CEO",https://cdn.snapi.dev/images/v1/b/c/biotech11---dojm3irmqj.jpg,Fox Business,Albert Bourla and his team overcame unproven science and manufacturing bottlenecks; ‘you're asking for too much.'.,https://www.foxbusiness.com/markets/behind-pfizer-record-covid-vaccine-effort,-0.5423,0.0
PFE,2020-12-14,Is It Too Late to Get in on This Millionaire-Maker Stock?,https://cdn.snapi.dev/images/v1/u/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6037722fgettyimages-1209372918jpgw700opresize.jpg,The Motley Fool,A biotech that no one has heard of has been making a few investors rich for much of 2020.,https://www.fool.com/investing/2020/12/12/is-it-too-late-to-get-in-on-this-millionaire-maker/,0.0,0.34
PFE,2020-12-14,Better Coronavirus Stock: Johnson & Johnson vs. Pfizer,https://cdn.snapi.dev/images/v1/k/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038382f2-scientists-in-lab-standing-side-by-sidejpgw700opresize.jpg,The Motley Fool,"Their COVID-19 vaccine programs are important, but both of these healthcare giants have other growth drivers.",https://www.fool.com/investing/2020/12/12/better-coronavirus-stock-johnson-johnson-vs-pfizer/,0.4404,0.5859
PFE,2020-12-11,White House pressured FDA to approve Pfizer vaccine: Report,https://cdn.snapi.dev/images/v1/7/z/white-house-pressured-fda-to-approve-pfizer-vaccine-report.jpg,Yahoo Finance,Yahoo Finance's Anjalee Khemlani reports on the latest vaccine news and the Washington Post article that stated the White House Chief of Staff Mark Meadows pressured Food and Drug Administration Commissioner Stephen Hahn to approve the coronavirus vaccine.,https://www.youtube.com/watch?v=O0ULBNlxKIY,-0.2263,-0.2263
PFE,2020-12-11,Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19,https://cdn.snapi.dev/images/v1/m/w/press3---croinkg44k.jpg,Business Wire,"NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of the mRNA vaccine, BNT162b2, against COVID-19 in individuals 16 years of age or older. The vaccine is now authorized under an Emergency Use Authorization (EUA) while Pfizer and BioNTech gather additional data and prepare to file a planned Biologics License Application (BLA) with the FDA for a possib",https://www.businesswire.com/news/home/20201211005640/en/Pfizer-and-BioNTech-Celebrate-Historic-First-Authorization-in-the-U.S.-of-Vaccine-to-Prevent-COVID-19/,0.5859,-0.6369
PFE,2020-12-11,FDA authorizes Pfizer's COVID-19 vaccine for emergency use,https://cdn.snapi.dev/images/v1/2/w/005-syringe-glove-mask-covid-coronavirus-vaccine-pfizer-moderna-astrazenica-race-stock-prices-biosecurity.jpg,CNET,Vaccinations could start as soon as next week.,https://www.cnet.com/news/fda-authorizes-pfizers-covid-19-vaccine-for-emergency-use/,-0.3818,0.0
PFE,2020-12-11,First COVID-19 vaccine receives emergency approval in U.S.,https://cdn.snapi.dev/images/v1/i/m/im-271342width620size15005861664712778.jpg,Market Watch,"The Food and Drug Administration authorized BioNTech and Pfizer Inc.'s COVID-19 vaccine Friday evening, which will make it the first vaccine for the coronavirus to reach Americans during the public-health crisis.",https://www.marketwatch.com/story/first-covid-19-vaccine-receives-emergency-approval-in-u-s-11607742063,0.128,-0.6124
PFE,2020-12-11,FDA Authorizes Emergency Use Of Pfizer's Coronavirus Vaccine,https://cdn.snapi.dev/images/v1/c/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6017202fgettyimages-1210736764jpgw700opresize.jpg,Deadline,"The Food and Drug Administration gave emergency use authorization for the first time to a coronavirus vaccine, a milestone in the fight against the pandemic that has resulted in the deaths of almost 100,000 Americans. “Today's action follows an open and transparent review process that included input from independent scientific and public health experts and...",https://deadline.com/2020/12/coronavirus-vaccine-fda-1234655445/,-0.3818,-0.6369
PFE,2020-12-11,"FDA grants emergency use authorization for Pfizer's COVID-19 vaccine, distribution to begin within days",https://cdn.snapi.dev/images/v1/b/5/gettyimages-1229654222jpgw600.jpg,TechCrunch,"The U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for the COVID-19 vaccine developed by Pfizer and its partner BioNTech, the New York Times first reported on Friday night, and later supported by The Wall Street Journal. This EUA follows a recommendation by an independent panel of experts commissioned by the […]",https://techcrunch.com/2020/12/11/fda-grants-emergency-use-authorization-for-pfizers-covid-19-vaccine-distribution-to-begin-within-days/,-0.1779,0.1779
PFE,2020-12-11,FDA approves Pfizer's Covid vaccine for emergency use as U.S. reaches pivotal moment in the pandemic,https://cdn.snapi.dev/images/v1/i/e/106787444-16049259982020-10-30t210259z-392434681-rc29tj9cenfb-rtrmadp-0-health-coronavirus-vaccine.jpeg,CNBC,"The FDA has approved Pfizer and BioNTech's coronavirus vaccine for emergency use, a monumental turning point in the once-in-a-century pandemic.",https://www.cnbc.com/2020/12/11/pfizer-covid-vaccine-approved-fda-emergency-use.html,0.0772,0.0516
PFE,2020-12-11,PFIZER SHOT GETS OK: US regulators greenlight first coronavirus vaccine for emergency use,https://cdn.snapi.dev/images/v1/u/k/uk-approves-pfizer-biontechs-covid-19-vaccine-the-first-country-to-do-so.jpg,Business Insider,"US regulators have authorized the first coronavirus vaccine for emergency use, marking an inflection point in the pandemic and kicking off what's set to be the largest vaccination campaign in US history. The US Food and Drug Administration OK'd a highly effective COVID-19 vaccine developed by the drugmakers Pfizer and BioNTech, FDA said in a letter on its website. The decision followed an endorsement from an independent expert panel that reviewed data on the shot.",https://www.businessinsider.com/fda-authorizes-pfizer-biontech-coronavirus-vaccine-for-us-emergency-use-2020-12,0.0857,0.4754
PFE,2020-12-11,FDA advisor who voted against recommending Pfizer's Covid vaccine explains why she would ‘be first in line' to get it,https://cdn.snapi.dev/images/v1/g/y/106809695-1607644402725-vac.jpg,CNBC,"Dr. Archana Chatterjee, dean of the Chicago Medical School, who was one of the four FDA panel “no” votes, explains her decision.",https://www.cnbc.com/2020/12/11/fda-advisor-who-voted-against-recommending-pfizers-covid-vaccine-explains-why-she-would-be-first-in-line-to-get-it.html,0.0,0.0
PFE,2020-12-11,Pfizer factory prepares to ship vaccine nationwide,https://cdn.snapi.dev/images/v1/x/n/pfizer-factory-prepares-to-ship-vaccine-nationwide.jpg,CNBC Television,NBC's Gabe Gutierrez reports on a Pfizer factory in the U.S. that's preparing to ship out the Covid vaccine nationwide.,https://www.youtube.com/watch?v=Li0oCFCiRTg,0.0,0.0
PFE,2020-12-11,"CDC will monitor for Bell's palsy among Pfizer vaccine recipients, but sees no causal relationship",https://cdn.snapi.dev/images/v1/o/f/106807760-1607433123297-gettyimages-1230009194-afp-8wp4z2.jpeg,CNBC,"There is ""no known or expected causal relationship between the vaccine and Bell's palsy,"" the Centers for Disease Control and Prevention said Friday.",https://www.cnbc.com/2020/12/11/cdc-monitors-for-bells-palsy-among-pfizer-vaccine-recipients-sees-no-causal-relationship.html,-0.4215,-0.296
PFE,2020-12-11,Institutional Interest In Volatile Bitcoin Could Bring Record Highs In 2021,https://cdn.snapi.dev/images/v1/x/e/etf19.jpg,InvestorPlace,"Although short-term profit-taking will likely put pressure on Bitcoin, long-term investors could consider investing in digital assets. The post Institutional Interest In Volatile Bitcoin Could Bring Record Highs In 2021 appeared first on InvestorPlace.",https://investorplace.com/2020/12/institutional-interest-in-volatile-bitcoin-could-bring-record-highs-in-2021/,0.4588,0.3612
PFE,2020-12-11,US closer to approving Pfizer coronavirus vaccine for emergency use,https://cdn.snapi.dev/images/v1/9/v/skynews-pfizer-coronavirus-5167467jpg20201110092122.jpg,Skynews,"The US government is expected to approve the Pfizer COVID-19 vaccine for emergency use within hours, according to reports.",https://news.sky.com/story/covid-19-us-closer-to-approving-pfizer-coronavirus-vaccine-for-emergency-use-12158491,-0.3818,-0.3818
PFE,2020-12-11,Pfizer Analyst Breaks Down The FDA Process For Coronavirus Vaccine Candidate,https://cdn.snapi.dev/images/v1/m/q/medicine-5103043-1920-27.jpg,Benzinga,"Pfizer Inc. (NYSE: PFE) and BioNTech SE's – ADR (NASDAQ: BNTX) coronavirus vaccine candidate passed the Adcom test, with the FDA panel voting 17-4 in favor of its risk-benefit profile in individuals 16 and older.  Here's SVB Leerink analyst Geoffrey Porges' take on the dynamics of the Adcom vote.",https://www.benzinga.com/analyst-ratings/analyst-color/20/12/18754175/pfizer-analyst-breaks-down-the-fda-process-for-coronavirus-vaccine-candidate,0.0,0.5859
PFE,2020-12-11,"White House threatens to fire FDA chief unless Pfizer Covid vaccine approved Friday, report says",https://cdn.snapi.dev/images/v1/7/d/106256485-1574272467663gettyimages-1183636908r.jpg,CNBC,"White House chief of staff Mark Meadows told the head of the FDA to submit his resignation if the agency doesn't clear Pfizer's vaccine for emergency use by day's end, according to reports.",https://www.cnbc.com/2020/12/11/white-house-threatens-to-fire-fda-chief-unless-covid-vaccine-oked-friday-report.html,-0.296,-0.717
PFE,2020-12-11,FDA vaccine committee member explains why he voted yes on Pfizer's vaccine,https://cdn.snapi.dev/images/v1/9/l/fda-vaccine-committee-member-explains-why-he-voted-yes-on-pfizers-vaccine.jpg,CNBC Television,"Dr. Paul Offit, Director of The Vaccine Center at Children's Hospital of Philadelphia, joins 'Power Lunch' to discuss why he voted to authorize Pfizer's vaccine and the concerns of those who voted against the vaccine.",https://www.youtube.com/watch?v=ALqHbPnsYuU,0.4019,0.0
PFE,2020-12-11,Coronavirus vaccine distribution in the US: Emergency use authorization expected this weekend,https://cdn.snapi.dev/images/v1/m/q/coronavirus-vaccine-distribution-in-the-us-emergency-use-authorization-expected-this-weekend.jpg,Yahoo Finance,Yahoo Finance's Anjalee Khemlani reports the latest news on vaccine distribution.,https://www.youtube.com/watch?v=2v5jaDYdwNg,-0.3818,0.0
PFE,2020-12-11,FDA's Pfizer COVID vaccine approval means Moderna's just days away,https://cdn.snapi.dev/images/v1/t/1/biotech40.jpg,Fox Business,Moderna is next in line to win FDA approval for its COVID-19 vaccine.,https://www.foxbusiness.com/markets/pfizers-coronavirus-fdamoderna-vaccine-approval-days-away,0.4767,0.7845
PFE,2020-12-11,The FDA is preparing to authorize Pfizer's vaccine,https://cdn.snapi.dev/images/v1/t/h/the-fda-is-preparing-to-authorize-pfizers-vaccine.jpg,Business Insider,"Hello, What a week it's been. If you had any doubts this month could be one long marathon of vaccine news, this week certainly proved the case.",https://www.businessinsider.com/business-insiders-biggest-healthcare-stories-week-ending-december-11-2020-12,0.0,0.0516
PFE,2020-12-11,FDA's review of Pfizer vaccine is encouraging: Caret Group's Hassan,https://cdn.snapi.dev/images/v1/p/i/fdas-review-of-pfizer-vaccine-is-encouraging-caret-groups-hassan.jpg,CNBC Television,"CNBC's ""Squawk on the Street"" team discusses the FDA's review of the Pfizer vaccine for emergency use authorization with Fred Hassan, Caret Group chairman.",https://www.youtube.com/watch?v=QglO19BHmxY,0.5267,-0.3818
PFE,2020-12-11,"California to begin vaccine rollout of 327,000 Pfizer doses",https://cdn.snapi.dev/images/v1/h/p/california-to-begin-vaccine-rollout-of-327000-pfizer-doses.jpg,CNBC Television,CNBC's Kate Rogers reports on how California is preparing to rollout vaccines.,https://www.youtube.com/watch?v=r5qdyJs97NA,0.0,0.0
PFE,2020-12-11,Pfizer board member Gottlieb on FDA's move toward emergency approval,https://cdn.snapi.dev/images/v1/j/4/pfizer-board-member-gottlieb-on-fdas-move-toward-emergency-approval.jpg,CNBC Television,"An FDA advisory panel voted Thursday to recommend emergency use authorization for Pfizer's vaccine, taking the U.S. one step closer to full approval. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins ""Squawk Box"" to discuss.",https://www.youtube.com/watch?v=i-spW_vk3ac,0.128,0.4588
PFE,2020-12-11,Coronavirus vaccine: Pfizer COVID-19 vaccine shots expected to start in a few days: Azar US Sec HHS,https://cdn.snapi.dev/images/v1/6/1/coronavirus-vaccine-pfizer-covid-19-vaccine-shots-expected-to-start-in-a-few-days-azar-us-sec-hhs.jpg,Yahoo Finance,"Yahoo Finance's Anjalee Khemlani reports on the latest news on coronavirus Pfizer vaccine approval and distribution. #coronavirusvaccine #COVID-19vaccine #Pfizervaccine For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.",https://www.youtube.com/watch?v=ohZU152lUv0,0.0,0.886
PFE,2020-12-11,FDA Says It Will 'Rapidly' Authorize Pfizer's Covid Vaccine; But Shares Fall,https://cdn.snapi.dev/images/v1/l/k/biotech33.jpg,Investors Business Daily,"Food and Drug Administration Commissioner Stephen Hahn said the agency would ""rapidly"" authorize Pfizer and BioNTech's coronavirus vaccine — but Pfizer stock fell early Friday. The post FDA Says It Will 'Rapidly' Authorize Pfizer's Covid Vaccine; But Shares Fall appeared first on Investor's Business Daily.",https://www.investors.com/news/technology/pfizer-stock-jumps-fda-rapidly-authorize-coronavirus-vaccine/,0.296,0.4215
PFE,2020-12-11,"LIVE | Pfizer, Disney, Costco: Jim Cramer's Stock Market Breakdown - Dec. 11",https://cdn.snapi.dev/images/v1/k/i/live-pfizer-disney-costco-jim-cramers-stock-market-breakdown-dec-11.jpg,The Street,"In Friday's stock market breakdown, Jim Cramer talks Costco, Disney, Lululemon, Pfizer, bitcoin and more.",https://www.youtube.com/watch?v=qBS1iW5KIj4,0.0,0.0
PFE,2020-12-11,Pfizer/BioNTech COVID-19 Vaccine Gets FDA Panel's Backing,https://cdn.snapi.dev/images/v1/n/c/biotech31.jpg,Zacks Investment Research,An FDA panel recommends granting approval for emergency use of Pfizer's (PFE)/BioNTech's (BNTX) COVID-19 vaccine,https://www.zacks.com/stock/news/1154123/pfizer-biontech-covid-19-vaccine-gets-fda-panels-backing,0.0258,0.5719
PFE,2020-12-11,Pfizer and Moderna could score $32 billion in Covid-19 vaccine sales -- in 2021 alone,https://cdn.snapi.dev/images/v1/w/r/201209123827-pfizer-biontech-coronavirus-vaccine-wales-1208-super-169.jpg,CNN Business,"The imminent authorization of Pfizer's Covid-19 vaccine in the United States is a momentous occasion for science, the economy and humanity. The milestone is also a major moneymaker for the companies that developed the vaccines.",https://www.cnn.com/2020/12/11/business/pfizer-vaccine-covid-moderna-revenue/index.html,-0.25,0.4215
PFE,2020-12-11,"Covid-19 Vaccinations Could Start ‘Monday Or Tuesday' As FDA Set To Approve Pfizer Vaccine, HHS Chief Says",https://cdn.snapi.dev/images/v1/q/w/covid-19-vaccinations-could-start-monday-or-tuesday-as-fda-set-to-approve-pfizer-vaccine-hhs-chief-says.jpg,Forbes,Alex Azar said the government is on “just the last dotting of i's and crossing of t's” before it approves the first vaccine.,https://www.forbes.com/sites/alisondurkee/2020/12/11/covid-19-vaccinations-could-start-monday-or-tuesday-as-fda-set-to-approve-pfizer-vaccine-hhs-chief-says/,0.0,0.4019
PFE,2020-12-11,"FDA 'Rapidly Working' On Emergency Use Authorization For Pfizer, BioNTech's Coronavirus Vaccine",https://cdn.snapi.dev/images/v1/x/i/syringe-1884758-1920-79.jpg,Benzinga,"In a historic development, an FDA committee overwhelmingly voted in favor Thursday of the agency approving BNT162b2, an mRNA vaccine being developed by Pfizer Inc. (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) against the coronavirus.  What Happened: FDA has informed Pfizer that the agency is rapidly working toward finalization and issuance of an emergency use authorization for its co-developed investigational vaccine, FDA Commissioner Stephen Hahn said in a Friday statement.",https://www.benzinga.com/general/biotech/20/12/18751042/fda-rapidly-working-on-emergency-use-authorization-for-pfizer-biontechs-coronavirus-vaccine,-0.3818,-0.1027
PFE,2020-12-11,Azar credits 'Trump's personal leadership' for speed of Pfizer vaccine,https://cdn.snapi.dev/images/v1/w/l/azar-credits-trumps-personal-leadership-for-speed-of-pfizer-vaccine.jpg,Fox Business,Health and Human Services Secretary Alex Azar gives update on Pfizer coronavirus vaccine emergency approval. Subscribe to Fox Business!,https://www.youtube.com/watch?v=tvxc88xmrtE,0.3612,0.2003
PFE,2020-12-11,Pfizer climbs 2% as FDA nears final authorization of its COVID-19 vaccine,https://cdn.snapi.dev/images/v1/p/f/pfizer-climbs-2-as-fda-nears-final-authorization-of-its-covid-19-vaccine.jpg,Business Insider,"Pfizer gained as much as 2.2% in early Friday trading after a panel of experts recommended that the US Food and Drug Administration approve its coronavirus vaccine for emergency use. The group, which included infectious disease experts, statisticians, and public health scientists, voted 17 to 4 on Thursday in favor of authorizing the shot for people at least 16 years old. One member abstained.",https://markets.businessinsider.com/news/stocks/pfizer-stock-price-fda-hahn-emergency-coronavirus-vaccine-authorization-pfe-2020-12-1029885460,0.0,0.5423
PFE,2020-12-11,"Pfizer's Vaccine Will Be Authorized for Emergency Use, Azar Says",https://cdn.snapi.dev/images/v1/r/e/regulator-says-yes-to-pfizer-and-biontech-uk-becomes-first-western-country-to-have-a-coronavirus-vaccine---gw4huskkzi.jpg,Barrons,Here's what you need to know about the impact of Covid-19 to navigate the markets today.,https://www.barrons.com/articles/news-updates-51607694694,-0.3818,0.0
PFE,2020-12-11,Physician on FDA advisory board explains her decision to vote against Pfizer vaccine,https://cdn.snapi.dev/images/v1/5/z/physician-on-fda-advisory-board-explains-her-decision-to-vote-against-pfizer-vaccine.jpg,CNBC Television,"Not every member of the FDA advisory panel voted in favor of emergency use authorization for the Pfizer-BioNTech's Covid vaccine. Dr. Archana Chatterjee, Dean of the Chicago Medical School, was a member of the FDA committee.",https://www.youtube.com/watch?v=vPTFb2Ebr0k,0.0,0.0258
PFE,2020-12-11,Pfizer coronavirus vaccine to receive FDA emergency-use authorization: Alex Azar,https://cdn.snapi.dev/images/v1/n/3/biotech21.jpg,Fox Business,"The Food and Drug Administration will grant emergency-use authorization for the COVID-19 vaccine developed by Pfizer and BioNTech, Health and Human Services Secretary Alex Azar said Friday.",https://www.foxbusiness.com/markets/pfizer-to-recieve-fda-emergency-use-authorization-alex-azar,0.0,0.3612
PFE,2020-12-11,FDA advisor explains why she voted against recommending Pfizer's Covid vaccine for emergency use,https://cdn.snapi.dev/images/v1/d/w/106787444-16049259982020-10-30t210259z-392434681-rc29tj9cenfb-rtrmadp-0-health-coronavirus-vaccine.jpeg,CNBC,"Dr. Archana Chatterjee told CNBC on Friday she's ""fully supportive"" of emergency use authorization for people who are 18 years and older.",https://www.cnbc.com/2020/12/11/dr-archana-chatterjee-explains-her-fda-panel-no-vote-on-pfizer-covid-vaccine.html,-0.3818,-0.0953
PFE,2020-12-11,"The FDA says it will authorize Pfizer's COVID-19 vaccine, which could be rolled out as early as Monday",https://cdn.snapi.dev/images/v1/t/h/the-fda-says-it-will-authorize-pfizers-covid-19-vaccine-which-could-be-rolled-out-as-early-as-monday.jpg,Business Insider,"The US Food and Drug Administration (FDA) has said it intends to authorize Pfizer and BioNTech's COVID-19 vaccine. It ""will rapidly work toward finalization and issuance of an emergency use authorization"" for Pfizer's shot, it said Friday morning. The vaccine would be the first to be authorized for use in the US.",https://www.businessinsider.com/fda-authorize-pfizer-covid-vaccine-biontech-alex-azar-2020-12,0.0,-0.3818
PFE,2020-12-11,BAVENCIO® (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma,https://cdn.snapi.dev/images/v1/p/o/press1---qpmj33rnju.jpg,PRNewsWire,"ROCKLAND, Mass. and NEW YORK, Dec. 11, 2020 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...",https://www.prnewswire.com/news-releases/bavencio-avelumab-receives-positive-chmp-opinion-for-first-line-maintenance-treatment-of-locally-advanced-or-metastatic-urothelial-carcinoma-301191189.html,0.6808,0.0
PFE,2020-12-11,FDA chief says agency will quickly approve Pfizer's Covid vaccine for emergency use,https://cdn.snapi.dev/images/v1/s/s/fda-chief-says-agency-will-quickly-approve-pfizers-covid-vaccine-for-emergency-use.jpg,CNBC Television,"The U.S. Food and Drug Administration is ""rapidly"" working toward clearing Pfizer's Covid-19 vaccine for emergency use after a key panel overwhelmingly endorsed the shots Thursday evening, Commissioner Stephen Hahn said in a statement on Friday. CNBC's Meg Tirrell reports.",https://www.youtube.com/watch?v=7pz4FiH0t88,-0.3818,-0.2732
PFE,2020-12-11,FDA chief says agency will quickly approve Pfizer's Covid vaccine for emergency use.,https://cdn.snapi.dev/images/v1/w/u/106809694-16076441102020-12-10t133915z-162623677-rc2dkk9lddra-rtrmadp-0-health-coronavirus-pfizer-vaccine.jpeg,CNBC,A key FDA advisory panel overwhelmingly endorsed the Pfizer's Covid-19 vaccine Thursday evening.,https://www.cnbc.com/2020/12/11/fda-chief-says-agency-will-quickly-approve-pfizers-covid-vaccine-for-emergency-use.html,-0.3818,0.128
PFE,2020-12-11,FDA said it plans to issue emergency authorization to BioNTech/Pfizer's COVID-19 vaccine,https://cdn.snapi.dev/images/v1/u/w/biotech20.jpg,Market Watch,"The Food and Drug Administration plans to finalize and issue an emergency use authorization to BioNTech and Pfizer Inc.'s experimental COVID-19 vaccine, the regulator said Friday. Shares of BioNTech gained 1.5% in premarket trading on Friday, while Pfizer's stock was up 2.1%.",https://www.marketwatch.com/story/fda-said-it-plans-to-issue-emergency-authorization-to-biontechpfizers-covid-19-vaccine-2020-12-11,-0.3818,0.296
PFE,2020-12-11,FDA advisory panel member Dr. Ofer Levy on voting to approve the Pfizer vaccine for emergency use,https://cdn.snapi.dev/images/v1/u/k/fda-advisory-panel-member-dr-ofer-levy-on-voting-to-approve-the-pfizer-vaccine-for-emergency-use.jpg,CNBC Television,"Dr. Ofer Levy, Director of the Precision Vaccines Program at Boston Children's Hospital, and a member of the FDA advisory committee evaluating the Pfizer and Moderna vaccines, joins Worldwide Exchange after the panel voted in favor of emergency use authorization for Pfizer's Covid-19 vaccine.",https://www.youtube.com/watch?v=M53BsTjQins,-0.3818,0.0258
PFE,2020-12-11,How hospitals are prepping to administer the Pfizer-BioNtech Covid vaccine,https://cdn.snapi.dev/images/v1/z/w/how-hospitals-are-prepping-to-administer-the-pfizer-biontech-covid-vaccine.jpg,CNBC Television,"Once the Covid vaccine is delivered, what happens inside the hospital? CNBC's Frank Holland got a look at how one hospital in Newark, New Jersey is preparing to administer hundreds of vaccinations daily.",https://www.youtube.com/watch?v=ckocLOMMkQs,0.0,0.0
PFE,2020-12-11,Pfizer raises quarterly cash dividend to 39 cents a share vs. 38 cents,https://cdn.snapi.dev/images/v1/8/w/drugs36.jpg,Market Watch,Pfizer Inc. said Friday's its board has raised its quarterly cash dividend to 39 cents a share from 38 cents in the year-earlier period. The new dividend will be payable March 5 to shareholders of record as of Jan. 29.,https://www.marketwatch.com/story/pfizer-raises-quarterly-cash-dividend-to-39-cents-a-share-vs-38-cents-2020-12-11,0.296,0.296
PFE,2020-12-11,Why two members of the FDA advisory panel on the Pfizer-BioNTech vaccine voted against approval,https://cdn.snapi.dev/images/v1/a/f/why-two-members-of-the-fda-advisory-panel-on-the-pfizer-biontech-vaccine-voted-against-approval.jpg,CNBC Television,"An FDA advisory panel voted Thursday to recommend emergency use authorization for Pfizer's vaccine, taking the U.S. one step closer to full approval. CNBC's Meg Tirrell reports.",https://www.youtube.com/watch?v=2EtAzVy89ZU,0.4767,0.4588
PFE,2020-12-11,2 Best Coronavirus Stocks to Buy Right Now,https://cdn.snapi.dev/images/v1/v/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6041482fgettyimages-1221650152jpgw700opresize.jpg,The Motley Fool,These companies haven't even started to report revenue from their COVID-19 projects yet.,https://www.fool.com/investing/2020/12/11/2-best-coronavirus-stocks-to-buy-right-now/,0.6369,0.0
PFE,2020-12-11,These 5 Mid-Cap Healthcare Stocks Had the Best Gains in 2020,https://cdn.snapi.dev/images/v1/n/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038852fgettyimages-1169477832jpgw700opresize.jpg,The Motley Fool,"Investors favored coronavirus vaccine work, late-stage trial victories, and genetic sequencing.",https://www.fool.com/investing/2020/12/11/these-5-mid-cap-healthcare-stocks-had-the-best-gai/,0.765,0.4215
PFE,2020-12-11,This COVID Vaccine Stock Is the Safest Bet of All,https://cdn.snapi.dev/images/v1/a/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038372frisk-and-rewardjpgw700opresize.jpg,The Motley Fool,"If you don't like taking on too big of a risk, here's the coronavirus vaccine stock that's likely right up your alley.",https://www.fool.com/investing/2020/12/11/this-covid-vaccine-stock-is-the-safest-bet-of-all/,0.4019,-0.4956
PFE,2020-12-11,FDA Committee Gives Thumbs Up for Pfizer's COVID Vaccine: 3 Most Important Things to Know,https://cdn.snapi.dev/images/v1/6/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038432fscientist-holding-covid-vaccine-with-thumbs-upjpgw700opresize.jpg,The Motley Fool,Here's what really matters from the FDA advisory committee's historic vote on Thursday.,https://www.fool.com/investing/2020/12/11/fda-committee-gives-thumbs-up-for-pfizers-covid-va/,0.2716,0.101
PFE,2020-12-11,Here's What Investors Need To Know Before Buying Pfizer Stock For Its Coronavirus Vaccine,https://cdn.snapi.dev/images/v1/l/3/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5948752fcovid-19-vaccinejpgw700opresize.jpg,The Motley Fool,"With all eyes on its COVID vaccine candidate, another drug may have more impact on the company's fate -- and its stock price.",https://www.fool.com/investing/2020/12/11/heres-what-investors-need-to-know-before-buying-pf/,0.0,0.0
PFE,2020-12-10,Pfizer-BioNTech COVID-19 Vaccine Gets FDA Advisors' Nod,https://cdn.snapi.dev/images/v1/q/t/cdc-hxhpw1v7-ze-unsplash-3-0.jpg,Benzinga,Pfizer Inc (NYSE: PFE and BioNTech SE (NASDAQ: BNTX) have got the green light on their COVID-19 vaccine from an external panel of experts that advise the United States Food and Drug Administration. What Happened: The Vaccines and Related Biological Products Advisory Committee (VRBPAC)  voted by a large majority of 17 to 4 in favor of giving emergency use authorization (EUA) to the companies' coronavirus vaccine.,https://www.benzinga.com/general/biotech/20/12/18745799/pfizer-biontech-covid-19-vaccine-gets-fda-advisors-nod,0.0,0.6486
PFE,2020-12-10,Michigan prepares for a vaccine rollout as soon as the FDA approves Pfizer vaccine,https://cdn.snapi.dev/images/v1/2/7/michigan-prepares-for-a-vaccine-rollout-as-soon-as-the-fda-approves-pfizer-vaccine.jpg,CNBC Television,"NBC's Gabe Guiterrez joins Shep Smith to report Michigan healthcare workers are already preparing for a vaccine rollout as soon as the FDA approves the Pfizer vaccine for emergency use authorization. Big states will receive 320,000 vaccines, medium states 50,000 and small states about 5,000 vaccines.",https://www.youtube.com/watch?v=rq0J8LXjpzw,0.4019,0.0258
PFE,2020-12-10,Pfizer-BioNTech Covid Vaccine Gets Nod From FDA Advisers,https://cdn.snapi.dev/images/v1/q/r/pfizer-biontech-covid-vaccine-gets-nod-from-fda-advisers.jpg,Bloomberg Markets and Finance,"Dec.10 -- A Food and Drug Administration advisory panel voted 17 to 4, with one abstention, that the benefits of the vaccine from Pfizer Inc. and BioNTech SE outweigh the risks for use in people ages 16 and older. Robert Langreth reports on ""Bloomberg Daybreak: Asia.",https://www.youtube.com/watch?v=sKcjU5l0cwI,0.0,0.128
PFE,2020-12-10,Pfizer Vaccine Gets FDA Nod,https://cdn.snapi.dev/images/v1/x/f/pfizer-vaccine-gets-fda-nod.jpg,Bloomberg Technology,"Dec.10 -- The first Covid-19 vaccine expected to be deployed in the U.S. won the backing of a panel of government advisers. Bloomberg's Michelle Cortez reports on ""Bloomberg Technology.",https://www.youtube.com/watch?v=iSBnx6teFNo,0.0,0.5859
PFE,2020-12-10,Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.,https://cdn.snapi.dev/images/v1/1/q/press12---3drcmqs0d9.jpg,GlobeNewsWire,"NEW YORK and MAINZ, GERMANY, December 10, 2020 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted (17 to 4) in support of the FDA granting Emergency Use Authorization (EUA) for the companies' COVID-19 mRNA vaccine (BNT162b2). There is one member of the Committee whose vote is not included in the 17 to 4 vote decision.",https://www.globenewswire.com/news-release/2020/12/10/2143492/0/en/Pfizer-and-BioNTech-Receive-FDA-Advisory-Committee-Vote-Supporting-Potential-First-Emergency-Use-Authorization-for-Vaccine-to-Combat-COVID-19-in-the-U-S.html,-0.2732,0.34
PFE,2020-12-10,Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.,https://cdn.snapi.dev/images/v1/i/a/press14---l0emak0jrr.jpg,Business Wire,"NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted 17 to 4 in support of the FDA granting Emergency Use Authorization (EUA) for the companies' COVID-19 mRNA vaccine (BNT162b2). There is one member of the Committee whose vote is not included in the 17 to 4 vote decision. VRBPAC based its recommendation on the",https://www.businesswire.com/news/home/20201210006182/en/Pfizer-and-BioNTech-Receive-FDA-Advisory-Committee-Vote-Supporting-Potential-First-Emergency-Use-Authorization-for-Vaccine-to-Combat-COVID-19-in-the-U.S./,-0.2732,0.34
PFE,2020-12-10,FDA advisory council signals support for Pfizer's COVID-19 vaccine,https://cdn.snapi.dev/images/v1/q/7/p-1-fda-vaccine-advisory-councils-signals-support-for-pfizer-vaccine.jpg,Fast Company,"Pfizer's vaccine now has the blessing of the FDA's advisory council, an important step in moving toward approval. A panel of vaccine and infectious disease experts advising the Food and Drug Administration voted to approve Pfizer's COVID-19 vaccine for anyone 16 years and above.",https://www.fastcompany.com/90584895/fda-advisory-council-signals-support-for-pfizers-covid-19-vaccine,0.4019,0.7964
PFE,2020-12-10,FDA Advisory Committee Recommends Emergency Authorization for Pfizer's COVID Vaccine,https://cdn.snapi.dev/images/v1/x/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6045612fphysician-holding-a-vaccine-shotjpgw700opresize.jpg,The Motley Fool,The final green light decision now rests in the FDA's hands.,https://www.fool.com/investing/2020/12/10/fda-advisory-committee-recommends-emergency-author/,-0.1779,0.0
PFE,2020-12-10,FDA Advisory Committee Recommends Authorization of Pfizer's Covid Vaccine,https://cdn.snapi.dev/images/v1/m/0/m02d20201110t2i1540707780w940fhfwllplsqrlynxmpega90pz.jpg,Barrons,"The vote is the final step needed before the FDA makes it's approval decision, which could happen as soon as Friday.",https://www.barrons.com/articles/fda-advisory-committee-recommends-authorizing-pfizer-covid-vaccine-51607642145,0.2263,0.4767
PFE,2020-12-10,FDA panel recommends approval of Pfizer's Covid vaccine for emergency use,https://cdn.snapi.dev/images/v1/f/q/fda-panel-recommends-approval-of-pfizers-covid-vaccine-for-emergency-use.jpg,CNBC Television,"A key Food and Drug Administration advisory panel on Thursday recommended the approval of Pfizer and BioNTech's coronavirus vaccine for emergency use in people over 16 years old, the last step before the FDA gives the final OK to broadly distribute the first doses throughout the United States. If the FDA accepts the nonbinding recommendation from the Vaccines and Related Biological Products Advisory Committee — which is expected — it would mark a pivotal moment in the Covid-19 pandemic, which has infected more than 15.4 million people and killed roughly 290,000 in the U.S. in less than a year.",https://www.youtube.com/watch?v=oBoW6K8XZ9c,0.34,0.1613
PFE,2020-12-10,FDA panel backs Pfizer's COVID-19 vaccine for emergency use in US,https://cdn.snapi.dev/images/v1/t/q/004-syringe-glove-mask-covid-coronavirus-vaccine-pfizer-moderna-astrazenica-race-stock-prices-biosecurity.jpg,CNET,Now it's up to the FDA to decide whether to accept that recommendation. Pfizer says the vaccine has shown 95% effectiveness in clinical trials.,https://www.cnet.com/news/fda-panel-backs-pfizers-covid-19-vaccine-for-emergency-use-in-us/,-0.4215,0.3818
PFE,2020-12-10,Medical experts vote in favor of FDA authorization of BioNTech/Pfizer COVID-19 vaccine candidate,https://cdn.snapi.dev/images/v1/1/a/im-271706width620size14988290398126465.jpg,Market Watch,The Food and Drug Administration will now make the final decision on whether to authorize the experimental vaccine.,https://www.marketwatch.com/story/medical-experts-vote-in-favor-of-fda-authorization-of-biontech-pfizer-covid-19-vaccine-candidate-11607640908,0.4019,0.0
PFE,2020-12-10,FDA panel recommends approving Pfizer's COVID-19 vaccine emergency use authorization,https://cdn.snapi.dev/images/v1/p/s/gettyimages-1230032451jpgw603.jpg,TechCrunch,An independent panel of experts has recommended Food and Drug Administration (FDA) has now voted to approve an official Emergency Use Authorization (EUA) for the Pfizer/BioNTech COVID-19 vaccine. This means that it's one step closer to beginning to be administered to people in special circumstances – including for front-line healthcare workers dealing with healthcare facilities […],https://techcrunch.com/2020/12/10/fda-panel-recommends-approving-pfizers-covid-19-vaccine-emergency-use-authorization/,-0.1779,0.2263
PFE,2020-12-10,"An influential expert panel just gave its blessing to Pfizer's 2-dose coronavirus shot, teeing up the FDA to imminently authorize the US' first COVID-19 vaccine",https://cdn.snapi.dev/images/v1/a/n/an-influential-expert-panel-just-gave-its-blessing-to-pfizers-2-dose-coronavirus-shot-teeing-up-the-fda-to-imminently-authorize-the-us-first-covid-19-vaccine.jpg,Business Insider,"A committee of 22 leading scientists and doctors just voted 17 to 4, with one abstention, encouraging the US Food and Drug Administration to grant emergency use authorization for Pfizer's COVID-19 vaccine in the US. Their vote is not a final verdict, it's really just advice.",https://www.businessinsider.com/fda-advisory-committee-endorses-pfizers-covid-19-vaccine-2020-12,0.7269,0.4322
PFE,2020-12-10,Pfizer COVID-19 vaccine recommended for approval by US government advisory panel,https://cdn.snapi.dev/images/v1/n/u/skynews-brexit-breaking-news-5177180jpg20201123152327.jpg,Skynews,The US government advisory panel has recommended the Pfizer COVID-19 be approved for use.,https://news.sky.com/story/covid-19-pfizer-vaccine-recommended-for-approval-by-us-government-advisory-panel-12157588,0.5994,0.5574
PFE,2020-12-10,FDA panel recommends approval of Pfizer's Covid vaccine for emergency use,https://cdn.snapi.dev/images/v1/h/e/106807762-16074332352020-12-08t113336z-1247632997-rc2zik92aws9-rtrmadp-0-health-coronavirus-britain-rollout.jpeg,CNBC,"If the FDA adopts the recommendation it would mark a pivotal moment in the Covid-19 pandemic, which has killed roughly 290,000 in the U.S. in less than a year.",https://www.cnbc.com/2020/12/10/pfizer-covid-vaccine-fda-panel-recommends-approval-for-emergency-use.html,0.34,-0.5859
PFE,2020-12-10,The Question to Ask About COVID-19 Vaccine Stocks,https://cdn.snapi.dev/images/v1/r/j/drugs30---wemrfr2b6z.jpg,InvestorPlace,The time to pick your horse in the vaccine race was months ago. These stocks were much cheaper before their trials started.,https://investorplace.com/2020/12/the-question-to-ask-about-covid-19-vaccine-stocks/,0.0,0.0
PFE,2020-12-10,Merck CEO: Pfizer and Moderna vaccines look fantastic,https://cdn.snapi.dev/images/v1/t/t/merck-ceo-pfizer-and-moderna-vaccines-look-fantastic.jpg,CNBC Television,"Ken Frazier, Merck Chairman and CEO, joins 'Closing Bell' to discuss Merck's coronavirus vaccines and his thoughts on the other coronavirus vaccines being worked on by other companies.",https://www.youtube.com/watch?v=MdmPtkYB6ko,0.5574,0.0
PFE,2020-12-10,How Safe Is Pfizer's Covid-19 Vaccine? Here's What You Should Know About Reports Of Allergic Reactions In Britain,https://cdn.snapi.dev/images/v1/e/0/how-safe-is-pfizers-covid-19-vaccine-heres-what-you-should-know-about-reports-of-allergic-reactions-in-britain.jpg,Forbes,Two people reported severe allergic reactions to Pfizer and BioNTech's Covid-19 vaccine when it was rolled out in the U.K.,https://www.forbes.com/sites/roberthart/2020/12/10/how-safe-is-pfizers-covid-19-vaccine-heres-what-you-should-know-about-reports-of-allergic-reactions-in-britain/,0.1779,-0.5859
PFE,2020-12-10,"No, there isn't evidence that Pfizer's vaccine causes infertility.",https://cdn.snapi.dev/images/v1/j/5/09distortions-brief-infertility-articlelarge-v2jpgquality75autowebpdisableupscale.jpg,NYTimes,A flurry of rumors online has prompted concern. But scientists assert the claims are baseless.,https://www.nytimes.com/2020/12/10/technology/no-there-isnt-evidence-that-pfizers-vaccine-causes-infertility.html,-0.296,0.0
PFE,2020-12-10,Pfizer/BioNTech COVID-19 Vaccine Raises New Safety Concerns,https://cdn.snapi.dev/images/v1/w/d/biotech8.jpg,Zacks Investment Research,The Bell's palsy related side-effects are not alarming enough to preclude FDA from granting emergency approval to Pfizer (PFE)/BioNTech's (BNTX) COVID-19 vaccine.,https://www.zacks.com/stock/news/1150644/pfizer-biontech-covid-19-vaccine-raises-new-safety-concerns,0.4215,0.4888
PFE,2020-12-10,Jim Cramer: I'm confused why U.S. seems to be taking longer to approve Pfizer's Covid-19 vaccine,https://cdn.snapi.dev/images/v1/w/a/jim-cramer-im-confused-why-us-seems-to-be-taking-longer-to-approve-pfizers-covid-19-vaccine.jpg,CNBC Television,CNBC's Jim Cramer asks CNBC's Meg Tirrell why it might be that Canada and the United Kingdom ended up approving the Pfizer-BioNTech coronavirus vaccine for emergency use before the United States.,https://www.youtube.com/watch?v=_CHMs4jBd5s,-0.3182,0.4588
PFE,2020-12-10,Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine,https://cdn.snapi.dev/images/v1/v/2/press20---du0wihpeqi.jpg,Business Wire,"NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the New England Journal of Medicine has published safety and final efficacy results from the pivotal Phase 3 trial of BNT162b2, their mRNA-based COVID-19 vaccine candidate. In the trial of 43,448 participants, who were 16 years and older, 21,720 of whom received BNT162b2 and 21,728 placebo, the two-dose regimen of 30 μg BNT162b2, which was given 21 days apart, was well-tolerat",https://www.businesswire.com/news/home/20201210005703/en/Pfizer-and-BioNTech-Announce-Publication-of-Results-from-Landmark-Phase-3-Trial-of-BNT162b2-COVID-19-Vaccine-Candidate-in-The-New-England-Journal-of-Medicine/,0.0772,0.4215
PFE,2020-12-10,5 Dividend-Paying Pharmaceutical Stocks to Buy for Solid 2021 Total Return,https://cdn.snapi.dev/images/v1/7/y/drugs21.jpg,24/7 Wall Street,Many prognosticators across Wall Street feel that interest rates will start to rise in 2021 Deutsche Bank is negative on duration and sees the 10-year Treasury bond yield rising to 1.5% in the second quarter of 2021 from the current yield of 0.95%.,https://247wallst.com/healthcare-business/2020/12/10/5-dividend-paying-pharmaceutical-stocks-to-buy-for-solid-2021-total-return/,0.1531,0.0258
PFE,2020-12-10,FDA director: The agency expects to approve Pfizer's vaccine after today's crucial hearing,https://cdn.snapi.dev/images/v1/f/d/fda-director-the-agency-expects-to-approve-pfizers-vaccine-after-todays-crucial-hearing.jpg,Business Insider,"A panel of independent experts is meeting today to evaluate Pfizer's coronavirus vaccine. By day's end, they're expected to come to a vote that will advise the US Food and Drug Administration (FDA) to approve or deny the shot for emergency use.  But FDA Commissioner Dr. Stephen Hahn said the outcome is already predictable, and that the agency intends to act on the advisory panel's advice immediately. ",https://www.businessinsider.com/fda-director-we-expect-to-approve-pfizers-vaccine-after-hearing-2020-12,0.0,-0.6124
PFE,2020-12-10,"Live | Airbnb, Facebook, Pfizer: Jim Cramer's Stock Market Breakdown - Dec. 10",https://cdn.snapi.dev/images/v1/a/8/live-airbnb-facebook-pfizer-jim-cramers-stock-market-breakdown-dec-10.jpg,The Street,"In Thursday's market breakdown, Jim Cramer talks Airbnb, Facebook, Pfizer, jobless claims and more. SUBSCRIBE | http://t.st/TheStreetTV MORE VIDEOS: https://www.thestreet.com/video MORE FROM JIM CRAMER: https://www.thestreet.com/jim-cramer' Sign up for ActionAlertsPlus.com today for exclusive insight into Jim Cramer's charitable portfolio: https://secure2.thestreet.com/cap/prm.do?OID=039029 #JimCramer #Investing #WallStreet",https://www.youtube.com/watch?v=k6tBHdGNLG0,0.0,0.4939
PFE,2020-12-10,FDA likely to weigh allergic reactions of Pfizer's COVID-19 vaccine,https://cdn.snapi.dev/images/v1/l/3/pfizer-covid-vaccinejpgquality90stripall.jpg,New York Post,"The feds will likely scrutinize recent allergic reactions to Pfizer's coronavirus vaccine before clearing it for emergency use, the government's top vaccine adviser said. Two people who received the groundbreaking COVID-19 shot in the UK suffered severe allergic reactions to it, leading British health officials to warn that individuals with “significant” allergic reactions may not.",https://nypost.com/2020/12/10/fda-may-weigh-allergic-reactions-to-pfizer-covid-19-vaccine/,-0.296,-0.9118
PFE,2020-12-10,Vaccine Euphoria Aids Oil in the Face of Huge Supply Build,https://cdn.snapi.dev/images/v1/a/w/oil27.jpg,Zacks Investment Research,"The top gainers of the S&P 500 during the past month are all energy firms - Occidental Petroleum (OXY), Apache (APA), Diamondback Energy (FANG), Marathon Oil (MRO) and Devon Energy (DVN).",https://www.zacks.com/stock/news/1150044/vaccine-euphoria-aids-oil-in-the-face-of-huge-supply-build,0.765,0.7269
PFE,2020-12-10,FDA advisory committee meets Thursday to discuss Pfizer vaccine data,https://cdn.snapi.dev/images/v1/w/d/fda-advisory-committee-meets-thursday-to-discuss-pfizer-vaccine-data.jpg,CNBC Television,The FDA will kick off a meeting Thursday morning made up of a group of independent medical experts who will discuss the risks and benefits of the Pfizer-BioNTech coronavirus vaccine. CNBC's Meg Tirrell reports.,https://www.youtube.com/watch?v=8YTdcGZB5CU,0.0,0.128
PFE,2020-12-10,6 things to know before FDA panel votes on Pfizer's Covid vaccine today,https://cdn.snapi.dev/images/v1/z/m/106808683-1607532026099-2020-12-08t183156z-1175983302-rc26jk9j1u2v-rtrmadp-3-health-coronavirus-vaccines-cdc.jpg,CNBC,A FDA panel is scheduled to vote Thursday on whether to recommend the approval of Pfizer and BioNTech's coronavirus vaccine for emergency use.,https://www.cnbc.com/2020/12/09/pfizer-covid-vaccine-6-things-to-know-before-fda-panel-votes-today.html,0.0,0.4588
PFE,2020-12-10,Pfizer Stock Faces Its Next Big Covid Challenge: An FDA Committee,https://cdn.snapi.dev/images/v1/j/1/drugs24.jpg,Investors Business Daily,A Food and Drug Administration panel will meet Thursday to discuss Pfizer's BioNTech-partnered coronavirus vaccine. The results could spark Pfizer stock and BioNTech stock.,https://www.investors.com/news/technology/pfizer-stock-fda-panel-slated-weigh-coronavirus-vaccine/,0.0772,0.2263
PFE,2020-12-10,3 Best Biotech Stocks of 2020: Are They Buys Now?,https://cdn.snapi.dev/images/v1/o/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038932fgettyimages-1236338088jpgw700opresize.jpg,The Motley Fool,There are plenty of catalysts on the horizon for these investments -- and a healthy dose of risk.,https://www.fool.com/investing/2020/12/10/3-best-biotech-stocks-of-2020-are-they-buys-now/,0.6369,0.1531
PFE,2020-12-10,3 Reasons to Buy Pfizer Stock Now,https://cdn.snapi.dev/images/v1/b/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6040872fgettyimages-1206825409jpgw700opresize.jpg,The Motley Fool,The company has a lot more going for it than just a coronavirus vaccine.,https://www.fool.com/investing/2020/12/10/3-reasons-to-buy-pfizer-stock-now/,0.0,0.0
PFE,2020-12-10,3 Warren Buffett Dividend Stocks You Can Buy Right Now,https://cdn.snapi.dev/images/v1/t/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038332fsmiling-warren-buffett-tmfjpgw700opresize.jpg,The Motley Fool,"Solid dividends and solid businesses. Buffett likes these stocks -- and you might, too.",https://www.fool.com/investing/2020/12/10/3-warren-buffett-dividend-stocks-you-can-buy-right/,0.0,0.6124
PFE,2020-12-10,"Americans with severe allergies may need to avoid Pfizer's COVID-19 shot until the risks are better understood, Trump's vaccine chief said",https://cdn.snapi.dev/images/v1/a/m/americans-with-severe-allergies-may-need-to-avoid-pfizers-covid-19-shot-until-the-risks-are-better-understood-trumps-vaccine-chief-said.jpg,Business Insider,"The Food and Drug Administration (FDA) could advise Americans with severe allergies to take Pfizer's COVID-19 vaccine until more information is known about two allergic reactions to the shot in the UK, Trump's vaccine chief said. The FDA is meeting Thursday to review the vaccine for emergency use, and the first shots could be given out as early as Friday.",https://www.businessinsider.com/slaoui-fda-allergic-reactions-pfizer-covid-19-vaccine-authorization-us-2020-12,-0.4588,-0.7506
PFE,2020-12-10,Pfizer-BioNTech vaccine documents were ‘unlawfully accessed' in a cyberattack on Europe's medicines agency,https://cdn.snapi.dev/images/v1/w/9/106807760-1607433123297-gettyimages-1230009194-afp-8wp4z2.jpeg,CNBC,Documents for the Pfizer-BioNTech Covid-19 vaccine were 'unlawfully accessed' in a cyberattack on the European Medicines Agency.,https://www.cnbc.com/2020/12/10/pfizer-biontech-vaccine-documents-unlawfully-accessed-in-ema-hack.html,0.0,0.0
PFE,2020-12-10,"Pfizer, BioNTech Say Hackers Accessed COVID-19 Vaccine Development Data",https://cdn.snapi.dev/images/v1/a/s/kaitlyn-baker-vzjdyl5jvxy-unsplash.jpg,Benzinga,Pfizer Inc (NYSE: PFE) and its German partner BioNTech SE (NASDAQ: BNTX) said on Wednesday that hackers illegally accessed documents related to their COVID-19 vaccine in an attack on the European Medicines Agency (EMA). What Happened: The two companies said in a statement they believe the personal data of trial participants were not compromised and that the EMA had assured them that the incident would not impact the timeline of the vaccine's review.,https://www.benzinga.com/general/biotech/20/12/18726861/pfizer-biontech-say-hackers-accessed-covid-19-vaccine-development-data,0.0,-0.1531
PFE,2020-12-09,"Canada becomes the latest to authorize Pfizer vaccine, US emergency use expected by end of week",https://cdn.snapi.dev/images/v1/c/m/canada-becomes-the-latest-to-authorize-pfizer-vaccine-us-emergency-use-expected-by-end-of-week.jpg,Yahoo Finance,"Yahoo Finance's Anjalee Khemlani reports on the latest news on COVID-19 vaccine approval in Canada and the United States. #coronavirusvaccine #COVID19vaccine #coronavirus For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.",https://www.youtube.com/watch?v=84AP-7r5uzw,-0.3818,0.9217
PFE,2020-12-09,2.9M Pfizer vaccines can be shipped within 24 hours of FDA clearance,https://cdn.snapi.dev/images/v1/p/u/29m-pfizer-vaccines-can-be-shipped-within-24-hours-of-fda-clearance.jpg,CNBC Television,Two people with a history of severe allergies experienced an allergic reaction after receiving the Pfizer vaccine. This is currently under investigation.,https://www.youtube.com/watch?v=OHYw1VK2DHc,0.0,-0.5859
PFE,2020-12-09,Pfizer (PFE) Dips More Than Broader Markets: What You Should Know,https://cdn.snapi.dev/images/v1/m/t/drugs16.jpg,Zacks Investment Research,"In the latest trading session, Pfizer (PFE) closed at $41.85, marking a -1.67% move from the previous day.",https://www.zacks.com/stock/news/1147953/pfizer-pfe-dips-more-than-broader-markets-what-you-should-know,0.0,0.0
PFE,2020-12-09,"FDA will likely scrutinize allergic reactions to Pfizer's Covid vaccine in UK before clearing use in U.S., Trump vaccine chief says",https://cdn.snapi.dev/images/v1/m/y/106807763-16074332922020-12-08t123316z-1123259786-rc20jk91l78u-rtrmadp-0-health-coronavirus-britain-rollout.jpeg,CNBC,"The allergic reactions reported by U.K. health-care workers vaccinated against Covid-19 shouldn't be a surprise, some medical experts said on Wednesday.",https://www.cnbc.com/2020/12/09/covid-vaccine-fda-will-likely-scrutinize-allergic-reactions-to-pfizers-vaccine-in-uk-before-clearing-use-in-us.html,-0.296,-0.4614
PFE,2020-12-09,Pfizer and BioNTech's Coronavirus Vaccine Approved in Canada,https://cdn.snapi.dev/images/v1/l/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6043572fgettyimages-1168877430jpgw700opresize.jpg,The Motley Fool,It was the third authorization of BNT162b2 by a national healthcare regulator in the space of a week.,https://www.fool.com/investing/2020/12/09/pfizer-and-biontech-coronavirus-vaccine-approved-i/,0.4215,0.0
PFE,2020-12-09,Canada authorizes BioNTech/Pfizer COVID-19 vaccine,https://cdn.snapi.dev/images/v1/w/f/biotech17.jpg,Market Watch,"Shares of BioNTech were down 0.6% and Pfizer Inc.'s stock fell 1.1% in trading on Wednesday after the companies announced that their COVID-19 vaccine candidate had received emergency authorization in Canada. This is the third country, after Bahrain and the United Kingdom, to authorize their coronavirus vaccine.",https://www.marketwatch.com/story/canada-authorizes-biontechpfizer-covid-19-vaccine-2020-12-09,0.0,0.34
PFE,2020-12-09,Canada beats the US to approving Pfizer and BioNTech's coronavirus vaccine,https://cdn.snapi.dev/images/v1/s/y/syringe-1884758-1920-36---xxgsgzmghw.jpg,Business Insider,"Canada approved Pfizer and BioNTech's coronavirus vaccine for use, the country's health department announced on Wednesday. The UK made a similar decision earlier this month, but the vaccine is still awaiting authorization for emergency use in the US.  The vaccine, made by US drugmaker Pfizer and German biotech firm BioNTech, is 95% effective at preventing COVID-19, according to the company's Phase 3 trials. Pfizer predicts it will produce up to 50 million vaccine doses for global distribution by the end of 2020, and up to 1.3 billion doses in 2021.",https://www.businessinsider.com/canada-beats-us-approves-pfizer-biontech-coronavirus-covid-vaccine-2020-12,0.0,0.3612
PFE,2020-12-09,Pfizer Stock Trips After U.K. Notes Possible Allergic Reactions To Covid Vaccine,https://cdn.snapi.dev/images/v1/l/y/drugs14.jpg,Investors Business Daily,Pfizer stock toppled Wednesday on reports of two allergic reactions after the U.K. began its widespread coronavirus vaccine campaign. Both were staff members of the National Health Service.,https://www.investors.com/news/technology/pfizer-stock-dips-possible-allergic-reactions-coronavirus-vaccine/,-0.296,-0.296
PFE,2020-12-09,Canada Approves Pfizer's Coronavirus Vaccine,https://cdn.snapi.dev/images/v1/t/i/canada-approves-pfizers-coronavirus-vaccine.jpg,Forbes,Both Canada and the U.K. have now approved the vaccine for emergency use. It's still under review in the U.S.,https://www.forbes.com/sites/jemimamcevoy/2020/12/09/canada-approves-pfizers-coronavirus-vaccine/,0.4019,0.0516
PFE,2020-12-09,"Pentagon reveals plans to distribute first 44,000 doses of Pfizer vaccine as early as next week",https://cdn.snapi.dev/images/v1/v/m/106808596-1607526062815-5257556-1.jpg,CNBC,"As early as next week, the Department of Defense is slated to receive nearly 44,000 of the first dose of Pfizer's coronavirus vaccine.",https://www.cnbc.com/2020/12/09/pentagon-to-distribute-44000-doses-of-pfizer-vaccine-by-next-week.html,0.0,0.128
PFE,2020-12-09,Artificial Intelligence Just Revealed a Potential Concern for COVID Vaccine Makers,https://cdn.snapi.dev/images/v1/r/k/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6036512fcovid-19-vaccine-vialsjpgw700opresize.jpg,The Motley Fool,Vaccines are another part of the COVID-19 story related to demographics and race.,https://www.fool.com/investing/2020/12/09/artificial-intelligence-just-revealed-a-potential/,0.4767,0.0
PFE,2020-12-09,7 Undervalued Stocks to Buy Now,https://cdn.snapi.dev/images/v1/i/m/computer-electronic38.jpg,InvestorPlace,"Everyone is on the hunt for undervalued stocks. Keep in mind, even more highly valued stocks can be undervalued.",https://investorplace.com/2020/12/7-undervalued-stocks-to-buy-now/,0.0,0.5379
PFE,2020-12-09,Pfizer (PFE) Pneumococcal Vaccine BLA Gets FDA's Priority Tag,https://cdn.snapi.dev/images/v1/g/w/drugs4.jpg,Zacks Investment Research,Pfizer's (PFE) 20-valent pneumococcal conjugate vaccine candidate helps protect against 20 serotypes responsible for the majority of invasive pneumococcal disease and pneumonia.,https://www.zacks.com/stock/news/1146393/pfizer-pfe-pneumococcal-vaccine-bla-gets-fdas-priority-tag,0.0,0.7579
PFE,2020-12-09,U.K. Warns That People With Severe Allergic Reactions Should Not Get Covid-19 Vaccine,https://cdn.snapi.dev/images/v1/p/f/pfizer-covid-19-vaccines-five-big-unknowns.jpg,Barrons,"Tuesday, the U.K. became the first country in the West to roll out a Covid-19 vaccine, administering Pfizer's vaccine less than a week after British regulators gave the go-ahead to begin mass inoculations.",https://www.barrons.com/articles/u-k-warns-that-people-with-severe-allergic-reactions-should-not-get-covid-19-vaccine-51607519895,-0.6369,0.0
PFE,2020-12-09,U.K. Regulator Warns People With ‘Significant' Allergies To Avoid Pfizer-BioNTech Vaccine,https://cdn.snapi.dev/images/v1/g/u/uk-regulator-warns-people-with-significant-allergies-to-avoid-pfizer-biontech-vaccine.jpg,Forbes,The U.K. began widespread vaccination Tuesday after becoming the first western country to authorize the vaccine.,https://www.forbes.com/sites/roberthart/2020/12/09/uk-regulator-warns-people-with-significant-allergies-to-avoid-pfizer-biontech-vaccine/,-0.3818,0.0
PFE,2020-12-09,UK investigates possible allergic reactions to Pfizer coronavirus shot,https://cdn.snapi.dev/images/v1/q/l/m02d20201118t2i1541636034w940fhfwllplsqrlynxmpegah137.jpg,Fox Business,"U.K. regulators said Wednesday that people who have a ""significant history'' of allergic reactions shouldn't receive the new Pfizer-BioNTech vaccine.",https://www.foxbusiness.com/markets/uk-prizer-coronavirus-vaccine-allergic-reactions,-0.296,-0.1027
PFE,2020-12-09,"He got the Pfizer vaccine in the UK, and says everyone else should do the same",https://cdn.snapi.dev/images/v1/q/g/he-got-the-pfizer-vaccine-in-the-uk-and-says-everyone-else-should-do-the-same.jpg,CNBC Television,"Paul Johnston, manager of the Palmerston Residential Home in Northern Ireland, discusses how the long-term facility was the first to receive the Pfizer COVID-19 vaccine.",https://www.youtube.com/watch?v=NZON_MZI1lM,0.0,0.0
PFE,2020-12-09,Could Pfizer Be a Millionaire-Maker Stock?,https://cdn.snapi.dev/images/v1/t/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6032942fgettyimages-1271178839jpgw700opresize.jpg,The Motley Fool,This pharma company has a wildly popular coronavirus vaccine. Will it be enough to lift its stock to record levels?,https://www.fool.com/investing/2020/12/09/could-pfizer-be-a-millionaire-maker-stock/,0.0,0.4215
PFE,2020-12-09,"U.K. regulators warn people with history of ‘significant' allergic reactions not to have Pfizer–BioNTech COVID-19 vaccine, after two adverse reactions",https://cdn.snapi.dev/images/v1/i/q/im-270482width620size15005861664712778.jpg,Market Watch,The U.K. regulator has warned people with a history of “significant allergic reactions” not to have the Pfizer–BioNTech COVID-19 vaccine after two health-care workers had adverse reactions on the first day of the rollout.,https://www.marketwatch.com/story/u-k-regulators-warn-people-with-history-of-significant-allergic-reactions-not-to-have-pfizerbiontech-covid-19-vaccine-after-two-adverse-reactions-11607514857,-0.6249,-0.7003
PFE,2020-12-09,2 Solid Coronavirus Testing Stocks to Buy Now,https://cdn.snapi.dev/images/v1/n/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6035662fcovid-imagejpgw700opresize.jpg,The Motley Fool,"Although vaccine makers are dominating headlines, these diagnostic companies will remain relevant in the fight against COVID-19.",https://www.fool.com/investing/2020/12/09/2-solid-coronavirus-testing-stocks-to-buy-now/,0.1531,-0.5859
PFE,2020-12-09,"After Moderna and Pfizer, Which Vaccine Makers May Cross the Finish Line Next?",https://cdn.snapi.dev/images/v1/1/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6040452fgettyimages-1287178632jpgw700opresize.jpg,The Motley Fool,Don't expect just one or two winners in the coronavirus vaccine race. Be prepared for several.,https://www.fool.com/investing/2020/12/09/after-moderna-and-pfizer-which-vaccine-makers-may/,0.0,0.6124
PFE,2020-12-09,"People with a history of 'significant' allergic reactions shouldn't have Pfizer jab, UK regulator warns",https://cdn.snapi.dev/images/v1/r/y/106807763-16074332922020-12-08t123316z-1123259786-rc20jk91l78u-rtrmadp-0-health-coronavirus-britain-rollout.jpeg,CNBC,"People who have a history of ""significant"" allergic reactions should not currently receive the coronavirus vaccine developed by Pfizer and BioNTech, the U.K. drug regulator said on Wednesday.",https://www.cnbc.com/2020/12/09/pfizer-jab-warning-for-people-with-history-of-significant-allergic-reactions.html,-0.3818,-0.296
PFE,2020-12-09,Here's What Could Make Moderna's COVID Vaccine a Bigger Winner Than Pfizer's,https://cdn.snapi.dev/images/v1/g/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038312f2-covid-vaccines-in-front-of-100jpgw700opresize.jpg,The Motley Fool,Two factors could give Moderna an edge.,https://www.fool.com/investing/2020/12/09/heres-what-could-make-modernas-covid-vaccine-a-big/,0.5859,0.0
PFE,2020-12-09,Pfizer Is Worth The Risk For A Vaccine Payoff,https://cdn.snapi.dev/images/v1/f/5/drugs1.jpg,Seeking Alpha,"Pfizer, Inc. recently made headlines as the first pharmaceutical company to produce a successful COVID-19 vaccine. The company, along with its German partner BioNTech SE, filed for emergency-use authorization in late November.",https://seekingalpha.com/article/4393755-pfizer-is-worth-risk-for-vaccine-payoff,-0.0516,0.5859
PFE,2020-12-08,FDA report finds Pfizer Covid vaccine safe and effective,https://cdn.snapi.dev/images/v1/b/5/fda-report-finds-pfizer-covid-vaccine-safe-and-effective.jpg,CNBC Television,The FDA advisory committee will meet on Dec. 10 to review the Pfizer BioNTech COVID-19 vaccine. CNBC's senior health and science reporter joins Shep Smith with the details.,https://www.youtube.com/watch?v=OriYCbbNAJ4,0.7184,0.0
PFE,2020-12-08,Why Despegar Soared 62% in November,https://cdn.snapi.dev/images/v1/3/f/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6037822fa-woman-walks-through-the-airport-with-a-rolling-suitcasejpgw700opresize.jpg,The Motley Fool,"The company's been in the eye of the storm, but things may be looking up.",https://www.fool.com/investing/2020/12/08/why-despegar-soared-62-in-november/,0.0,0.0
PFE,2020-12-08,The 7 Best Coronavirus Vaccine Stocks Still In The Race For A Cure,https://cdn.snapi.dev/images/v1/m/c/drugs48.jpg,InvestorPlace,Buying strong vaccine stocks at the forefront of the scientific race to treat Covid-19 will help any long-term portfolio in 2021. The post The 7 Best Coronavirus Vaccine Stocks Still In The Race For A Cure appeared first on InvestorPlace.,https://investorplace.com/2020/12/the-7-best-coronavirus-vaccine-stocks-still-in-the-race-for-a-cure/,0.6369,0.9169
PFE,2020-12-08,Pfizer's pneumonia vaccine candidate gets FDA review,https://cdn.snapi.dev/images/v1/3/q/drugs49.jpg,Market Watch,"Shares of Pfizer Inc. rose 0.5% in the extended session Tuesday after the company said the U.S. Food and Drug Administration has accepted for priority review the company's vaccine candidate against bacteria causing pneumonia and other illnesses in adults. The vaccine candidate would cover more strains of the bacteria than other vaccines in the market and in late-stage trials, the company said.",https://www.marketwatch.com/story/pfizers-pneumonia-vaccine-candidate-gets-fda-review-2020-12-08,0.0,-0.3384
PFE,2020-12-08,U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer's Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age and Older,https://cdn.snapi.dev/images/v1/v/k/press9---on1rhnglwr.jpg,Business Wire,"NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for priority review a Biologics License Application (BLA) for its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate, as submitted for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults ages 18 years and older. The Prescription Drug User Fee Act (PDUFA) goal date for a decision by the FDA on the 2",https://www.businesswire.com/news/home/20201208006015/en/U.S.-FDA-Accepts-for-Priority-Review-the-Biologics-License-Application-for-Pfizer%E2%80%99s-Investigational-20-valent-Pneumococcal-Conjugate-Vaccine-for-Adults-18-Years-of-Age-and-Older/,0.3182,0.2732
PFE,2020-12-08,"The FDA says Pfizer's Covid vaccine is safe and effective. But brace yourself for the second shot, trial participants warn",https://cdn.snapi.dev/images/v1/e/q/106791886-1605096960804-gettyimages-1229031575.jpg,CNBC,The FDA says the Pfizer Covid vaccine is both safe and effective. CNBC spoke with Pfizer and Moderna trial participants about what side effects you can expect.,https://www.cnbc.com/2020/12/08/pfizer-moderna-covid-vaccine-side-effects-trials.html,0.6808,0.7184
PFE,2020-12-08,4 Undervalued Bargain Stocks to Buy Before They Bounce,https://cdn.snapi.dev/images/v1/g/5/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5305732fimage-4-internet-connections-across-a-smart-cityjpgw700opresize.jpg,InvestorPlace,These bargain stocks could potentially outperform in the coming year. They have strong fundamentals and are worth holding long-term as well.,https://investorplace.com/2020/12/four-undervalued-bargain-stocks-to-buy-before-they-bounce/,0.2023,0.7964
PFE,2020-12-08,U.S. inches closer to FDA authorization of first COVID-19 vaccine,https://cdn.snapi.dev/images/v1/i/m/im-270120width620size15005861664712778.jpg,Market Watch,An all-day regulatory meeting scheduled to take place Thursday is the next step toward the likely authorization of the first COVID-19 vaccine in the U.S.,https://www.marketwatch.com/story/u-s-inches-closer-to-fda-authorization-of-first-covid-19-vaccine-11607457278,0.0,0.0
PFE,2020-12-08,Stock ETFs Rally Amid Pfizer Vaccine Rollout Enthusiasm,https://cdn.snapi.dev/images/v1/z/u/stock-etfs-rally-amid-pfizer-vaccine-rollout-enthusiasm-440x250.jpg,ETF Trends,"Stocks and index ETFs are breaking new ground again on Tuesday, scrambling back from posting losses earlier in the day, as enthusiasm around the Pfizer vaccine rollout is spurring investors. The S&P 500 gained 0.3% to reach a record high, where it breached the 3,700 level for the first time.",https://www.etftrends.com/stock-etfs-rally-amid-pfizer-vaccine-rollout-enthusiasm/,0.4404,0.4404
PFE,2020-12-08,White House claims Pfizer 'negotiating in public' on coronavirus vaccine allocation,https://cdn.snapi.dev/images/v1/h/b/pfizer-22jpgquality90stripall.jpg,Fox Business,The White House on Tuesday claimed that Pfizer is “negotiating in public” on the allocation of the forthcoming coronavirus vaccine and trying to embarrass the U.S. government in an effort to gain market share over its vaccine competitors.,https://www.foxbusiness.com/markets/white-house-pfizer-negotiating-in-public-coronavirus-vaccine-allocation,0.0,0.5267
PFE,2020-12-08,Pfizer Board Member Gottlieb Confirms Trump Administration Rejected ‘Multiple' Offers For More Vaccine Doses,https://cdn.snapi.dev/images/v1/8/p/pfizer-board-member-gottlieb-confirms-trump-administration-rejected-multiple-offers-for-more-vaccine-doses.jpg,Forbes,The U.S. will have to wait until summer 2021 to acquire additional doses of the vaccine.,https://www.forbes.com/sites/roberthart/2020/12/08/pfizer-board-member-gottlieb-confirms-trump-administration-rejected-multiple-offers-for-more-vaccine-doses/,-0.5106,0.0
PFE,2020-12-08,The U.K. Has Begun Its BioNTech-Pfizer Vaccine Rollout. Here's How | WSJ,https://cdn.snapi.dev/images/v1/i/n/the-uk-has-begun-its-biontech-pfizer-vaccine-rollout-heres-how-wsj.jpg,Wall Street Journal,"The U.K. became the first Western nation to vaccinate patients against Covid-19. WSJ explains how the country is planning to roll out the BioNTech-Pfizer vaccine at record speed, making it a test case for the rest of the world.",https://www.youtube.com/watch?v=nlA2eT_Ieto,0.0,0.0
PFE,2020-12-08,Pfizer Stock Rallies As FDA Appears To Support Covid Vaccine Approval,https://cdn.snapi.dev/images/v1/8/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5819542fvaccination-syringejpgw700opresize.jpg,Investors Business Daily,Pfizer stock eked out a small gain Tuesday after Food and Drug Administration documents appeared to support authorizing its coronavirus vaccine. An advisory committee will meet Thursday.,https://www.investors.com/news/technology/pfizer-stock-rises-fda-documents-appear-support-coronavirus-vaccine-ok/,0.7003,0.7269
PFE,2020-12-08,FDA says Pfizer's vaccine meets prescribed success criteria,https://cdn.snapi.dev/images/v1/x/e/fda-says-pfizers-vaccine-meets-prescribed-success-criteria.jpg,CNBC Television,The FDA has announced that the Pfizer vaccine meets its prescribed success criteria. CNBC's Meg Tirrell reports on the announcement and how the FDA is thinking about the vaccine ahead of its Thursday meeting with outside advisors.,https://www.youtube.com/watch?v=L0wAwmEMaeY,0.5719,0.5719
PFE,2020-12-08,BNTX Stock: Buy at the High?,https://cdn.snapi.dev/images/v1/y/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6039992fstock-chartjpgw700opresize.jpg,The Motley Fool,The company's development of a gene-based vaccine should help investors get over a high stock price,https://www.fool.com/investing/2020/12/08/bntx-stock-buy-at-the-high/,0.0,0.4019
PFE,2020-12-08,Pfizer CEO confident of getting U.S. advisory panel nod for COVID-19 vaccine,https://cdn.snapi.dev/images/v1/4/m/m02d20201208t2i1543839336w940fhfwllplsqrlynxmpegb7198.jpg,Reuters,"Pfizer Chief Executive Albert Bourla said on Tuesday he expects a ""very intense"" meeting with a U.S. vaccine advisory panel this week but is counting on the panel of outside experts to sign off on his company's COVID-19 vaccine candidate.",https://www.reuters.com/article/us-health-coronavirus-vaccines/pfizer-ceo-confident-of-getting-u-s-advisory-panel-nod-for-covid-19-vaccine-idUSKBN28I26X,0.4939,0.0763
PFE,2020-12-08,UK begins rollout of Pfizer's coronavirus vaccine: Here's what you need to know,https://cdn.snapi.dev/images/v1/z/v/106807771-16074335942020-12-08t090448z-722051655-rc2xik975sm5-rtrmadp-0-health-coronavirus-britain-rollout.jpeg,CNBC,Ninety-year-old Margaret Keenan on Tuesday became the first person in the world to receive the Pfizer-BioNTech vaccine outside of trial conditions.,https://www.cnbc.com/2020/12/08/uk-rolls-out-pfizer-coronavirus-vaccine-heres-what-you-need-to-know.html,0.0,0.0
PFE,2020-12-08,Cramer on the White House declining Pfizer's offer for additional vaccine doses,https://cdn.snapi.dev/images/v1/w/y/cramer-on-the-white-house-declining-pfizers-offer-for-additional-vaccine-doses.jpg,CNBC Television,"Dr. Scott Gottlieb, a member of Pfizer's board, told CNBC on Tuesday the company's offers to provide the U.S. additional doses of its coronavirus vaccine in 2021 was declined by the Trump administration. CNBC's Jim Cramer and David Faber discuss.",https://www.youtube.com/watch?v=ucD-R6BuQVc,0.0,0.0
PFE,2020-12-08,"LIVE | Apple, Pfizer, Tesla: Jim Cramer's Stock Market Breakdown - Dec. 8",https://cdn.snapi.dev/images/v1/h/q/live-apple-pfizer-tesla-jim-cramers-stock-market-breakdown-dec-8.jpg,The Street,"In Tuesday's market breakdown, Jim Cramer talks Apple, Pfizer, Tesla, Toll Brothers, and more. SUBSCRIBE | http://t.st/TheStreetTV MORE VIDEOS: https://www.thestreet.com/video MORE FROM JIM CRAMER: https://www.thestreet.com/jim-cramer' Sign up for ActionAlertsPlus.com today for exclusive insight into Jim Cramer's charitable portfolio: https://secure2.thestreet.com/cap/prm.do?OID=039029 #JimCramer #Investing #WallStreet",https://www.youtube.com/watch?v=x6UyyaNHACU,0.0,0.4939
PFE,2020-12-08,Pfizer's Coronavirus Vaccine Is 52.4% Effective After First Dose,https://cdn.snapi.dev/images/v1/9/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6040682finjecting-vaccine-gettyjpgw700opresize.jpg,The Motley Fool,"That conclusion is based on a new, unfiltered look at clinical trial data from the BNT162b2 program.",https://www.fool.com/investing/2020/12/08/pfizers-coronavirus-vaccine-is-524-effective-after/,0.4767,0.0
PFE,2020-12-08,FDA highlights safety profile of BioNTech/Pfizer vaccine in advance of advisory committee meeting,https://cdn.snapi.dev/images/v1/y/e/biotech4---z0wiunsy5v.jpg,Market Watch,"The COVID-19 vaccine candidate developed by BioNTech and Pfizer Inc. likely has a ""favorable safety profile,"" according to documents published Tuesday by the Food and Drug Administration. In premarket trading on Tuesday, BioNTech's stock was up 1.3%, and shares of Pfizer gained 0.9%.",https://www.marketwatch.com/story/fda-highlights-safety-profile-of-biontechpfizer-vaccine-in-advance-of-advisory-committee-meeting-2020-12-08,0.4215,0.8658
PFE,2020-12-08,Pfizer's COVID-19 vaccine data gets positive FDA review,https://cdn.snapi.dev/images/v1/o/f/drugs32.jpg,Fox Business,WASHINGTON (AP) — Documents released by U.S. regulators Tuesday confirmed that Pfizer and BioNTech's COVID-19 vaccine was strongly protective against COVID-19 -- offering the world's first detailed look at the evidence behind the shots.,https://www.foxbusiness.com/markets/pfizers-covid-19-vaccine-data-gets-positive-fda-review,0.5574,0.2732
PFE,2020-12-08,3 Stay-at-Home Stocks That Could Make You Rich -- Even After the Pandemic Is Over,https://cdn.snapi.dev/images/v1/j/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6035782fgettyimages-1258140616jpgw700opresize.jpg,The Motley Fool,People will eventually return to pre-coronavirus routines. But that doesn't mean they'll abandon the goods and services of these companies.,https://www.fool.com/investing/2020/12/08/3-stay-at-home-stocks-that-may-make-you-rich-even/,0.5574,0.3412
PFE,2020-12-08,FDA Analysis Confirms Safety of Pfizer Vaccine,https://cdn.snapi.dev/images/v1/1/0/106788079-16049431642020-11-05t095723z-1430031187-rc2xwj91w57a-rtrmadp-0-china-trade-expo.jpeg,Barrons,Here's what you need to know about the impact of Covid-19 to navigate the markets today.,https://www.barrons.com/articles/news-updates-51607437051,0.4215,0.0
PFE,2020-12-08,"FDA likely to approve Pfizer-BioNTech vaccine, research head says",https://cdn.snapi.dev/images/v1/4/n/fda-likely-to-approve-pfizer-biontech-vaccine-research-head-says.jpg,CNBC International TV,"Andrew Baum, global head of health care research at Citi, says the U.S. Food and Drug Administration (FDA) is very likely to approve the Pfizer-BioNTech vaccine soon.",https://www.youtube.com/watch?v=sZoXA_NuVFs,0.0,0.4939
PFE,2020-12-08,Here's what goes into shipping Pfizer's Covid vaccine,https://cdn.snapi.dev/images/v1/g/l/heres-what-goes-into-shipping-pfizers-covid-vaccine.jpg,CNBC Television,Delivering the Covid vaccine is being called the biggest logistical challenge in a generation. It's a global public health event that involves a complex web of shipping and technology where every step matters.,https://www.youtube.com/watch?v=GXyVzY9Xv9E,0.0,0.1027
PFE,2020-12-08,These 5 Large-Cap Healthcare Stocks Had the Best Gains in 2020,https://cdn.snapi.dev/images/v1/q/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6034192ftelemedicine-visit-gettyjpgw700opresize.jpg,The Motley Fool,Here's how these big businesses became enormous during a year most of us would rather forget.,https://www.fool.com/investing/2020/12/08/these-5-large-cap-healthcare-stocks-had-the-best-g/,0.765,-0.2263
PFE,2020-12-08,Pfizer (PFE) Up 14% in 3 Months on COVID-19 Vaccine Progress,https://cdn.snapi.dev/images/v1/x/n/drugs33.jpg,Zacks Investment Research,Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine candidate is now approved for emergency use in United Kingdom and Bahrain.,https://www.zacks.com/stock/news/1142654/pfizer-pfe-up-14-in-3-months-on-covid-19-vaccine-progress,0.4215,0.4588
PFE,2020-12-08,White House declined Pfizer's offer to secure more Covid vaccine doses: Board member Gottlieb,https://cdn.snapi.dev/images/v1/4/m/white-house-declined-pfizers-offer-to-secure-more-covid-vaccine-doses-board-member-gottlieb.jpg,CNBC Television,"Dr. Scott Gottlieb, board member at Pfizer and biotech company Illumina as well as former FDA commissioner, told CNBC's ""Squawk Box"" on Tuesday that Pfizer offered its second quarter allotment of Covid-19 vaccine to the Trump administration multiple times, but the government declined to strike an additional agreement on the option to purchase, relying instead on multiple other vaccine agreements.",https://www.youtube.com/watch?v=1ZvwqAC_Zdo,0.34,0.775
PFE,2020-12-08,"U.S. declined Pfizer offer for additional Covid vaccine doses, says board member Dr. Scott Gottlieb",https://cdn.snapi.dev/images/v1/r/p/106804951-1606914066901-gettyimages-1229766595-afp-8vt2pc.jpeg,CNBC,"""Pfizer did offer up an additional allotment ... to the United States government multiple times,"" Dr. Scott Gottlieb told CNBC.",https://www.cnbc.com/2020/12/08/covid-vaccine-us-declined-pfizer-offer-for-more-doses-says-scott-gottlieb-.html,0.0,0.4215
PFE,2020-12-08,FDA says Pfizer Covid vaccine data did not raise safety concerns,https://cdn.snapi.dev/images/v1/a/3/fda-says-pfizer-covid-vaccine-data-did-not-raise-safety-concerns.jpg,CNBC Television,The Food and Drug Administration said Tuesday data from Pfizer's coronavirus vaccine trials did not raise any specific safety concerns. CNBC's Meg Tirrell reports.,https://www.youtube.com/watch?v=avqDyCdxNj8,-0.3252,0.4215
PFE,2020-12-08,Looking for a Dependable Stock? Buy This Industrial Behemoth,https://cdn.snapi.dev/images/v1/i/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6035412fgettyimages-1277731016jpgw700opresize.jpg,The Motley Fool,This dividend stock is using its internally developed IP to become a leader in SaaS for the industrial sector.,https://www.fool.com/investing/2020/12/08/looking-for-a-dependable-stock-buy-this-industrial/,0.0,0.0
PFE,2020-12-08,FDA says Pfizer Covid vaccine data did not raise safety concerns.,https://cdn.snapi.dev/images/v1/e/j/106807754-1607432767035-gettyimages-1230009248-britain-health-virus.jpeg,CNBC,The Food and Drug Administration said Tuesday data from Pfizer's coronavirus vaccine trials did not raise any specific safety concerns.,https://www.cnbc.com/2020/12/08/fda-says-pfizer-covid-vaccine-data-did-not-raise-safety-concerns.html,-0.3252,0.4215
PFE,2020-12-08,FDA to release detailed data on Pfizer's COVID-19 vaccine,https://cdn.snapi.dev/images/v1/n/k/pfizer-covidjpgquality90stripall.jpg,New York Post,The Food and Drug Administration is reportedly expected to release detailed data about Pfizer's coronavirus vaccine on Tuesday as regulators consider whether to clear it for emergency use. The data will give the public an in-depth look at how well the vaccine works before the FDA's vaccine committee meets Thursday to consider Pfizer's application for.,https://nypost.com/2020/12/08/fda-to-release-detailed-data-on-pfizer-covid-19-vaccine/,0.0,0.2732
PFE,2020-12-08,Did You Miss Out on a 5000% Gain With Trillium Stock?,https://cdn.snapi.dev/images/v1/7/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6039882fgettyimages-1181608651jpgw700opresize.jpg,The Motley Fool,A new CEO and prioritization of research could have more big gains in store for the company,https://www.fool.com/investing/2020/12/08/did-you-miss-out-on-5000-gain-with-trillium-stock/,0.4215,0.3976
PFE,2020-12-08,"When a COVID-19 Vaccine Is Ready, This Company Is Prepared for Action",https://cdn.snapi.dev/images/v1/p/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6018072fhospital-supply-roomjpgw700opresize.jpg,The Motley Fool,One medical distribution company has been through this before.,https://www.fool.com/investing/2020/12/08/when-a-covid-19-vaccine-is-ready-this-company-is-p/,0.5267,0.0
PFE,2020-12-08,"Pfizer, Moderna Face Public-Relations Hurdle For Covid Vaccines: IBD/TIPP Poll",https://cdn.snapi.dev/images/v1/y/f/biotech18.jpg,Investors Business Daily,"The latest IBD/TIPP Poll shows just 52% of Americans are likely to get a coronavirus vaccine — a fact that could hamstring Pfizer and Moderna, the makers of the two front-running drugs. The post Pfizer, Moderna Face Public-Relations Hurdle For Covid Vaccines: IBD/TIPP Poll appeared first on Investor's Business Daily.",https://www.investors.com/news/technology/moderna-stock-pfizer-stock-hurdle-public-relations-challenge-coronavirus-vaccines/,0.0,0.0
PFE,2020-12-08,"No, the Pfizer and Moderna vaccine development has not been ‘reckless.'",https://cdn.snapi.dev/images/v1/q/p/merlin-180945753-1366f93c-246a-49d0-9b9b-8bbf36d6949a-articlelargejpgquality75autowebpdisableupscale.jpg,NYTimes,"Experts maintain that widespread rollout of these vaccines, which have undergone rigorous testing, is very likely to be safe.",https://www.nytimes.com/2020/12/08/technology/covid-vaccines-senate-hearing.html,-0.296,0.2023
PFE,2020-12-08,U.K. becomes first to administer Pfizer-BioNTech Covid vaccine outside of trials,https://cdn.snapi.dev/images/v1/d/d/uk-becomes-first-to-administer-pfizer-biontech-covid-vaccine-outside-of-trials.jpg,CNBC Television,"Tuesday has been dubbed ""V-Day"" in the U.K. as the first doses of the coronavirus vaccine are being injected into patients. CNBC's Julianna Tatelbaum reports.",https://www.youtube.com/watch?v=sQIwWMYVOLk,0.0,0.0
PFE,2020-12-08,World watches as first person receives Pfizer-BioNTech COVID shot,https://cdn.snapi.dev/images/v1/x/y/im-269823width620size15005861664712778.jpg,Market Watch,The U.K. will receive just 4 million doses of the vaccine being developed by AstraZeneca and the University of Oxford — by year-end — short of the 30 million doses hoped for.,https://www.marketwatch.com/story/world-watches-as-first-person-receives-pfizer-biontech-covid-shot-11607426453,0.0,0.3818
PFE,2020-12-08,$40 Billion COVID Vaccine Market in 2021: These 3 Stocks Are Likely to Be the Biggest Winners,https://cdn.snapi.dev/images/v1/o/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6038292fvaccine-bottles-forming-a-dollar-signjpgw700opresize.jpg,The Motley Fool,The companies with the biggest gains won't necessarily be those with the highest sales of coronavirus vaccines.,https://www.fool.com/investing/2020/12/08/40-billion-covid-vaccine-market-in-2021-these-3-st/,0.4767,0.34
PFE,2020-12-08,COVID-19 vaccine: 90-year-old woman becomes first to receive Pfizer vaccine in UK,https://cdn.snapi.dev/images/v1/c/h/gettyimages-1230005171.jpg,CNET,The UK is the first country to approve Pfizer's vaccine and is beginning its rollout on Tuesday.,https://www.cnet.com/news/covid-19-vaccine-90-year-old-woman-becomes-first-to-receive-pfizer-vaccine-in-uk/,0.0,0.0
PFE,2020-12-08,Pfizer Vs. Merck Vs. AbbVie Vs.,https://cdn.snapi.dev/images/v1/z/l/drugs26.jpg,Seeking Alpha,"Healthcare stocks are a staple of every portfolio. With an ageing population, healthcare stocks are here to stay.",https://seekingalpha.com/article/4393529-pfizer-vs-merck-vs-abbvie-vs-bristol-myers-vs-johnson-johnson-vs-amgen,0.0,0.0
PFE,2020-12-08,"Pfizer, AstraZeneca Vaccine Combination To Be Tested Against COVID-19 In UK",https://cdn.snapi.dev/images/v1/s/c/cdc-v-nbumdfzm-unsplash.jpg,Benzinga,"The United Kingdom will administer one shot each of COVID-19 vaccines made by Pfizer Inc (NYSE: PFE) and AstraZeneca plc (NASDAQ: AZN) to test whether the approach would result in increased immunity, Bloomberg reported Monday. What Happened: The studies planned for the next year, will be “relatively small” as per Clive Dix, Deputy Chair of U.K. Vaccine Taskforce, who added — “They'll only be with the approved vaccines.",https://www.benzinga.com/general/biotech/20/12/18688604/pfizer-astrazeneca-vaccine-combination-to-be-tested-against-covid-19-in-uk,0.0,0.7717
PFE,2020-12-08,Pfizer Tells US It Can't Provide Substantial Extra Doses Before June As Other Countries Have Already Secured Supply: WaPo,https://cdn.snapi.dev/images/v1/d/6/kristine-wook-gwuhbsrzovo-unsplash.jpg,Benzinga,"Pfizer Inc (NYSE: PFE) has told the outgoing Donald Trump administration that it cannot supply a considerable amount of additional doses of its COVID-19 vaccine to the United States until late June because other countries have hastened to secure the supply, the Washington Post reported Monday. What Happened: The development means that the U.S. government may have difficulty in procurement beyond the 100 million doses it has already secured earlier this year, according to the Post.",https://www.benzinga.com/general/biotech/20/12/18687865/pfizer-tells-us-it-cant-provide-substantial-extra-doses-before-june-as-other-countries-have-alrea,0.2751,0.7717
PFE,2020-12-07,"Pfizer COVID-19 Vaccine Could Get Emergency Approval By Friday, FDA Advisor Says",https://cdn.snapi.dev/images/v1/h/o/dimitri-houtteman-qbhppxw3ess-unsplash-1-0.jpg,Benzinga,"A member of a United States Food and Drug Administration committee on vaccines said that the agency could issue an emergency authorization for Pfizer Inc's (NYSE: PFE) COVID-19 vaccine as early as Friday. What Happened: James Hildreth, a member of the Vaccines and Related Biological Products Advisory Committee, said on NBC's “Weekend Today” show that the body would meet on Thursday to review the COVID-19 vaccine developed by Pfizer and its German partner BioNTech SE (NASDAQ: BNTX).",https://www.benzinga.com/general/biotech/20/12/18687083/pfizer-covid-19-vaccine-could-get-emergency-approval-by-friday-fda-advisor-says,0.128,0.0516
PFE,2020-12-07,"Trump is hosting a 'vaccine summit' to discuss the 'success' of Operation Warp Speed. The governors of Florida and Texas will join, Moderna and Pfizer declined the invite.",https://cdn.snapi.dev/images/v1/t/r/trump-is-hosting-a-vaccine-summit-to-discuss-the-success-of-operation-warp-speed-the-governors-of-florida-and-texas-will-join-moderna-and-pfizer-declined-the-invite.jpg,Business Insider,"President Donald Trump will host a ""vaccine summit"" Tuesday night to ""congratulate"" his administration's vaccine effort. The White House released details of President Donald Trump's summit, an event where the president will sign an executive order stating the US would provide vaccines to Americans before aiding other nations. STAT News first reported on the summit and Fox News first reported on the executive order. ",https://www.businessinsider.com/trump-to-host-vaccine-summit-with-governors-fdas-peter-marks-2020-12,0.4215,0.0
PFE,2020-12-07,"President Trump will hold vaccine summit Tuesday, as Pfizer and Moderna decline to attend",https://cdn.snapi.dev/images/v1/n/a/president-trump-will-hold-vaccine-summit-tuesday-as-pfizer-and-moderna-decline-to-attend.jpg,CNBC Television,"NBC's Hallie Jackson joins Shep Smith to report details on President Trump's vaccine summit. HHS Secretary Alex Azar told Lester Holt President Trump is not concerned about the shortage of vaccines, but that he wants to reinforce his 'America first vaccine' strategy, Jackson reports.",https://www.youtube.com/watch?v=7hx-2QpU7-8,0.0,-0.128
PFE,2020-12-07,Capitol Report: White House denies report saying it passed when Pfizer offered additional vaccine doses,https://cdn.snapi.dev/images/v1/t/b/im-268289width620size14988290398126465.jpg,Market Watch,Trump administration officials on Monday deny a New York Times report that says they passed when Pfizer offered in late summer to sell the U.S. government additional doses. They also play down news that Moderna and Pfizer won't take part in Trump's vaccine summit.,https://www.marketwatch.com/story/white-house-denies-report-saying-it-passed-when-pfizer-offered-additional-vaccine-doses-11607382780,-0.4215,0.0
PFE,2020-12-07,Pfizer And Moderna Steer Clear Of White House Vaccine Summit,https://cdn.snapi.dev/images/v1/n/v/pfizer-and-moderna-steer-clear-of-white-house-vaccine-summit.jpg,Forbes,The two companies will be conspicuous by their absence at an event some administration sources are viewing as a publicity stunt for President Donald Trump.,https://www.forbes.com/sites/joewalsh/2020/12/07/pfizer-and-moderna-steer-clear-of-white-house-vaccine-summit/,0.3818,0.0
PFE,2020-12-07,"The Trump administration reportedly rejected an offer from Pfizer for more COVID-19 vaccine doses, and now other countries might get them",https://cdn.snapi.dev/images/v1/t/h/the-trump-administration-reportedly-rejected-an-offer-from-pfizer-for-more-covid-19-vaccine-doses-and-now-other-countries-might-get-them.jpg,Business Insider,"The Trump administration declined an offer from Pfizer in late summer for additional COVID-19 vaccine doses, the New York Times reported on Monday, citing people familiar with the matter.  This means that Americans may struggle to get more doses of Pfizer's COVID-19 vaccine given commitments it's made to other countries, the Times said. ",https://www.businessinsider.com/trump-administration-rejected-pfizer-offer-more-covid-19-vaccine-doses-2020-12,-0.5106,-0.1779
PFE,2020-12-07,FDA could authorize Pfizer's Covid vaccine this week as U.S. deaths surge,https://cdn.snapi.dev/images/v1/s/g/106807115-1607348018052-gettyimages-1229988084-htum30010.jpeg,CNBC,The move would be a pivotal moment in the pandemic as public health officials say the U.S. is likely to face its worst health crisis in history this winter.,https://www.cnbc.com/2020/12/07/covid-vaccine-fda-may-authorize-pfizers-this-week.html,0.0,-0.8481
PFE,2020-12-07,Buy Pfizer Stock Or JNJ For Vaccine Run?,https://cdn.snapi.dev/images/v1/q/j/buy-pfizer-stock-or-jnj-for-vaccine-run.jpg,Forbes,"Pfizer or JNJ for vaccine run? While Pfizer's stock and Johnson & Johnson's stock look hot with vaccines, data suggests Merck stock is better than both!",https://www.forbes.com/sites/greatspeculations/2020/12/07/buy-pfizer-stock-or-jnj-for-vaccine-run/,0.0,0.4926
PFE,2020-12-07,Pfizer Reports Positive Clinical Data for BCMA-CD3 Bispecific Antibody (PF-06863135) in Multiple Myeloma,https://cdn.snapi.dev/images/v1/h/k/press12---4qtp0yiy6t.jpg,Business Wire,"NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced safety and clinical response results from the ongoing Phase 1 study (NCT03269136) for PF-06863135, an investigational B-cell maturation antigen (BCMA) CD3-targeted bispecific antibody. Data from 30 patients with relapsed or refractory multiple myeloma showed manageable safety across all subcutaneous dose levels with no dose-limiting toxicities observed, and 83% of patients achieved a clinical response at the highest dose level. T",https://www.businesswire.com/news/home/20201207005166/en/Pfizer-Reports-Positive-Clinical-Data-for-BCMA-CD3-Bispecific-Antibody-PF-06863135-in-Multiple-Myeloma/,0.5574,0.5267
PFE,2020-12-07,Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x1013 VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy,https://cdn.snapi.dev/images/v1/e/y/press20---vrjs5bifzw.jpg,Business Wire,"NEW YORK & BRISBANE, Calif.--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced updated follow-up data from the Phase 1/2 Alta study of giroctocogene fitelparvovec (SB-525 or PF-07055480), an investigational gene therapy for patients with severe hemophilia A. These data are being presented today at the 62nd American Society for Hematology Annual meeting taking place virtually from December 5th - 8th. The oral pres",https://www.businesswire.com/news/home/20201207005251/en/Pfizer-and-Sangamo-Announce-Updated-Phase-12-Results-Showing-Sustained-Factor-VIII-Activity-Levels-in-3x1013-VGKG-Cohort-Through-One-Year-Following-Hemophilia-A-Gene-Therapy/,0.0,-0.3818
PFE,2020-12-07,AstraZeneca Follows Pfizer In Seeking India Emergency Use Approval For COVID-19 Vaccine,https://cdn.snapi.dev/images/v1/m/p/cdc-p5auv6sk1xc-unsplash-2.jpg,Benzinga,"AstraZeneca Plc's  (NASDAQ: AZN) partner, the Serum Institute of India, applied for emergency use authorization of the former's COVID-19 vaccine candidate on Sunday, as per the Press Trust Of India. What Happened: The SII is conducting the phase-3 clinical trial of the Oxford-AstraZeneca vaccine — dubbed Covishield — in India, which is co-sponsored by the Indian Council of Medical Research, as per PTI.",https://www.benzinga.com/general/biotech/20/12/18666832/astrazeneca-follows-pfizer-in-seeking-india-emergency-use-approval-for-covid-19-vaccine,0.128,0.1779
PFE,2020-12-07,PFE Stock Price Increased 6.3% This Past Week: Why It Happened,https://cdn.snapi.dev/images/v1/w/j/drugs14.jpg,Pulse2,"The stock price of Pfizer Inc. (NYSE:PFE) increased 6.3% this past week as it went from $37.95 per share on November 30 morning to a closing price of $40.34 on Friday, December 4. These are some of the reasons why it happened.",https://pulse2.com/pfe-stock-price-increased-nyse-pfizer-6-3-this-past-week-why-it-happened/,0.2732,0.5106
PFE,2020-12-07,Week In Review: CANbridge Closes $43 Million E Round For Rare Disease Drugs,https://cdn.snapi.dev/images/v1/s/t/drugs13.jpg,Seeking Alpha,"CANbridge Pharma completed a $43 million Series E financing that is a follow-on to its $98 million Series D round, announced in February. Pfizer and Germany's BioNTech announced their partnered mRNA COVID-19 vaccine has been approved for use in the UK, the first acceptance of a coronavirus vaccine in the west.",https://seekingalpha.com/article/4393252-week-in-review-canbridge-closes-43-million-e-round-for-rare-disease-drugs,0.0,0.7003
PFE,2020-12-07,Pfizer Applies For Emergency Approval For COVID-19 Vaccine In India: Media Reports,https://cdn.snapi.dev/images/v1/b/h/vaccine-4.jpeg,Benzinga,"Pfizer Inc. (NYSE: PFE) is seeking emergency approval for its COVID-19 vaccine in India, according to media sources in the country. What Happened: The vaccine developed together with BioNTech SE - ADR (NASDAQ: BNTX) was approved in the U.K. last week.",https://www.benzinga.com/news/20/12/18664716/pfizer-applies-for-emergency-approval-for-covid-19-vaccine-in-india-media-reports,0.128,0.5106
PFE,2020-12-07,The 5 Biggest Threats to the Stock Market in 2021,https://cdn.snapi.dev/images/v1/e/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6035302fnyse-wall-street-trading-new-york-financial-stock-market-gettyjpgw700opresize.jpg,The Motley Fool,Is another big crash on the horizon?,https://www.fool.com/investing/2020/12/06/the-5-biggest-threats-to-the-stock-market-in-2021/,-0.4215,-0.4019
PFE,2020-12-07,3 Top Healthcare Stocks to Buy Right Now,https://cdn.snapi.dev/images/v1/v/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6030792fgettyimages-1166581794jpgw700opresize.jpg,The Motley Fool,These companies have growth opportunities that will last long after the COVID vaccine gets life back to normal.,https://www.fool.com/investing/2020/12/06/3-top-healthcare-stocks-to-buy-right-now/,0.2023,0.6369
PFE,2020-12-07,3 Value Stocks Warren Buffett Owns That You Should Consider Buying Too,https://cdn.snapi.dev/images/v1/6/s/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026562fwarren-buffett-tmfjpgw700opresize.jpg,The Motley Fool,The Oracle of Omaha knows a good bargain when he sees one.,https://www.fool.com/investing/2020/12/06/3-value-stocks-warren-buffett-owns-that-you-should/,0.34,0.5719
PFE,2020-12-07,This COVID Vaccine Stock Has Been the Biggest Millionaire-Maker by Far,https://cdn.snapi.dev/images/v1/n/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026572fgolden-dollar-signsjpgw700opresize.jpg,The Motley Fool,You'll probably be surprised at just great the returns from investing in this stock have been.,https://www.fool.com/investing/2020/12/06/this-covid-vaccine-stock-has-been-the-biggest-mill/,0.0,0.7184
PFE,2020-12-07,Is Pfizer a Great Dividend Stock?,https://cdn.snapi.dev/images/v1/r/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6032582fstack-of-100-dollar-billsjpgw700opresize.jpg,The Motley Fool,There's a lot more to the company besides its vaccine.,https://www.fool.com/investing/2020/12/05/is-pfizer-a-great-dividend-stock/,0.6249,0.0
PFE,2020-12-07,5 Safe And Cheap Dividend Stocks To Invest In (December 2020),https://cdn.snapi.dev/images/v1/i/w/semi15.jpg,Seeking Alpha,"This article is part of our monthly series where we highlight five companies that are large cap, relatively safe, dividend paying, and are offering large discounts to their historical norms. It's always a good idea to keep your wish list ready by separating the wheat from the chaff.",https://seekingalpha.com/article/4392796-5-safe-and-cheap-dividend-stocks-to-invest-in-december-2020,0.4404,0.9081
PFE,2020-12-07,"Pfizer: Coronavirus Vaccine Playing Out, Still Inexpensive And Offering A High Yield",https://cdn.snapi.dev/images/v1/t/z/drugs4.jpg,Seeking Alpha,Pfizer's vaccine for COVID looks promising and should boost revenues substantially. The company is trading at an inexpensive valuation and offers an above-average dividend yield.,https://seekingalpha.com/article/4393119-pfizer-coronavirus-vaccine-playing-out-still-inexpensive-and-offering-high-yield,0.2023,0.6597
PFE,2020-12-07,Here's the Dark Horse in the COVID Vaccine Race That You'll Want to Watch,https://cdn.snapi.dev/images/v1/i/5/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026542fglass-vial-and-ampulejpgw700opresize.jpg,The Motley Fool,Don't be surprised if this small biotech takes off in 2021.,https://www.fool.com/investing/2020/12/05/heres-the-dark-horse-in-the-covid-vaccine-race-tha/,0.0772,-0.1695
PFE,2020-12-04,Bahrain joins U.K. in authorizing emergency use of Pfizer–BioNTech vaccine,https://cdn.snapi.dev/images/v1/e/y/im-268900width620size15005861664712778.jpg,Market Watch,Bahrain joins U.K. in authorizing emergency use of Pfizer–BioNTech vaccine,https://www.marketwatch.com/story/bahrain-becomes-second-country-to-grant-the-pfizer-biontech-vaccine-emergency-use-authorization-01607140898,-0.3818,-0.3818
PFE,2020-12-04,Why You Shouldn't Yet Bet on the “Value Rally”,https://cdn.snapi.dev/images/v1/w/q/software5.jpg,InvestorPlace,"You'd have to take a “brave pill” to follow the ""value rally"" trend right now. Here's why and what you need to be focusing on instead.",https://investorplace.com/2020/12/why-you-shouldnt-yet-bet-on-the-value-rally/,0.0,0.34
PFE,2020-12-04,Pfizer's Scaled-Down COVID-19 Vaccine Manufacturing Plan Is Old News: BofA,https://cdn.snapi.dev/images/v1/e/m/new-york-city-pfizer-world-headquarters-01-1.jpg,Benzinga,"Pfizer Inc. (NYSE: PFE)-BioNTech SE – ADR (NASDAQ: BNTX) is first among coronavirus vaccine developers to secure authorization for emergency use of candidate BNT162b2, with the first approval granted by U.K. regulators. Scale-Down Previously Disclosed: An analyst at BofA Securities shrugged off a Thursday report in The Wall Street Journal that hinted at manufacturing constraints, resulting in a modest pullback in Pfizer shares.",https://www.benzinga.com/analyst-ratings/analyst-color/20/12/18653755/pfizers-scaled-down-covid-19-vaccine-manufacturing-plan-is-old-news-bofa,0.0,0.8074
PFE,2020-12-04,FDA Expected to Approve Use of Pfizer Vaccine: Johns Hopkins,https://cdn.snapi.dev/images/v1/q/b/fda-expected-to-approve-use-of-pfizer-vaccine-johns-hopkins.jpg,Bloomberg Markets and Finance,Dec.04 -- Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz discusses he timeline for a rollout of a Covid-19 vaccine in the U.S. and adjusting coronavirus self-isolation guidelines. He speaks with Bloomberg's Francine Lacqua on “Bloomberg Surveillance.,https://www.youtube.com/watch?v=oT_mL1oPIM4,0.0,0.0
PFE,2020-12-04,"LIVE | Jobs, Stimulus, Pfizer: Jim Cramer's Stock Market Breakdown 12/4",https://cdn.snapi.dev/images/v1/e/o/live-jobs-stimulus-pfizer-jim-cramers-stock-market-breakdown-124.jpg,The Street,"In Friday's market breakdown, Jim Cramer talks jobs, stimulus. Pfizer, theater stocks and more.",https://www.youtube.com/watch?v=Ozg4cuBHii0,0.0,0.0
PFE,2020-12-04,What The Approval Of The Covid Vaccine In The U.K Means For Pfizer Stock,https://cdn.snapi.dev/images/v1/9/w/what-the-approval-of-the-covid-vaccine-in-the-uk-means-for-pfizer-stock.jpg,Forbes,"Pfizer's Covid-19 vaccine has been approved for emergency use in the United Kingdom, with initial shots likely to be given as soon as next week. The U.K is the first western country to ratify the shot and the country is expected to be allotted between four million to five million doses of the.",https://www.forbes.com/sites/greatspeculations/2020/12/04/what-the-approval-of-the-covid-vaccine-in-the-uk-means-for-pfizer-stock/,0.4767,0.4588
PFE,2020-12-04,"Dow Jones 30,000: Here's Why It's Still Underperforming the S&P 500 and the Nasdaq",https://cdn.snapi.dev/images/v1/h/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6024962fgettyimages-177320725jpgw700opresize.jpg,The Motley Fool,"Coronavirus vaccine news and a Biden presidency are pushing the stock market higher, but certain sectors are contributing most of the gains.",https://www.fool.com/investing/2020/12/04/dow-jones-30000-heres-why-it-still-underperforming/,0.0,0.7307
PFE,2020-12-04,Wells Fargo Finally Sees Light At the End of the Tunnel,https://cdn.snapi.dev/images/v1/i/p/bank7.jpg,InvestorPlace,"After a rough couple of years, 2021 may finally be the year Wells Fargo returns to its glory days. WFC stock sees a lot of upside ahead.",https://investorplace.com/2020/12/wfc-stock-finally-sees-the-light-at-the-end-of-the-tunnel/,0.25,0.6705
PFE,2020-12-04,2 Stocks to Buy With Multiple COVID-19 Vaccines in Sight,https://cdn.snapi.dev/images/v1/y/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6028712fmask-showing-map-of-the-worldjpgw700opresize.jpg,The Motley Fool,The demand for cold storage and transportation could make these stocks scorching-hot buys.,https://www.fool.com/investing/2020/12/04/2-stocks-to-buy-with-multiple-covid-19-vaccines-in/,0.0,-0.128
PFE,2020-12-04,Pfizer details how supply chain constraints impacted vaccine forecast,https://cdn.snapi.dev/images/v1/q/a/pfizer-details-how-supply-chain-constraints-impacted-vaccine-forecast.jpg,CNBC Television,Pfizer shares came under pressure late in Thursday's trading session after a Wall Street Journal report shed light on the company's shifting vaccine forecast. CNBC's Meg Tirrell reports.,https://www.youtube.com/watch?v=MbODRZ-dOWA,0.0,0.0
PFE,2020-12-04,3 Top Coronavirus Stocks to Watch in December,https://cdn.snapi.dev/images/v1/x/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5940292fgettyimages-1215388990jpgw700opresize.jpg,The Motley Fool,Vaccine makers of all sizes and development stages face crucial news this month.,https://www.fool.com/investing/2020/12/04/3-top-coronavirus-stocks-to-watch-in-december/,0.2023,0.0
PFE,2020-12-04,3 COVID Vaccine Stocks to Invest in for the Long Run,https://cdn.snapi.dev/images/v1/w/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026532fhand-holding-hourglass-with-dollar-signsjpgw700opresize.jpg,The Motley Fool,These aren't just temporary sensations.,https://www.fool.com/investing/2020/12/04/3-covid-vaccine-stocks-to-invest-in-for-the-long-r/,0.0,0.0
PFE,2020-12-03,Pfizer Cuts 2020 Vaccine Rollout Target,https://cdn.snapi.dev/images/v1/c/u/pfizer-cuts-2020-vaccine-rollout-target.jpg,Bloomberg Markets and Finance,Dec.03 -- Moderna says its shot has the potential for “durable immunity” and Pfizer has scaled back production targets for its dose. Bloomberg's Michelle Cortez reports on “Bloomberg Daybreak: Asia.,https://www.youtube.com/watch?v=2F-8Ks2E5Wk,-0.296,0.0
PFE,2020-12-03,I'm hopeful we'll have enough Covid-19 supply in 2021: Dr. Scott Gottlieb on Pfizer vaccine rollout,https://cdn.snapi.dev/images/v1/j/w/im-hopeful-well-have-enough-covid-19-supply-in-2021-dr-scott-gottlieb-on-pfizer-vaccine-rollout.jpg,CNBC Television,"Pfizer's shares dropped after a report said the U.S. drugmaker expects to ship half of the Covid-19 vaccines it originally planned for this year due to supply-chain problems. Pfizer is now planning to ship 50 million vaccines by the end of the year, down from the original 100 million it hoped to send out initially.",https://www.youtube.com/watch?v=uOyZwZbKahI,0.5106,0.5267
PFE,2020-12-03,"Supply chain delays marred Pfizer's initial vaccine rollout plans, but the company says it will still deliver on the supply it promised the US",https://cdn.snapi.dev/images/v1/s/u/supply-chain-delays-marred-pfizers-initial-vaccine-rollout-plans-but-the-company-says-it-will-still-deliver-on-the-supply-it-promised-the-us.jpg,Business Insider,"Supply chain problems reportedly caused Pfizer to cut projections for its COVID-19 vaccine rollout.  Sources close to the Pfizer vaccine development told The Wall Street Journal delays scaling up raw materials, coupled with an ""unprecedented"" effort to deliver millions of vaccines within a year, led the company to miss target shipments.",https://www.businessinsider.com/pfizer-vaccine-rollout-supply-chain-problems-hinder-distribution-2020-12,0.5023,-0.6597
PFE,2020-12-03,Pfizer Scales Back Covid Vaccine Production Targets,https://cdn.snapi.dev/images/v1/q/a/pfizer-scales-back-covid-vaccine-production-targets.jpg,Bloomberg Markets and Finance,"Dec.03 -- Pfizer Inc. scaled back its Covid-19 production targets earlier this year after the drugmaker ran into difficulties securing all the materials it needs to produce the shots at a large scale. Roberg Langreth reports on ""Bloomberg Markets: The Close.",https://www.youtube.com/watch?v=X3v5JBk6ck0,0.0,0.0258
PFE,2020-12-03,Pfizer slashes Covid vaccine rollout,https://cdn.snapi.dev/images/v1/e/k/pfizer-slashes-covid-vaccine-rollout.jpg,CNBC Television,"CNBC's Meg Tirrell reports on what's behind Pfizer's announcement it would be slashing its Covid vaccine rollout. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Steve Grasso and Dan Nathan.",https://www.youtube.com/watch?v=xer2OJNMSx8,-0.2023,-0.2732
PFE,2020-12-03,"As U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to Rally",https://cdn.snapi.dev/images/v1/x/t/biotech-etfs-continue-rally-as-uk-authorizes-pfizer-vaccine-440x250.jpg,ETF Trends,"Both stock index ETFs and biotech stocks and ETFs have been on a tear lately thanks to promising coronavirus vaccine developments from several major pharmaceutical companies. But this week, the U.K. became the first country to authorize Pfizer's coronavirus vaccine for emergency use, which is likely to increase pressure on the U.S. Food and Drug [.",https://www.etftrends.com/u-k-authorizes-pfizer-vaccine-biotech-etfs-rally/,0.0,0.4767
PFE,2020-12-03,Pfizer to Ship Half as Many Coronavirus Vaccine Doses as Originally Planned in Initial Phase,https://cdn.snapi.dev/images/v1/3/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6034632fgloved-hand-filling-a-syringe-from-a-vialjpgw700opresize.jpg,The Motley Fool,"The company puts the blame on difficulties with raw materials, among other challenges.",https://www.fool.com/investing/2020/12/03/pfizer-to-ship-half-as-many-coronavirus-vaccine-do/,0.0,-0.5106
PFE,2020-12-03,Pfizer Stock Trips As Supply-Chain Issues Hamper Covid Vaccine Delivery,https://cdn.snapi.dev/images/v1/3/i/drugs20.jpg,Investors Business Daily,Pfizer stock tumbled Thursday after the company reportedly slashed its expectations for coronavirus vaccine deliveries in 2020 due to supply-chain issues. The post Pfizer Stock Trips As Supply-Chain Issues Hamper Covid Vaccine Delivery appeared first on Investor's Business Daily.,https://www.investors.com/news/technology/pfizer-stock-dives-drugmaker-reportedly-cuts-coronavirus-vaccine-deliveries-2020/,0.0,-0.2263
PFE,2020-12-03,Pfizer shares fall on report company cut its Covid vaccine rollout target,https://cdn.snapi.dev/images/v1/q/x/106806046-1607028491927-gettyimages-1229921016-belgium-pfizer.jpeg,CNBC,"The Wall Street Journal, citing a person directly involved in the development, said some early batches of the raw materials needed for the vaccine failed to meet standards.",https://www.cnbc.com/2020/12/03/pfizer-shares-fall-on-report-company-cut-its-covid-vaccine-rollout-target.html,0.0258,-0.5106
PFE,2020-12-03,Gold Prices Are Torn Between the Bulls and the Bears,https://cdn.snapi.dev/images/v1/e/7/biotech19.jpg,InvestorPlace,"Some think that positive vaccine news will be bad for the gold price, while others point to continuing uncertainty and a weak dollar. The post Gold Prices Are Torn Between the Bulls and the Bears appeared first on InvestorPlace.",https://investorplace.com/2020/12/gold-prices-are-torn-between-the-bulls-and-the-bears/,-0.25,-0.7351
PFE,2020-12-03,Supply Chain Issues Cause Pfizer To Cut Initial COVID-19 Vaccine Shipments In Half,https://cdn.snapi.dev/images/v1/5/h/vaccine-5074670-1920-20.jpg,Benzinga,"Pfizer (NYSE: PFE) shares fell after reports emerged the company expects to ship half of the COVID-19 vaccines it originally planned for this year due to supply-chain issues, according to The Wall Street Journal. What To Know: In November, Pfizer and BioNTech's (NASDAQ: BNTX) vaccine candidate showed a 95% efficacy rate.",https://www.benzinga.com/news/20/12/18643855/supply-chain-issues-cause-pfizer-to-cut-initial-covid-19-vaccine-shipments-in-half,-0.2732,0.296
PFE,2020-12-03,Dr. Fauci says UK's Pfizer Covid vaccine review 'much less deep' than U.S.,https://cdn.snapi.dev/images/v1/r/2/106799890-16058235172020-11-19t220406z-593852167-rc2m6k9wi6x1-rtrmadp-0-health-coronavirus-usa.jpeg,CNBC,"""The U.K. has decided to do it a little bit differently, they've gone over it very quickly,"" Fauci told Sky News.",https://www.cnbc.com/2020/12/03/pfizer-covid-vaccine-dr-fauci-says-uks-review-less-deep-than-us.html,0.0,0.0
PFE,2020-12-03,Pfizer CEO Is ‘Confident' In Covid-19 Vaccine Rollout And Looking Beyond The Pandemic,https://cdn.snapi.dev/images/v1/7/t/pfizer-ceo-is-confident-in-covid-19-vaccine-rollout-and-looking-beyond-the-pandemic.jpg,Forbes,"At the 2020 Forbes Healthcare Summit, Albert Bourla is already looking beyond his company's vaccine success and into a post-pandemic world.",https://www.forbes.com/sites/katiejennings/2020/12/03/pfizer-ceo-is-confident-in-covid-19-vaccine-rollout-and-looking-beyond-the-pandemic/,0.0,0.5719
PFE,2020-12-03,Pfizer gears up for mass rollout of Covid vaccine as the U.K. approves emergency use,https://cdn.snapi.dev/images/v1/9/p/pfizer-gears-up-for-mass-rollout-of-covid-vaccine-as-the-uk-approves-emergency-use.jpg,CNBC Television,Pfizer workers are gearing up for a mass rollout of the company's Covid-19 vaccine. The United Kingdom became the first country to approve Pfizer's vaccine.,https://www.youtube.com/watch?v=zqLXuO4gVX8,0.0258,0.4215
PFE,2020-12-03,Why Pfizer's Covid vaccine has been authorized in the U.K. but not the U.S. yet,https://cdn.snapi.dev/images/v1/8/x/106804951-1606914066901-gettyimages-1229766595-afp-8vt2pc.jpeg,CNBC,"Pfizer had been submitting data on its vaccine on a ""rolling basis"" to the U.K., meaning regulators there were able to review the data in real-time.",https://www.cnbc.com/2020/12/03/pfizers-covid-vaccine-why-uk-approved-but-not-the-us-yet.html,0.0,0.0
PFE,2020-12-03,What Happens Next for Moderna's and Pfizer's Coronavirus Vaccine Candidates,https://cdn.snapi.dev/images/v1/m/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6028692fgettyimages-1173258771jpgw700opresize.jpg,The Motley Fool,"With FDA meetings near, Moderna and Pfizer enter a new phase of the vaccine race.",https://www.fool.com/investing/2020/12/03/what-happens-next-for-modernas-and-pfizers-coronav/,0.0,0.0
PFE,2020-12-03,Stocks to Track in December as Markets Peak,https://cdn.snapi.dev/images/v1/a/d/adasads2---mhwboynbly.jpg,Zacks Investment Research,December is likely to be filled with events or stock/sector specific news that could provide a boost to the stocks.,https://www.zacks.com/stock/news/1126014/stocks-to-track-in-december-as-markets-peak,0.0,0.4019
PFE,2020-12-03,Oil Ends Higher on Vaccine News Despite EIA's Bearish Report,https://cdn.snapi.dev/images/v1/a/g/oil17.jpg,Zacks Investment Research,"The top five gainers of the S&P 500 in November were all energy firms - Occidental Petroleum (OXY), Devon Energy (DVN), Apache (APA), Diamondback Energy (FANG) and TechnipFMC (FTI).",https://www.zacks.com/stock/news/1125776/oil-ends-higher-on-vaccine-news-despite-eias-bearish-report,0.0,0.7269
PFE,2020-12-03,Here's Why Pfizer Stock Looks Inviting At $39 Levels,https://cdn.snapi.dev/images/v1/d/k/heres-why-pfizer-stock-looks-inviting-at-39-levels.jpg,Forbes,"Pfizer's stock is up just 3% since the start of the year and it has gained around 45% from its March lows. Despite the recent rally, Pfizer could offer an upside in the near term, as the company's revenues and earnings are expected to see strong gains going forward.",https://www.forbes.com/sites/greatspeculations/2020/12/03/heres-why-pfizer-stock-looks-inviting-at-39-levels/,0.3182,0.7579
PFE,2020-12-03,Should Investors Buy Pfizer Stock for Its Coronavirus Vaccine?,https://cdn.snapi.dev/images/v1/p/o/podc4---viooyvdwvl.jpg,The Motley Fool,Consider the outlook for the rest of the company's units before investing.,https://www.fool.com/investing/2020/12/03/should-investors-buy-pfizer-stock-for-its-coronavi/,0.0,0.0
PFE,2020-12-03,Why vaccine-maker stocks didn't move as much as expected during the pandemic,https://cdn.snapi.dev/images/v1/m/q/why-vaccine-maker-stocks-didnt-move-as-much-as-expected-during-the-pandemic.jpg,CNBC Television,"Sel Hardy, analyst at CFRA, joins ""Squawk Box"" to discuss the performance of the drug maker stocks as the race for the vaccine is nearing the finish line.",https://www.youtube.com/watch?v=WNzGLv4nTZA,0.0,0.4019
PFE,2020-12-03,2 Surprising Coronavirus Vaccine Stocks to Buy Right Now,https://cdn.snapi.dev/images/v1/b/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6010762fgettyimages-1251020606jpgw700opresize.jpg,The Motley Fool,"If we judge by return on investment, these two mid-cap biotechs may be the ultimate winners of the coronavirus vaccine race.",https://www.fool.com/investing/2020/12/03/2-surprising-coronavirus-vaccine-stocks-buy-right-/,0.2732,0.4767
PFE,2020-12-03,"Got $5,000 and 5 Years to Wait? Buy This Under-the-Radar Biotech Stock Now",https://cdn.snapi.dev/images/v1/d/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6029482fscientists-examining-flask-in-pharmaceutical-laboratory-gettyjpgw700opresize.jpg,The Motley Fool,"This company's about to begin delivering a stream of new drugs that target genetic diseases, and hardly anyone's heard about it.",https://www.fool.com/investing/2020/12/03/got-5000-and-5-years-to-wait-buy-this-under-the-ra/,0.0,0.0
PFE,2020-12-03,7 Undervalued Stocks to Snap Up Today,https://cdn.snapi.dev/images/v1/u/t/stocks111-20.jpg,InvestorPlace,"There aren't many undervalued stocks out there, but some familiar, quality names fit the bill. We've pulled that list together for you.",https://investorplace.com/2020/12/undervalued-stocks-are-out-there-including-some-familiar-names/,0.0,0.5023
PFE,2020-12-03,'This is going to be challenging:' How the UK will roll out Pfizer's coronavirus vaccine,https://cdn.snapi.dev/images/v1/5/s/106492459-1587069194538london.jpg,CNBC,"The U.K. was the first country in the world to approve Pfizer and BioNTech's coronavirus vaccine for widespread use. In a way, that was the easy part.",https://www.cnbc.com/2020/12/03/how-the-uk-will-roll-out-the-covid-vaccine.html,0.0,0.4404
PFE,2020-12-03,Dividend Stock Watch List: Lanny's December 2020 Edition,https://cdn.snapi.dev/images/v1/h/r/semi17.jpg,Seeking Alpha,"As a dividend stock investor, for the first time, I feel a little uncertain of what the future may hold. We have three completely different industries here with Pharmaceutical/healthcare, Technology/IT and consumer-goods.",https://seekingalpha.com/article/4392698-dividend-stock-watch-list-lannys-december-2020-edition,0.0,-0.228
PFE,2020-12-02,Pfizer's Coronavirus Vaccine Gets a Nod in UK: ETFs to Shine,https://cdn.snapi.dev/images/v1/a/e/drugs49.jpg,Zacks Investment Research,Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development.,https://www.zacks.com/stock/news/1123973/pfizers-coronavirus-vaccine-gets-a-nod-in-uk-etfs-to-shine,0.0,0.9001
PFE,2020-12-02,"5 Top Stock Trades for Thursday: SNAP, PFE, WKHS, BOX, SPOT",https://cdn.snapi.dev/images/v1/t/m/data-internet21.jpg,InvestorPlace,"Snap, Pfizer, Workhorse, Box and Spotify were our top stock trades for Thursday. With that in mind, let's have a look at the charts.",https://investorplace.com/2020/12/5-top-stock-trades-for-thursday-snap-pfe-wkhs-box-spot/,0.2023,0.2023
PFE,2020-12-02,European officials say UK rushed approval of Pfizer COVID-19 vaccine,https://cdn.snapi.dev/images/v1/p/y/pfizerjpgquality90stripall.jpg,New York Post,"European Union officials slammed the UK on Wednesday for rushing its landmark approval of Pfizer's coronavirus vaccine, saying health authorities shouldn't put speed ahead of safety. The British government cleared the COVID-19 shot early Wednesday, just 10 days after it started examining data from large-scale clinical trials run by Pfizer and its German partner, BioNTech.",https://nypost.com/2020/12/02/eu-officials-say-uk-approved-pfizer-covid-vaccine-too-fast/,0.4767,0.765
PFE,2020-12-02,Why Pfizer and BioNTech Stocks Popped Today,https://cdn.snapi.dev/images/v1/1/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6032222fcoronavirus-vaccine-gettyimages-1219401083jpgw700opresize.jpg,The Motley Fool,The healthcare leaders became the first to receive emergency authorization for their coronavirus vaccine.,https://www.fool.com/investing/2020/12/02/why-pfizer-and-biontech-stocks-popped-today/,0.0,-0.3818
PFE,2020-12-02,What we still don't know about COVID vaccines after the U.K.'s emergency-use authorization of the Pfizer-BioNTech candidate,https://cdn.snapi.dev/images/v1/u/x/mw-iv178-covidv-20201202141635-zqjpguuide517a956-34d2-11eb-a8b3-9c8e992d421e.jpg,Market Watch,"The U.K. government granted emergency use authorization to the COVID-19 vaccine being developed by Pfizer Inc. and German partner BioNTech SE with some fanfare on Wednesday, but experts cautioned that the news does not mean the pandemic is close to being over.",https://www.marketwatch.com/story/what-we-still-dont-know-about-covid-vaccines-after-the-uks-emergency-use-authorization-of-the-pfizer-biontech-candidate-2020-12-02,0.0,-0.0772
PFE,2020-12-02,Blue-Chip Pharmaceutical Stock Surges Following Vaccine Update,https://cdn.snapi.dev/images/v1/s/s/ss222ff.,Schaeffers Research,"Blue-chip pharmaceutical giant Pfizer Inc. (NYSE:PFE) is making waves, as the company's coronavirus vaccine -- which was developed with BioNTech (BNTX) -- was granted emergency use approval in the U.K, after it was shown to be 95% effective in preventing COVID-19 infections.",https://www.schaeffersresearch.com/content/options/2020/12/02/blue-chip-pharmaceutical-stock-surges-following-vaccine-update,0.0,0.6705
PFE,2020-12-02,"What Pfizer, BioNTech Investors Need To Know About COVID-19 Vaccine With Conditional UK Approval",https://cdn.snapi.dev/images/v1/c/p/virus-4933201-1280-8.png,Benzinga,Pfizer Inc. (NYSE: PFE)-BioNTech SE – ADR (NASDAQ: BNTX) earned the distinction of being the first companies to receive regulatory authorization for emergency use of their investigational coronavirus vaccine candidate BNT162b2 following a positive verdict from the United Kingdom's drug regulator. Here's what investors should know about the combo's vaccine candidate:,https://www.benzinga.com/general/biotech/20/12/18619579/what-pfizer-biontech-investors-need-to-know-about-covid-19-vaccine-with-conditional-uk-approval,0.4767,0.6597
PFE,2020-12-02,"United Kingdom approves Pfizer, BioNTech's COVID-19 vaccine",https://cdn.snapi.dev/images/v1/y/6/united-kingdom-approves-pfizer-biontechs-covid-19-vaccine.jpg,Fox Business,"The United Kingdom has approved Pfizer and BioNTech's COVID-19 vaccine and plans to begin vaccinations next week, FOX Business' Edward Lawrence reports. #FoxBusiness Subscribe to Fox Business!",https://www.youtube.com/watch?v=e4f4bxxGF0k,0.6705,0.7088
PFE,2020-12-02,Here's what U.K. approval of Pfizer's Covid vaccine could mean for the U.S.,https://cdn.snapi.dev/images/v1/h/w/heres-what-uk-approval-of-pfizers-covid-vaccine-could-mean-for-the-us.jpg,CNBC Television,"The U.K. on Wednesday became the first country to authorize the Pfizer-BioNTech vaccine for emergency use. The development has many hopeful the vaccine could soon be approved in the U.S. Here's how a vaccine rollout could work in the U.S., and what it means for businesses.",https://www.youtube.com/watch?v=lnqLS8Y25OI,0.4767,0.5423
PFE,2020-12-02,COVID-19 Vaccines Are on the Way and Major Players Are Cashing In,https://cdn.snapi.dev/images/v1/e/u/biotech4.jpg,24/7 Wall Street,COVID-19 stocks were on the move on Wednesday after a few huge updates in regards to vaccine approval.,https://247wallst.com/healthcare-business/2020/12/02/covid-19-vaccines-are-on-the-way-and-major-players-are-cashing-in/,0.0,0.6597
PFE,2020-12-02,Pfizer team evaluates higher shipping temperature for COVID vaccine,https://cdn.snapi.dev/images/v1/r/v/operation-warp-speed-1.jpg,FreightWaves,"The drugmakers behind the COVID-19 vaccine approved Wednesday by United Kingdom authorities are studying whether it can be transported at higher temperatures than minus 94 degrees Fahrenheit (minus 70 Celsius), which would ease logistics challenges for getting people immunized, BioNTech CEO Ugar Sahin said.  In an interview on CNN shortly after the U.K. became the first Western nation to approve public use of the vaccine from U.S. pharmaceutical giant Pfizer (NYSE: PFE) and German partner BioNTech, Sahin said people in the U.K. could begin getting vaccinations by early next week.",https://www.freightwaves.com/news/pfizer-team-evaluates-higher-shipping-temperature-for-covid-vaccine,0.0,0.8126
PFE,2020-12-02,Pfizer CEO speaks at virtual roundtable event after UK approves emergency use of coronavirus vaccine,https://cdn.snapi.dev/images/v1/3/9/pfizer-ceo-speaks-at-virtual-roundtable-event-after-uk-approves-emergency-use-of-coronavirus-vaccine.jpg,Yahoo Finance,"Pfizer CEO speaks at virtual roundtable event after UK approves emergency use of coronavirus vaccine For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. About Yahoo Finance Premium: With a subscription to Yahoo Finance Premium, get the tools you need to invest with confidence.",https://www.youtube.com/watch?v=d0VHQEE-78M,0.0258,0.8934
PFE,2020-12-02,Pfizer and BioNTech's Coronavirus Vaccine Approved for Use in the U.K.,https://cdn.snapi.dev/images/v1/y/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6030662fchild-getting-a-jab-from-a-medical-professionaljpgw700opresize.jpg,The Motley Fool,"The vaccine will begin to be available to the public next week, says the government.",https://www.fool.com/investing/2020/12/02/pfizer-and-biontechs-coronavirus-vaccine-approved/,0.4215,0.0
PFE,2020-12-02,Pfizer/BioNTech's COVID-19 Vaccine Gets Approval in U.K.,https://cdn.snapi.dev/images/v1/m/f/biotech3---gptomp0aia.jpg,Zacks Investment Research,Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine candidate becomes the first-ever vaccine to get authorization.,https://www.zacks.com/stock/news/1123061/pfizer-biontechs-covid-19-vaccine-gets-approval-in-uk,0.4767,0.0
PFE,2020-12-02,Encouraging News on COVID-19 Vaccine,https://cdn.snapi.dev/images/v1/o/y/laboratory-3827745-1920-7.jpg,Zacks Investment Research,Encouraging News on COVID-19 Vaccine,https://www.zacks.com/stock/news/1123037/encouraging-news-on-covid-19-vaccine,0.5267,0.5267
PFE,2020-12-02,CDC Panel Recommends Which Groups Should Get Coronavirus Vaccines First,https://cdn.snapi.dev/images/v1/l/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6030632fa-syringe-being-filled-with-a-vaccine-from-a-vialjpgw700opresize.jpg,The Motley Fool,The recommendation for early inoculation against COVID-19 covers around 24 million people.,https://www.fool.com/investing/2020/12/02/cdc-panel-recommends-which-groups-should-get-coron/,0.2263,0.0
PFE,2020-12-02,"UK approves Pfizer, BioNTech COVID-19 vaccine for use next week",https://cdn.snapi.dev/images/v1/t/h/uk-approves-pfizer-biontech-covid-19-vaccine-for-use-next-week.jpg,Yahoo Finance,"The UK government has approved the BioNTech/Pfizer vaccine against COVID-19 for emergency use, becoming the first country to do so for widespread use. Yahoo Finance's Anjalee Khemlani breaks down the details.",https://www.youtube.com/watch?v=fxA_pEvCXok,0.4019,0.0516
PFE,2020-12-02,'This is monumental'—Cramer on the U.K. approving Pfizer's Covid vaccine for general use,https://cdn.snapi.dev/images/v1/a/7/this-is-monumentalcramer-on-the-uk-approving-pfizers-covid-vaccine-for-general-use.jpg,CNBC Television,"The U.K. on Wednesday authorized the Pfizer-BioNTech vaccine for emergency use, marking another step in the global battle against the pandemic. The vaccine will now be rolled out in the country next week, with elderly people in care homes and medical workers first in line.",https://www.youtube.com/watch?v=qOkr7ATl7gc,0.0,-0.25
PFE,2020-12-02,Pfizer/BioNTech COVID-19 Vaccine Approved in the U.K.,https://cdn.snapi.dev/images/v1/q/n/adobestock-199783080-8d5f276111e4444784eef4133c18583f.jpeg,Investopedia,Vaccine hopes are starting to be fulfilled as the first COVID-19 vaccine gets authorized.,https://www.investopedia.com/pfizer-biontech-covid-19-vaccine-approved-in-the-u-k-5089614,0.4215,0.6808
PFE,2020-12-02,Pfizer Jumps After Nabbing First-Ever Coronavirus Vaccine Approval,https://cdn.snapi.dev/images/v1/g/d/drugs43---ijddi2kwj2.jpg,Investors Business Daily,"Pfizer stock jumped early Wednesday after the pharmaceutical company's BioNTech-partnered coronavirus vaccine gained authorization in the U.K. Also, Merck sold its investment in Moderna. The post Pfizer Jumps After Nabbing First-Ever Coronavirus Vaccine Approval appeared first on Investor's Business Daily.",https://www.investors.com/news/technology/pfizer-stock-jumps-gains-coronavirus-vaccine-approval-uk/,0.4767,0.6908
PFE,2020-12-02,"LIVE | Pfizer, Salesforce, Slack: Jim Cramer's Stock Market Breakdown 12/2",https://cdn.snapi.dev/images/v1/e/f/live-pfizer-salesforce-slack-jim-cramers-stock-market-breakdown-122.jpg,The Street,"In Wednesday's market breakdown, Jim Cramer talks Pfizer's U.K. vaccine approval, Salesforce buying Slack, President-elect Biden's economic team and more. SUBSCRIBE | http://t.st/TheStreetTV MORE VIDEOS: https://www.thestreet.com/video MORE FROM JIM CRAMER: https://www.thestreet.com/jim-cramer' Sign up for ActionAlertsPlus.com today for exclusive insight into Jim Cramer's charitable portfolio: https://secure2.thestreet.com/cap/prm.do?OID=039029 #JimCramer #Investing #WallStreet",https://www.youtube.com/watch?v=yKUyN1J7Y2s,0.0,0.743
PFE,2020-12-02,Pfizer/BioNTech Seek Marketing Nod for COVID-19 Vaccine in EU,https://cdn.snapi.dev/images/v1/e/g/biotech35---gr1wiiv9tc.jpg,Zacks Investment Research,Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine candidate is 95% effective in final analysis.,https://www.zacks.com/stock/news/1122924/pfizer-biontech-seek-marketing-nod-for-covid-19-vaccine-in-eu,0.0,0.4767
PFE,2020-12-02,Pfizer-BioNTech seeks full marketing approval from UK for COVID-19 vaccine,https://cdn.snapi.dev/images/v1/p/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5757652fcoronavirus-vaccine-bottlesjpgw700opresize.jpg,Reuters,"Pfizer is seeking full marketing authorisation from Britain for its COVID-19 vaccine, an executive said on Wednesday as the U.S. drugmaker gears up to deliver by the weekend the first shots following approval for emergency use in the country.",https://www.reuters.com/article/us-health-coronavirus-britain-pfizer/pfizer-biontech-seeks-full-marketing-approval-from-uk-for-covid-19-vaccine-idUSKBN28C22V,0.4767,0.128
PFE,2020-12-02,Will Americans Get COVID-19 Vaccine Sooner Than Europeans?,https://cdn.snapi.dev/images/v1/2/f/gettyimages-1227406908.jpg,Zacks Investment Research,"Moderna (MRNA), and Pfizer (PFE)/BioNTech (BNTX) file for emergency use authorization of their COVID-19 vaccine candidates in Europe",https://www.zacks.com/stock/news/1122868/will-americans-get-covid-19-vaccine-sooner-than-europeans,0.0,-0.3818
PFE,2020-12-02,Pfizer surges 5% on emergency UK approval for COVID-19 vaccine (PFE),https://cdn.snapi.dev/images/v1/m/0/m02d20201106t2i1540189418w940fhfwllplsqrlynxmpega500i.jpg,Business Insider,"The UK became the first country in the world on Tuesday to grant emergency use authorization to Pfizer and BioNTech's COVID-19 vaccine. The vaccine, which demonstrated an efficacy rate of 95% in preventing COVID-19 among patients, will be made available to the country next week for a rollout to hospitals and vaccination centers across the country.",https://www.businessinsider.com/pfizer-stock-price-emergency-uk-approval-for-covid19-vaccine-2020-12,0.128,-0.0516
PFE,2020-12-02,UK approves its first vaccine,https://cdn.snapi.dev/images/v1/u/k/uk-approves-its-first-vaccine.jpg,Business Insider,"Hi, The UK has approved Pfizer and BioNTech's coronavirus vaccine, becoming the first Western country to give a vaccine an OK. The plan is to make the vaccine available next week. ",https://www.businessinsider.com/business-insiders-biggest-healthcare-stories-for-december-2-2020-12,0.4019,0.694
PFE,2020-12-02,Who will be first in line for the Pfizer-BioNTech COVID-19 vaccine?,https://cdn.snapi.dev/images/v1/v/z/im-267048width620size15744157441574416.jpg,Market Watch,"Care home residents and people over the age of 80 will be among the first to receive the Pfizer-BioNTech COVID-19 vaccine, when the U.K. rollout starts next week.",https://www.marketwatch.com/story/who-will-be-first-in-line-for-the-pfizer-biontech-covid-19-vaccine-11606914711,0.0,0.4939
PFE,2020-12-02,Pfizer Covid-19 vaccine approved for use in UK,https://cdn.snapi.dev/images/v1/n/q/gettyimages-1229904522.jpg,CNET,Senior citizens will be first in line as the UK is the first country to approve Pfizer's vaccine.,https://www.cnet.com/health/pfizer-covid-19-coronavirus-vaccine-approved-for-use-in-uk/,0.4215,0.0
PFE,2020-12-02,"How the U.K. became first to approve the Pfizer-BioNTech vaccine, and are there dangers authorizing so fast?",https://cdn.snapi.dev/images/v1/z/a/im-267040width620size15005861664712778.jpg,Market Watch,"The U.K.'s regulator had been delegated much of the work to authorize Europe's medicines, and seemed better prepared than most to approve the vaccine.",https://www.marketwatch.com/story/how-the-u-k-became-first-to-approve-the-pfizer-biontech-vaccine-and-are-there-dangers-authorizing-so-fast-11606912465,-0.4939,0.5859
PFE,2020-12-02,Why We Need All 5 of These Coronavirus Vaccine Companies to End the Pandemic,https://cdn.snapi.dev/images/v1/s/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026872fgettyimages-1216778258jpgw700opresize.jpg,The Motley Fool,It's time to count how many vaccine doses leading companies can provide -- and how many may be needed.,https://www.fool.com/investing/2020/12/02/why-we-need-all-5-of-these-coronavirus-vaccine-com/,0.0,0.0
PFE,2020-12-02,"The UK has approved Pfizer and BioNTech's COVID-19 vaccine, but the US is still waiting. Here's why.",https://cdn.snapi.dev/images/v1/t/h/the-uk-has-approved-pfizer-and-biontechs-covid-19-vaccine-but-the-us-is-still-waiting-heres-why.jpg,Business Insider,"The UK has approved Pfizer and its German partner BioNTech's COVID-19 vaccine — but regulators in the US are yet to make a decision on authorization. The UK's vaccine regulator approved the shot Wednesday morning, making it the first western country to authorize a COVID-19 vaccine. Vaccinations will start next week, the government said.",https://www.businessinsider.com/us-fda-approve-pfizer-vaccine-biontech-covid-uk-mhra-2020-12,0.2263,0.6808
PFE,2020-12-02,UK approves Pfizer-BioNTech coronavirus vaccine to begin rolling out next week,https://cdn.snapi.dev/images/v1/g/x/uk-approves-pfizer-biontech-coronavirus-vaccine-to-begin-rolling-out-next-week.jpg,CNBC Television,"The U.K. on Wednesday authorized the Pfizer-BioNTech vaccine for emergency use, marking another step in the global battle against the pandemic. The vaccine will now be rolled out in the country next week, with elderly people in care homes and medical workers first in line.",https://www.youtube.com/watch?v=_gTCGoMnWI8,0.4019,-0.25
PFE,2020-12-02,7 Of The Best Long-Term Tech Stocks To Buy As Sector Looks Ready to Charge,https://cdn.snapi.dev/images/v1/v/7/biotech25.jpg,InvestorPlace,These seven long-term stocks are likely to bring stable returns to any tech portfolio. The post 7 Of The Best Long-Term Tech Stocks To Buy As Sector Looks Ready to Charge appeared first on InvestorPlace.,https://investorplace.com/2020/12/7-long-term-tech-stocks-cibr-ogig-pypl-roku-qcom-xsd-twtr/,0.7717,0.836
PFE,2020-12-02,U.K. Becomes First Country to Approve Pfizer's Covid-19 Vaccine,https://cdn.snapi.dev/images/v1/w/h/why-pfizers-covid-19-vaccine-is-unlikely-to-move-the-needle-for-the-stock.jpg,Barrons,"The U.K. has become the first country to approve the Pfizer-BioNTech Covid-19 vaccine, with preparations under way to begin the rollout next week.",https://www.barrons.com/articles/u-k-becomes-first-country-to-approve-pfizers-covid-19-vaccine-the-rollout-will-start-next-week-51606907329,0.0,0.0
PFE,2020-12-02,COVID Vaccine Stocks Update: Where Things Stand Now,https://cdn.snapi.dev/images/v1/u/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026442fcovid-vaccine-with-dollar-signjpgw700opresize.jpg,The Motley Fool,Here's what you need to know about all of the leaders in the coronavirus vaccine race.,https://www.fool.com/investing/2020/12/02/covid-vaccine-stocks-update-where-things-stand-now/,0.0,0.0
PFE,2020-12-02,"U.K. Approves Pfizer-BioNTech's Covid-19 Vaccine, The First Country To Do So",https://cdn.snapi.dev/images/v1/b/b/uk-approves-pfizer-biontechs-covid-19-vaccine-the-first-country-to-do-so.jpg,Forbes,The vaccine will be available across the U.K. starting next week with the elderly and frontline healthcare workers being the first to receive a shot.,https://www.forbes.com/sites/siladityaray/2020/12/02/uk-approves-pfizer-biontechs-covid-19-vaccine-the-first-country-to-do-so/,0.4019,0.0
PFE,2020-12-02,Pfizer and BioNTech's COVID-19 vaccine wins U.K. approval — rollout to begin next week,https://cdn.snapi.dev/images/v1/5/p/im-267020width620size15005861664712778.jpg,Market Watch,"U.K. becomes first country to approve a coronavirus vaccine, with immunisations to start within days for those most at risk",https://www.marketwatch.com/story/pfizer-and-biontechs-covid-19-vaccine-wins-u-k-approval-rollout-to-begin-next-week-11606903369,0.7783,-0.3353
PFE,2020-12-02,Vaccine approval is a historic moment for the UK,https://cdn.snapi.dev/images/v1/s/k/skynews-vials-syringe-pfizer-5166962jpg20201109153700.jpg,Skynews,This is an historic moment. The beginning of the end of the pandemic.,https://news.sky.com/story/covid-19-approval-of-pfizer-vaccine-is-a-historic-moment-for-the-uk-12148876,0.4767,0.0
PFE,2020-12-02,The UK approves the BioNTech/Pfizer COVID-19 vaccine for emergency use,https://cdn.snapi.dev/images/v1/b/q/gettyimages-1229305401jpgw600.jpg,TechCrunch,"The UK's medicines regulator has approved the BioNTech/Pfizer vaccine against COVID-19 for emergency use, the companies said today. The UK is the first country to approve the vaccine for widespread use — paving the way for some of the most “high risk” citizens, such as elderly care home residents, to get the jab before the end […]",https://techcrunch.com/2020/12/02/the-uk-approves-the-biontech-pfizer-covid-19-vaccine-for-emergency-use/,0.0258,0.5267
PFE,2020-12-02,U.K. Clears Pfizer-BioNTech Covid-19 Vaccine,https://cdn.snapi.dev/images/v1/d/m/uk-clears-pfizer-biontech-covid-19-vaccine.jpg,Bloomberg Markets and Finance,"Dec.02 -- The U.K. became the first western country to approve a Covid-19 vaccine, with its regulator clearing Pfizer Inc. and BioNTech SE's shot ahead of decisions in the U.S. and European Union. Sam Fazeli, senior pharmaceutical analyst at Bloomberg Intelligence, has the details on ""Bloomberg Markets: European Open.",https://www.youtube.com/watch?v=Wo1jqhfedWs,0.0772,0.4767
PFE,2020-12-02,Pfizer-BioNTech COVID-19 Vaccine Gets UK Approval For Emergency Use,https://cdn.snapi.dev/images/v1/w/r/dimitri-houtteman-qbhppxw3ess-unsplash-5.jpg,Benzinga,Pfizer Inc (NYSE: PFE) and its German partner BioNTech SE (NASDAQ: BNTX) said Wednesday they have received regulatory approval in the United Kingdom for their COVID-19 vaccine. What Happened: The go-ahead from the Medicines and Healthcare Products Regulatory Agency (MHRA) means the U.K. has become the first country to approve a COVID-19 vaccine on an emergency basis ahead of the United States and the European Union.,https://www.benzinga.com/general/biotech/20/12/18609434/pfizer-biontech-covid-19-vaccine-gets-uk-approval-for-emergency-use,0.128,0.7269
PFE,2020-12-02,Regulator says yes to Pfizer and BioNTech: UK becomes first Western country to have a coronavirus vaccine,https://cdn.snapi.dev/images/v1/r/e/regulator-says-yes-to-pfizer-and-biontech-uk-becomes-first-western-country-to-have-a-coronavirus-vaccine.jpg,Business Insider,"The UK has become the first Western country to officially have a new coronavirus vaccine, marking a potential exit route out of the pandemic. And it's happened in record time.   The vaccine developed by US drugmaker Pfizer and the small German biotech, BioNTech, can be used in the UK, after the independent regulatory body in the UK, the Medicines and Healthcare products Regulatory Agency (MHRA) signed off the vaccine.",https://www.businessinsider.com/pfizer-and-biontech-covid-19-vaccines-approved-by-uk-regulator-2020-11,0.4019,0.0
PFE,2020-12-02,UK becomes first country to approve the Pfizer-BioNTech coronavirus vaccine for use,https://cdn.snapi.dev/images/v1/g/p/106800281-16058888822020-11-11t235006z-1966379303-rc2b1k9qa10w-rtrmadp-0-health-coronavirus-vaccines-pfizer.jpeg,CNBC,"The U.K. has authorized the Pfizer/BioNtech coronavirus vaccine, making it the first country in the world to do so.",https://www.cnbc.com/2020/12/02/uk-approves-pfizer-biontech-coronavirus-vaccine-for-use.html,0.0,0.0
PFE,2020-12-02,Pfizer and BioNTech Achieve First Authorization in the World for a Vaccine to Combat COVID-19,https://cdn.snapi.dev/images/v1/3/c/press16---uhgzyix2ws.jpg,Business Wire,"NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in the U.K. has granted a temporary authorization for emergency use for their COVID-19 mRNA vaccine (BNT162b2), against COVID-19. This constitutes the first Emergency Use Authorization following a worldwide Phase 3 trial of a vaccine to help fight the pandemic. Pfizer and BioNTech are anticipating further regulat",https://www.businesswire.com/news/home/20201201006304/en/Pfizer-and-BioNTech-Achieve-First-Authorization-in-the-World-for-a-Vaccine-to-Combat-COVID-19/,-0.34,-0.4767
PFE,2020-12-02,UK approves use of Pfizer's coronavirus vaccine,https://cdn.snapi.dev/images/v1/c/b/m02d20201109t2i1540528426w940fhfwllplsqrlynxmpega80rr.jpg,Skynews,The UK's independent healthcare regulator has approved use of the Pfizer/BioNtech COVID-19 vaccine.,https://news.sky.com/story/covid-19-uk-approves-use-of-pfizers-coronavirus-vaccine-12148786,0.4019,0.4215
PFE,2020-12-01,7 Safe Growth Stocks To Buy For 2021 Catalysts,https://cdn.snapi.dev/images/v1/s/s/ss02924---gm3vc03rrc.,InvestorPlace,Growth stocks to buy shouldn't mean pricey or risky. Here are 7 safe growth stocks that look set for a great 2021.,https://investorplace.com/2020/12/7-safe-growth-stocks-to-buy-for-2021-catalysts/,0.6705,0.886
PFE,2020-12-01,"European Drug Regulator Gives 6-Week Time Frame For Opinions On Pfizer-BioNTech, Moderna COVID-19 Vaccines",https://cdn.snapi.dev/images/v1/1/d/syringe-866550-1920-1-8.jpg,Benzinga,"The European Medicines Agency said Tuesday it has received conditional marketing approval applications from Pfizer Inc. (NYSE: PFE)-BioNTech SE – ADR (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA), the two frontrunners in the development of a coronavirus vaccine.  The decision isn't likely to come early, thereby pushing out the vaccine launch timeline.",https://www.benzinga.com/general/biotech/20/12/18598746/european-drug-regulator-gives-6-week-time-frame-for-opinions-on-pfizer-biontech-moderna-covid-19-,0.0,0.4767
PFE,2020-12-01,EARS Stock: Why Auris Medical Shares Are Soaring 450%,https://cdn.snapi.dev/images/v1/n/k/biotech23.jpg,InvestorPlace,"EARS stock typically flies under the radar, but today it is getting a boost thanks to trial data from a Covid-19 treatment. The post EARS Stock: Why Auris Medical Shares Are Soaring 450% appeared first on InvestorPlace.",https://investorplace.com/2020/12/ears-stock-why-auris-medical-shares-are-soaring-450/,0.296,0.8807
PFE,2020-12-01,How United Airlines overcame one of the largest limitations to being transporting Pfizer's COVID-19 vaccine to the US,https://cdn.snapi.dev/images/v1/h/o/how-united-airlines-overcame-one-of-the-largest-limitations-to-being-transporting-pfizers-covid-19-vaccine-to-the-us.jpg,Business Insider,"The COVID-19 vaccine has taken flight en route to the US.  Pfizer has tasked United Airlines with transporting the first doses of its vaccine to the US, the Wall Street Journal reported on Friday, in preparation for an expected emergency authorization from the Food and Drug Administration scheduled to come in the upcoming weeks.",https://www.businessinsider.com/how-united-airlines-overcame-major-limitation-to-fly-pfizer-vaccine-2020-11,0.4215,0.0516
PFE,2020-12-01,4 Pharmaceutical Stocks That Aren't Worth Their Outsized 2020 Gains,https://cdn.snapi.dev/images/v1/w/s/drugs35.jpg,InvestorPlace,"Now that companies such as Pfizer, Moderna and AstraZeneca have emerged with viable vaccines against Covid-19, the hype around many pharmaceutical stocks is fading. Here are four stocks investors should be weary of in the weeks ahead.",https://investorplace.com/2020/12/4-pharmaceutical-stocks-ino-regn-abbv-nvax-that-arent-worth-their-2020-gains/,0.1862,-0.2732
PFE,2020-12-01,7 Warren Buffett Stocks That Belong On Your 2021 Watchlist,https://cdn.snapi.dev/images/v1/p/v/etf5-8.jpg,InvestorPlace,"In the third quarter, Berkshire Hathaway made a number of changes. Here are seven Warren Buffett stocks that ought to be on your radar.",https://investorplace.com/2020/12/7-warren-buffett-stocks-that-belong-on-your-2021-watchlistthese-7-warren-buffett-stocks-ought-to-be-on-your-2021-watchlist/,0.0,0.0772
PFE,2020-12-01,Buffett Buys Pharma: Two Out Of Four Seem Compelling,https://cdn.snapi.dev/images/v1/s/q/drugs32.jpg,Seeking Alpha,"Berkshire's latest filing revealed the Oracle of Omaha and his team opening new positions in four pharma giants as of late. From a quality standpoint, all companies seem like a natural fit considering Buffett's reported preference for wide-moat businesses.",https://seekingalpha.com/article/4392293-buffett-buys-pharma-two-out-of-four-seem-compelling,0.2263,0.7579
PFE,2020-12-01,"Europe May Not Get Covid-19 Vaccine Before 2021, Earliest Approval Process Scheduled For December 29",https://cdn.snapi.dev/images/v1/e/u/europe-may-not-get-covid-19-vaccine-before-2021-earliest-approval-process-scheduled-for-december-29.jpg,Forbes,Moderna and Pfizer applied to the EU's vaccine regulator this week.,https://www.forbes.com/sites/siladityaray/2020/12/01/europe-may-not-get-covid-19-vaccine-before-2021-earliest-approval-process-scheduled-for-december-29/,0.4767,0.0
PFE,2020-12-01,3 Pharma Stocks With Dividends Above 4% to Buy Now,https://cdn.snapi.dev/images/v1/a/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6022222fpharmaceutical-manufacturing-gettyjpgw700opresize.jpg,The Motley Fool,Should you buy these drugmaker stocks for their juicy dividend yields?,https://www.fool.com/investing/2020/12/01/3-pharma-stocks-with-dividends-above-4-to-buy-now/,0.0,0.0
PFE,2020-12-01,Very Good News For REITs,https://cdn.snapi.dev/images/v1/g/q/catalog-mail7.jpg,Seeking Alpha,Most investors are focused on the bad news affecting REITs. But there has been a lot of very good news lately.,https://seekingalpha.com/article/4392082-good-news-for-reits,0.4927,0.3729
PFE,2020-12-01,COVID-19 Vaccine Race Heats Up: Drugmarkers on Final Lap,https://cdn.snapi.dev/images/v1/r/l/drugs29.jpg,Zacks Investment Research,"Shares of Moderna, Inc. (MRNA), Pfizer, Inc. (PFE) and AstraZeneca plc (AZN) are poised for substantial gains on encouraging final-stage trial results.",https://www.zacks.com/stock/news/1121020/covid-19-vaccine-race-heats-up-drugmarkers-on-final-lap,0.0,0.8689
PFE,2020-12-01,Regenerative Medicines: Universal Cell Therapy Gaining Momentum,https://cdn.snapi.dev/images/v1/9/y/biotech4.jpg,Seeking Alpha,"Allogeneic cell therapies have a significant cost, convenience and efficiency advantage over autologous. Data from three of the leaders: Allogene, Atara and CRISPR are expected in the next 12-to-24 months to further elucidate safety and efficacy.",https://seekingalpha.com/article/4392250-regenerative-medicines-universal-cell-therapy-gaining-momentum,0.4215,0.7964
PFE,2020-12-01,"Pfizer, BioNTech seek COVID-19 vaccine approval in Europe",https://cdn.snapi.dev/images/v1/w/r/pfizer-51jpgquality90stripall.jpg,New York Post,"Pfizer and BioNTech have asked European regulators for conditional approval of their experimental coronavirus vaccine — and officials say they could make a decision by the end of the month. The companies said they submitted an application to the European Medicines Agency on Monday for a conditional marketing authorization for their COVID-19 shot, which was.",https://nypost.com/2020/12/01/pfizer-biontech-seek-covid-vaccine-approval-in-europe/,0.4767,0.4767
PFE,2020-12-01,Pfizer and BioNTech have asked the EU to approve their vaccine — but first shots might not come until next year,https://cdn.snapi.dev/images/v1/p/f/pfizer-and-biontech-have-asked-the-eu-to-approve-their-vaccine-but-first-shots-might-not-come-until-next-year.jpg,Business Insider,"Pfizer and its German partner BioNTech said Tuesday they have asked the European Union to approve their COVID-19 vaccine, but that distribution is unlikely to start until January. After submitting an application on Monday to the European Medicines Agency (EMA), the drugmakers said the EU regulator accepted the application on Tuesday, per the Wall Street Journal.",https://www.businessinsider.com/pfizer-biontech-seek-clearance-for-covid-19-vaccine-in-europe-2020-12,0.0,0.3919
PFE,2020-12-01,"Pfizer, BioNTech apply for CMA in Europe for COVID-19 vaccine candidate",https://cdn.snapi.dev/images/v1/p/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5642132fcoronavirus-vialsjpgw700opresize.jpg,Market Watch,"Shares of Pfizer Inc. rallied 2.8% while Germany-based BioNTech SE dropped 2.5% in premarket trading Tuesday, after the company said they submitted their COVID-19 vaccine candidate BNT162b2 for Conditional Marketing Authorization (CMA) to the European Medicines Agency (EMA). If the EMA recommends granting a CMA, that could lead to use of BNT162b2 in Europe before the end of 2020.",https://www.marketwatch.com/story/pfizer-biontech-apply-for-cma-in-europe-for-covid-19-vaccine-candidate-2020-12-01,0.0,0.6597
PFE,2020-12-01,Pfizer-BioNTech apply for EU emergency authorization for COVID-19 vaccine,https://cdn.snapi.dev/images/v1/g/e/m02d20201201t2i1543038402w940fhfwllplsqrlynxmpegb02ex.jpg,Reuters,"Pfizer Inc and BioNTech have applied to the European drugs regulator for conditional authorization of their COVID-19 vaccine, following similar steps in the United States and Britain, the companies said on Tuesday.",https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer/pfizer-biontech-apply-for-eu-emergency-authorization-for-covid-19-vaccine-idUSKBN28B4F3,-0.3818,0.4215
PFE,2020-12-01,4 Reasons the Stock Market Could Crash in the Next 3 Months,https://cdn.snapi.dev/images/v1/u/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026212fdollar-bill-stock-chart-plunge-correction-dow-sp-500-invest-gettyjpgw700opresize.jpg,The Motley Fool,Big-time volatility may be right around the corner.,https://www.fool.com/investing/2020/12/01/4-reasons-the-stock-market-could-crash-in-3-months/,-0.4019,0.0
PFE,2020-12-01,This COVID Vaccine Is Already Shipping,https://cdn.snapi.dev/images/v1/v/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6026422fjet-flying-over-airportjpgw700opresize.jpg,The Motley Fool,Here's what it means -- and doesn't mean.,https://www.fool.com/investing/2020/12/01/this-covid-vaccine-is-already-shipping/,0.0,0.0
PFE,2020-12-01,"Pfizer, BioNTech apply for coronavirus vaccine approval in Europe",https://cdn.snapi.dev/images/v1/a/p/106717238-16010339862020-09-25t020720z-1743677146-rc2e5j97rka1-rtrmadp-0-health-coronavirus-usa.jpeg,CNBC,Pfizer and BioNTech said they have applied to the European Medicines Agency for the conditional marketing authorization of their coronavirus vaccine.,https://www.cnbc.com/2020/12/01/pfizer-biontech-apply-for-coronavirus-vaccine-approval-in-europe.html,0.4767,0.0
PFE,2020-11-30,Pfizer: A 'New' Growth Foundation In Genomic Medicine,https://cdn.snapi.dev/images/v1/v/z/drugs25.jpg,Seeking Alpha,Pfizer has been working on New Pfizer for almost a decade. The spin offs of Consumer Health and Upjohn appear to be the last steps. Continuation of the policy of dividend growth is a stated priority.,https://seekingalpha.com/article/4392067-pfizer-new-growth-foundation-in-genomic-medicine,0.3818,0.3818
PFE,2020-11-30,Eighth Review Of My Dividend Portfolio,https://cdn.snapi.dev/images/v1/f/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5686502fgettyimage-stockchartjpgw700opresize.jpg,Seeking Alpha,Top five holdings add up to 50% of my portfolio. Portfolio currently yields approximately 3.91%.,https://seekingalpha.com/article/4392066-eighth-review-of-dividend-portfolio,0.0,0.2023
PFE,2020-11-30,First 'mass air shipment' of Pfizer's Covid vaccine arrives as airlines prepare for more,https://cdn.snapi.dev/images/v1/p/j/106099577-1595363154393-jet.jpg,CNBC,United's first flight carrying Pfizer's Covid-19 vaccines arrived in Chicago on Friday.,https://www.cnbc.com/2020/11/30/first-mass-air-shipment-of-pfizers-covid-vaccine-arrives-as-airlines-prepare-for-more.html,0.0,0.0
PFE,2020-11-30,"This could be the first country to distribute the Pfizer-BioNTech vaccine, as Moderna seeks FDA approval",https://cdn.snapi.dev/images/v1/j/g/im-265884width620size15005861664712778.jpg,Market Watch,The U.K. government has told NHS hospitals to be ready to distribute the COVID-19 vaccine manufactured by Pfizer and BioNTech as soon as next Monday.,https://www.marketwatch.com/story/this-could-be-the-first-country-to-distribute-the-pfizer-biontech-vaccine-as-moderna-seeks-fda-approval-11606751481,0.4767,0.3612
PFE,2020-11-30,"Pfizer-BioNTech vaccine could be approved ‘within days,' with U.K. set to be first to start COVID-19 shots",https://cdn.snapi.dev/images/v1/v/v/im-265863width620size15005861664712778.jpg,Market Watch,"COVID-19 infections fall 30% across England in second lockdown, study finds.",https://www.marketwatch.com/story/pfizer-biontech-vaccine-could-be-approved-within-days-with-u-k-set-to-be-first-to-start-covid-19-shots-11606741593,0.4215,0.0
PFE,2020-11-30,Why Novavax Could Be a Bigger COVID Vaccine Winner Than Pfizer and Moderna,https://cdn.snapi.dev/images/v1/k/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019532fscientist-holding-covid-vaccine-with-thumbs-upjpgw700opresize.jpg,The Motley Fool,The small biotech's promising coronavirus vaccine candidate is only half of the reason.,https://www.fool.com/investing/2020/11/30/why-novavax-could-be-a-bigger-covid-vaccine-winner/,0.5859,0.4019
PFE,2020-11-30,"UK To Approve Pfizer-BioNTech Vaccine 'Within Days,' Secures 2M More Doses From Moderna",https://cdn.snapi.dev/images/v1/7/6/covidvaccinee.jpeg,Benzinga,"The U.K. has secured two million more doses of COVID-19 vaccine from Moderna Inc (NASDAQ: MRNA) and is expected to approve the vaccine made by Pfizer Inc (NYSE: PFE) and BioNTech SE - ADR (NASDAQ: BNTX) this week. What Happened: Moderna is to provide another two million vaccines to the U.K., in addition to a previous 5 million doses, Reuters has reported.",https://www.benzinga.com/general/biotech/20/11/18564552/uk-to-approve-pfizer-biontech-vaccine-within-days-secures-2m-more-doses-from-moderna,0.3182,0.4019
PFE,2020-11-30,3 Key Advantages Moderna Holds Over Pfizer and AstraZeneca,https://cdn.snapi.dev/images/v1/a/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019522fscientists-holding-vaccine-bottlejpgw700opresize.jpg,The Motley Fool,They could add up to make Moderna a much bigger winner for investors than either of the two big pharma stocks.,https://www.fool.com/investing/2020/11/29/3-key-advantages-moderna-holds-pfizer-and-astra-z/,0.3612,0.5859
PFE,2020-11-30,Berkshire Hathaway Makes Big Bet on Pharma,https://cdn.snapi.dev/images/v1/b/g/asset-management33.jpg,GuruFocus,"Despite solid gains in pharma sales and profits, Big Pharma's overall share value has pretty much stagnated over the past five years—but better days appear to be ahead, in my opinion.",https://www.gurufocus.com/news/1298016/berkshire-hathaway-makes-big-bet-on-pharma,0.0,0.8784
PFE,2020-11-30,Pfizer's Vaccine Candidate Is Effective -- But It Has Issues,https://cdn.snapi.dev/images/v1/r/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6018082fgettyimages-147091611jpgw700opresize.jpg,The Motley Fool,The company's offering presents challenges at every step from the lab to the syringe.,https://www.fool.com/investing/2020/11/28/pfizers-vaccine-is-effective-but-it-has-issues/,0.4767,0.0772
PFE,2020-11-30,"Pfizer's COVID-19 vaccine is reportedly being flown by United Airlines chartered flights to distribution hubs, in anticipation of FDA approval",https://cdn.snapi.dev/images/v1/p/f/pfizers-covid-19-vaccine-is-reportedly-being-flown-by-united-airlines-chartered-flights-to-distribution-hubs-in-anticipation-of-fda-approval.jpg,Business Insider,"As drugmaker Pfizer seeks regulatory approval for its COVID-19 vaccine, shipments have already begun making their way to distribution centers via United Airlines charters, according to a Wall Street Journal report.  The Federal Aviation Administration (FAA) approved the shipments, which require the vaccine candidate to be packed in dry ice, according to CNN. ",https://www.businessinsider.com/united-airlines-flying-pfizer-covid-19-vaccines-distribution-hubs-2020-11,0.743,0.8271
PFE,2020-11-30,Where Will Pfizer Be in 5 Years?,https://cdn.snapi.dev/images/v1/n/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019482f2025-with-pushpinjpgw700opresize.jpg,The Motley Fool,A prediction: In a much better position than it has been in during the last half a decade.,https://www.fool.com/investing/2020/11/28/where-will-pfizer-be-in-5-years/,0.0,0.4404
PFE,2020-11-27,United Airlines starts charter flights to distribute Pfizer's COVID-19 vaccine: WSJ,https://cdn.snapi.dev/images/v1/7/6/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6009472ftwo-test-tubesjpgw700opresize.jpg,Market Watch,"United Airlines Holdings Inc. on Friday started operating charter flights to get doses of Pfizer Inc.'s and BioNTech SE's COVID-19 vaccine ready for quick distribution if the vaccine candidate is approved by regulators, according to a Wall Street Journal report that cited people familiar with the matter. Pfizer and BioNTech last Friday submitted an application for the vaccine trial's emergency use authorization, making their vaccine candidate the first in line with U.S. regulators.",https://www.marketwatch.com/story/united-airlines-starts-charter-flights-to-distribute-pfizers-covid-19-vaccine-wsj-2020-11-27,0.4215,0.6808
PFE,2020-11-27,Is Bitcoin Millenials' Alternative to Gold?,https://cdn.snapi.dev/images/v1/o/w/biotech16.jpg,GuruFocus,The price of gold this year rallied to new historical highs as the coronavirus pandemic sent equity markets plunging. The safe-haven asset has since pulled back significantly after several pharma companies announced good results from clinical trials for the Covid-19 vaccine.,https://www.gurufocus.com/news/1297901/is-bitcoin-millenials-alternative-to-gold,0.0,0.6597
PFE,2020-11-27,3 Dividend Stocks Ideal for Retirees,https://cdn.snapi.dev/images/v1/p/3/14dow.jpg,The Motley Fool,These buy-and-forget-about stocks offer above-average payouts and consistent profits.,https://www.fool.com/investing/2020/11/27/3-dividend-stocks-ideal-for-retirees/,0.5267,0.4404
PFE,2020-11-27,Top 10 Stocks Warren Buffett Just Bought,https://cdn.snapi.dev/images/v1/e/r/gettyimages-957725692-6dbce81323da4b118e7f88b79dfdf468.jpg,Insider Monkey,"In this article we'll run through the Top 10 Stocks Warren Buffett Just Bought. If you're in a hurry to see the hedge fund legend's highest conviction new stock purchases, you can jump straight to the Top 5 Stocks Warren Buffett Just Bought .",https://www.insidermonkey.com/blog/top-10-stocks-warren-buffett-just-bought-892035/,0.2023,0.5423
PFE,2020-11-26,UPS Soars 71.1% in the Past 6 Months: More Room for Rally?,https://cdn.snapi.dev/images/v1/e/h/biotech9---gysic6fveo.jpg,Zacks Investment Research,The surge in e-commerce demand in the current pandemic scenario bodes well for the UPS stock.,https://www.zacks.com/stock/news/1113499/ups-soars-711-in-the-past-6-months-more-room-for-rally,0.0,0.1531
PFE,2020-11-26,Wall Street Set to Close the Year Higher: 5 Top Growth Picks,https://cdn.snapi.dev/images/v1/e/b/auto36.jpg,Zacks Investment Research,"The stock market is poised to close the year positively, driven by a flurry of encouraging developments, making it a good time to invest in growth stocks like Beazer Homes (BZH) and Axcelis (ACLS).",https://www.zacks.com/stock/news/1113422/wall-street-set-to-close-the-year-higher-5-top-growth-picks,0.5267,0.9413
PFE,2020-11-26,3 Cheap Stocks to Buy Before the Economy Makes a Full Recovery,https://cdn.snapi.dev/images/v1/j/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019702finvestor-looking-at-whether-to-buy-or-sell-a-stockjpgw700opresize.jpg,The Motley Fool,"They may be down this year, but don't count these stocks out for a rally in 2021.",https://www.fool.com/investing/2020/11/26/3-cheap-stocks-to-buy-before-the-economy-makes-a-f/,0.0,0.0
PFE,2020-11-26,Who's Ready for a Stock Market Crash?,https://cdn.snapi.dev/images/v1/j/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019802fstock-market-crash-plunge-dollar-newspaper-invest-dow-sp-500-gettyjpgw700opresize.jpg,The Motley Fool,A perfect storm could be brewing for equities.,https://www.fool.com/investing/2020/11/26/whos-ready-for-a-stock-market-crash/,-0.0516,0.5719
PFE,2020-11-25,How to Invest in a Post-COVID World,https://cdn.snapi.dev/images/v1/l/t/drugs3---vorhrahhci.jpg,InvestorPlace,"Buying stocks that have been hit by a serious but solvable problem, can lead to extraordinary gains when things work out positively. The post How to Invest in a Post-COVID World appeared first on InvestorPlace.",https://investorplace.com/moneywire/2020/11/post-covid-investing-where-to-invest-for-the-pandemics-end/,0.0,0.6124
PFE,2020-11-25,"Pfizer Stock Moved Markets This Month, But Can it Rally?",https://cdn.snapi.dev/images/v1/o/o/drug1.jpg,InvestorPlace,The company is a proven winner but Pfizer stock won't win any awards for excitement. Long term investors can reap strong dividend rewards; short term movement is murkier.,https://investorplace.com/2020/11/pfizer-stock-moved-markets-this-month-but-can-it-rally/,0.0,0.839
PFE,2020-11-25,The Top 5 Telehealth Stocks Disrupting the Healthcare Sector,https://cdn.snapi.dev/images/v1/8/d/insurance10.jpg,InvestorPlace,Don't count out telehealth stocks just yet. There's still plenty of demand as patients and providers become comfortable with virtual care.,https://investorplace.com/2020/11/the-top-5-telehealth-stocks-disrupting-the-healthcare-sector/,0.2023,0.7184
PFE,2020-11-25,Should Value Investors Pick Pfizer (PFE) Stock Right Now?,https://cdn.snapi.dev/images/v1/5/m/drugs45.jpg,Zacks Investment Research,Is Pfizer (PFE) a great pick from the value investor's perspective right now? Read on to know more.,https://www.zacks.com/stock/news/1111858/should-value-investors-pick-pfizer-pfe-stock-right-now,0.34,0.7579
PFE,2020-11-25,The challenges Pfizer faces distributing its Covid-19 vaccine to the masses,https://cdn.snapi.dev/images/v1/r/s/106787444-16049259982020-10-30t210259z-392434681-rc29tj9cenfb-rtrmadp-0-health-coronavirus-vaccine.jpeg,CNBC,"Pfizer's Covid-19 vaccine, made in partnership with BioNTech, needs to be stored at subzero temperatures and distribution challenges lie ahead.",https://www.cnbc.com/2020/11/25/challenges-pfizer-faces-distributing-covid-19-vaccine-to-the-masses-.html,0.0772,0.0772
PFE,2020-11-25,Permian Producers in Focus as Crude Price Picks Up,https://cdn.snapi.dev/images/v1/t/4/oil42.jpg,Zacks Investment Research,"Improving oil prices are definitely a boon for Permian explorers like Devon (DVN), Diamondback (FANG), Concho (CXO) and Matador (MTDR).",https://www.zacks.com/stock/news/1111716/permian-producers-in-focus-as-crude-price-picks-up,-0.5719,0.7906
PFE,2020-11-25,"Forget the Vaccine, Buy Pfizer Stock for Its Impressive Cash Flow",https://cdn.snapi.dev/images/v1/n/j/pfizer-56a530e23df78cf77286d4a7.jpg,InvestorPlace,Vaccine news thrust Pfizer center stage this month. But it's PFE stock's beefy dividend that's the real story.,https://investorplace.com/2020/11/forget-the-vaccine-buy-pfizer-pfe-stock-for-cash-flow/,0.34,0.0
PFE,2020-11-25,Here's How the Top 3 Coronavirus Vaccine Candidates Stack Up,https://cdn.snapi.dev/images/v1/s/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019952fpreparting-injection-artsy-gettyjpgw700opresize.jpg,The Motley Fool,Which leading coronavirus vaccine candidate looks best so far?,https://www.fool.com/investing/2020/11/25/heres-how-the-top-3-coronavirus-vaccine-candidates/,0.2023,0.6369
PFE,2020-11-25,The Most Important Coronavirus Vaccine Questions Yet to Be Answered,https://cdn.snapi.dev/images/v1/k/1/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6021422fcoronavirus-vaccine-doctor-patient-healthcare-gettyjpgw700opresize.jpg,The Motley Fool,"Despite exceptional clinical efficacy, it's far too early to declare victory over COVID-19.",https://www.fool.com/investing/2020/11/25/the-most-important-coronavirus-vaccine-questions-y/,0.2716,0.0
PFE,2020-11-25,Could AstraZeneca's Coronavirus Vaccine Beat Pfizer and Moderna?,https://cdn.snapi.dev/images/v1/b/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6021932fgettyimages-1247981297jpgw700opresize.jpg,The Motley Fool,"It depends on what you mean by ""beat.""",https://www.fool.com/investing/2020/11/25/could-astrazenecas-coronavirus-vaccine-beat-pfizer/,0.0,0.0
PFE,2020-11-25,Better Coronavirus Stock: Pfizer or Moderna?,https://cdn.snapi.dev/images/v1/5/l/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6021622fgettyimages-842612564jpgw700opresize.jpg,The Motley Fool,The companies might both win the coronavirus vaccine race -- but only one may dominate the market in the long term.,https://www.fool.com/investing/2020/11/25/better-coronavirus-stock-pfizer-or-moderna/,0.4404,0.1655
PFE,2020-11-25,6.4M Pfizer COVID-19 Vaccine Doses To Be Distributed Across US Within 24 Hours Of FDA Approval: WaPo,https://cdn.snapi.dev/images/v1/z/t/hush-naidoo-zco-5y29s8k-unsplash.jpg,Benzinga,"Over six million doses of Pfizer Inc's  (NYSE: PFE) COVID-19 vaccine could be distributed within 24 hours of it being given the go-ahead by the United States Food And Drug Administration, The Washington Post reported Tuesday. What Happened: The vaccine's 6.4 million doses would be sent across communities and the first shots are expected to be given to front-line health-care workers, according to the Post.",https://www.benzinga.com/general/biotech/20/11/18525106/6-4m-pfizer-covid-19-vaccine-doses-to-be-distributed-across-us-within-24-hours-of-fda-approval-wa,0.4767,0.4215
PFE,2020-11-24,Pfizer Looks Like Good Value With Its Vaccine Catalyst and Dividend Yield,https://cdn.snapi.dev/images/v1/j/r/isksk22.jpg,InvestorPlace,Pfizer looks like good value with its vaccine catalyst and dividend yield. PFE stock will be 60% higher within several years after the FDA grants EUA for its Covid-19 vaccine.,https://investorplace.com/2020/11/pfe-stock-could-be-worth-60-percent-more-once-vaccine-is-approved/,0.7783,0.8271
PFE,2020-11-24,Pfizer (PFE) Begins Phase III Study on Hemophilia Candidate,https://cdn.snapi.dev/images/v1/r/y/drugs33---cmgcfz29fw.jpg,Zacks Investment Research,"Pfizer (PFE) doses the first participant in the late-stage BASIS study, currently investigating marstacimab to address severe hemophilia A or B with or without inhibitors.",https://www.zacks.com/stock/news/1111125/pfizer-pfe-begins-phase-iii-study-on-hemophilia-candidate,0.0,-0.2168
PFE,2020-11-24,3 Coronavirus Vaccine Makers Near Finish Line in November,https://cdn.snapi.dev/images/v1/l/f/m02d20200625t2i1523586457w940fhfwllplsqrlynxmpeg5o16t.jpg,Zacks Investment Research,Positive developments related to coronavirus vaccine candidates have supported stock markets in November. Three leading coronavirus vaccine candidates achieve encouraging efficacy rate.,https://www.zacks.com/stock/news/1111005/3-coronavirus-vaccine-makers-near-finish-line-in-november,0.0,0.8519
PFE,2020-11-24,"The Vaccines Are Almost Ready, but the Challenges Are Only Beginning",https://cdn.snapi.dev/images/v1/w/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6015632fgettyimages-540123226jpgw700opresize.jpg,The Motley Fool,"Even when a coronavirus vaccine is ready, distribution could be a challenge -- but recent innovations in medical glass could benefit the public and investors alike.",https://www.fool.com/investing/2020/11/24/the-vaccines-are-almost-ready-but-the-challenges-a/,0.2625,0.7096
PFE,2020-11-24,3 Long-Shot Coronavirus Vaccine Stocks to Watch in December,https://cdn.snapi.dev/images/v1/v/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6015662fgettyimages-1242456322jpgw700opresize.jpg,The Motley Fool,These dark horses are getting their second wind.,https://www.fool.com/investing/2020/11/24/3-long-shot-coronavirus-vaccine-stocks-to-watch-in/,0.0,0.0
PFE,2020-11-24,What to Watch for Next in the Coronavirus Vaccine Race,https://cdn.snapi.dev/images/v1/x/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019882fgettyimages-1221407317jpgw700opresize.jpg,The Motley Fool,Requests for Emergency Use Authorization and formal FDA approvals are next on the agenda.,https://www.fool.com/investing/2020/11/24/what-to-watch-for-next-in-the-coronavirus-vaccine/,0.0,-0.3818
PFE,2020-11-24,Should Pfizer Shareholders Sell Their Viatris Stock?,https://cdn.snapi.dev/images/v1/2/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6019422fbuysell-hold-paper-fortune-tellerjpgw700opresize.jpg,The Motley Fool,There are several factors to consider.,https://www.fool.com/investing/2020/11/24/should-pfizer-shareholders-sell-their-viatris-stoc/,0.0,0.0
PFE,2020-11-24,Pfizer/BioNTech Seek Nod for Emergency Use of COVID-19 Vaccine,https://cdn.snapi.dev/images/v1/e/f/biotech13.jpg,Zacks Investment Research,Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine candidate is 95% effective in final analysis.,https://www.zacks.com/stock/news/1110610/pfizer-biontech-seek-nod-for-emergency-use-of-covid-19-vaccine,-0.3818,0.4767
PFE,2020-11-24,4 Sectors to Prosper in Thanksgiving Week,https://cdn.snapi.dev/images/v1/6/0/600petf-1.jpg,Zacks Investment Research,Back-to-back positive vaccine updates have offered sweet surprises to Wall Street from the start of the Thanksgiving month this year.,https://www.zacks.com/stock/news/1110596/4-sectors-to-prosper-in-thanksgiving-week,0.0,0.8176
PFE,2020-11-23,Markets Up on Sunny Holiday Outlook,https://cdn.snapi.dev/images/v1/7/h/airline7.jpg,Zacks Investment Research,"The NRF announced it expects U.S. holiday shopping season to grow 5.2% year over year, based on pent-up demand and higher U.S. savings rates during the pandemic.",https://www.zacks.com/stock/news/1110490/markets-up-on-sunny-holiday-outlook,0.6705,0.296
PFE,2020-11-23,"With Pfizer Partnership, BioNTech Stock Should Push Higher",https://cdn.snapi.dev/images/v1/o/v/biotech5.jpg,InvestorPlace,"In light of a collaboration with a major drugmaker and a fast-track toward possible FDA approval, BNTX stock is practically irresistible. The post With Pfizer Partnership, BioNTech Stock Should Push Higher appeared first on InvestorPlace.",https://investorplace.com/2020/11/with-pfizer-partnership-bntx-stock-should-push-higher/,0.0,0.6705
PFE,2020-11-23,Can Coronavirus Vaccine Stocks Keep Lifting the Stock Market?,https://cdn.snapi.dev/images/v1/o/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6020232fcovid-gettyimages-1206790646jpgw700opresize.jpg,The Motley Fool,The market woke up a little tired on Monday morning.,https://www.fool.com/investing/2020/11/23/can-coronavirus-vaccine-stocks-lift-stock-market/,0.0,-0.3832
PFE,2020-11-23,"With a Vaccine Coming Soon, Where Do These COVID-19 Stocks Stand?",https://cdn.snapi.dev/images/v1/6/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5563602fpills-on-top-of-100-billjpgw700opresize.jpg,24/7 Wall Street,"A COVID-19 vaccine appears to be just around the corner, and many of the companies developing drugs, cocktails, vaccines and treatments are very close to crossing the finish line.",https://247wallst.com/healthcare-business/2020/11/23/with-a-vaccine-coming-soon-where-do-these-covid-19-stocks-stand/,0.0,0.0
PFE,2020-11-23,"With 2 Effective Coronavirus Vaccine Candidates, How Should Investors Proceed?",https://cdn.snapi.dev/images/v1/k/0/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6015622fgettyimages-1212506028jpgw700opresize.jpg,The Motley Fool,It isn't as simple as buying stock in the most recent winners.,https://www.fool.com/investing/2020/11/23/with-2-effective-coronavirus-vaccine-candidates-ho/,0.4767,0.5233
PFE,2020-11-23,3 Dividend Stocks Gurus Like,https://cdn.snapi.dev/images/v1/a/y/3okjn333-4.jpg,GuruFocus,The Dividend Stocks screener at GuruFocus finds 616 dividend stocks held by the gurus as of the writing of this article. Another 19 are listed as over-the-counter stocks.,https://www.gurufocus.com/news/1294406/3-dividend-stocks-gurus-like,0.3612,0.0
PFE,2020-11-23,"Decision on approving Pfizer-BioNTech vaccine to be made in ‘shortest time possible,' U.K. regulator says",https://cdn.snapi.dev/images/v1/0/q/im-263561width620size15960099750623442.jpg,Market Watch,The U.K. has ordered 40 million vaccine doses from Pfizer and BioNTech — enough for up to a third of the population.,https://www.marketwatch.com/story/decision-on-approving-pfizer-biontech-vaccine-to-be-made-in-shortest-time-possible-u-k-regulator-says-11606142910,0.0,0.0
PFE,2020-11-23,Could Late-Stage Coronavirus Vaccine Trials Fail?,https://cdn.snapi.dev/images/v1/d/z/podc2.jpg,The Motley Fool,"Dr. Jeremy Brown says that historically, 90% of vaccine trials fail. Does this data still hold or has the game changed?",https://www.fool.com/investing/2020/11/23/could-late-stage-coronavirus-vaccine-trials-fail/,-0.5423,-0.5423
PFE,2020-11-23,Pandemic Expert Answers: 'Do You Foresee Challenges with Vaccine Distribution?',https://cdn.snapi.dev/images/v1/z/d/podc1.jpg,The Motley Fool,"Investors have questions about the cold chain, particularly for Pfizer's potential vaccine.",https://www.fool.com/investing/2020/11/23/pandemic-expert-answers-do-you-foresee-challenges/,0.0772,0.0
PFE,2020-11-23,Key Tips for Buying COVID Vaccine Stocks,https://cdn.snapi.dev/images/v1/g/l/podc15.jpg,The Motley Fool,One principle is especially important.,https://www.fool.com/investing/2020/11/23/key-tips-for-buying-covid-vaccine-stocks/,0.0,0.2716
PFE,2020-11-23,Ask A Virologist: What's The Timeline for Coronavirus Vaccine Distribution?,https://cdn.snapi.dev/images/v1/c/f/podc14.jpg,The Motley Fool,Dr. Angela Rasmussen answers the million-dollar question on everyone's mind.,https://www.fool.com/investing/2020/11/23/ask-a-virologist-whats-the-timeline-for-coronaviru/,0.0,0.0
PFE,2020-11-23,Thinking About Buying Coronavirus Vaccine Stocks? Watch This First,https://cdn.snapi.dev/images/v1/c/0/podc13.jpg,The Motley Fool,Dr. Jeremy Brown gives investors a helpful tip about valuation,https://www.fool.com/investing/2020/11/23/thinking-about-buying-coronavirus-vaccine-stocks-w/,0.0,0.4215
PFE,2020-11-23,What Investors Need To Know About Companies Working on Coronavirus Vaccines,https://cdn.snapi.dev/images/v1/y/e/podc12.jpg,The Motley Fool,Dr. Leo Nissola shares 1 major thing investors should consider before buying coronavirus vaccine stocks.,https://www.fool.com/investing/2020/11/23/what-investors-need-to-know-about-companies-workin/,0.0,0.296
PFE,2020-11-23,Could The Coronavirus Pandemic Mean Fewer Flu Deaths This Year?,https://cdn.snapi.dev/images/v1/b/u/podc9.jpg,The Motley Fool,Dr. Jeremy Brown shares how COVID-19 will impact the seasonal flu.,https://www.fool.com/investing/2020/11/23/could-the-coronavirus-pandemic-mean-fewer-flu-deat/,-0.3818,-0.1027
PFE,2020-11-23,"Pfizer Doses First Participant in Phase 3 Study Evaluating anti-TFPI Investigational Therapy, Marstacimab, for People With Severe Hemophilia A and B With or Without Inhibitors",https://cdn.snapi.dev/images/v1/f/8/press7---iqhqj3g8pm.jpg,Business Wire,"NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the first participant has been dosed in the Phase 3 BASIS study of marstacimab (PF-06741086), an anti-tissue factor pathway inhibitor (anti-TFPI) being evaluated for the treatment of people with severe hemophilia A or B, with or without inhibitors. BASIS is a global Phase 3, open-label, multicenter study that will evaluate annualized bleed rate (ABR) through 12 months on prophylaxis treatment with marstacimab, an investigat",https://www.businesswire.com/news/home/20201123005602/en/Pfizer-Doses-First-Participant-in-Phase-3-Study-Evaluating-anti-TFPI-Investigational-Therapy-Marstacimab-for-People-With-Severe-Hemophilia-A-and-B-With-or-Without-Inhibitors/,-0.2168,-0.2869
PFE,2020-11-23,Is It Too Late to Get In on This Millionaire-Maker Stock?,https://cdn.snapi.dev/images/v1/o/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6017102fgettyimages-1179580489jpgw700opresize.jpg,The Motley Fool,"This coronavirus vaccine maker started the year at $4. It's since gained more than 2,000%.",https://www.fool.com/investing/2020/11/23/is-it-too-late-to-get-in-on-this-millionaire-maker/,0.0,0.3818
PFE,2020-11-23,Better Buy: Gilead Sciences vs. Pfizer,https://cdn.snapi.dev/images/v1/a/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6009472ftwo-test-tubesjpgw700opresize.jpg,The Motley Fool,Both drugmakers are at critical crossroads with new COVID-19 programs. Which has the stronger prospects?,https://www.fool.com/investing/2020/11/23/better-buy-gilead-sciences-vs-pfizer/,0.4404,0.3612
PFE,2020-11-23,Americans could start receiving Pfizer vaccine 'as early as 11 December',https://cdn.snapi.dev/images/v1/k/o/skynews-vials-syringe-pfizer-5166962jpg20201109153700.jpg,Skynews,"Americans could start receiving a COVID-19 vaccine as early as 11 December, according to the chief scientific adviser for the US government's vaccine programme.",https://news.sky.com/story/covid-19-americans-could-start-receiving-pfizer-vaccine-as-early-as-11-december-12139867,0.0,0.0
PFE,2020-11-23,Unanswered Questions for the Top COVID Vaccines,https://cdn.snapi.dev/images/v1/n/m/podc2---k5ly8doidd.jpg,The Motley Fool,There's still a lot we don't yet know.,https://www.fool.com/investing/2020/11/22/unanswered-questions-for-the-top-covid-vaccines/,0.2023,0.0
PFE,2020-11-23,Top COVID Vaccine Stocks to Buy Now,https://cdn.snapi.dev/images/v1/k/l/podc15.jpg,The Motley Fool,Here are ideas for both conservative and aggressive investors.,https://www.fool.com/investing/2020/11/22/top-covid-vaccine-stocks-to-buy-now/,0.2023,-0.1531
PFE,2020-11-23,How Do Pfizer's and Moderna's COVID Vaccine Results Compare?,https://cdn.snapi.dev/images/v1/j/k/podc13.jpg,The Motley Fool,Hint: They stack up very closely.,https://www.fool.com/investing/2020/11/22/how-do-pfizers-and-modernas-covid-vaccine-results/,0.0,0.0
PFE,2020-11-23,Here's Why Moderna's Coronavirus Vaccine Could Outsell Pfizer's,https://cdn.snapi.dev/images/v1/w/d/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6012002fgettyimages-1215061073jpgw700opresize.jpg,The Motley Fool,Moderna's candidate is cool with being kept at warmer temperatures.,https://www.fool.com/investing/2020/11/22/heres-why-modernas-coronavirus-vaccine-could-outse/,0.0,0.5423
PFE,2020-11-23,Is Pfizer and BioNTech's Potential mRNA Coronavirus Vaccine Revolutionary?,https://cdn.snapi.dev/images/v1/v/v/podc10.jpg,The Motley Fool,Dr. Leo Nissola shares what investors need to know about the latest developments in the mRNA vaccine space.,https://www.fool.com/investing/2020/11/22/is-pfizer-and-biontechs-potential-mrna-coronavirus/,0.0,0.296
PFE,2020-11-23,Is Pfizer Stock A Good Bet On Coronavirus Vaccines?,https://cdn.snapi.dev/images/v1/8/j/podc7.jpg,The Motley Fool,Dr. Angela Rasmussen shares tips for investors thinking about buying stocks like Pfizer and Moderna.,https://www.fool.com/investing/2020/11/22/is-pfizer-stock-a-good-bet-on-coronavirus-vaccines/,0.4404,0.5719
PFE,2020-11-23,3 Best Pharma Stocks to Buy Right Now,https://cdn.snapi.dev/images/v1/q/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6005412fgettyimages-1214342283jpgw700opresize.jpg,The Motley Fool,These three stocks are ready to break out.,https://www.fool.com/investing/2020/11/22/3-best-pharma-stocks-to-buy-right-now/,0.6369,0.3612
PFE,2020-11-23,Why Ultra-Cold Storage and Two-Dose Shots Could Spell A Logistical Nightmare for Pfizer,https://cdn.snapi.dev/images/v1/s/n/podc1.jpg,The Motley Fool,Pfizer's coronavirus vaccine candidate comes with two hurdles that might give its competitors an edge.,https://www.fool.com/investing/2020/11/22/why-ultra-cold-storage-and-two-dose-shots-could-sp/,0.0,0.0
PFE,2020-11-23,What This Virus Expert Thinks About mRNA Vaccine Candidates for COVID-19,https://cdn.snapi.dev/images/v1/k/h/podc15.jpg,The Motley Fool,Dr. Angela Rasmussen explains why news from Pfizer and Moderna's mRNA vaccine trials is so promising.,https://www.fool.com/investing/2020/11/22/what-this-virus-expert-thinks-about-mrna-vaccine-c/,0.0,0.541
PFE,2020-11-23,How Big Of A Deal Is mRNA Vaccine Efficacy? Imagine If It Had Failed,https://cdn.snapi.dev/images/v1/w/u/podc14.jpg,The Motley Fool,Here's what a doctor and pandemic expert thinks about the exciting trial data coming from Pfizer and Moderna.,https://www.fool.com/investing/2020/11/22/how-big-of-a-deal-is-mrna-vaccine-efficacy-imagine/,-0.5106,0.4939
PFE,2020-11-23,Blockchain: How This Next Great Tech Platform Could Help Fight COVID-19,https://cdn.snapi.dev/images/v1/i/5/biotech10.jpg,InvestorPlace,"Simply put, blockchain is the safest way to store and transfer information ever created, which makes it ideal for tracking vaccines. The post Blockchain: How This Next Great Tech Platform Could Help Fight COVID-19 appeared first on InvestorPlace.",https://investorplace.com/moneywire/2020/11/the-blockchain-how-this-next-great-technology-platform-fight-covid-19/,0.6369,0.9062
PFE,2020-11-23,FDA to Discuss Pfizer's Coronavirus Vaccine Authorization Request in December,https://cdn.snapi.dev/images/v1/t/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6018842fsales-rep-and-physician-gettyjpgw700opresize.jpg,The Motley Fool,The group of independent experts will discuss Pfizer's request for emergency use authorization of its coronavirus vaccine candidate.,https://www.fool.com/investing/2020/11/21/fda-to-discuss-pfizers-coronavirus-vaccine-authori/,0.0,-0.3818
PFE,2020-11-23,Near-Term Catalysts to Watch for COVID Vaccine Stocks,https://cdn.snapi.dev/images/v1/w/h/podc9.jpg,The Motley Fool,More big news for leaders in the coronavirus vaccine race will be on the way soon.,https://www.fool.com/investing/2020/11/21/near-term-catalysts-to-watch-for-covid-vaccine-sto/,0.0,0.0
PFE,2020-11-23,A Doctor Explains: What Pfizer's Big Coronavirus Vaccine News Means,https://cdn.snapi.dev/images/v1/s/f/podc8.jpg,The Motley Fool,Here's what a pandemic expert thinks about the recent coronavirus vaccine trial data.,https://www.fool.com/investing/2020/11/21/a-doctor-explains-what-pfizers-big-coronavirus-vac/,0.0,0.0
PFE,2020-11-23,Moderna and Pfizer Investors: There's Room For Multiple mRNA Coronavirus Vaccine Winners,https://cdn.snapi.dev/images/v1/1/f/podc7.jpg,The Motley Fool,Dr. Leo Nissola explains why these two stocks are both likely winners.,https://www.fool.com/investing/2020/11/21/heres-how-this-doctor-thinks-a-covid-19-vaccine-wi/,0.4767,0.4767
PFE,2020-11-23,What Investors Should Look For In Vaccine Trials' Raw Data,https://cdn.snapi.dev/images/v1/b/u/podc6.jpg,The Motley Fool,Dr. Leo Nissola shares what more he wants to see from Pfizer and Moderna as they move toward submitting their potential vaccines to the FDA.,https://www.fool.com/investing/2020/11/21/what-investors-should-look-for-in-vaccine-trials-r/,0.0,0.296
PFE,2020-11-23,Ask A Virologist: How Do mRNA Vaccines Work?,https://cdn.snapi.dev/images/v1/j/r/podc5.jpg,The Motley Fool,Dr. Angela Rasmussen explains how this new class of vaccines can help prevent COVID-19.,https://www.fool.com/investing/2020/11/21/ask-a-virologist-how-do-mrna-vaccines-work/,0.0,0.4215
PFE,2020-11-23,Is There Room for Latecomers to the COVID-19 Party?,https://cdn.snapi.dev/images/v1/q/f/podc3.jpg,The Motley Fool,"Despite multiple treatments, vaccines, and tests for COVID-19 developed by leading competitors, Sorrento's CEO Henry Ji thinks the company still has an opportunity to thrive.",https://www.fool.com/investing/2020/11/21/is-there-room-for-latecomers-to-the-covid-19-party/,0.4019,0.4215
PFE,2020-11-23,3 Healthcare IPOs to Watch This Month,https://cdn.snapi.dev/images/v1/f/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6016682fipojpgw700opresize.jpg,The Motley Fool,"Sotera Health, Maravai Life Sciences, and Olema Pharmaceuticals all have an Initial Public Offering with the NASDAQ this month. Are these healthcare companies worth getting excited about?",https://www.fool.com/investing/2020/11/21/3-healthcare-ipos-to-watch-this-month/,0.0,0.5106
PFE,2020-11-23,Ask A Doctor: What's A Realistic Prediction for When A Coronavirus Vaccine Will Be Available?,https://cdn.snapi.dev/images/v1/g/f/podc11.jpg,The Motley Fool,Dr. Jeremy Brown answers the question on everyone's mind: When will there be a COVID-19 vaccine on the market?,https://www.fool.com/investing/2020/11/21/ask-a-doctor-whats-a-realistic-prediction-for-when/,0.0,0.0
PFE,2020-11-20,Coronavirus vaccine: Pfizer and Biontech to submit emergency use authorization for vaccines,https://cdn.snapi.dev/images/v1/p/q/coronavirus-vaccine-pfizer-and-biontech-to-submit-emergency-use-authorization-for-vaccines.jpg,Yahoo Finance,"Yahoo FInance's Anjalee Khemlani reports on the latest vaccine development, CDC recommends Americans avoid Thanksgiving. #coronavirus #COVID19 #vaccines Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.",https://www.youtube.com/watch?v=2vNfBb5IcK8,-0.3818,0.6908
PFE,2020-11-20,Pfizer applies for emergency use authorization for its vaccine,https://cdn.snapi.dev/images/v1/l/4/pfizer-applies-for-emergency-use-authorization-for-its-vaccine.jpg,CNBC Television,"CNBC's Meg Tirrell reports on the latest developments in the race to get a coronavirus vaccine to the American public. Dr. Ashish Jha, Brown University, weighs in.",https://www.youtube.com/watch?v=qIAZ8ZE3Ihk,-0.3818,0.0
PFE,2020-11-20,"Pfizer's 95% Efficacy Is Exciting, Says Ginkgo Bioworks CEO",https://cdn.snapi.dev/images/v1/k/z/pfizers-95-efficacy-is-exciting-says-ginkgo-bioworks-ceo.jpg,Bloomberg Technology,"Nov.20 -- Jason Kelly, chief executive officer and co-founder at Ginkgo Bioworks Inc., discusses news of a potential vaccine to prevent Covid-19 on ""Bloomberg Technology.""",https://www.youtube.com/watch?v=zKCBxTj0A78,0.4939,0.0258
PFE,2020-11-20,Pfizer's Covid-19 vaccine should be relatively safe and could given to first patients in December,https://cdn.snapi.dev/images/v1/3/x/pfizers-covid-19-vaccine-should-be-relatively-safe-and-could-given-to-first-patients-in-december.jpg,CNBC Television,Dr. Scott Gottlieb says the application for Pfizer's Covid vaccine was sent today. It will take the FDA two to four weeks to review the application and the vaccine could be given to the first patients sometime in December.,https://www.youtube.com/watch?v=uWltWH42ywY,0.4404,0.0
PFE,2020-11-20,"Pfizer, BioNTech make it official: COVID-19 vaccine EUA submitted",https://cdn.snapi.dev/images/v1/o/x/biotech5---wlgfv6mwhh.jpg,Market Watch,"Pfizer Inc. and BioNTech on Friday submitted an application for an emergency use authorization for their trial COVID-19 vaccine candidate, making their vaccine candidate the first in line with U.S. regulators. The two companies had said earlier Friday that the submission to the Food and Drug Administration was coming.",https://www.marketwatch.com/story/pfizer-biontech-make-it-official-covid-19-vaccine-eua-submitted-2020-11-20,0.0,-0.3818
PFE,2020-11-20,Pharma Sector Did Its Job With COVID-19 Vaccine: Barclays Analyst,https://cdn.snapi.dev/images/v1/m/1/syringe-866550-1920-1-7.jpg,Benzinga,"The pharmaceutical industry has succeeded in doing its job in manufacturing multiple vaccines for the novel coronavirus, and it's ""now in the hands"" of government authorities to manage the distribution, Emily Field, head of European pharmaceutical research at Barclays, Emily Field said Friday on CNBC's ""Squawk Box Europe."" Price Not A Factor: Early indications suggest AstraZeneca plc (NASDAQ: AZN) and Johnson & Johnson's (NYSE: JNJ) vaccine will cost $3 to $5, while pricing for Pfizer Inc. (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) could reach $40 on the high end.",https://www.benzinga.com/analyst-ratings/analyst-color/20/11/18467156/pharma-sector-did-its-job-with-covid-19-vaccine-barclays-analyst,0.0,0.6369
PFE,2020-11-20,GOP senator in Pfizer trial urges trust in Covid vaccines: 'This is how we bring an end to this pandemic',https://cdn.snapi.dev/images/v1/x/w/106666814-1597688425659-gettyimages-1225248702-gop-dc-state398-070120.jpeg,CNBC,"""It reminded me of getting the flu shot. It was virtually painless, the vaccine itself,"" Republican Sen.",https://www.cnbc.com/2020/11/20/covid-vaccine-pfizer-trial-participant-sen-steve-daines-urges-trust.html,0.5106,-0.1027
PFE,2020-11-20,"Coronavirus: WHO advises against remdesivir for COVID-19, Pfizer and Biontech file EUA for vaccines",https://cdn.snapi.dev/images/v1/j/v/coronavirus-who-advises-against-remdesivir-for-covid-19-pfizer-and-biontech-file-eua-for-vaccines.jpg,Yahoo Finance,"Yahoo Finance's Anjalee Khemlani reports on the World Health Organization advising against treating COVID-19 with remdesivir and Pfizer and Biontech filing for emergency use authorization. #coronavirus #COVID19 #coronavirusvaccine Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.",https://www.youtube.com/watch?v=XiAxtNX1VeE,0.0,0.5267
PFE,2020-11-20,"BioNTech, Pfizer Ready To Submit Coronavirus Vaccine To FDA",https://cdn.snapi.dev/images/v1/n/j/biotech40.jpg,Investors Business Daily,"Shares of BioNTech and Pfizer rose after the pharmaceutical companies announced they would submit their coronavirus vaccine to U.S. regulators Friday, the first drugmakers to seek approval. The post BioNTech, Pfizer Ready To Submit Coronavirus Vaccine To FDA appeared first on Investor's Business Daily.",https://www.investors.com/news/technology/pfizer-stock-biontech-stock-rise-coronavirus-vaccine-submission-fda-approval/,0.3612,0.7783
PFE,2020-11-20,Why Pfizer and BioNTech Stocks Rose Today,https://cdn.snapi.dev/images/v1/c/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6017452fcoronavirus-vaccine-gettyimages-1205966780jpgw700opresize.jpg,The Motley Fool,Emergency Use Authorization could pave the way for a rapid rollout of their coronavirus vaccine.,https://www.fool.com/investing/2020/11/20/why-pfizer-and-biontech-stocks-rose-today/,0.0,-0.3818
PFE,2020-11-20,Capitol Report: Trump to announce rules to lower drug prices,https://cdn.snapi.dev/images/v1/i/m/im-262881width620size15005861664712778.jpg,Market Watch,"President Donald Trump on Friday is expected to announce two rules intended to lower U.S. drug prices, as he continues to contest the results of the Nov. 3 election.",https://www.marketwatch.com/story/trump-to-announce-rules-to-lower-drug-prices-11605889605,-0.296,-0.296
PFE,2020-11-20,Pfizer and BioNTech Will Ask the FDA to Authorize Their Coronavirus Vaccine Today,https://cdn.snapi.dev/images/v1/q/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6017202fgettyimages-1210736764jpgw700opresize.jpg,The Motley Fool,Emergency Use Authorization could enable shipments to high-risk populations in the U.S. in December.,https://www.fool.com/investing/2020/11/20/pfizer-and-biontech-will-ask-the-fda-to-authorize/,0.0,-0.3818
PFE,2020-11-20,University of Iowa Hospital & Clinics CEO on Pfizer vaccine authorization request,https://cdn.snapi.dev/images/v1/9/p/university-of-iowa-hospital-clinics-ceo-on-pfizer-vaccine-authorization-request.jpg,CNBC Television,"Suresh Gunasekaran, University of Iowa Hospitals and Clinics CEO, joins CNBC's ""Squawk on the Street"" to discuss the coronavirus infection rate in Iowa and the state's plans to distribute Pfizer's Covid-19 vaccine, once approved.",https://www.youtube.com/watch?v=CajHrWRRpX8,0.0,0.4215
PFE,2020-11-20,Operation Warp Speed chief on Pfizer applying for emergency authorization for Covid-19 vaccine,https://cdn.snapi.dev/images/v1/7/w/operation-warp-speed-chief-on-pfizer-applying-for-emergency-authorization-for-covid-19-vaccine.jpg,CNBC Television,"Pfizer and BioNTech will apply Friday for an emergency use authorization from the Food and Drug Administration for their coronavirus vaccine. Dr. Moncef Slaoui, Operation Warp Speed's chief science advisor, joins ""Squawk on the Street"" to discuss.",https://www.youtube.com/watch?v=98GvOadKJo8,-0.3818,-0.3818
PFE,2020-11-20,"Pfizer, BioNTech gain after saying they'll submit their COVID-19 vaccine to the FDA for emergency approval (PFE, BNTX)",https://cdn.snapi.dev/images/v1/p/f/pfizer-biontech-gain-after-saying-theyll-submit-their-covid-19-vaccine-to-the-fda-for-emergency-approval.jpg,Business Insider,"Pfizer and BioNTech gained on Friday after saying they would submit their COVID-19 vaccine candidate to the FDA today for Emergency Use Authorization. Phase III trial results released earlier this month were encouraging, with the vaccine demonstrating an efficacy rate of 95% in a trial with 44,000 participants. ",https://www.businessinsider.com/pfizer-biontech-stock-price-coronavirus-vaccine-fda-emergency-authorization-2020-11,0.5994,0.5267
PFE,2020-11-20,"Pfizer, BioNTech File First For Emergency Use Authorization Of Coronavirus Vaccine",https://cdn.snapi.dev/images/v1/u/y/medicine-5103043-1920-26.jpg,Benzinga,"Signaling that Pfizer Inc. (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) are nearing the finish line, the companies announced plans Friday to apply for emergency use authorization for the coronavirus vaccine candidate BNT162b2. First To File: The filing means the vaccine could be available for high-risk populations in the U.S. by the middle or end of December.",https://www.benzinga.com/general/biotech/20/11/18464284/pfizer-biontech-file-first-for-emergency-use-authorization-of-coronavirus-vaccine,-0.3818,-0.3818
PFE,2020-11-20,What Emergency FDA Authorization Means for Covid-19 Vaccine,https://cdn.snapi.dev/images/v1/m/q/what-emergency-fda-authorization-means-for-covid-19-vaccine.jpg,Bloomberg Markets and Finance,Nov.20 -- Johns Hopkins Bloomberg School of Public Health Professor and Virologist Andrew Pekosz offers insight into emergency authorization of a vaccine as Pfizer Inc. and BioNTech SE plan to file Friday for use of their coronavirus vaccine in December. He speaks with Bloomberg's Francine Lacqua on “Bloomberg Surveillance.,https://www.youtube.com/watch?v=vfEaapJk2hM,-0.3818,-0.3818
PFE,2020-11-20,"Pfizer, BioNTech To Seek Emergency Approval For Covid-19 Vaccine On Friday",https://cdn.snapi.dev/images/v1/m/v/pfizer-biontech-to-seek-emergency-approval-for-covid-19-vaccine-on-friday.jpg,Forbes,Clinical trials show the vaccine to be 95% effective at preventing Covid-19.,https://www.forbes.com/sites/roberthart/2020/11/20/pfizer-biontech-to-seek-emergency-approval-for-covid-19-vaccine-on-friday/,0.128,0.4588
PFE,2020-11-20,Warren Buffett Just Bought These Stocks,https://cdn.snapi.dev/images/v1/d/h/dhdy22.jpg,The Motley Fool,Berkshire Hathaway's 13-F filing shows the Oracle of Omaha's bullish on healthcare.,https://www.fool.com/investing/2020/11/20/warren-buffett-just-bought-these-stocks/,0.0,0.0
PFE,2020-11-20,"Pharma industry has 'done it's job' on Covid vaccine, Barclays says",https://cdn.snapi.dev/images/v1/i/l/pharma-industry-has-done-its-job-on-covid-vaccine-barclays-says.jpg,CNBC International TV,Barclays Head of European Pharmaceutical Research Emily Field speaks about the pharmaceutical industry's efforts to produce a Covid-19 vaccine.,https://www.youtube.com/watch?v=SqubFGjgj4s,0.0,0.0
PFE,2020-11-20,Pfizer to request emergency FDA approval for its COVID-19 vaccine,https://cdn.snapi.dev/images/v1/4/p/pfizer-22jpgquality90stripall.jpg,New York Post,Pfizer and BioNTech said they will ask the feds for emergency approval of their experimental coronavirus vaccine on Friday.,https://nypost.com/2020/11/20/pfizer-to-request-emergency-fda-approval-for-its-covid-19-vaccine/,0.128,0.128
PFE,2020-11-20,Pfizer/BioNTech to seek emergency authorization of Covid-19 vaccine Friday,https://cdn.snapi.dev/images/v1/m/x/im-262745width620size15005861664712778.jpg,Market Watch,Pfizer/BioNTech said they intend to submit applications to other regulatory agencies worldwide in coming days.,https://www.marketwatch.com/story/pfizer-biontech-to-seek-emergency-authorization-of-covid-19-vaccine-friday-11605876318,-0.3818,0.0
PFE,2020-11-20,Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today,https://cdn.snapi.dev/images/v1/k/q/gettyimages-1229685402jpgw600.jpg,TechCrunch,"Two of the companies behind one of the leading COVID-19 vaccine candidates will seek approval from the U.S. Food and Drug Administration for emergency use authorization (EUA) of their preventative treatment with an application to be delivered today. Pfizer and BioNTech, who revealed earlier this week that their vaccine was 95% effective based on Phase […]",https://techcrunch.com/2020/11/20/pfizer-and-biontech-to-submit-request-for-emergency-use-approval-of-their-covid-19-vaccine-today/,0.128,0.5574
PFE,2020-11-20,Pfizer COVID-19 vaccine: The timeline now that FDA emergency use has been requested,https://cdn.snapi.dev/images/v1/6/a/p-1-pfizer-covid-19-vaccine-the-timeline-now-that-fda-emergency-use-requested.jpg,Fast Company,"However, even if the EUA is granted, the chances of the average American receiving Pfizer's COVID-19 vaccine in 2020 is slim. Just days after announcing their COVID-19 vaccine has an efficacy rating of at least 95%, Pfizer has announced that they plan to ask the Food and Drug Administration for emergency use authorization (EUA) today, reports CNBC.",https://www.fastcompany.com/90578562/pfizer-covid-19-vaccine-the-timeline-now-that-fda-emergency-use-requested,-0.3818,0.0516
PFE,2020-11-20,"BioNTech, Pfizer say they plan to submit COVID-19 vaccine application on Friday",https://cdn.snapi.dev/images/v1/g/2/biotech22---2dqgiilwn6.jpg,Market Watch,Shares of Pfizer Inc. gained 1.4% in premarket trading on Friday after it announced plans with BioNTech to submit an application later in the day for an emergency use authorization for their experimental COVID-19 vaccine candidate. BioNTech's stock jumped 6.9% before the market opened.,https://www.marketwatch.com/story/biontech-pfizer-say-they-plan-to-submit-covid-19-vaccine-application-on-friday-2020-11-20,0.0,0.296
PFE,2020-11-20,"Pfizer is about to ask the FDA to authorize its coronavirus vaccine, a critical step before it can be given to more people",https://cdn.snapi.dev/images/v1/a/v/ave3---t3anm1u4uy.jpg,Business Insider,"Pfizer and BioNTech will on Friday ask regulators to sign off on the emergency use of their coronavirus vaccine, a step that could allow the shot to be given more widely. Pfizer said Friday that it was preparing to file for an emergency use authorization with the US Food and Drug Administration, days after announcing that the vaccine was 95% effective at preventing COVID-19 in a late-stage trial.",https://www.businessinsider.com/pfizer-coronavirus-vaccine-filed-for-emergency-authorization-with-fda-2020-11,-0.3182,-0.0772
PFE,2020-11-20,Pfizer applies for U.S. emergency use for COVID-19 vaccine,https://cdn.snapi.dev/images/v1/y/1/m02d20201120t2i1541888667w940fhfwllplsqrlynxmpegaj0mm.jpg,Reuters,"Pfizer Inc said on Friday it has applied to U.S. health regulators for emergency use authorization (EUA) of its COVID-19 vaccine, a major step toward providing protection against the new coronavirus for pandemic-weary Americans.",https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer/pfizer-applies-for-u-s-emergency-use-for-covid-19-vaccine-idUSKBN2801BT,-0.3818,-0.3818
PFE,2020-11-20,"Pfizer, Moderna COVID-19 Vaccines Could Get Limited EU Approval Before Year-End: Report",https://cdn.snapi.dev/images/v1/g/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5989662fgettyimages-1213501739jpgw700opresize.jpg,Benzinga,"In an attempt to “synchronize” COVID-19 vaccine distribution at par with the U.S., the European Union is deliberating the idea of granting  Pfizer Inc (NYSE: PFE)-BioNTech SE (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA), a conditional marketing authorization, Bloomberg reports. What Happened: The European authority is holding constant talks with the U.S. Food and Drug Administration to evaluate and assess the vaccine's efficacy, Ursula von der Leyen, President of the European Commission, told Bloomberg.",https://www.benzinga.com/general/biotech/20/11/18460619/pfizer-moderna-covid-19-vaccines-could-get-limited-eu-approval-before-year-end-report,0.296,0.3818
PFE,2020-11-20,Pfizer and BioNTech to request emergency authorization from FDA for Covid-19 vaccine,https://cdn.snapi.dev/images/v1/l/m/pfizer-and-biontech-to-request-emergency-authorization-from-fda-for-covid-19-vaccine.jpg,CNBC Television,Pfizer and BioNTech will apply for an emergency use authorization from the Food and Drug Administration for its coronavirus vaccine. CNBC's Meg Tirrell reports.,https://www.youtube.com/watch?v=aBcokz5fBN0,-0.3818,-0.3818
PFE,2020-11-20,Pfizer and BioNTech to request emergency authorization from FDA for Covid-19 vaccine.,https://cdn.snapi.dev/images/v1/k/y/106788079-16049431642020-11-05t095723z-1430031187-rc2xwj91w57a-rtrmadp-0-china-trade-expo.jpeg,CNBC,"The FDA process is expected to take a few weeks, and an advisory committee meeting to review the vaccine has been tentatively scheduled for early December.",https://www.cnbc.com/2020/11/20/covid-19-vaccine-pfizer-will-apply-for-fda-emergency-use-authorization.html,-0.3818,0.0
PFE,2020-11-20,Doctor and Pandemic Expert Shares What Investors Need To Know About Coronavirus Vaccines,https://cdn.snapi.dev/images/v1/u/z/podc14.jpg,The Motley Fool,Dr. Jeremy Brown knows a lot about pandemics. Here's what he thinks about the exciting trial data coming from Pfizer and BioNTech.,https://www.fool.com/investing/2020/11/20/doctor-and-pandemic-expert-shares-what-investors-n/,0.296,0.4939
PFE,2020-11-20,Pfizer and BioNTech to Submit Emergency Use Authorization Request Today to the U.S. FDA for COVID-19 Vaccine,https://cdn.snapi.dev/images/v1/6/n/press3---o0ebskvavg.jpg,Business Wire,"NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 against SARS-CoV-2, which will potentially enable use of the vaccine in high-risk populations in the U.S. by the middle to end of December 2020. The submission is based on a vaccine efficacy rate of 95% (p",https://www.businesswire.com/news/home/20201120005370/en/Pfizer-and-BioNTech-to-Submit-Emergency-Use-Authorization-Request-Today-to-the-U.S.-FDA-for-COVID-19-Vaccine/,-0.3818,-0.3818
PFE,2020-11-20,Pfizer requests emergency authorisation for coronavirus vaccine in US,https://cdn.snapi.dev/images/v1/9/s/skynews-pfizer-coronavirus-5167467jpg20201110092122.jpg,Skynews,Pfizer and BioNTech are submitting an emergency authorisation request in the US which could allow its coronavirus vaccine to be used to treat high-risk populations in the country by mid-December.,https://news.sky.com/story/covid-19-pfizer-requests-emergency-authorisation-for-coronavirus-vaccine-in-us-12137091,-0.3818,0.25
PFE,2020-11-20,Exclusive: EU could pay over $10 billion for Pfizer and CureVac vaccines - source,https://cdn.snapi.dev/images/v1/k/m/m02d20201120t2i1541856540w940fhfwllplsqrlynxmpegaj087.jpg,Reuters,"The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters.",https://www.reuters.com/article/us-health-coronavirus-eu-pfizer-exclusiv/exclusive-eu-could-pay-over-10-billion-for-pfizer-and-curevac-vaccines-source-idUSKBN2800IC,0.0258,0.25
PFE,2020-11-19,"Pfizer, Moderna to file FDA COVID-19 vaccine emergency usage as soon as Friday",https://cdn.snapi.dev/images/v1/r/n/biotech19---w7s3ayfzbv.jpg,Fox Business,FDA approval for emergency usage is the first step to getting the COVID-19 vaccine to the public.,https://www.foxbusiness.com/markets/pfizer-covid-november-20-2020,-0.3818,0.128
PFE,2020-11-19,Jefferies Jared Holz lays out why you should be cautious on vaccine stocks,https://cdn.snapi.dev/images/v1/m/q/jefferies-jared-holz-lays-out-why-you-should-be-cautious-on-vaccine-stocks.jpg,CNBC Television,"Jared Holz from Jefferies on vaccine news and new risks for biotech. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Dan Nathan and Bonawyn Eison",https://www.youtube.com/watch?v=s4D8mxfUPJo,-0.1027,-0.2732
PFE,2020-11-19,HHS Secretary Azar says Pfizer is expected to file FDA application for coronavirus vaccine Friday with Moderna soon to follow,https://cdn.snapi.dev/images/v1/n/e/106799927-1605825796975-gettyimages-1229686231-afp-8vj3nw.jpeg,CNBC,"Health and Human Services Secretary Alex Azar said Thursday that Pfizer is expected to file an application to the FDA for emergency use of its coronavirus vaccine on Friday, with Moderna soon to follow.",https://www.cnbc.com/2020/11/19/hhs-chief-says-pfizer-is-expected-to-file-fda-application-for-coronavirus-vaccine-friday.html,0.0,-0.3818
PFE,2020-11-19,Maravai IPO: What Investors Should Know About Pfizer/BioNTech COVID-19 Vaccine Partner,https://cdn.snapi.dev/images/v1/o/u/vaccine-4892017-1920-6.jpg,Benzinga,Maravai Life Sciences Holdings (NASDAQ:MRVI) will hit the public markets with perfect timing as it sees its mRNA product used by COVID-19 vaccine makers. The Offering: Maravai Life Sciences plans on selling 50 million shares at a price point of $24 to $27.,https://www.benzinga.com/news/20/11/18456768/maravai-ipo-what-investors-should-know-about-pfizerbiontech-covid-19-vaccine-partner,0.0,0.7096
PFE,2020-11-19,4 Stocks To Sell If Covid-19 Hurts Oil Demand Again,https://cdn.snapi.dev/images/v1/d/2/d2efg3334---namxgnszr4.jpg,InvestorPlace,"Another wave of Covid-19 could result in a double-dip recession, hurting leveraged oil companies. Put these on your list of stocks to sell.",https://investorplace.com/2020/11/4-stocks-to-sell-if-covid-19-hurts-oil-demand-again/,-0.5574,-0.6705
PFE,2020-11-19,7 Growth Stocks to Buy as We Head Into 2021,https://cdn.snapi.dev/images/v1/d/y/software36.jpg,InvestorPlace,Growth stocks have been in favor since the lows in March. Let's look at a few that are worth buying on the latest pullback.,https://investorplace.com/2020/11/7-growth-stocks-to-buy-as-we-head-into-2021/,0.3818,0.6597
PFE,2020-11-19,What Lies Ahead for Pfizer ETFs After Another Round of Upbeat Vaccine Data,https://cdn.snapi.dev/images/v1/z/s/drugs37.jpg,Zacks Investment Research,Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in the coronavirus vaccine development.,https://www.zacks.com/stock/news/1105757/what-lies-ahead-for-pfizer-etfs-after-another-round-of-upbeat-vaccine-data,-0.4215,0.9001
PFE,2020-11-19,3 5G Stocks to Stream Profits into Your Portfolio in 2021,https://cdn.snapi.dev/images/v1/o/w/biotech10---ctt6cehgs0.jpg,InvestorPlace,"Amidst the confusion in the world today, we know on fact for sure: Everyone wants 5G. Therefore 5G stocks belong in investor portfolios.",https://investorplace.com/2020/11/3-5g-stocks-to-stream-profits-into-your-portfolio-in-2021/,0.4404,0.0258
PFE,2020-11-19,Pfizer/BioNTech COVID-19 Vaccine Shows Final Efficacy of 95%,https://cdn.snapi.dev/images/v1/9/7/biotech5.jpg,Zacks Investment Research,Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine candidate proves to be 95% effective in final analysis.,https://www.zacks.com/stock/news/1105322/pfizer-biontech-covid-19-vaccine-shows-final-efficacy-of-95,0.0,0.4767
PFE,2020-11-19,What Awaits Pharma Giants in Last Lap of COVID-19 Vaccine Race?,https://cdn.snapi.dev/images/v1/k/z/drugs30.jpg,Zacks Investment Research,"Pfizer, Inc. (PFE), BioNTech SE (BNTX), Eli Lilly and Company (LLY), AstraZeneca plc (AZN), Moderna, Inc. (MRNA) and Gilead Sciences, Inc. (GILD) are leading the race to come up with a vaccine for coronavirus.",https://www.zacks.com/stock/news/1105044/what-awaits-pharma-giants-in-last-lap-of-covid-19-vaccine-race,0.0772,0.0
PFE,2020-11-19,Pfizer and LianBio Announce Strategic Collaboration to Expand Development of Novel Therapeutics in Greater China,https://cdn.snapi.dev/images/v1/o/s/press19---wl8czozvch.jpg,Business Wire,"NEW YORK & SHANGHAI & PRINCETON, N.J.--(BUSINESS WIRE)--Pfizer, Inc. (NYSE: PFE) and LianBio announced today that they have entered into a collaboration aimed at developing and commercializing transformative pharmaceutical products in Greater China. LianBio, founded by Perceptive Advisors, forged a collaboration with Pfizer to pursue an innovative business development opportunity. Both companies will be dedicated to advancing best-in-class therapies for patients, leveraging both LianBio's and P",https://www.businesswire.com/news/home/20201119005290/en/Pfizer-and-LianBio-Announce-Strategic-Collaboration-to-Expand-Development-of-Novel-Therapeutics-in-Greater-China/,0.7269,0.8807
PFE,2020-11-19,Morgan Stanley's Matthew Harrison on new vaccine data,https://cdn.snapi.dev/images/v1/m/q/morgan-stanleys-matthew-harrison-on-new-vaccine-data.jpg,CNBC Television,"Matthew Harrison, Analyst at Morgan Stanley, joins Worldwide Exchange on the heels of vaccine data from Oxford, to discuss the space and the race for a cure.",https://www.youtube.com/watch?v=bW-LGpy-HOM,0.0,0.0
PFE,2020-11-19,Results from Phase 3 CROWN Trial of Pfizer's LORBRENA® (lorlatinib) in Previously Untreated ALK-Positive Lung Cancer Published in the New England Journal of Medicine,https://cdn.snapi.dev/images/v1/0/4/press4.jpg,Business Wire,"NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) today announced results from the Phase 3 CROWN trial of LORBRENA® (lorlatinib, available in Europe under the brand name LORVIQUA®) versus XALKORI® (crizotinib) in people with previously untreated anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC) were published online ahead of print in the New England Journal of Medicine. At a planned interim analysis, LORBRENA treatment resulted in statistically significant an",https://www.businesswire.com/news/home/20201119005392/en/Results-from-Phase-3-CROWN-Trial-of-Pfizer%E2%80%99s-LORBRENA%C2%AE-lorlatinib-in-Previously-Untreated-ALK-Positive-Lung-Cancer-Published-in-the-New-England-Journal-of-Medicine/,-0.6597,-0.3818
PFE,2020-11-19,Is Pfizer a Smart Coronavirus Stock to Buy After Moderna's Great Vaccine Results?,https://cdn.snapi.dev/images/v1/q/i/pfizer-covid-vaccine-457x274.jpg,The Motley Fool,"For some investors, the answer is ""yes.""",https://www.fool.com/investing/2020/11/19/is-pfizer-a-smart-coronavirus-stock-to-buy-after-m/,0.7783,0.0
PFE,2020-11-18,Coronavirus vaccine: Pfizer to apply for emergency use authorization for vaccine,https://cdn.snapi.dev/images/v1/0/m/coronavirus-vaccine-pfizer-to-apply-for-emergency-use-authorization-for-vaccine.jpg,Yahoo Finance,"Yahoo Finance's Anjalee Khemlani reports on the latest news in vaccine development. #Pfizer #Moderna #coronavirusvaccine For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.",https://www.youtube.com/watch?v=l_0uyLFzNsc,-0.3818,0.8074
PFE,2020-11-18,BioNTech says vaccine approval possible in mid-December under ideal conditions,https://cdn.snapi.dev/images/v1/4/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5965132fboy-receiving-a-vaccinejpgw700opresize.jpg,Reuters,"U.S. and European regulators could approve Pfizer and BioNTech's experimental COVID-19 vaccine as early as mid-December, the German firm's chief executive said on Wednesday, following the release of positive trial results.",https://www.reuters.com/article/us-health-coronavirus-biontech-approval/biontech-says-vaccine-approval-possible-in-mid-december-under-ideal-conditions-idUSKBN27Y2NB,0.7579,0.5574
PFE,2020-11-18,Pfizer Provides More Details on Vaccine & Seeks FDA Emergency Authorization,https://cdn.snapi.dev/images/v1/r/m/pfizer-provides-more-details-on-vaccine-seeks-fda-emergency-authorization.jpg,Cheddar,"Stocks moved higher on news that Pfizer is reporting its vaccine has 95 percent effectiveness in preventing the coronavirus and that it plans to submit to the FDA in days. Michael Jones, Chairman & CEO at Caravel Concepts, an investment planning software company, joined Cheddar to discuss.",https://www.youtube.com/watch?v=Z_C1aM37N0U,-0.3818,-0.0258
PFE,2020-11-18,New Data Shows Higher Efficacy Rate for Pfizer and BioNTech Coronavirus Vaccine Candidate,https://cdn.snapi.dev/images/v1/1/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6014302fa-syringe-being-filled-with-a-vaccine-from-a-vialjpgw700opresize.jpg,The Motley Fool,The two companies plan to submit BNT162b2 for Emergency Use Authorization in the very near future.,https://www.fool.com/investing/2020/11/18/new-data-reveals-pfizer-and-biontechs-coronavirus/,0.0,-0.3818
PFE,2020-11-18,Pfizer Inc. (PFE) Management on 2nd Annual Wolfe Research Healthcare Conference (Transcript),https://cdn.snapi.dev/images/v1/w/u/transcript18---vgtgifgztf.jpg,Seeking Alpha,Pfizer Inc. (PFE) Management on 2nd Annual Wolfe Research Healthcare Conference (Transcript),https://seekingalpha.com/article/4390083-pfizer-inc-pfe-management-on-2nd-annual-wolfe-research-healthcare-conference-transcript,0.0,0.0
PFE,2020-11-18,"Pfizer, BioNTech Filing Planned as Vaccine Proves 95% Effective",https://cdn.snapi.dev/images/v1/h/5/pfizer-biontech-filing-planned-as-vaccine-proves-95-effective.jpg,Bloomberg Markets and Finance,Nov.18 -- Pfizer Inc. and partner BioNTech SE said their Covid-19 vaccine was 95% effective in a final-analysis trial. Bloomberg Intelligence's Sam Fazeli has the details on “Bloomberg Surveillance.,https://www.youtube.com/watch?v=2DVoO_pshF0,0.4767,0.4767
PFE,2020-11-18,Mike Pence Falsely Gives Credit To Trump For Pfizer Vaccine Success,https://cdn.snapi.dev/images/v1/o/j/mike-pence-falsely-gives-credit-to-trump-for-pfizer-vaccine-success.jpg,Forbes,Pfizer has repeatedly said its vaccine research and development is “entirely self-funded.”,https://www.forbes.com/sites/roberthart/2020/11/18/mike-pence-falsely-gives-credit-to-trump-for-pfizer-vaccine-success/,0.743,0.0
PFE,2020-11-18,BioNTech Will Apply in U.S. For Emergency Use of Covid Vaccine,https://cdn.snapi.dev/images/v1/g/y/biontech-will-apply-in-us-for-emergency-use-of-covid-vaccine.jpg,Bloomberg Markets and Finance,"Nov.18 -- Pfizer and partner BioNTech SE say their Covid-19 vaccine was 95% effective in clinical trials. They will now apply for emergency use authorization in the U.S. BioNTech SE's Chief Executive Officer Ugur Sahin appears on ""Bloomberg Markets.",https://www.youtube.com/watch?v=NUlPue7Wd4k,-0.3818,0.128
PFE,2020-11-18,Here's What's Bumping BioNTech Stock Higher Today,https://cdn.snapi.dev/images/v1/s/0/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6014162fphysician-holding-a-vaccine-shotjpgw700opresize.jpg,The Motley Fool,There's more good news regarding the biotech's coronavirus vaccine candidate.,https://www.fool.com/investing/2020/11/18/heres-whats-bumping-biontech-stock-higher-today/,0.0,0.4927
PFE,2020-11-18,Pfizer and BioNTech Conclude Late-Stage COVID-19 Trial,https://cdn.snapi.dev/images/v1/3/3/biotech28.jpg,24/7 Wall Street,"The COVID-19 vaccine duo, Pfizer Inc. (NYSE: PFE) and BioNTech S.E.",https://247wallst.com/healthcare-business/2020/11/18/pfizer-and-biontech-conclude-late-stage-covid-19-trial/,0.0,0.0
PFE,2020-11-18,Covid Vaccine Update: How Do the Moderna and Pfizer Coronavirus Vaccines Compare?,https://cdn.snapi.dev/images/v1/v/4/biotech26.jpg,InvestorPlace,"With a new Covid vaccine update today, how do the Moderna and Pfizer coronavirus vaccines compare? Dive in here.",https://investorplace.com/2020/11/covid-vaccine-update-moderna-and-pfizer-coronavirus-vaccines-compare/,0.0,0.0
PFE,2020-11-18,Coronavirus vaccine: Pfizer says vaccine is safe and 95% effective,https://cdn.snapi.dev/images/v1/g/s/coronavirus-vaccine-pfizer-says-vaccine-is-safe-and-95-effective.jpg,Yahoo Finance,"Dr. Céline Gounder Clinical Assistant Professor of Infectious Diseases and member of President-elect Joe Biden's COVID-19 advisory board discusses vaccine development, and the importance taking measures to reduce the spread of COVID-19 with Yahoo Finance's Myles Udland. #Coronavirusvaccine #COVID19vaccine #Pfizer #Moderna Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.",https://www.youtube.com/watch?v=8ndW9cKr6lY,0.7184,0.8176
PFE,2020-11-18,"Pfizer, BioNTech Stocks Rise After Final Vaccine Update",https://cdn.snapi.dev/images/v1/j/0/biotech23.jpg,Schaeffers Research,"Once again, Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) are dominating headlines, after the two drugmakers announced their coronavirus vaccine candidate was 95% effective as its final result.",https://www.schaeffersresearch.com/content/news/2020/11/18/pfizer-biontech-stocks-rise-after-final-vaccine-update,0.0,0.2263
PFE,2020-11-18,"LIVE | Boeing, Pfizer Fly Higher: Jim Cramer's Market Breakdown Nov. 18",https://cdn.snapi.dev/images/v1/l/g/live-boeing-pfizer-fly-higher-jim-cramers-market-breakdown-nov-18.jpg,The Street,"In Wednesday's market, Jim Cramer talks Pfizer, Boeing, Lowe's and Apple and more. SUBSCRIBE | http://t.st/TheStreetTV MORE VIDEOS: https://www.thestreet.com/video MORE FROM JIM CRAMER: https://www.thestreet.com/jim-cramer' Sign up for ActionAlertsPlus.com today for exclusive insight into Jim Cramer's charitable portfolio: https://secure2.thestreet.com/cap/prm.do?OID=039029 #JimCramer #Investing #WallStreet",https://www.youtube.com/watch?v=9-3lukWodRI,0.0,0.4939
PFE,2020-11-18,"Target, Boeing, Pfizer Lead Stock Market Gains As Vaccine Rally Resumes",https://cdn.snapi.dev/images/v1/d/c/target-boeing-pfizer-lead-stock-market-gains-as-vaccine-rally-resumes.jpg,Forbes,Pfizer says it will apply for an emergency use authorization from the FDA within days.,https://www.forbes.com/sites/jonathanponciano/2020/11/18/stock-market-gains-target-boeing-pfizer-vaccine-rally/,0.34,-0.3818
PFE,2020-11-18,"Pfizer, Moderna Vaccines Show Promise for mRNA: Johns Hopkins",https://cdn.snapi.dev/images/v1/a/2/pfizer-moderna-vaccines-show-promise-for-mrna-johns-hopkins.jpg,Bloomberg Markets and Finance,"Nov.18 -- Johns Hopkins Assistant Professor of Emergency Medicine Lauren Sauer discusses fast authorization for coronavirus vaccines from Pfizer Inc. and Moderna Inc. She speaks on ""Bloomberg Surveillance."" The Bloomberg School of Public Health is supported by Michael R.",https://www.youtube.com/watch?v=rt-9LgdDYek,0.3182,-0.0772
PFE,2020-11-18,Pfizer says analysis shows 3.8% of participants experienced fatigue,https://cdn.snapi.dev/images/v1/e/3/m02d20201118t2i1541637949w940fhfwllplsqrlynxmpegah149.jpg,Reuters,"Pfizer Inc on Tuesday updated its analysis of the safety profile of its COVID-19 vaccine seen during its large, late-stage trial, saying that 3.8% of participants experienced fatigue after receiving a second dose of the shot.",https://www.reuters.com/article/us-health-coronavirus-vaccines-safety/pfizer-says-analysis-shows-3-8-of-participants-experienced-fatigue-idUSKBN27Y1XM,-0.25,0.2023
PFE,2020-11-18,Pfizer's coronavirus shot is 95% effective,https://cdn.snapi.dev/images/v1/p/f/pfizers-coronavirus-shot-is-95-effective.jpg,Business Insider,"Hello, In an update Wednesday, Pfizer and its partner BioNTech said their coronavirus vaccine was 95% effective at preventing COVID-19, after a larger analysis of 170 cases of the disease seen in the study.",https://www.businessinsider.com/business-insider-biggest-healthcare-stories-for-november-1-2020-11,0.4767,0.4588
PFE,2020-11-18,Factbox: Development of Pfizer-BioNTech coronavirus vaccine,https://cdn.snapi.dev/images/v1/g/g/m02d20201118t2i1541636034w940fhfwllplsqrlynxmpegah137.jpg,Reuters,"Drugmaker Pfizer said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine showed it was 95% effective, and that it would apply for emergency U.S. authorization within days.",https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-fa/factbox-development-of-pfizer-biontech-coronavirus-vaccine-idUSKBN27Y1WA,0.0,0.128
PFE,2020-11-18,Pfizer and BioNTech climb as 95% vaccine effectiveness tees up application for FDA approval,https://cdn.snapi.dev/images/v1/p/f/pfizer-and-biontech-climb-as-95-vaccine-effectiveness-tees-up-application-for-fda-approval.jpg,Business Insider,"Pfizer and BioNTech gained in early Wednesday trading after the companies announced their experimental coronavirus vaccine was 95% effective at protecting patients against COVID-19. The updated figure comes from final analysis of trial data. Preliminary results released on November 9 showed the drug to be 90% effective in the nearly 44,000-person trial. The newest information clears the way for Pfizer and BioNTech to apply for emergency-use authorization from the Food and Drug Administration in a matter of days.",https://www.businessinsider.com/pfizer-biontech-stock-price-coronavirus-vaccine-trial-effectiveness-fda-authorization-2020-11,0.4767,0.8481
PFE,2020-11-18,Warren Buffett's Berkshire Hathaway plowed more than $5 billion into 4 pharma stocks last quarter. He's been teasing a bet on the sector for more than 20 years,https://cdn.snapi.dev/images/v1/w/a/warren-buffetts-berkshire-hathaway-plowed-more-than-5-billion-into-4-pharma-stocks-last-quarter-hes-been-teasing-a-bet-on-the-sector-for-more-than-20-years.jpg,Business Insider,"Warren Buffett's Berkshire Hathaway plowed more than $5 billion in total into AbbVie, Bristol Myers Squibb, Merck, and Pfizer in the third quarter. Close followers of the company won't be surprised, as Buffett has been mulling a bet on the pharmaceutical sector for more than 20 years. ""You could've just bought the whole industry and done very well,"" the famed investor said at Berkshire's annual shareholder meeting in 1997. He was referring to the downturn in drug stocks in the early 1990s, sparked by President Bill Clinton's proposed healthcare reforms. ""We didn't do it. It was a mistake.""",https://www.businessinsider.com/warren-buffett-berkshire-hathaway-buy-4-pharma-stocks-20-years-2020-11,-0.0772,-0.1695
PFE,2020-11-18,"Pfizer-BioNTech Plan Vaccine Emergency Use Filing Within Days After Final Analysis Confirm Efficacy, Safety",https://cdn.snapi.dev/images/v1/a/c/vaccine-5074670-1920-17.jpg,Benzinga,"Pfizer Inc. (NYSE: PFE) andBioNTech SE – ADR (NASDAQ: BNTX) have managed to stay ahead in the vaccine race by a hair's breadth. Within days after Moderna Inc (NASDAQ: MRNA) released its first interim analysis, the U.S.-German combo announced results from the final analysis of their late-stage study of their jointly-developed mRNA vaccine, codenamed BNT162b2.",https://www.benzinga.com/analyst-ratings/analyst-color/20/11/18425383/pfizer-biontech-plan-vaccine-emergency-use-filing-within-days-after-final-analysis-,0.0516,0.0
PFE,2020-11-18,Barron's Daily: Are Pfizer and Boeing pointing a path back to normal?,https://cdn.snapi.dev/images/v1/e/i/im-261568width620size15.jpg,Market Watch,Barron's Daily: Are Pfizer and Boeing pointing a path back to normal?,https://www.marketwatch.com/articles/pfizers-covid-vaccine-boeings-737-max-and-signs-of-life-returning-to-normal-51605704033,0.0,0.0
PFE,2020-11-18,Futures Movers: Oil surges on vaccine prospects after Pfizer says candidate is 95% effective,https://cdn.snapi.dev/images/v1/c/y/im-241658width620size15628815628815629.jpg,Market Watch,Oil futures add to gains Wednesday after Pfizer Inc. says its COVID-19 vaccine candidate was more than 95% effective.,https://www.marketwatch.com/story/oil-surges-on-vaccine-prospects-after-pfizer-says-candidate-is-95-effective-11605704841,0.6486,0.6969
PFE,2020-11-18,"Pfizer COVID-19 vaccine update: Final results shows it's 95% effective, too",https://cdn.snapi.dev/images/v1/u/d/p-1-pfizer-covid-19-vaccine-update-final-results-shows-itand8217s-95-effective-too.jpg,Fast Company,But don't let your COVID-19 guard down yet. There's still a long way to go before most people will receive the vaccine.,https://www.fastcompany.com/90577025/pfizer-covid-19-vaccine-update-final-results-shows-its-95-effective-too,0.4767,0.0
PFE,2020-11-18,"Pfizer's and Moderna's vaccines likely work for all existing coronavirus strains. Don't worry about mutations for now, scientists say.",https://cdn.snapi.dev/images/v1/p/f/pfizers-and-modernas-vaccines-likely-work-for-all-existing-coronavirus-strains-dont-worry-about-mutations-for-now-scientists-say.jpg,Business Insider,"Don't worry about mutated strains of the coronavirus, experts say — the leading vaccine candidates should protect you against every version of the virus they've seen. Moderna and Pfizer each announced this month that their coronavirus vaccines prevent COVID-19 — the former's is 94.5% effective, while the latter's is 90%. Both companies hope to get approval from the FDA in the coming weeks.",https://www.businessinsider.com/coronavirus-vaccines-should-work-for-all-strains-mutations-2020-11,0.0531,0.9002
PFE,2020-11-18,"Pfizer's COVID-19 vaccine 95% effective in final results, company to seek approval within days",https://cdn.snapi.dev/images/v1/s/t/104685035-m-740x416.jpg,Fox Business,"The companies said they have collected the two months of safety data on about 19,000 study subjects requested by the U.S. Food and Drug Administration.",https://www.foxbusiness.com/markets/pfizers-covid-19-vaccine-95-effective-in-final-results-company-to-seek-approval-within-days,0.7351,0.4215
PFE,2020-11-18,Pfizer puts COVID vaccine effectiveness at 95%; authorization to be sought soon,https://cdn.snapi.dev/images/v1/q/l/im-261569width620size15005861664712778.jpg,Market Watch,Pfizer puts COVID vaccine effectiveness at 95%; authorization to be sought soon,https://www.marketwatch.com/story/pfizer-says-it-will-seek-u-s-emergency-use-authorization-within-days-for-coronavirus-vaccine-01605702946,0.0,0.0
PFE,2020-11-18,"Pfizer ends COVID-19 trial with 95% efficacy, to seek emergency-use authorization",https://cdn.snapi.dev/images/v1/v/e/m02d20201118t2i1541623973w940fhfwllplsqrlynxmpegah0um.jpg,Reuters,"Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective, adding it had the required two-months of safety data and would apply for emergency U.S. authorization within days.",https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer/pfizer-ends-covid-19-trial-with-95-efficacy-to-seek-emergency-use-authorization-idUSKBN27Y1GM,0.0,0.5106
PFE,2020-11-18,Moderna's and Pfizer's Vaccine News May Signal a Market Top,https://cdn.snapi.dev/images/v1/y/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6011452fdoctor-giving-vaccine-flu-shot-to-senior-gettyjpgw700opresize.jpg,The Motley Fool,Great news for humanity might not be such excellent news for Wall Street.,https://www.fool.com/investing/2020/11/18/moderna-and-pfizer-vaccine-may-signal-a-market-top/,0.2023,0.2737
PFE,2020-11-18,Instant View: Pfizer ends COVID-19 trial with 95% efficacy,https://cdn.snapi.dev/images/v1/g/z/m02d20201118t2i1541628501w940fhfwllplsqrlynxmpegah0wg.jpg,Reuters,"Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine showed it was 95% effective, adding it had the required two-months of safety data and would apply for emergency U.S. authorization within days.",https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-in/instant-view-pfizer-ends-covid-19-trial-with-95-efficacy-idUSKBN27Y1K4,0.0,0.5106
PFE,2020-11-18,"Pfizer-BioNTech Says Covid-19 Vaccine Is 95% Effective, Will Seek Emergency Approval Within Days",https://cdn.snapi.dev/images/v1/s/n/pfizer-biontech-says-covid-19-vaccine-is-95-effective-will-seek-emergency-approval-within-days.jpg,Forbes,It comes after Moderna announced interim data from Phase 3 trials showed its vaccine candidate to be 94.5% effective.,https://www.forbes.com/sites/roberthart/2020/11/18/pfizer-biontech-says-covid-19-vaccine-is-95-effective-will-seek-emergency-approval-within-days/,0.5574,0.4767
PFE,2020-11-18,Pfizer says full vaccine results indicate its Covid-19 vaccine is 95% effective,https://cdn.snapi.dev/images/v1/3/d/pfizer-says-full-vaccine-results-indicate-its-covid-19-vaccine-is-95-effective.jpg,CNBC Television,"Pfizer and BioNTech said Wednesday that a final data analysis found their coronavirus vaccine was 95% effective in preventing Covid-19 and, in addition, appeared to fend off severe disease. CNBC's Meg Tirrell reports.",https://www.youtube.com/watch?v=W9Xb61Ik7no,0.4767,0.1027
PFE,2020-11-18,2 Reasons Why Moderna's Coronavirus Vaccine Candidate Just Took the Lead Away from Pfizer,https://cdn.snapi.dev/images/v1/w/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6011732fgettyimages-1127763296jpgw700opresize.jpg,The Motley Fool,"In this close race, Moderna offers a key data point -- and a logistical advantage.",https://www.fool.com/investing/2020/11/18/2-reasons-why-modernas-coronavirus-vaccine-candida/,0.0,0.25
PFE,2020-11-18,Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis,https://cdn.snapi.dev/images/v1/a/5/gettyimages-1229654222jpgw600.jpg,TechCrunch,"Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 vaccine candidate proved 95% percent effective. This is a better efficacy rate than Pfizer reported previously, when it announced a 90% effectiveness metric based on […]",https://techcrunch.com/2020/11/18/pfizer-says-its-covid-19-vaccine-is-95-effective-in-final-clinical-trial-results-analysis/,0.4767,0.7184
PFE,2020-11-18,"Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints",https://cdn.snapi.dev/images/v1/a/k/press6---1xx5bhanxs.jpg,Business Wire,"NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all of the study's primary efficacy endpoints. Analysis of the data indicates a vaccine efficacy rate of 95% (p",https://www.businesswire.com/news/home/20201118005595/en/Pfizer-and-BioNTech-Conclude-Phase-3-Study-of-COVID-19-Vaccine-Candidate-Meeting-All-Primary-Efficacy-Endpoints/,0.0,0.0
PFE,2020-11-18,The Motley Fool Sits Down With A Doctor About Pfizer's Coronavirus Vaccine News,https://cdn.snapi.dev/images/v1/b/m/podc6.jpg,The Motley Fool,Dr. Leo Nissola shares what investors need to know about the latest developments in the mRNA vaccine space.,https://www.fool.com/investing/2020/11/18/the-motley-fool-sits-down-with-a-doctor-about-pfiz/,-0.4404,0.296
PFE,2020-11-18,Pfizer says final data analysis shows Covid vaccine is 95% effective – plans to submit to FDA in 'days',https://cdn.snapi.dev/images/v1/k/x/106791886-1605096960804-gettyimages-1229031575.jpg,CNBC,Pfizer and BioNTech said final analysis found coronavirus vaccine was 95% effective in preventing Covid-19 and appeared to fend off severe disease.,https://www.cnbc.com/2020/11/18/coronavirus-pfizer-vaccine-is-95percent-effective-plans-to-submit-to-fda-in-days.html,0.4767,0.1027
PFE,2020-11-18,Pfizer says its coronavirus vaccine is 95% effective as it gears up to ask the FDA to authorize the shot,https://cdn.snapi.dev/images/v1/p/f/pfizer-says-its-coronavirus-vaccine-is-95-effective-as-it-gears-up-to-ask-the-fda-to-authorize-the-shot.jpg,Business Insider,"On November 9, the world learned that Pfizer's coronavirus vaccine is highly effective.  Even though details were sparse in that release, the news that the vaccine was highly protective against COVID-19 showed a potential exit path from this pandemic. ",https://www.businessinsider.com/pfizer-says-coronavirus-vaccine-effective-will-submit-to-fda-eua-2020-11,0.4767,0.5256
PFE,2020-11-18,Pfizer CEO says COVID-19 vaccine candidate has passed FDA safety milestone,https://cdn.snapi.dev/images/v1/n/a/drugs19.jpg,Market Watch,"Pfizer Inc. Chief Executive Albert Bourla said the company and its partner BioNTech SE have passed the minimum two-month follow-up that the U.S. Food and Drug Administration requires as a safety milestone to obtain emergency use authorization for its COVID-19 vaccine candidate, according to media reports. Bourla made the comment at New York Times and STAT summits on Tuesday.",https://www.marketwatch.com/story/pfizer-ceo-says-covid-19-vaccine-candidate-has-passed-fda-safety-milestone-2020-11-18,0.4215,0.0516
PFE,2020-11-18,Here's Exactly Why Warren Buffett Loaded Up on Big Pharma Stocks,https://cdn.snapi.dev/images/v1/e/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6011112fwarren-buffett-tmfjpgw700opresize.jpg,The Motley Fool,"The Oracle of Omaha and his investing lieutenants knew what they were doing in buying AbbVie, BMS, Merck, and Pfizer.",https://www.fool.com/investing/2020/11/18/heres-exactly-why-warren-buffett-loaded-up-on-big/,0.0,0.0
PFE,2020-11-18,Pfizer vaccine 95% effective and will be submitted for authorisation 'within days',https://cdn.snapi.dev/images/v1/a/p/skynews-vials-syringe-pfizer-5166962jpg20201109153700.jpg,Skynews,"The Pfizer-BioNTech vaccine has now proved 95% effective in preventing coronavirus and has met the safety criteria needed for emergency authorisation, the firms have said.",https://news.sky.com/story/covid-19-pfizer-biontech-vaccine-now-95-effective-and-will-be-submitted-for-authorisation-within-days-12135473,0.4767,0.4939
PFE,2020-11-17,Pfizer May File for Emergency Authorization of Coronavirus Vaccine Within the Week,https://cdn.snapi.dev/images/v1/3/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6012992fcoronavirus-vaccine-gettyimages-1210736764jpgw700opresize.jpg,The Motley Fool,The drugmaker is at the vanguard of the global battle against COVID-19.,https://www.fool.com/investing/2020/11/17/pfizer-may-file-for-emergency-authorization-of-cor/,-0.3818,-0.3818
PFE,2020-11-17,Pfizer's Pilot Program For Vaccine Distribution In 4 States: What You Should Know,https://cdn.snapi.dev/images/v1/h/u/medicine-5103043-1920-25.jpg,Benzinga,"Pfizer, Inc. (NYSE: PFE) shares, which came under selling pressure Monday in response to positive news on a rival vaccine candidate from Moderna, Inc. (NASDAQ: MRNA), were rebounding Tuesday after Pfizer unveiled an action plan to distribute its COVID-19 vaccine candidate upon successful regulatory clearance. What Happened: Pfizer announced the U.S. COVID-19 Immunization Pilot Program, which will facilitate delivery and deployment of BNT162b2, the investigational vaccine it is co-developing with German biopharma BioNTech SE – ADR (NASDAQ: BNTX).",https://www.benzinga.com/general/biotech/20/11/18405875/pfizers-pilot-program-for-vaccine-distribution-in-4-states-what-you-should-know,0.0,0.8126
PFE,2020-11-17,Pfizer Inc. initiates Covid-19 vaccine shipment trial,https://cdn.snapi.dev/images/v1/4/s/pfe2.jpg,The Dog of Wall Street,"The company has selected Texas, New Mexico, Tennessee, and Rhode Island for the pilot program",https://thedogofwallstreet.com/pfe/pfizer-inc-initiates-covid-19-vaccine-shipment-trial,0.0,0.0
PFE,2020-11-17,Warren Buffett makes big investment in US pharmaceutical firms,https://cdn.snapi.dev/images/v1/5/1/5173jpgwidth460quality85autoformatfitmaxse847f4895082da26e2565294d5ec2ea2.jpg,The Guardian,Berkshire Hathaway bought $5.7bn worth of shares in four companies in third quarter,https://www.theguardian.com/business/2020/nov/17/warren-buffett-makes-big-investment-in-us-pharmaceutical-firms,0.0,0.4767
PFE,2020-11-17,Pfizer To Test Covid-19 Vaccine Delivery Program In Four States,https://cdn.snapi.dev/images/v1/d/s/pfizer-to-test-covid-19-vaccine-delivery-program-in-four-states.jpg,Forbes,The company hopes to preemptively tackle any distribution problems caused by the ultra-cold storage requirements of the vaccine.,https://www.forbes.com/sites/roberthart/2020/11/17/pfizer-to-test-covid-19-vaccine-delivery-program-in-four-states/,0.0,0.0258
PFE,2020-11-17,"Scott+Scott Attorneys at Law LLP Investigates Pfizer, Inc.'s (PFE) Directors and Officers for Breach of Fiduciary Duties",https://cdn.snapi.dev/images/v1/p/r/press17---uwebrwr7bw.jpg,Business Wire,"NEW YORK--(BUSINESS WIRE)-- #PFE--Scott+Scott Attorneys at Law LLP Investigates Pfizer, Inc.'s (PFE) Directors and Officers for Breach of Fiduciary Duties",https://www.businesswire.com/news/home/20201117006048/en/ScottScott-Attorneys-at-Law-LLP-Investigates-Pfizer-Inc.%E2%80%99s-PFE-Directors-and-Officers-for-Breach-of-Fiduciary-Duties/,0.0,0.0
PFE,2020-11-17,"Despite Buffett Bullishness, Stock Markets Are Falling",https://cdn.snapi.dev/images/v1/5/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6012052fbuffett-image-biggerjpgw700opresize.jpg,The Motley Fool,Find out what the Oracle of Omaha's company has been buying lately.,https://www.fool.com/investing/2020/11/17/despite-buffett-bullishness-stock-markets-are-fall/,-0.1531,0.0
PFE,2020-11-17,Has Buffett Become an Expert on Big Pharma?,https://cdn.snapi.dev/images/v1/d/n/drugs37.jpg,GuruFocus,"Warren Buffett (Trades, Portfolio)'s Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B) filed its 13F report for the third quarter on Monday this week. The announcement revealed that the Oracle of Omaha made some exciting changes to his portfolio during the reported period, including several investments in pharmaceutical companies.",https://www.gurufocus.com/news/1288599/has-buffett-become-an-expert-on-big-pharma,0.0,0.4939
PFE,2020-11-17,How two companies sprinted ahead in extraordinary race for a COVID vaccine,https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998182fbntx-stock-biontech-stock-why-bntx-stock-up-today-monday-covid-vaccinejpgw700opresize.jpg,Reuters,"Just as the novel coronavirus was gaining a foothold in the United States in mid-March, Pfizer Inc Chief Executive Albert Bourla called on his top vaccine scientists and laid out a clear mission:",https://www.reuters.com/article/us-health-coronavirus-pfizer-vaccine-ins/how-two-companies-sprinted-ahead-in-extraordinary-race-for-a-covid-vaccine-idUSKBN27X25J,0.0,0.8834
PFE,2020-11-17,Moderna's (MRNA) Coronavirus Vaccine Progress Hurts Pfizer,https://cdn.snapi.dev/images/v1/m/c/biotech40.jpg,Zacks Investment Research,Moderna's (MRNA) coronavirus vaccine candidate seems to be more effective and its logistics less onerous than Pfizer and BioNTech's candidate.,https://www.zacks.com/stock/news/1102508/modernas-mrna-coronavirus-vaccine-progress-hurts-pfizer,-0.0772,0.5256
PFE,2020-11-17,Pfizer Launching Coronavirus Immunization Pilot Program in the U.S.,https://cdn.snapi.dev/images/v1/6/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6011492fchild-getting-a-jab-from-a-medical-professionaljpgw700opresize.jpg,The Motley Fool,The four states involved won't be getting COVID-19 vaccine doses early. They will be helping develop systems to ensure that the vaccine is distributed efficiently.,https://www.fool.com/investing/2020/11/17/pfizer-launching-coronavirus-immunization-pilot-pr/,0.0,0.7579
PFE,2020-11-17,7 Pharmaceutical Stocks to Buy for 2021 and Beyond ,https://cdn.snapi.dev/images/v1/f/r/drugs13.jpg,InvestorPlace,"Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives.",https://investorplace.com/2020/11/7-pharmaceutical-stocks-to-buy-for-2021-and-beyond/,0.0,0.4019
PFE,2020-11-17,"Pfizer (PFE), BioNTech Fall After Moderna COVID-19 Vaccine Data",https://cdn.snapi.dev/images/v1/r/m/biotech38.jpg,Zacks Investment Research,Pfizer (PFE) and BioNTech's (BNTX) stocks decline after Moderna COVID-19 vaccine candidate proves 94.5% effective and can be stored at standard refrigerator temperature.,https://www.zacks.com/stock/news/1102461/pfizer-pfe-biontech-fall-after-moderna-covid-19-vaccine-data,0.0,0.4767
PFE,2020-11-17,Better Coronavirus Vaccine: Moderna's mRNA-1273 or Pfizer and BioNTech's BNT162b2?,https://cdn.snapi.dev/images/v1/i/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6011232fvaccination-syringejpgw700opresize.jpg,The Motley Fool,It's a two-horse race -- for now.,https://www.fool.com/investing/2020/11/17/better-coronavirus-vaccine-modernas-mrna-1273-or-p/,0.4404,0.0
PFE,2020-11-17,3 Stocks to Win Big as Race for Coronavirus Vaccine Heats Up,https://cdn.snapi.dev/images/v1/m/b/biotech32.jpg,Zacks Investment Research,Coronavirus vaccine race is now at its peak following Moderna's (MRNA) 94.5% effective vaccine in Phase 3 trials. Pfizer (PFE) also bragged about the effectiveness of its vaccine to be more than 90%.,https://www.zacks.com/stock/news/1102330/3-stocks-to-win-big-as-race-for-coronavirus-vaccine-heats-up,0.5859,0.4767
PFE,2020-11-17,The Huge Technology News That Went Totally Under the Radar on Monday,https://cdn.snapi.dev/images/v1/s/2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6010882fgettyimages-1256532426jpgw700opresize.jpg,The Motley Fool,"Moderna's vaccine data gobbled up headlines, but there was also big news for semiconductors.",https://www.fool.com/investing/2020/11/17/the-huge-technology-news-that-went-totally-under-t/,0.3182,0.0
PFE,2020-11-17,Stocks Are Soaring. Here's What to Do as an Investor.,https://cdn.snapi.dev/images/v1/f/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6010182fwoman-pointing-to-graphs-on-computer-screens-gettyimages-1170740969jpgw700opresize.jpg,The Motley Fool,"High stock prices make for a challenge, but here's how to capitalize.",https://www.fool.com/investing/2020/11/17/stocks-are-soaring-heres-what-to-do-as-an-investor/,0.0,0.0387
PFE,2020-11-17,"AbbVie, Merck, and Pfizer shares jump after Warren Buffett's Berkshire Hathaway reveals it bought them last quarter",https://cdn.snapi.dev/images/v1/a/b/abbvie-merck-and-pfizer-shares-jump-after-warren-buffetts-berkshire-hathaway-reveals-it-bought-them-last-quarter.jpg,Business Insider,"AbbVie, Merck, Bristol Myers Squibb, and Pfizer are the latest beneficiaries of the ""Buffett Effect."" The quartet of pharmaceutical stocks jumped in pre-market trading on Tuesday after Warren Buffett's Berkshire Hathaway revealed on Monday that it invested in them last quarter. AbbVie, Merck, and Pfizer gained as much as 2%, and BMS rose as much as 3%, whereas benchmark S&P futures slid around 0.5%.",https://www.businessinsider.com/abbvie-merck-pfizer-stock-price-warren-buffett-berkshire-hathaway-pharmaceuticals-2020-11,0.296,0.6597
PFE,2020-11-17,2 Top Coronavirus Stocks to Watch in November,https://cdn.snapi.dev/images/v1/v/1/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6008662fgettyimages-1221692768jpgw700opresize.jpg,The Motley Fool,"As vaccine hype fades, Pfizer and BioNTech are on the cusp of a breakout -- but will they suceed?",https://www.fool.com/investing/2020/11/17/2-top-coronavirus-stocks-to-watch-in-november/,0.2023,0.0
PFE,2020-11-17,This 1 Factor May Limit the Reach of Pfizer's Coronavirus Vaccine,https://cdn.snapi.dev/images/v1/z/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6007542fgettyimages-1230863267jpgw700opresize.jpg,The Motley Fool,Pfizer's vaccine candidate is on the path to being first to market. But one element may keep it from becoming a market leader.,https://www.fool.com/investing/2020/11/17/this-1-factor-may-limit-the-reach-of-pfizers-coron/,0.0258,0.0
PFE,2020-11-17,"3 mRNA Coronavirus Vaccine Stocks to Check Out That Aren't Pfizer, BioNTech, or Moderna",https://cdn.snapi.dev/images/v1/i/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6009362fmrna-vaccine-vial-on-palmjpgw700opresize.jpg,The Motley Fool,Great efficacy results for mRNA COVID-19 vaccines so far could bode well for these three stocks.,https://www.fool.com/investing/2020/11/17/3-mrna-coronavirus-vaccine-stocks-to-check-out-tha/,0.0,0.7351
PFE,2020-11-17,"Buffett's Berkshire Hathaway Buys New Stakes in Vaccine Makers, Cuts Banks",https://cdn.snapi.dev/images/v1/a/s/asset-management27---v1uayxzxlp.jpg,InvestorPlace,"Warren Buffett is ditching bank stocks and loading up on drug makers, according to Berkshire Hathaway's latest regulatory filing. The post Buffett's Berkshire Hathaway Buys New Stakes in Vaccine Makers, Cuts Banks appeared first on InvestorPlace.",https://investorplace.com/2020/11/buffets-berkshire-hathaway-stock-buys-new-stakes-in-vaccine-makers-cut-banks/,-0.296,-0.296
PFE,2020-11-16,Pfizer to start pilot program for COVID-19 immunization in four U.S. states,https://cdn.snapi.dev/images/v1/x/u/m02d20201117t2i1541441079w940fhfwllplsqrlynxmpegag04n.jpg,Reuters,Pfizer Inc said on Monday it was starting a pilot program for COVID-19 immunization in four U.S. states to help refine the plan for the delivery and deployment of its vaccine candidate.,https://www.reuters.com/article/us-health-coronavirus-usa-pfizer/pfizer-to-start-pilot-program-for-covid-19-immunization-in-four-u-s-states-idUSKBN27X09A,0.0,0.4019
PFE,2020-11-16,Warren Buffett's Berkshire Bets On These Four Drugmakers Amid Pandemic,https://cdn.snapi.dev/images/v1/x/x/6212237872-e74dd4f049-o.jpg,Benzinga,Berkshire Hathaway Inc (NYSE: BRK-A) (NYSE: BRK-B) Chairman Warren Buffett has invested in four large drugmakers as the world faces yet another wave of the raging COVID-19 pandemic. What Happened: Regulatory filings made with the United States Securities and Exchange Commission reveal that the legendary investor picked up shares worth nearly $136 million in drugmaker Pfizer Inc (NYSE: PFE) in the latest quarter.,https://www.benzinga.com/general/biotech/20/11/18398427/warren-buffetts-berkshire-bets-on-these-four-drugmakers-amid-pandemic,0.0,0.5719
PFE,2020-11-16,Both Moderna and Pfizer will file for FDA authorization as next step,https://cdn.snapi.dev/images/v1/z/b/both-moderna-and-pfizer-will-file-for-fda-authorization-as-next-step.jpg,CNBC Television,"CNBC's senior health and science correspondent Meg Tirrell says it's very meaningful to have two Covid-19 vaccines, one from Pfizer and another one from Moderna that have well over 90 percent efficacy rates. She joins Shep Smith to discuss the next steps in accelerating these vaccines to the market.",https://www.youtube.com/watch?v=VLdKcf2BSAk,0.0,0.5709
PFE,2020-11-16,Warren Buffett Bought 4 Pharma Giants in Q3,https://cdn.snapi.dev/images/v1/9/8/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6011182fwarren-buffett-4-tmf-may-2014jpgw700opresize.jpg,The Motley Fool,The Oracle of Omaha and his team opened new positions in the underperforming sector.,https://www.fool.com/investing/2020/11/16/warren-buffett-bought-4-pharma-giants-in-q3/,0.0,0.0
PFE,2020-11-16,Moderna Vaccine Had Decade Head Start Over Pfizer: Chairman,https://cdn.snapi.dev/images/v1/o/q/moderna-vaccine-had-decade-head-start-over-pfizer-chairman.jpg,Bloomberg Technology,"Nov.16 -- Moderna Inc. reported its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial. Noubar Afeyan, Moderna co-founder and chairman, discusses the company's new data, distribution, plan for emergency use authorization and its advantage over a vaccine by Pfizer Inc. Afeyan spoke with Bloomberg's Emily Chang.",https://www.youtube.com/watch?v=DuJcMWwROZA,0.0,0.3612
PFE,2020-11-16,"Warren Buffett Buys 6 Stocks in 3rd Quarter, Dumps Costco",https://cdn.snapi.dev/images/v1/z/y/st23-1.jpg,GuruFocus,"Warren Buffett (Trades, Portfolio)'s $545.8 billion conglomerate, Berkshire Hathaway Inc. (NYSE:BRK.A)(NYSE:BRK.B), disclosed its equity portfolio for the third quarter of 2020 on Monday.",https://www.gurufocus.com/news/1287807/warren-buffett-buys-6-stocks-in-3rd-quarter-dumps-costco,-0.4019,0.0
PFE,2020-11-16,Warren Buffett's Berkshire Hathaway makes big bets on drug stocks,https://cdn.snapi.dev/images/v1/j/w/200221091117-warren-buffett-1013-file-super-169.jpg,CNN Business,Warren Buffett's Berkshire Hathaway is making a big bet on the health care sector at a time when the Covid-19 pandemic continues to be a major crisis in the United States.,https://www.cnn.com/2020/11/16/investing/warren-buffett-berkshire-hathaway-drug-stocks/index.html,0.0,0.2263
PFE,2020-11-16,"Warren Buffett's Berkshire Hathaway reveals stakes in AbbVie, Merck, Pfizer, and other 'big pharma' stocks",https://cdn.snapi.dev/images/v1/d/r/drugs25---ifdb3um7ds.jpg,Business Insider,"Warren Buffett's Berkshire Hathaway invested in AbbVie, Bristol-Myers Squibb, Merck, and Pfizer in the third quarter. The billionaire investor's company disclosed the new holdings in a regulatory filing on Monday. Berkshire boasted stakes worth more than $1.8 billion in each of AbbVie, Bristol Myers Squibb, and Merck as of September 30. It also owned $136 million of Pfizer stock. Buffett and his team also trimmed their Apple stake, which is easily the most valuable holding in their stock portfolio. Visit Business Insider's homepage for more stories. Warren Buffett's Berkshire Hathaway plowed billions of dollars into Pfizer, Merck, and other pharmaceutical stocks in the third quarter, a regulatory filing revealed on Monday.",https://www.businessinsider.com/warren-buffett-berkshire-hathaway-invests-pfizer-merck-abbvie-pharmaceutical-stocks-2020-11,0.0,0.7713
PFE,2020-11-16,Buffett's Berkshire invests in several big drugmakers,https://cdn.snapi.dev/images/v1/t/2/m02d20201116t2i1541413016w940fhfwllplsqrlynxmpegaf1kl.jpg,Reuters,Warren Buffett's Berkshire Hathaway Inc said on Monday it has begun investing in four large drugmakers.,https://www.reuters.com/article/us-investment-funds-berkshire/buffetts-berkshire-invests-in-several-big-drugmakers-idUSKBN27W2TS,0.0,0.0
PFE,2020-11-16,5 Bank Stocks to Buy for the Covid-19 Vaccine Recovery,https://cdn.snapi.dev/images/v1/d/z/bank12---0amclwtvww.jpg,InvestorPlace,"Thanks to favorable Covid-19 vaccine developments, the stage is set for bank stocks to rebound in a big way in 2021. The post 5 Bank Stocks to Buy for the Covid-19 Vaccine Recovery appeared first on InvestorPlace.",https://investorplace.com/2020/11/bank-stocks-to-buy-covid-19-vaccine-recovery/,0.0,0.7184
PFE,2020-11-16,Pfizer shares drop as Moderna vaccine seen easier to distribute,https://cdn.snapi.dev/images/v1/a/m/m02d20201116t2i1541382658w940fhfwllplsqrlynxmpegaf171.jpg,Reuters,Shares in Pfizer fell on Monday after rival drugmaker Moderna said its experimental vaccine against COVID-19 was 94.5% effective and that it can be stored at normal fridge temperatures.,https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-ho/pfizer-shares-drop-as-moderna-vaccine-seen-easier-to-distribute-idUSKBN27W276,0.4404,0.6486
PFE,2020-11-16,"Why Pfizer, BioNTech, and Novavax Stocks Are Sinking Today",https://cdn.snapi.dev/images/v1/f/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6010062fholding-coronavirus-vaccine-bottlesjpgw700opresize.jpg,The Motley Fool,Investors are worried that Moderna's good news could be bad news for these coronavirus vaccine leaders.,https://www.fool.com/investing/2020/11/16/why-pfizer-biontech-and-novavax-stocks-are-sinking/,0.0,-0.4215
PFE,2020-11-16,"Former FDA Commissioner Says Pandemic Could ‘Effectively End In 2021' If Pfizer, Moderna Vaccines Live Up To Early Data",https://cdn.snapi.dev/images/v1/j/m/former-fda-commissioner-says-pandemic-could-effectively-end-in-2021-if-pfizer-moderna-vaccines-live-up-to-early-data.jpg,Forbes,Early data has indicated Pfizer's vaccine could be up to 90% effective and Moderna's could be more than 94% effective.,https://www.forbes.com/sites/elanagross/2020/11/16/former-fda-commissioner-says-pandemic-could-effectively-end-in-2021-if-pfizer-moderna-vaccines-live-up-to-early-data/,0.0,0.7351
PFE,2020-11-16,"WHO Chief Warns Vaccine Won't End Covid-19 Pandemic As Moderna, Pfizer Announce Early Successes",https://cdn.snapi.dev/images/v1/j/3/who-chief-warns-vaccine-wont-end-covid-19-pandemic-as-moderna-pfizer-announce-early-successes.jpg,Forbes,"The public health leader stressed the need to continue other methods of disease control, like contact tracing, isolating infected patients and testing.",https://www.forbes.com/sites/roberthart/2020/11/16/who-chief-warns-vaccine-wont-end-covid-19-pandemic-as-moderna-pfizer-announce-early-successes/,0.4939,-0.4767
PFE,2020-11-16,HHS Secretary Azar says the FDA will move 'as quickly as possible' to clear Moderna and Pfizer's Covid vaccines,https://cdn.snapi.dev/images/v1/g/j/106756463-1603370248431-gettyimages-1229208330-azar-redfield-cdc.jpeg,CNBC,"HHS Secretary Alex Azar said Monday that the FDA will move ""as quickly as possible"" to issue an authorization for Covid-19 vaccines from Pfizer and Moderna.",https://www.cnbc.com/2020/11/16/coronavirus-hhs-secretary-azar-says-fda-will-move-as-quickly-as-possible-to-ok-moderna-and-pfizers-vaccines.html,0.3818,0.0
PFE,2020-11-16,Pfizer and AstraZeneca slide as Moderna's rival COVID-19 vaccine shows strong efficacy,https://cdn.snapi.dev/images/v1/p/f/pfizer-and-astrazeneca-slide-as-modernas-rival-covid-19-vaccine-shows-strong-efficacy.jpg,Business Insider,"Another round of strong COVID-19 vaccine data, this time from Moderna, has put pressure on pharmaceutical companies developing their own vaccine, namely Pfizer, BioNTech, and AstraZeneca. On Monday, Moderna said its late-stage trial evaluating a COVID-19 vaccine candidate demonstrated efficacy of 94.5%, putting the company on track to receive emergency use authorization from the FDA by the end of this year.",https://www.businessinsider.com/pfizer-astrazeneca-stock-price-moderna-covid19-vaccine-shows-strong-efficacy-2020-11,0.5106,-0.128
PFE,2020-11-16,This Household Brand Name Just Tripled Profits and Raised Its Dividend. Time to Buy?,https://cdn.snapi.dev/images/v1/i/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6009182fgettyimages-1209015108jpgw700opresize.jpg,The Motley Fool,"The video game vendor is firing on all cylinders, but will it last?",https://www.fool.com/investing/2020/11/16/this-household-brand-name-just-tripled-its-profits/,0.4404,-0.1779
PFE,2020-11-16,"BioNTech, Pfizer stocks fall after upbeat news on Moderna's COVID-19 vaccine candidate",https://cdn.snapi.dev/images/v1/4/x/biotech37.jpg,Market Watch,"Shares of BioNTech SE dropped 5.9% in premarket trading Monday, and Pfizer Inc.'s stock fell 1.7%, after Moderna Inc. said its COVID-19 vaccine candidate can be stored at standard refrigerator temperatures for 30 days, while BioNTech's and Pfizer's vaccine needed to be stored at ""ultra-low"" temperatures. In addition, Moderna's candidate demonstrated an efficacy rate that may be higher than the BioNTech's and Pfizer's vaccine candidate.",https://www.marketwatch.com/story/biontech-pfizer-stocks-fall-after-upbeat-news-on-modernas-covid-19-vaccine-candidate-2020-11-16,0.0,0.296
PFE,2020-11-16,Pfizer (PFE) and the Headline Effect,https://cdn.snapi.dev/images/v1/w/h/pfizer-56b002a05f9b58b7d01f655b.jpg,Investopedia,"Pfizer's (PFE) vaccine announcement caused euphoria in the market, but sober second thoughts are now setting in.",https://www.investopedia.com/pfizer-and-the-headline-effect-5087757,0.0,0.3919
PFE,2020-11-16,Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan,https://cdn.snapi.dev/images/v1/3/i/press9---e7pkcant6o.jpg,Business Wire,"NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it has completed the transaction to spin off its Upjohn Business and combine it with Mylan N.V. to form Viatris Inc. Pfizer Chairman and Chief Executive Officer Dr. Albert Bourla said, “We are proud to have completed the combination of Upjohn and Mylan to create Viatris and pleased to have delivered value to our shareholders through this transaction. I want to express my gratitude to our Upjohn colleagues for their dedicati",https://www.businesswire.com/news/home/20201116005378/en/Pfizer-Completes-Transaction-to-Combine-Its-Upjohn-Business-with-Mylan/,0.0,0.9201
PFE,2020-11-16,Dangerous Coronavirus Vaccine Myths: Scientific Expert Explains The Truth,https://cdn.snapi.dev/images/v1/3/1/stock-advisor-vs-sp-small.png,The Motley Fool,The Lancet's Richard Horton says we have to renegotiate our relationship with the virus and find a peaceful coexistence.,https://www.fool.com/investing/2020/11/16/dangerous-coronavirus-vaccine-myths-scientific-exp/,-0.2023,0.4939
PFE,2020-11-16,Coronavirus Expert on mRNA Vaccines Versus The Old Fashioned Approach,https://cdn.snapi.dev/images/v1/g/y/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5955382fsyringe-and-needle-on-top-of-calendarjpgw700opresize.jpg,The Motley Fool,The Editor-in-Chief of the British medical journal The Lancet explains why Pfizer and Moderna's approach is revolutionary.,https://www.fool.com/investing/2020/11/16/coronavirus-expert-on-mrna-vaccines-versus-the-old/,0.0,0.0
PFE,2020-11-16,The creator of the Pfizer-BioNTech vaccine says life could return to normal by next winter,https://cdn.snapi.dev/images/v1/q/3/106797189-1605519286495-gettyimages-1188140352-urn-newsml-dpa-com-20090101-191213-99-123106-2.jpeg,CNBC,"Professor Ugur Sahin, co-founder and chief executive of BioNTech, also suggested the coronavirus vaccine could halve transmission of the virus.",https://www.cnbc.com/2020/11/16/coronavirus-biontech-ceo-says-life-could-return-to-normal-next-winter.html,0.0,0.0
PFE,2020-11-16,How Long Will It Take for Coronavirus Vaccines to Help the U.S. Move Past the Pandemic?,https://cdn.snapi.dev/images/v1/7/z/stock-advisor-vs-sp-small.png,The Motley Fool,Vaccines probably won't be a quick fix.,https://www.fool.com/investing/2020/11/15/how-long-will-it-take-for-coronavirus-vaccines-to/,0.4019,0.0
PFE,2020-11-16,"Week In Review: RemeGen, A Yantai Biologics Company, Completes $515 Million Hong Kong IPO",https://cdn.snapi.dev/images/v1/d/e/dew2w3e3---ziqctr4yxo.jpg,Seeking Alpha,"Innoforce, a Hangzhou company, formed a JV with Thermo Fisher Scientific to build a large biologics and steriles drug development and manufacturing facility in the Hangzhou Airport Economic Demonstration Area. Decheng Capital had good reason to be pleased when Merck paid $2.75 billion to acquire VelosBio, a company formed in 2017 to develop ROR1 ADCs for cancer.",https://seekingalpha.com/article/4389122-week-in-review-remegen-yantai-biologics-company-completes-515-million-hong-kong-ipo,0.0,0.2023
PFE,2020-11-16,"Emirates working with Pfizer, others on vaccine transport ‘challenge'",https://cdn.snapi.dev/images/v1/i/0/105715107-1549037812276gettyimages-1055511710.jpeg,CNBC,Emirates said it was working with Pfizer on the complex logistics of transporting its vaccine to the world.,https://www.cnbc.com/2020/11/15/emirates-working-with-pfizer-others-on-vaccine-transport-challenge-.html,0.0,0.0
PFE,2020-11-16,Coronavirus Vaccine Stocks: How Long Will COVID-19 Immunity Last?,https://cdn.snapi.dev/images/v1/0/u/stock-advisor-vs-sp-small.png,The Motley Fool,"This big question will have significant impacts on dosing, reentering society, and how often people will need vaccinations.",https://www.fool.com/investing/2020/11/15/coronavirus-vaccine-stocks-how-long-will-covid-19/,0.0,0.2023
PFE,2020-11-16,Coronavirus Expert: 'The Virus Is Bouncing Back',https://cdn.snapi.dev/images/v1/p/1/stock-advisor-vs-sp-small.png,The Motley Fool,New cases of COVID-19 are increasing rapidly as the winter months and holidays approach.,https://www.fool.com/investing/2020/11/15/coronavirus-expert-the-virus-is-bouncing-back/,0.0,0.3818
PFE,2020-11-16,What Data This Coronavirus Expert Is Looking For In Pfizer and Moderna's Vaccine Trials,https://cdn.snapi.dev/images/v1/h/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5956072fgettyimages-1264722487jpgw700opresize.jpg,The Motley Fool,It's important to look beyond the headlines and find out more about how effective coronavirus vaccine candidates are.,https://www.fool.com/investing/2020/11/15/what-data-this-coronavirus-expert-is-looking-for-i/,0.0,0.6326
PFE,2020-11-16,5 Moves to Make if the Stock Market Soars Tomorrow,https://cdn.snapi.dev/images/v1/v/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5997562fstock-market-image-gettyjpgw700opresize.jpg,The Motley Fool,You know to stay calm if the stock market crashes. But can you control yourself when it surges?,https://www.fool.com/investing/2020/11/15/5-moves-to-make-if-the-stock-market-soars-tomorrow/,0.0,0.3182
PFE,2020-11-16,3 Top Biotech Stocks to Watch in November,https://cdn.snapi.dev/images/v1/3/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6001802fgettyimages-1224223647jpgw700opresize.jpg,The Motley Fool,"These three stocks are loaded with potential, but need to be watched carefully over the next few weeks.",https://www.fool.com/investing/2020/11/15/3-top-biotech-stocks-to-watch-in-november/,0.2023,0.1901
PFE,2020-11-16,Should You Buy a Basket of Late-Stage Coronavirus Vaccine Stocks?,https://cdn.snapi.dev/images/v1/c/c/afdew1.jpg,The Motley Fool,It's a definite maybe.,https://www.fool.com/investing/2020/11/15/should-you-buy-a-basket-of-late-stage-coronavirus/,0.0,0.2732
PFE,2020-11-16,Investors Wish They Could Vote These 2 Healthcare CEOs Out,https://cdn.snapi.dev/images/v1/q/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5964712fgettyimages-1147352097jpgw700opresize.jpg,The Motley Fool,"With immobile stock prices and a hangover of legal issues, these CEOs might be glad Wall Street doesn't operate like a democracy.",https://www.fool.com/investing/2020/11/15/with-the-election-coming-investors-wish-they-could/,0.4019,0.3378
PFE,2020-11-16,The Pandemic's Still Not Over: 3 Stay-at-Home Stocks to Buy Right Now,https://cdn.snapi.dev/images/v1/f/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6003702fwoman-in-isolation-during-covid-19jpgw700opresize.jpg,The Motley Fool,"GoodRx, Nintendo, and Roku are all great growth investments to hang on to for the long term.",https://www.fool.com/investing/2020/11/15/the-pandemics-still-not-over-3-stay-at-home-stocks/,0.0,0.7717
PFE,2020-11-16,The Biggest Takeaway From Pfizer's Coronavirus Vaccine Results,https://cdn.snapi.dev/images/v1/5/q/m02d20201111t2i1540854359w940fhfwllplsqrlynxmpegaa0s6.jpg,The Motley Fool,It could help Americans feel more confident about getting vaccinated for COVID-19.,https://www.fool.com/investing/2020/11/14/the-biggest-takeaway-from-pfizers-coronavirus-vacc/,0.0,0.7346
PFE,2020-11-16,Which Coronavirus Vaccine Maker Is Poised to Be the Top Supplier?,https://cdn.snapi.dev/images/v1/p/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6003332fgettyimages-1205913548jpgw700opresize.jpg,The Motley Fool,"The numbers are close, but two players stand out at the moment.",https://www.fool.com/investing/2020/11/14/which-coronavirus-vaccine-maker-poised-to-be-top-s/,0.4215,0.0
PFE,2020-11-16,Pfizer (PFE) Stock Price: $44 Target By Mizuho Securities,https://cdn.snapi.dev/images/v1/i/7/drugs47.jpg,Pulse2,Shares of Pfizer Inc. (NYSE: PFE) have received a price target increase from $43 to $44 by Mizuho Securities. These are the details.,https://pulse2.com/pfizer-nyse-pfe-stock-price-44-target-by-mizuho-securities/,0.296,0.6908
PFE,2020-11-16,Here's Why Pfizer's Coronavirus Vaccine Would Be Revolutionary,https://cdn.snapi.dev/images/v1/q/a/m02d20201106t2i1540189418w940fhfwllplsqrlynxmpega500i.jpg,The Motley Fool,"If approved and launched, an mRNA vaccine would disrupt the vaccine development landscape and go leaps and bounds toward helping the world recover from the pandemic.",https://www.fool.com/investing/2020/11/14/heres-why-pfizers-coronavirus-vaccine-would-be-rev/,0.0,0.6705
PFE,2020-11-16,How To Invest In COVID-19 Vaccine Stocks: Bet On The Jockey,https://cdn.snapi.dev/images/v1/e/x/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5918892fvaccine-bottle-and-syringe-with-blue-backgroundjpgw700opresize.jpg,The Motley Fool,The best way to pick coronavirus stocks is to make sure you trust the scientists running the company's COVID-19 program.,https://www.fool.com/investing/2020/11/14/how-to-invest-in-covid-19-vaccine-stocks-bet-on-th/,0.0,0.8689
PFE,2020-11-16,3 Potentially Explosive Stocks for a Vaccine-Driven Bull Market,https://cdn.snapi.dev/images/v1/d/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998462fgettyimages-1210633307jpgw700opresize.jpg,The Motley Fool,Find out why you might want to own these stocks in a post-vaccine world.,https://www.fool.com/investing/2020/11/14/3-potentially-explosive-stocks-for-a-vaccine-drive/,0.0,0.0772
PFE,2020-11-16,Vaccine Hopes Sent These 3 Oil Stocks Up More Than 15%: Here's Why They're Still Cheap,https://cdn.snapi.dev/images/v1/i/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6004242fan-oil-pump-and-barrel-on-top-of-moneyjpgw700opresize.jpg,The Motley Fool,These oil stocks look like they have lots of room to run.,https://www.fool.com/investing/2020/11/14/vaccine-hopes-sent-these-3-oil-stocks-up-more-than/,0.4215,0.3612
PFE,2020-11-16,3 Top Coronavirus Stocks to Buy Right Now,https://cdn.snapi.dev/images/v1/f/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6005092fgettyimages-987070228jpgw700opresize.jpg,The Motley Fool,Potential for emergency use authorizations and presidential promises are reasons to pick up these leaders today.,https://www.fool.com/investing/2020/11/14/3-top-coronavirus-stocks-to-buy-right-now/,0.2023,0.0
PFE,2020-11-16,How To Invest In Coronavirus Vaccines: Interview with The Lancet Editor-In-Chief,https://cdn.snapi.dev/images/v1/a/h/stock-advisor-vs-sp-small.png,The Motley Fool,Here's why this top COVID-19 expert says trusting the scientists behind the stocks is the key to investing in companies developing coronavirus vaccines.,https://www.fool.com/investing/2020/11/14/how-to-invest-in-coronavirus-vaccines-interview-wi/,0.0,0.5719
PFE,2020-11-16,"Coronavirus Vaccine Stocks: Challenges With Manufacturing, Distribution, And the Cold Chain",https://cdn.snapi.dev/images/v1/8/c/podc11-moswiwvev7.jpg,The Motley Fool,Getting FDA authorization for a COVID-19 vaccine may be just the first hurdle of many.,https://www.fool.com/investing/2020/11/14/coronavirus-vaccine-stocks-challenges-with-manufac/,0.0772,0.0
PFE,2020-11-16,3 Best Biotech Stocks to Buy Right Now,https://cdn.snapi.dev/images/v1/t/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5984552fgettyimages-1172482193jpgw700opresize.jpg,The Motley Fool,Biotech is on every investor's mind as we move closer and closer to a successful vaccine for the coronavirus. Here are three contenders for your portfolio.,https://www.fool.com/investing/2020/11/14/3-best-biotech-stocks-to-buy-right-now/,0.6369,0.5859
PFE,2020-11-13,DGRW: Pfizer's Vaccine News Could Set This ETF Into Motion,https://cdn.snapi.dev/images/v1/g/b/etf38.jpg,Seeking Alpha,"A re-opening rally could look like the opposite of how the market reacted at the beginning of the COVID outbreak and shift leadership back to cyclicals. In that case, DGRW is a dividend ETF that could be uniquely positioned to benefit in such an environment.",https://seekingalpha.com/article/4389018-dgrw-pfizers-vaccine-news-set-this-etf-motion,0.0,0.6705
PFE,2020-11-13,"The Tell: Pfizer vaccine news sparks $44.5 billion flood into the stock market—its biggest weekly inflow ever, says BofA",https://cdn.snapi.dev/images/v1/a/a/m02d20201109t2i1540528724w940fhfwllplsqrlynxmpega80ww.jpg,Market Watch,"How seismic was the stock-market move that kicked off the week following news of an effective coronavirus vaccine candidate? It was the best week ever for inflows, according to BofA Global Research",https://www.marketwatch.com/story/pfizer-vaccine-news-sparks-44-5-billion-flood-into-the-stock-marketits-biggest-weekly-inflow-ever-says-bofa-11605287707,0.0,0.8074
PFE,2020-11-13,"Pfizer Has A Head Start, But The Covid-19 Vaccine Market Is Still Up For Grabs",https://cdn.snapi.dev/images/v1/y/5/pfizer-has-a-head-start-but-the-covid-19-vaccine-market-is-still-up-for-grabs.jpg,Forbes,"Any first-mover advantage won't last long, as some vaccine candidates may be easier to transport and administer than others.",https://www.forbes.com/sites/katiejennings/2020/11/13/pfizer-has-a-head-start-but-the-covid-19-vaccine-market-is-still-up-for-grabs/,0.0,0.5859
PFE,2020-11-13,Pfizer COVID Vaccine Volunteer Describes Side Effects From Trial,https://cdn.snapi.dev/images/v1/1/5/pfizer-covid-vaccine-volunteer-describes-side-effects-from-trial.jpg,Cheddar,"Giora Griffel, a participant in the Pfizer COVID-19 vaccine trial, joined Cheddar's Search for a Cure to explain the process of being selected for the trial and what it was like to be part of medical history. Subscribe to Cheddar Now on YouTube: https://chdr.tv/NowYT",https://www.youtube.com/watch?v=5Y1kghg1DRw,0.0,0.3612
PFE,2020-11-13,Global stock funds see record inflows on Pfizer's COVID-19 vaccine,https://cdn.snapi.dev/images/v1/x/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5954072fgettyimages-1210977583jpgw700opresize.jpg,Fox Business,The biggest catalyst for global equities: COVID-19 vaccine.,https://www.foxbusiness.com/markets/global-stock-funds-see-record-inflows-on-pfizers-covid-19-vaccine,0.0,0.0
PFE,2020-11-13,Is Pfizer Stock A Buy After Its Coronavirus Vaccine Proved 90% Effective?,https://cdn.snapi.dev/images/v1/i/z/106599913-1593620338844ap-20183543531451.jpg,Investors Business Daily,Pfizer stock jumped in early November after the pharma company's coronavirus vaccine proved 90% effective in a final-phase study. But if the pharmaceutical company's stock a buy now?,https://www.investors.com/news/technology/pfizer-stock-buy-now/,0.4767,0.4767
PFE,2020-11-13,"BioNTech and Pfizer's COVID-19 vaccine is surprisingly effective, though experts question what effectiveness will look like in the real world",https://cdn.snapi.dev/images/v1/u/2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5984562fgettyimages-1203194637jpgw700opresize.jpg,Market Watch,"BioNTech and Pfizer Inc.'s unexpectedly efficacious COVID-19 vaccine candidate caught Wall Street and the medical community by surprise this week, yet the same experts who are thrilled by the news caution that the effectiveness of the vaccine will likely be lower in the real world.",https://www.marketwatch.com/story/biontech-and-pfizers-covid-19-vaccine-is-surprisingly-effective-though-experts-question-what-effectiveness-will-look-like-in-the-real-world-2020-11-13,0.7783,0.4215
PFE,2020-11-13,Pfizer's Covid-19 Vaccine News Is Pushing These 18 Stocks Up – Time To Invest?,https://cdn.snapi.dev/images/v1/q/h/pfizers-covid-19-vaccine-news-is-pushing-these-18-stocks-up-time-to-invest.jpg,Forbes,"Amid some volatility, the S&P 500 has climbed nearly 2.5% in the past week. The triggers?",https://www.forbes.com/sites/greatspeculations/2020/11/13/pfizers-covid-19-vaccine-news-is-pushing-these-18-stocks-up--time-to-invest/,0.0,0.0
PFE,2020-11-13,3 Pharmaceutical Stocks to Buy in November,https://cdn.snapi.dev/images/v1/9/t/drugs44.jpg,InvestorPlace,Here are pharmaceutical stocks for November 2020 with a focus on companies that are close to delivering a vaccine against Covid-19. The post 3 Pharmaceutical Stocks to Buy in November appeared first on InvestorPlace.,https://investorplace.com/2020/11/pharmaceutical-stocks-to-buy-in-november/,0.0,0.0
PFE,2020-11-13,3 Dividend Stocks That Pay You Better Than Coca-Cola Does,https://cdn.snapi.dev/images/v1/b/p/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5167282fresized-iphone-rain-2.jpg,The Motley Fool,"These companies are well-positioned to maintain leadership positions in their industries for years to come, and to keep rewarding shareholders with steadily rising payouts.",https://www.fool.com/investing/2020/11/13/3-dividend-stocks-that-pay-better-than-coca-cola/,0.3612,0.5267
PFE,2020-11-13,Pfizer's CEO sold $5.6 million worth of shares on the day of its big vaccine news. So what?,https://cdn.snapi.dev/images/v1/d/r/drugs43.jpg,Market Watch,Pfizer said sale of shares by Albert Bourla was prearranged under plan set up in August,https://www.marketwatch.com/story/pfizers-ceo-sold-5-6-million-worth-of-shares-on-the-day-of-its-big-vaccine-news-so-what-11605280170,0.4767,0.296
PFE,2020-11-13,Coronavirus Fears to Boost Packaged Food Sales: 4 Picks,https://cdn.snapi.dev/images/v1/d/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5373772fyoung-man-comparing-bottles-grocery-shopping-cropjpgw700opresize.jpg,Zacks Investment Research,"The Hain Celestial Group, Inc. (HAIN), United Natural Foods, Inc. (UNFI) and Tyson Foods, Inc. (TSN) may one again witness a surge in the demand for their products as surging coronavirus cases may once again compel people to confine themselves indoors.",https://www.zacks.com/stock/news/1101332/coronavirus-fears-to-boost-packaged-food-sales-4-picks,-0.0258,0.5859
PFE,2020-11-13,Should Coronavirus Vaccine Investors Worry About The Cold Chain?,https://cdn.snapi.dev/images/v1/v/l/stock-advisor-vs-sp-small.png,The Motley Fool,Do Pfizer and Moderna need to worry about keeping mRNA vaccines ultra-cold and could that hinder vaccine distribution?,https://www.fool.com/investing/2020/11/13/should-coronavirus-vaccine-investors-worry-about-t/,-0.4404,-0.4404
PFE,2020-11-13,"Got $10,000? These 3 Top Growth Stocks Could Set You Up for Life",https://cdn.snapi.dev/images/v1/g/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6002112fgettyimages-925466034jpgw700opresize.jpg,The Motley Fool,"If you're worried about another lockdown-fueled market crash, these three recession-proof stocks should be on your buy list.",https://www.fool.com/investing/2020/11/13/got-10000-these-3-top-growth-stocks-could-set-you/,0.5267,-0.5994
PFE,2020-11-13,Why Regional Bank Stocks Will Benefit More From a COVID-19 Vaccine,https://cdn.snapi.dev/images/v1/x/9/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5999622fgeneric-bank-gettyjpgw700opresize.jpg,The Motley Fool,"All banks are anticipating loan losses due to the pandemic, but the regional players appear more exposed to those risks than both their larger and smaller peers.",https://www.fool.com/investing/2020/11/13/why-regional-bank-stocks-will-benefit-more-from-a/,0.4588,-0.6586
PFE,2020-11-13,5 Companies to Invest in for 2021 as Markets Price in Economy's Prospects,https://cdn.snapi.dev/images/v1/1/4/14mflfef-1.jpg,InvestorPlace,"After the volatility of 2020, analysts see some calm in the offing. Here are 5 companies to invest in on those prospects.",https://investorplace.com/2020/11/5-companies-pfe-abl-nio-spwr-ccl-to-invest-in-for-2021/,0.296,0.5423
PFE,2020-11-12,Pfizer Negotiates COVID-19 Vaccine Supply With Brazil For Early Next Year,https://cdn.snapi.dev/images/v1/d/q/science-in-hd-9kstf9pvetm-unsplash-1-0.jpg,Benzinga,"Pfizer Inc (NYSE: PFE) is in negotiations with the government of Brazil to supply its COVID-19 vaccine to the country, Reuters reported Thursday. What Happened: The negotiations are reportedly centered around supplying the vaccine in the first quarter of 2021.",https://www.benzinga.com/general/biotech/20/11/18353348/pfizer-negotiates-covid-19-vaccine-supply-with-brazil-for-early-next-year,0.0,0.0
PFE,2020-11-12,"With Pfizer Winning the Vaccine Race, Novavax Is a Strong Sell",https://cdn.snapi.dev/images/v1/w/v/biotech39.jpg,InvestorPlace,"Novavax made a valiant effort at developing the leading Covid-19 vaccine, but it fell short. Now poor earnings will sink NVAX stock.",https://investorplace.com/2020/11/with-pfizer-winning-the-vaccine-race-nvax-stock-is-a-strong-sell/,0.7717,-0.631
PFE,2020-11-12,7 Stocks That Could Benefit From Pfizer's COVID-19 Vaccine That Requires Cold Chain Storage,https://cdn.snapi.dev/images/v1/h/j/virus-4933201-1280-5.png,Benzinga,"Pfizer Inc.'s (NYSE: PFE) coronavirus vaccine candidate may have turned in strong efficacy results, but the logistics it requires could impact the vaccine's eventual uptake.  Opportunity In Adversity: The mRNA vaccine jointly developed by Pfizer and BioNTech SE – ADR (NASDAQ: BNTX) requires a storage temperature of negative 70 degrees Celsius.",https://www.benzinga.com/general/health-care/20/11/18324905/7-stocks-that-could-benefit-from-pfizers-covid-19-vaccine-that-requires-cold-chain-storage,0.4588,-0.5994
PFE,2020-11-12,Pfizer's CEO cashed out $5.6 million of stock after trumpeting its COVID-19 vaccine. That's 30% of his total compensation last year,https://cdn.snapi.dev/images/v1/p/f/pfizers-ceo-cashed-out-56-million-of-stock-after-trumpeting-its-covid-19-vaccine-thats-30-of-his-total-compensation-last-year.jpg,Business Insider,"Pfizer CEO Albert Bourla sold shares worth more than triple his base salary on Monday, hours after proclaiming that excellent results from the pharmaceutical company's COVID-19 vaccine in a late-stage trial made it a ""great day for science and humanity."" Bourla described the results in a press release as a ""critical milestone"" in the race to develop a vaccine, and a ""significant step"" towards ending the coronavirus pandemic. Pfizer's stock price jumped as much as 15% on the news.",https://www.businessinsider.com/pfizer-ceo-sold-stock-6-million-30-percent-compensation-vaccine-2020-11,0.0,0.886
PFE,2020-11-12,Analysis from Phase 3 ATTR-ACT and Its Long-Term Extension Study Demonstrates VYNDAQEL® 80 mg/VYNDAMAX® 61 mg Significantly Improved Survival in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Compared to VYNDAQEL 20 mg,https://cdn.snapi.dev/images/v1/j/c/press11---h8bqqkgttz.jpg,Business Wire,"NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today the publication of an analysis showing that VYNDAQEL® (tafamidis meglumine) 80 mg/VYNDAMAX® (tafamidis) 61 mg were associated with a statistically significant improvement in long-term survival in patients with transthyretin amyloid cardiomyopathy (ATTR-CM) compared to VYNDAQEL 20 mg, reaffirming optimal dosing for these patients. Results from the analysis of the Phase 3 Tafamidis in Transthyretin Amyloid Cardiomyopathy Clinical",https://www.businesswire.com/news/home/20201112005882/en/Analysis-from-Phase-3-ATTR-ACT-and-Its-Long-Term-Extension-Study-Demonstrates-VYNDAQEL%C2%AE-80-mgVYNDAMAX%C2%AE-61-mg-Significantly-Improved-Survival-in-Patients-with-Transthyretin-Amyloid-Cardiomyopathy-ATTR-CM-Compared-to-VYNDAQEL-20-mg/,0.4767,0.743
PFE,2020-11-12,Pfizer (PFE) to Supply 200M Doses of COVID-19 Vaccine to EU,https://cdn.snapi.dev/images/v1/k/t/drugs32---713l8xlqyf.jpg,Zacks Investment Research,Pfizer (PFE) and BioNTech sign a supply deal with the European Union for up to 300 million doses of their coronavirus vaccine.,https://www.zacks.com/stock/news/1100811/pfizer-pfe-to-supply-200m-doses-of-covid-19-vaccine-to-eu,0.0,0.0
PFE,2020-11-12,BioNTech CEO discusses Pfizer coronavirus vaccine on 'Mornings with Maria',https://cdn.snapi.dev/images/v1/r/m/biontech-ceo-discusses-pfizer-coronavirus-vaccine-on-mornings-with-maria.jpg,Fox Business,BioNTech co-founder and CEO Dr. Ugur Sahin provides insight into the vaccine progress with Pfizer. Subscribe to Fox Business!,https://www.youtube.com/watch?v=VBWbbq66JRU,0.0,0.4753
PFE,2020-11-12,Tracking stock sales of executives involved in Covid-19 drug developments,https://cdn.snapi.dev/images/v1/m/q/tracking-stock-sales-of-executives-involved-in-covid-19-drug-developments.jpg,CNBC Television,"Pfizer CEO Albert Bourla sold almost $5.6 million worth of stock on Monday, the same day the drugmaker announced positive early data on its experimental coronavirus vaccine that sent shares soaring. But Bourla isn't the only executive officer of a pharmaceutical company involved in the race for Covid-19 vaccine and treatments who are selling stocks.",https://www.youtube.com/watch?v=k8I41B-foNM,0.0,0.7533
PFE,2020-11-12,What Investors Need To Know About Pfizer's Potential Coronavirus Vaccine,https://cdn.snapi.dev/images/v1/p/o/podc10---1gxdczglmu.jpg,The Motley Fool,Here's why The Lancet's editor-in-chief thinks an mRNA vaccine to prevent COVID-19 could be groundbreaking.,https://www.fool.com/investing/2020/11/12/what-investors-need-to-know-about-pfizers-potentia/,0.0,0.0258
PFE,2020-11-12,Pfizer coronavirus vaccine expected to protect patients for a year: BioNTech founder,https://cdn.snapi.dev/images/v1/s/g/biotech11.jpg,Fox Business,"The Pfizer-BioNTech coronavirus vaccine could protect patients from the virus for a year, BioNTech CEO Ugur Sahin told ""Mornings with Maria"" on Thursday.",https://www.foxbusiness.com/markets/pfizer-coronavirus-vaccine-reinfection-year-ugur-sahin,0.3818,0.3818
PFE,2020-11-12,What The U.S. Election Results Likely Mean For Midstream Investors,https://cdn.snapi.dev/images/v1/l/z/oil3.jpg,Seeking Alpha,"With a divided Congress, there are severe limitations to what a president-elect Biden could accomplish. This is the primary reason analysts believe the stock market has reacted with such a vigorous rally.",https://seekingalpha.com/article/4388226-what-u-s-election-results-likely-mean-for-midstream-investors,0.0,0.0516
PFE,2020-11-12,Pfizer CEO Sold Shares on Same Day as the Company's Coronavirus Vaccine News: Should You Be Outraged?,https://cdn.snapi.dev/images/v1/0/o/m02d20201109t2i1540533856w940fhfwllplsqrlynxmpega80yo.jpg,The Motley Fool,Hold your fire until you understand the full story.,https://www.fool.com/investing/2020/11/12/pfizer-ceo-sold-shares-on-same-day-as-the-companys/,-0.3182,-0.34
PFE,2020-11-11,A securities lawyer breaks down the Pfizer CEO stock sale,https://cdn.snapi.dev/images/v1/s/w/a-securities-lawyer-breaks-down-the-pfizer-ceo-stock-sale.jpg,CNBC Television,"Lisa Braganca, securities lawyer and former SEC branch chief, on Pfizer's CEO stock sale. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen Finerman and Dan Nathan.",https://www.youtube.com/watch?v=MO1IveRJ3KE,0.296,0.296
PFE,2020-11-11,ETFs to Consider on Pfizer's Vaccine Announcement,https://cdn.snapi.dev/images/v1/n/p/drugs24---rrbmtzl2kk.jpg,Zacks Investment Research,ETFs with exposure to Pfizer (PFE) are beginning to look good after the results of BNT162b2's Phase 3 trial.,https://www.zacks.com/stock/news/1100428/etfs-to-consider-on-pfizers-vaccine-announcement,0.0,0.4404
PFE,2020-11-11,Pfizer CEO Sells Stock Same Day as Vaccine Announcement,https://cdn.snapi.dev/images/v1/i/5/pfizer-56a530e23df78cf77286d4a7.jpg,Investopedia,Pfizer CEO Albert Bourla sold nearly $5.6 million of the company's stock on Monday as the share price soared as much as 15% on the news that its COVID-19 vaccine candidate is 90% effective.,https://www.investopedia.com/pfizer-ceo-sells-stock-same-day-as-breakthrough-vaccine-announcement-5087140,0.0,0.6486
PFE,2020-11-11,Pfizer CEO sold $5.6 million worth of stock amid the pandemic,https://cdn.snapi.dev/images/v1/9/e/pfizer-ceo-sold-56-million-worth-of-stock-amid-the-pandemic.jpg,CNBC Television,"Pfizer's CEO sold about $5.6 million worth of stock on Monday, according to a filing. CNBC's Meg Tirrell reports on the sale and the company's response.",https://www.youtube.com/watch?v=mjPlXMb4ZXQ,0.2263,0.2263
PFE,2020-11-11,Bet Big on Industrial Metal ETFs on Vaccine Optimism,https://cdn.snapi.dev/images/v1/8/5/etf5.jpg,Zacks Investment Research,Wall Street has been on a rallying mode in recent sessions on upbeat vaccine data and recovering global manufacturing activities.,https://www.zacks.com/stock/news/1100425/bet-big-on-industrial-metal-etfs-on-vaccine-optimism,0.5423,0.0
PFE,2020-11-11,Moderna Pops After Fauci Predicts Its Vaccine Will Be As Effective As Pfizer's,https://cdn.snapi.dev/images/v1/w/w/biotech39.jpg,Investors Business Daily,"Moderna popped Wednesday after Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, predicted its coronavirus vaccine would be as effective as Pfizer's. The post Moderna Pops After Fauci Predicts Its Vaccine Will Be As Effective As Pfizer's appeared first on Investor's Business Daily.",https://www.investors.com/news/technology/moderna-stock-pops-anthony-fauci-predicts-coronavirus-vaccine-effective-pfizer/,0.4767,0.7351
PFE,2020-11-11,Pfizer Nabs Supply Deal For Covid-19 Vaccine; Executives Sell Stock,https://cdn.snapi.dev/images/v1/k/a/drugs23.jpg,Investors Business Daily,Pfizer and BioNTech reached a supply deal Wednesday with the European Union for up to 300 million doses of their coronavirus vaccine. The EU will initially buy 200 million doses.,https://www.investors.com/news/technology/coronavirus-vaccine-pfizer-inks-deal-eu-300-million-doses-branch/,0.0,0.1027
PFE,2020-11-11,Why Investors Should Bank On Well Fargo,https://cdn.snapi.dev/images/v1/s/z/bank15---i2dz0yskn8.jpg,InvestorPlace,"Yes, there are considerable problems at Wells Fargo. But WFC stock still looks very attractive at current levels.",https://investorplace.com/2020/11/why-investors-should-bank-on-well-fargo-wfc-stock/,0.2732,0.6361
PFE,2020-11-11,Pfizer CEO Bourla Offloads $5.6M In Stock In Preplanned Sale Amid Vaccine Rally,https://cdn.snapi.dev/images/v1/a/s/syringe-1884758-1920-76.jpg,Benzinga,Pfizer Inc. (NYSE: PFE) shares rose to a 52-week high of $41.99 Monday thanks to strong late-stage interim readout for the mRNA vaccine candidate BNT162b2 the company is co-developing with its German partner BioNTech SE – ADR (NASDAQ: BNTX). Some insider stock sales at the company are coinciding with the strong upward move.,https://www.benzinga.com/general/biotech/20/11/18322660/pfizer-ceo-bourla-offloads-5-6m-in-stock-in-preplanned-sale-amid-vaccine-rally,0.0,0.8934
PFE,2020-11-11,Pfizer CEO sold $5.6 million of stock as company announced vaccine data that sent shares soaring,https://cdn.snapi.dev/images/v1/9/o/106635982-1604927371759-106635982-1595948992117-gettyimages-1132313750-wm2-7799-20190226114402859.jpg,CNBC,Bourla is not the first pharmaceutical or biotech executive to cash in on his company's stock gains during the pandemic.,https://www.cnbc.com/2020/11/11/coronavirus-vaccine-pfizer-ceo-sold-5point6-million-of-stock-as-company-announced-positive-data.html,0.296,0.34
PFE,2020-11-11,"What you need to know about BioNTech, the European company behind Pfizer's Covid-19 vaccine",https://cdn.snapi.dev/images/v1/a/w/106792254-1605109106759-gettyimages-1229548499-20090101201109-99-269063.jpeg,CNBC,Pfizer developed its coronavirus vaccine in partnership with BioNTech. CNBC takes a look at the company's history.,https://www.cnbc.com/2020/11/11/biontech-the-european-company-behind-pfizers-covid-19-vaccine.html,0.0,0.0
PFE,2020-11-11,"Pfizer, BioNTech Ink EU Deal For 300 Million Coronavirus Vaccine Doses",https://cdn.snapi.dev/images/v1/w/r/biotech34.jpg,Investors Business Daily,Pfizer and BioNTech reached a supply deal Wednesday with the European Union for up to 300 million doses of their coronavirus vaccine. The EU will initially buy 200 million doses.,https://www.investors.com/news/technology/coronavirus-vaccine-pfizer-inks-deal-eu-300-million-doses/,0.0,0.1027
PFE,2020-11-11,Pfizer's Covid-19 Success Bodes Very Well For Moderna,https://cdn.snapi.dev/images/v1/g/r/pfizers-covid-19-success-bodes-very-well-for-moderna.jpg,Forbes,"While Pfizer‘s surprisingly strong initial Covid-19 vaccine efficacy readout likely marks the beginning of the end of the Covid-19 pandemic, it probably doesn't mean too much for Pfizer stock, given the limited potential profits and challenges with distribution. In fact, we think that the strong.",https://www.forbes.com/sites/greatspeculations/2020/11/11/pfizers-covid-19-success-bodes-very-well-for-moderna/,0.7264,0.8779
PFE,2020-11-11,Could Pfizer Be a Millionaire-Maker Stock?,https://cdn.snapi.dev/images/v1/f/f/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5987982fgettyimages-1238772468jpgw700opresize.jpg,The Motley Fool,Big news from the drugmaker on a coronavirus vaccine may be just the first in a string of successes.,https://www.fool.com/investing/2020/11/11/could-pfizer-be-a-millionaire-maker-stock/,0.0,0.5574
PFE,2020-11-11,Pfizer's CEO sold $5.6 million in stock the day he announced promising vaccine news,https://cdn.snapi.dev/images/v1/f/j/201111092154-albert-bourla-pfizer-file-restricted-super-169.jpg,CNN Business,Pfizer CEO Albert Bourla filed to sell millions of dollars of his company's stock Monday -- the day the pharmaceutical giant announced positive data about its coronnavirus vaccine.,https://www.cnn.com/2020/11/11/investing/pfizer-ceo-albert-bourla-stock-sale-vaccine/index.html,0.4019,0.5574
PFE,2020-11-11,Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference,https://cdn.snapi.dev/images/v1/g/a/conf13.jpg,Business Wire,"NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Angela Hwang, Group President, Biopharmaceuticals Group, at the 2nd Annual Wolfe Research Healthcare Conference on Wednesday, November 18, 2020 at 9:50 a.m. EST. To listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Visitor",https://www.businesswire.com/news/home/20201111005209/en/Pfizer-Invites-Public-to-Listen-to-Webcast-of-Pfizer-Discussion-at-Healthcare-Conference/,0.0,0.0
PFE,2020-11-11,Exclusive: Europe to pay less than U.S. for Pfizer vaccine under initial deal: source,https://cdn.snapi.dev/images/v1/v/o/m02d20201111t2i1540854359w940fhfwllplsqrlynxmpegaa0s6.jpg,Reuters,"The European Union has struck a deal to initially pay less for Pfizer's COVID-19 vaccine candidate than the United States, an EU official told Reuters as the bloc announced on Wednesday it had secured an agreement for up to 300 million doses.",https://www.reuters.com/article/us-health-coronavirus-eu-pfizer-exclusiv/exclusive-europe-to-pay-less-than-u-s-for-pfizer-vaccine-under-initial-deal-source-idUSKBN27R1F5,0.0258,0.743
PFE,2020-11-11,Pfizer CEO sold $5.6 million stock in pre-planned sale on day of vaccine news release,https://cdn.snapi.dev/images/v1/i/k/pfizer-ceo-sold-56-million-stock-in-pre-planned-sale-on-day-of-vaccine-news-release.jpg,CNBC Television,"CNBC's Meg Tirrell reports the details of a stock sale by Pfizer CEO Albert Bourla on Monday, the same day the company announced its early vaccine trial results.",https://www.youtube.com/watch?v=4SCtZIYI4DQ,0.0,0.0
PFE,2020-11-11,CEO sells stock worth $5.6 million on same day as Pfizer's COVID-19 vaccine update,https://cdn.snapi.dev/images/v1/m/l/m02d20201111t2i1540849465w940fhfwllplsqrlynxmpegaa13p.jpg,Reuters,"Pfizer Inc Chief Executive Officer Albert Bourla has sold stake worth $5.56 million, according to a regulatory filing that showed the sale was made on Monday, the same day the drugmaker reported positive data on its experimental COVID-19 vaccine.",https://www.reuters.com/article/us-pfizer-albert-bourla-stake/ceo-sells-stock-worth-5-6-million-on-same-day-as-pfizers-covid-19-vaccine-update-idUSKBN27R1Z5,0.2263,0.6705
PFE,2020-11-11,Pfizer-BioNTech Seals 200M Dose Vaccine Supply Deal With European Commission,https://cdn.snapi.dev/images/v1/c/d/vaccine-5074670-1920-16.jpg,Benzinga,"After reporting stellar efficacy results for their vaccine candidate earlier this week, Pfizer Inc. (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) announced a supply deal with the European Commission. What Happened: The U.S. pharma giant and its German partner said have reached an agreement with the European Commission to supply 200 million doses of their investigational mRNA vaccine, codenamed BNT162b2, against SARS-CoV-2.",https://www.benzinga.com/general/biotech/20/11/18319375/pfizer-biontech-seals-200m-dose-vaccine-supply-deal-with-european-commission,0.0,0.5574
PFE,2020-11-11,Vaccine Hopes Rise as Pharma Giants Inch Closer Toward Success,https://cdn.snapi.dev/images/v1/a/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5916012fhypodermic-needles-syringe-drug-pharmajpgw700opresize.jpg,Zacks Investment Research,"Stocks of Eli Lilly and Company (LLY), Pfizer, Inc. (PFE) and Moderna, Inc. (MRNA) have been in focus since the coronavirus outbreak as they have been the frontrunners in the vaccine race.",https://www.zacks.com/stock/news/1100121/vaccine-hopes-rise-as-pharma-giants-inch-closer-toward-success,0.7579,0.0
PFE,2020-11-11,Pfizer CEO Albert Bourla sold millions in stock on same day of vaccine reveal,https://cdn.snapi.dev/images/v1/8/y/albert-bourlajpgquality90stripall.jpg,New York Post,"Pfizer CEO Albert Bourla cashed in on his company's coronavirus vaccine breakthrough. The executive sold more than $5.5 million worth of Pfizer stock on Monday — the same day the drugmaker said its experimental COVID-19 shot was more than 90 percent effective, records show.",https://nypost.com/2020/11/11/pfizer-ceo-sold-5-5m-in-stock-amid-covid-19-vaccine-reveal/,0.0,0.6124
PFE,2020-11-11,Pfizer CEO unloads $5.6M of stock as coronavirus vaccine hopes send shares soaring,https://cdn.snapi.dev/images/v1/n/j/106048558-1564499644537rtx71gap.jpg,Fox Business,"Albert Bourla sold 132,508 Pfizer shares at a price of $41.94 apiece through a scheduled Rule 10b5-1 trading plan adopted on Aug. 19, one day after the company announced positive results from a Phase 1 study.",https://www.foxbusiness.com/markets/pfizer-ceo-stock-sale-coronavirus-vaccine-news,0.6124,0.7003
PFE,2020-11-11,"After Promising Coronavirus Vaccine Data, Is Pfizer a Buy?",https://cdn.snapi.dev/images/v1/i/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998512fvaccination-in-progress-gettyjpgw700opresize.jpg,The Motley Fool,An effective coronavirus vaccine candidate is just the tip of this gigantic pharmaceutical iceberg.,https://www.fool.com/investing/2020/11/11/after-promising-coronavirus-vaccine-data-is-pfizer/,0.4019,0.4767
PFE,2020-11-11,How to Invest in the Coronavirus Vaccine Race Right Now,https://cdn.snapi.dev/images/v1/w/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998472fgettyimages-1213011325jpgw700opresize.jpg,The Motley Fool,Pfizer grabbed the spotlight when it released efficacy data from its phase 3 study earlier this week. But is it too late to get in on the action?,https://www.fool.com/investing/2020/11/11/how-to-invest-in-the-coronavirus-vaccine-race-righ/,0.0,0.0
PFE,2020-11-11,"Pfizer Announces Positive Results from Fifth Phase 3 Trial of Abrocitinib, Evaluating Safety and Efficacy Across Different Dosing Regimens",https://cdn.snapi.dev/images/v1/4/a/press8---n9hbkegbtu.jpg,Business Wire,"NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today positive top-line results from the Phase 3 JADE REGIMEN study. This 52-week study investigated abrocitinib, an investigational oral once-daily Janus kinase 1 (JAK1) inhibitor, in patients 12 and older with moderate to severe atopic dermatitis (AD) following response to initial open label induction treatment with abrocitinib 200mg. Patients were randomized into one of three arms: 200mg, 100mg, or placebo. Both doses of abrocitini",https://www.businesswire.com/news/home/20201111005237/en/Pfizer-Announces-Positive-Results-from-Fifth-Phase-3-Trial-of-Abrocitinib-Evaluating-Safety-and-Efficacy-Across-Different-Dosing-Regimens/,0.7506,0.1779
PFE,2020-11-11,"Pfizer, BioNTech reach deal to supply EU with 200 million doses of its COVID-19 vaccine candidate",https://cdn.snapi.dev/images/v1/n/8/biotech18.jpg,Market Watch,"Pfizer Inc. and BioNTech SE announced Wednesday a deal to provide a supply of 200 million doses of its COVID-19 vaccine candidate to the European Union, marking the largest order for the potential vaccine to date. As part of the deal, the EU has an option to request an additional 100 million doses.",https://www.marketwatch.com/story/pfizer-biontech-reach-deal-to-supply-eu-with-200-million-doses-of-its-covid-19-vaccine-candidate-2020-11-11,0.0258,0.0
PFE,2020-11-11,Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2,https://cdn.snapi.dev/images/v1/i/a/press9---awq9udxjup.jpg,Business Wire,"NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that they have reached an agreement with the European Commission to supply 200 million doses of their investigational BNT162b2 mRNA-based vaccine candidate against SARS-CoV-2 to European Union (EU) Member States, with an option for the European Commission to request an additional 100 million doses. Deliveries are anticipated to start by the end of 2020, subject to clinical success and r",https://www.businesswire.com/news/home/20201111005405/en/Pfizer-and-BioNTech-Reach-an-Agreement-to-Supply-the-EU-With-200-Million-Doses-of-Their-BNT162b2-mRNA-Based-Vaccine-Candidate-Against-SARS-CoV-2/,0.5106,0.8074
PFE,2020-11-11,5 Reasons Chasing COVID-19 Vaccine Stocks Is a Bad Idea,https://cdn.snapi.dev/images/v1/w/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f6000002fdoctor-giving-vaccine-flu-shot-to-senior-gettyjpgw700opresize.jpg,The Motley Fool,Investors are setting themselves up for disappointment.,https://www.fool.com/investing/2020/11/11/5-reasons-chasing-covid-19-vaccine-stocks-is-a-bad/,-0.5423,-0.5106
PFE,2020-11-11,Pfizer's Coronavirus Vaccine Data Is Better Than Meets the Eye,https://cdn.snapi.dev/images/v1/d/h/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998842fgettyimages-1219400893jpgw700opresize.jpg,The Motley Fool,The probable winner of the vaccine race demonstrated that its candidate is at least 90% effective at preventing COVID-19 infection.,https://www.fool.com/investing/2020/11/11/pfizers-coronavirus-vaccine-data-is-better-than-me/,0.4404,0.7783
PFE,2020-11-11,Pfizer's CEO cashed out 60% of his stock on the same day the company unveiled the results of its COVID-19 vaccine trial,https://cdn.snapi.dev/images/v1/p/f/pfizers-ceo-cashed-out-60-of-his-stock-on-the-same-day-the-company-unveiled-the-results-of-its-covid-19-vaccine-trial.jpg,Business Insider,Pfizer CEO Albert Bourla sold 62% of his stock on the same day the company announced its experimental COVID-19 vaccine succeeded in clinical trials. The announcement sent Pfizer's shares soaring almost 15% on the day.,https://markets.businessinsider.com/news/stocks/pfizer-ceo-sold-stock-day-covid-19-vaccine-results-unveiled-2020-11-1029790705,0.0,0.6124
PFE,2020-11-11,Pfizer's vaccine news seems 'almost too good to be true': Standard Chartered,https://cdn.snapi.dev/images/v1/6/y/pfizers-vaccine-news-seems-almost-too-good-to-be-true-standard-chartered.jpg,CNBC International TV,Clive McDonnell of Standard Chartered Private Bank outlines risks and opportunities for the markets in light of the coronavirus pandemic and post-U.S. election.,https://www.youtube.com/watch?v=x3MFkfaSyOs,0.3862,0.128
PFE,2020-11-11,Freeze! Standex International And The Pfizer Vaccine,https://cdn.snapi.dev/images/v1/f/6/drugs15.jpg,Seeking Alpha,"The Pfizer vaccine must be stored at -70 degrees Celsius. Anyone who wants to administer it will need an ultra low temp freezer. The market is mostly large companies like Thermo Fisher, but there is one public microcap, Standex International, that makes a limited line of these freezers.",https://seekingalpha.com/article/4387925-freeze-standex-international-and-pfizer-vaccine,0.126,-0.3182
PFE,2020-11-11,"Pfizer's coronavirus vaccine faces 'huge' logistical challenges, says professor",https://cdn.snapi.dev/images/v1/8/z/pfizers-coronavirus-vaccine-faces-huge-logistical-challenges-says-professor.jpg,CNBC International TV,"Maintaining optimal storage and shipping conditions for the coronavirus vaccine especially in low and middle-income countries will be a major challenge for Pfizer and its partners, says Paul Tambyah from the NUS Yong Loo Lin School of Medicine.",https://www.youtube.com/watch?v=cyMN13-pb5o,0.0772,0.1082
PFE,2020-11-10,Pfizer vaccine results bode well for others in development: Biotech analyst,https://cdn.snapi.dev/images/v1/5/t/pfizer-vaccine-results-bode-well-for-others-in-development-biotech-analyst.jpg,CNBC Television,"CNBC's Kelly Evans discusses the unknowns of Pfizer's vaccine effectiveness, including efficacy with older people and how long it may last, with Dr. Vincent Chen of Bernstein. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis.",https://www.youtube.com/watch?v=10eAXfdcmPE,0.2732,0.128
PFE,2020-11-10,"Why these biotech, pharma stocks have more upside: Analyst",https://cdn.snapi.dev/images/v1/m/q/why-these-biotech-pharma-stocks-have-more-upside-analyst.jpg,CNBC Television,CNBC's Kelly Evans talks with Ronny Gal of Bernstein to discuss how to invest in health care and pharma stocks right now. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis.,https://www.youtube.com/watch?v=9t19zL3tjCU,0.0,0.5719
PFE,2020-11-10,"Pfizer's Covid-19 vaccine candidate shows promise, but faces supply and distribution hurdles",https://cdn.snapi.dev/images/v1/f/h/pfizers-covid-19-vaccine-candidate-shows-promise-but-faces-supply-and-distribution-hurdles.jpg,CNBC Television,"Dr. Kathleen Neuzil, University of Maryland School of Medicine director of the Center for Vaccine Development and Global Health, discusses the 90% efficacy of the Pfizer Covid-19 vaccine, and the supply and distribution challenges still ahead.",https://www.youtube.com/watch?v=a7pe6B0G7so,0.1655,0.0772
PFE,2020-11-10,Gold Prices: Yesterday's Rally Put Our ‘Trade of the Decade' on Sale,https://cdn.snapi.dev/images/v1/q/g/drugs13.jpg,InvestorPlace,"I've been saying that I expect the gold price to double over the next two or three years, and I've also told you that gold will win out over the dollar. Yesterday's news changes none of that.",https://investorplace.com/2020/11/gold-prices-yesterdays-rally-put-trade-of-decade-on-sale/,0.0,0.5859
PFE,2020-11-10,‘I Trust Pfizer': Fauci Says He Would Take Coronavirus Vaccine Upon FDA Approval,https://cdn.snapi.dev/images/v1/s/k/i-trust-pfizer-fauci-says-he-would-take-coronavirus-vaccine-upon-fda-approval.jpg,Forbes,"“If they look at this data, and they say this data is solid, let's go ahead and approve it.”",https://www.forbes.com/sites/carlieporterfield/2020/11/10/i-trust-pfizer-fauci-says-he-would-take-coronavirus-vaccine-upon-fda-approval/,0.7506,0.1531
PFE,2020-11-10,Market Insight: What's Behind Monday's Huge Rally,https://cdn.snapi.dev/images/v1/b/w/drugs12.jpg,InvestorPlace,"At first glance, this rally looks great. But if you dig underneath the surface, you'll see that this was actually a “mean reversion” rally and a big shift out of growth and into value.",https://investorplace.com/2020/11/market-insight-whats-behind-mondays-huge-rally/,0.3182,0.8442
PFE,2020-11-10,MoneyLine Podcast: The Best Sectors for a Biden Administration,https://cdn.snapi.dev/images/v1/g/z/biotech7---8r9txcronv.jpg,InvestorPlace,"On this episode of MoneyLine, Matt McCall talks about what a Biden presidency would mean, as well as which sectors and stocks are set to blow. The post MoneyLine Podcast: The Best Sectors for a Biden Administration appeared first on InvestorPlace.",https://investorplace.com/moneywire/2020/11/moneyline-podcast-the-best-sectors-for-a-biden-administration/,0.6369,0.743
PFE,2020-11-10,Causeway Capital Commentary- Update on Covid019 Vaccines: A Major Breakthrough for mRNA Technology,https://cdn.snapi.dev/images/v1/i/s/isksk22.jpg,GuruFocus,"November 9, 2020",https://www.gurufocus.com/news/1282089/causeway-capital-commentary-update-on-covid019-vaccines-a-major-breakthrough-for-mrna-technology,0.0,0.0
PFE,2020-11-10,Sales of Pfizer's Covid Vaccine Could Hit $4.6 Billion in 2021,https://cdn.snapi.dev/images/v1/4/k/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5811442fdoctor-holding-covid-19-vaccine-with-thumb-upjpgw700opresize.jpg,GuruFocus,"Nearly four months ago I wrote that should the Covid-19 vaccine being developed by Pfizer Inc. (NYSE:PFE) prove successful, it could generate revenue of $15 billion. That expectation is moving closer to reality after the New York-based pharmaceutical leader and partner BioNTech SE (NASDAQ:BNTX) announced on Monday their leading candidate worked 90% of the time.",https://www.gurufocus.com/news/1282068/sales-of-pfizers-covid-vaccine-could-hit-46-billion-in-2021,0.0,0.5859
PFE,2020-11-10,Pfizer plans ‘just-in-time' COVID-19 vaccine distribution in Canada,https://cdn.snapi.dev/images/v1/a/p/covid19vaccine1110.jpg,FreightWaves,"Pfizer (NYSE:PFE) plans to distribute its potential COVID-19 vaccine directly to the locations where it will be administered in Canada in specialized, temperature-controlled containers filled with dry ice under a “flexible just-in-time” logistics scheme, the company said. The pharmaceutical giant is developing its Canadian distribution plan with federal and provincial government agencies to deploy the vaccine in the event it is approved for use.",https://www.freightwaves.com/news/pfizer-plans-just-in-time-covid-19-vaccine-distribution-in-canada,0.0,0.4215
PFE,2020-11-10,BioNTech CEO on vaccine progress with Pfizer,https://cdn.snapi.dev/images/v1/c/h/biontech-ceo-on-vaccine-progress-with-pfizer.jpg,CNBC Television,"BioNTech CEO Dr. Ugur Sahin joins 'Power Lunch' to discuss the Covid-19 vaccine it is working on with Pfizer, the high efficiency rate and the storage of the vaccine.",https://www.youtube.com/watch?v=k9VNPMpfneA,0.4215,0.3612
PFE,2020-11-10,Pfizer and BioNTech could make $13bn from coronavirus vaccine,https://cdn.snapi.dev/images/v1/d/n/3500jpgwidth460quality85autoformatfitmaxs562e35b06414ab497c157f16bf2eac08.jpg,The Guardian,Johnson & Johnson and AstraZeneca pledged to make their vaccines available on a not-for-profit basis,https://www.theguardian.com/business/2020/nov/10/pfizer-and-biontech-could-make-13bn-from-coronavirus-vaccine,0.0,0.0
PFE,2020-11-10,Vaccine Hopes & Divided Government: Sector ETFs to Win,https://cdn.snapi.dev/images/v1/l/b/biotech2---kbdvltrcw4.jpg,Zacks Investment Research,News that a Pfizer and BioNTech vaccine candidate was more than 90% effective in avoiding COVID-19 in its clinical trial has instilled more optimism in the markets.,https://www.zacks.com/stock/news/1099853/vaccine-hopes-divided-government-sector-etfs-to-win,0.765,0.6962
PFE,2020-11-10,Former FDA chief scientist on Pfizer vaccine,https://cdn.snapi.dev/images/v1/q/s/former-fda-chief-scientist-on-pfizer-vaccine.jpg,CNBC Television,"The FDA has granted Eli Lilly's treatment emergency use authorization. Jesse Goodman, former FDA vaccine division chief, joins 'Squawk Alley' to discuss the Pfizer vaccine and the rise of coronavirus cases.",https://www.youtube.com/watch?v=EdVB0oy0oXw,0.0,-0.1531
PFE,2020-11-10,Why Pfizer's Covid-19 Vaccine Is Unlikely To Move The Needle For The Stock,https://cdn.snapi.dev/images/v1/d/w/why-pfizers-covid-19-vaccine-is-unlikely-to-move-the-needle-for-the-stock.jpg,Forbes,"Pfizer (NYSE: PFE) and its German partner BioNTech indicated that their Coronavirus vaccine, dubbed BNT162b2, was over 90% effective at preventing Covid-19 infections among volunteers, based on early data from phase 3 trials.",https://www.forbes.com/sites/greatspeculations/2020/11/10/why-pfizers-covid-19-vaccine-is-unlikely-to-move-the-needle-for-the-stock/,0.0,0.4588
PFE,2020-11-10,Here's how millennials traded stocks on the Pfizer news,https://cdn.snapi.dev/images/v1/7/7/heres-how-millennials-traded-stocks-on-the-pfizer-news.jpg,CNBC Television,Millennials were taking profits on the travel stock rise while doubling down on the stay-at-home stocks. CNBC's Kate Rooney reports.,https://www.youtube.com/watch?v=kd-wio3VpFU,0.0,0.4404
PFE,2020-11-10,Pfizer Vaccine Puts a Return to Normal Within Reach in 2021,https://cdn.snapi.dev/images/v1/a/g/pfizer-vaccine-puts-a-return-to-normal-within-reach-in-2021-440x250.png,ETF Trends,Election Outcome Boosted Risk-On Theme Last Week One headline changes the narrative about the pandemic; or does it? Pfizer's vaccine study results Monday morning are shockingly good with over 90% effectiveness in preventing infection.,https://www.etftrends.com/etf-strategist-channel/pfizer-vaccine-puts-a-return-to-normal-within-reach-in-2021/,0.0258,0.5574
PFE,2020-11-10,"Trump Falsely Takes Credit For Pfizer Vaccine Success, Accuses FDA And Democrats Of Stalling News Until After Election",https://cdn.snapi.dev/images/v1/a/k/trump-falsely-takes-credit-for-pfizer-vaccine-success-accuses-fda-and-democrats-of-stalling-news-until-after-election.jpg,Forbes,"Trump's Operation Warp Speed didn't fund the Pfizer drug, though the government did agree to buy the vaccine when approved.",https://www.forbes.com/sites/roberthart/2020/11/10/trump-falsely-takes-credit-for-pfizer-vaccine-success-accuses-fda-and-democrats-of-stalling-news-until-after-election/,0.4767,0.6486
PFE,2020-11-10,Pfizer's Covid-19 vaccine has nothing to do with politics: Caret Group's Fred Hassan,https://cdn.snapi.dev/images/v1/i/x/pfizers-covid-19-vaccine-has-nothing-to-do-with-politics-caret-groups-fred-hassan.jpg,CNBC Television,"Fred Hassan, The Caret Group chairman and Amgen board member, joins 'Squawk on the Street' to discuss how he would distribute the Pfizer Covid-19 vaccine and the money beyond Operation Warp Speed.",https://www.youtube.com/watch?v=vFMhE3WbQzk,0.0,0.0
PFE,2020-11-10,Health secretary Alex Azar said Pfizer's coronavirus vaccine will be available to 'all Americans' by April,https://cdn.snapi.dev/images/v1/h/e/health-secretary-alex-azar-said-pfizers-coronavirus-vaccine-will-be-available-to-all-americans-by-april.jpg,Business Insider,"When pharmaceutical company Pfizer announced Monday its experimental coronavirus vaccine may be 90% effective, many questions remained, including when it may be available and for whom. On Tuesday's episode of the Today Show, Secretary of Health and Human Services Alex Azar addressed those questions, saying the general public should have access to the vaccine and potentially others, like one in development by Moderna, by the end of March and early April 2021.",https://www.businessinsider.com/alex-azar-pfizer-vaccine-available-to-all-americans-by-april-2020-11,0.0,0.6808
PFE,2020-11-10,Pfizer Analysts Raise Odds Of Success For Coronavirus Vaccine Candidate To 100%,https://cdn.snapi.dev/images/v1/e/d/virus-4030721-1920-0.jpg,Benzinga,Pfizer Inc. (NYSE: PFE) reported Monday with strong Phase 3 interim efficacy data for its coronavirus vaccine candidate. The Pfizer Analysts: Morgan Stanley analyst David Risinger has an Equal-weight rating on Pfizer with a $42 price target.,https://www.benzinga.com/analyst-ratings/analyst-color/20/11/18299631/pfizer-analysts-raise-odds-of-success-for-coronavirus-vaccine-candidate-to-100,0.5719,0.5106
PFE,2020-11-10,"Blue Chips & Tech Going Separate Directions: PFE, GOOGL, FB, LLY & More",https://cdn.snapi.dev/images/v1/r/n/data-internet13.jpg,Zacks Investment Research,"The last time we saw the Dow surge strongly ahead while the Nasdaq dipped into the red was back in 2000, when the tech bubble of the pre-Y2K market began to burst.",https://www.zacks.com/stock/news/1099621/blue-chips-tech-going-separate-directions-pfe-googl-fb-lly-more,0.0,0.2732
PFE,2020-11-10,"Pfizer COVID-19 Vaccine Data Raises Hopes for Industry, Economy",https://cdn.snapi.dev/images/v1/1/5/drugs7---taxmwmtpoc.jpg,Zacks Investment Research,Pfizer (PFE)/BioNTech's (BNTX) COVID-19 vaccine candidate proves to be 90% effective in phase III.,https://www.zacks.com/stock/news/1099561/pfizer-covid-19-vaccine-data-raises-hopes-for-industry-economy,0.4215,0.4767
PFE,2020-11-10,Pfizer Covid-19 Vaccine's next big challenge: giving it to enough people,https://cdn.snapi.dev/images/v1/n/c/drugs4.jpg,Fox Business,"Even for rich nations with developed vaccination programs, that presents a host of problems ranging including building new databases to track who is getting the shot, working out ways to encourage mass uptake among younger people, ensuring adequate supply and running large-scale inoculation centers where the shots can be safely and quickly administered.",https://www.foxbusiness.com/markets/pfizer-covid-19-vaccines-next-big-challenge-giving-it-to-enough-people,0.4019,0.886
PFE,2020-11-10,Pfizer Covid-19 Vaccine's Five Big Unknowns,https://cdn.snapi.dev/images/v1/g/w/pfizer-covid-19-vaccines-five-big-unknowns.jpg,Forbes,Pfizer's Covid-19 vaccine could grab $15 billion in profit from a $100 billion market -- if it can answer five big questions,https://www.forbes.com/sites/petercohan/2020/11/10/pfizer-covid-19-vaccines-five-big-unknowns/,0.0,0.4404
PFE,2020-11-10,Novavax Steals Some of Pfizer's Thunder With Fast Track Designation,https://cdn.snapi.dev/images/v1/g/4/biotech17.jpg,InvestorPlace,Novavax delivered good news Nov. 9. It announced its Covid-19 vaccine's been fast-tracked by the FDA.,https://investorplace.com/2020/11/novavax-nvax-stock-steals-pfizers-thunder-with-fast-track-designation/,-0.5106,0.4404
PFE,2020-11-10,Vaccine Developments Knock Election News Off Front Page - Scott Martin Joins Alpha Trader,https://cdn.snapi.dev/images/v1/a/6/podc1.jpg,Seeking Alpha,Vaccine Developments Knock Election News Off Front Page - Scott Martin Joins Alpha Trader,https://seekingalpha.com/article/4387272-vaccine-developments-knock-election-news-off-front-page-scott-martin-joins-alpha-trader,0.0,0.0
PFE,2020-11-10,Pfizer has a potential vaccine. Now what?,https://cdn.snapi.dev/images/v1/m/f/pfi1a.jpg,The Dog of Wall Street,"Industries like entertainment, travel and hospitality, airlines, cruise ships, and casinos, were just a few of the sectors that reacted positively to the news.",https://thedogofwallstreet.com/pfe/pfizer-has-a-potential-vaccine-now-what,0.0,0.8271
PFE,2020-11-10,"Meet Kathrin Jansen, the woman leading Pfizer's COVID-19 vaccine effort",https://cdn.snapi.dev/images/v1/z/p/poster-kathrin-jansen-pfizer.jpg,Fast Company,The rock star scientist has a track record of producing difficult vaccines against the odds. Pfizer has made an incredible announcement: Its COVID-19 vaccine looks like it is 90% effective at preventing the disease inside its clinical trial.,https://www.fastcompany.com/90573460/kathrin-jansen-pfizer-covid-19-vaccine-scientist,0.0,0.4588
PFE,2020-11-10,20 Million Doses Of Pfizer's Covid-19 Vaccine Headed To Spain In Early 2021,https://cdn.snapi.dev/images/v1/r/a/20-million-doses-of-pfizers-covid-19-vaccine-headed-to-spain-in-early-2021.jpg,Forbes,Early data from the vaccine's clinical trial shows it could be 90% effective at preventing the disease.,https://www.forbes.com/sites/roberthart/2020/11/10/20-million-doses-of-pfizers-covid-19-vaccine-headed-to-spain-in-early-2021/,0.0,0.4588
PFE,2020-11-10,These are the non-pharma winners and losers from the Pfizer vaccine results,https://cdn.snapi.dev/images/v1/b/q/im-257642width620size15005861664712778.jpg,Market Watch,The 7 most important takeaways for investors.,https://www.marketwatch.com/story/these-are-the-non-pharma-winners-and-losers-from-the-pfizer-vaccine-results-11604970629,-0.0772,0.2716
PFE,2020-11-10,3 Stocks That Should Be Big Winners Under Joe Biden's Coronavirus Plan,https://cdn.snapi.dev/images/v1/j/f/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5997762fjoe-biden-whitehousegovjpgw700opresize.jpg,The Motley Fool,They check off the boxes for three of the President-elect's top COVID-19 priorities.,https://www.fool.com/investing/2020/11/10/3-stocks-that-should-be-big-winners-under-joe-bide/,0.4767,0.2023
PFE,2020-11-10,2 Best Pharma Stocks to Buy in November,https://cdn.snapi.dev/images/v1/q/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5987972fgettyimages-1205966780jpgw700opresize.jpg,The Motley Fool,The two pharma stocks offer investors the upside of a coronavirus vaccine with the peace of mind of century-old businesses.,https://www.fool.com/investing/2020/11/10/2-best-pharma-stocks-to-buy-in-november/,0.6369,0.5423
PFE,2020-11-10,Health care researcher: Four questions to ask about Pfizer and BioNTech vaccine,https://cdn.snapi.dev/images/v1/o/d/health-care-researcher-four-questions-to-ask-about-pfizer-and-biontech-vaccine.jpg,CNBC International TV,"Tara Raveendran, head of life sciences research at Shore Capital, analyzes the read-outs from the late-stage Pfizer and BioNTech Covid-19 vaccine trial.",https://www.youtube.com/watch?v=nejJ5mPxQF4,0.4939,0.0
PFE,2020-11-10,Regulatory agencies still need to review Pfizer's vaccine on safety: Professor,https://cdn.snapi.dev/images/v1/v/r/regulatory-agencies-still-need-to-review-pfizers-vaccine-on-safety-professor.jpg,CNBC International TV,"Joshua Sharfstein from Johns Hopkins Bloomberg School of Public Health says Pfizer's coronavirus vaccine still needs to go through regulatory review for safety, and in the meantime, the public should continue practicing good hygience and social distancing.",https://www.youtube.com/watch?v=mpgDyEW3Xq8,0.4215,0.6908
PFE,2020-11-10,"Spain to get first Pfizer vaccines in early 2021, Health Minister says",https://cdn.snapi.dev/images/v1/s/y/m02d20201110t2i1540664257w940fhfwllplsqrlynxmpega90iq.jpg,Reuters,"Spain would get the first vaccines developed by U.S. pharmaceutical giant Pfizer in early 2021, Health Minister Salvador Illa said on Tuesday.",https://www.reuters.com/article/us-health-coronavirus-spain-vaccine/spain-to-get-first-pfizer-vaccines-in-early-2021-health-minister-says-idUSKBN27Q0Y3,0.0,0.0
PFE,2020-11-10,Pfizer's COVID-19 Vaccine News Throws Bitcoin Rally Off Course,https://cdn.snapi.dev/images/v1/p/g/dmitry-demidko-og3a-ilg8ay-unsplash-2.jpg,Benzinga,"Bitcoin traded nearly flat but above the $15,000 level at press-time after going as low as $14,865.33 in a 24-hour period. What Happened: Bitcoin's price fell by nearly $1,000 on Monday as stocks rallied after Pfizer Inc (NYSE: PFE) said its coronavirus vaccine was 90% effective in preventing COVID-19.",https://www.benzinga.com/markets/cryptocurrency/20/11/18290619/pfizers-covid-19-vaccine-news-throws-bitcoin-rally-off-course,0.0,0.3291
PFE,2020-11-10,The New York Post: Pfizer COVID-19 vaccine could be given by the end of the year: Fauci,https://cdn.snapi.dev/images/v1/k/f/im-257683width620size14988290398126465.jpg,Market Watch,Dr. Anthony Fauci said Monday that Pfizer's coronavirus vaccine could be administered to people by the end of the year.,https://www.marketwatch.com/story/pfizer-covid-19-vaccine-could-be-given-by-the-end-of-the-year-fauci-11604994465,0.0,0.0
PFE,2020-11-10,Coronavirus vaccine: Pfizer's vaccine trials show a vaccine is 90% effective,https://cdn.snapi.dev/images/v1/r/z/coronavirus-vaccine-pfizers-vaccine-trials-show-a-vaccine-is-90-effective.jpg,Yahoo Finance,"Yahoo Lifestyle writer and editor Abby Haglage breaks down Pfizer's news of a vaccine that shows 90% effective rate in trials. In long-awaited good news Monday, drugmaker Pfizer announced that its vaccine candidate — created with German biotechnology company BioNTech SE — was 90 percent effective in preventing COVID-19 in phase III clinical trials.",https://www.youtube.com/watch?v=xOmAcVEbEps,0.4767,0.875
PFE,2020-11-09,Why Video Game and Streaming Stocks Plunged Today,https://cdn.snapi.dev/images/v1/q/5/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5999262fgame-controller-on-a-tablejpgw700opresize.jpg,The Motley Fool,"If people go back to work, will they really stop playing video games?",https://www.fool.com/investing/2020/11/09/why-video-game-stocks-plunged-today/,0.0,-0.1065
PFE,2020-11-09,Jim Cramer: Pfizer vaccine news is a 'new chapter for the market',https://cdn.snapi.dev/images/v1/f/k/jim-cramer-pfizer-vaccine-news-is-a-new-chapter-for-the-market.jpg,CNBC Television,"""I expect the reopening plays to keep climbing, while the Covid-winners get hammered for the rest of the week,"" the ""Mad Money"" host said.",https://www.youtube.com/watch?v=Y6aIEtO4T_s,0.0,-0.296
PFE,2020-11-09,Who will be first to get the Pfizer Covid vaccine?,https://cdn.snapi.dev/images/v1/8/d/who-will-be-first-to-get-the-pfizer-covid-vaccine.jpg,CNBC Television,There are limited dosages available for Pfizer's Covid vaccine. Former FDA Commissioner Dr. Scott Gottlieb discusses who is likely to get the vaccine first in the United States.,https://www.youtube.com/watch?v=lEZgMvNZ26s,0.0,0.2263
PFE,2020-11-09,"Pfizer's Covid vaccine is more than 90% effective, but there is low supply",https://cdn.snapi.dev/images/v1/q/q/pfizers-covid-vaccine-is-more-than-90-effective-but-there-is-low-supply.jpg,CNBC Television,"Stocks rallied today on news of Pfizer's Covid vaccine, which has proven to be more than 90% effective in trials. There will be 50 million doses of it available this year and about 1.3 billion in 2021.",https://www.youtube.com/watch?v=H0p5I0SH_u4,-0.12,0.5209
PFE,2020-11-09,Brazil in talks with Pfizer to buy promising COVID-19 vaccine,https://cdn.snapi.dev/images/v1/q/0/m02d20201109t2i1540615121w940fhfwllplsqrlynxmpega81l9.jpg,Reuters,"The Brazilian federal government is in talks with Pfizer Inc in Brazil to buy its experimental COVID-19 vaccine for inclusion in its national vaccination program, a spokesman for the company said on Monday.",https://www.reuters.com/article/us-health-coronavirus-pfizer-brazil/brazil-in-talks-with-pfizer-to-buy-promising-covid-19-vaccine-idUSKBN27P2LD,0.4019,0.0
PFE,2020-11-09,"As S&P 500 Roars to Near-Highs, Here's One Mindblowing Stat About Today's 100 Best- Performing Stocks",https://cdn.snapi.dev/images/v1/c/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5999472fman-with-rocketsjpgw700opresize.jpg,The Motley Fool,"Despite a bad day for some of 2020's best stocks, news of what looks like an effective coronavirus vaccine has investors buying big today.",https://www.fool.com/investing/2020/11/09/as-sp-500-roars-to-near-highs-heres-one-mindblowin/,0.6369,0.9127
PFE,2020-11-09,Pfizer's ‘90% Effective' Vaccine News Doesn't Mean Stimulus Is Dead,https://cdn.snapi.dev/images/v1/7/u/pfizers-90-effective-vaccine-news-doesnt-mean-stimulus-is-dead.jpg,Forbes,"Investors cheered the long-awaited good news, but we're not out of the woods yet.",https://www.forbes.com/sites/sarahhansen/2020/11/09/pfizers-90-effective-vaccine-news-doesnt-mean-stimulus-is-dead/,-0.296,0.4767
PFE,2020-11-09,Market Insight: 3 Takeaways From Today's Massive Rally,https://cdn.snapi.dev/images/v1/z/c/data-internet5.jpg,InvestorPlace,"While Matt McCall hopes some of your stocks were up big today, he also suggests keeping an even keel. Here are his three key takeaways to today's market action.",https://investorplace.com/moneywire/2020/11/market-insight-3-takeaways-from-todays-massive-rally/,0.0,0.4215
PFE,2020-11-09,Vaccine Hope Sent These Retailers Soaring Monday,https://cdn.snapi.dev/images/v1/z/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5597632fbusy-retail-mall-closing-slide-source-gettyjpgw700opresize.jpg,The Motley Fool,"These four retailers are soaring today as an effective vaccine would help return the world, and shopping, to near-normal.",https://www.fool.com/investing/2020/11/09/vaccine-hope-sent-these-retailers-soaring-monday/,0.4404,0.7003
PFE,2020-11-09,Stocks Are Crushing It Today: Here's Why These 4 Stocks Fell,https://cdn.snapi.dev/images/v1/y/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5999162farrows-up-and-downjpgw700opresize.jpg,The Motley Fool,"The likelihood of a coronavirus vaccine has investors looking away from these companies, despite their great prospects.",https://www.fool.com/investing/2020/11/09/stocks-are-crushing-it-today-heres-why-these-5-sto/,-0.3612,-0.6348
PFE,2020-11-09,Why a COVID-19 Vaccine in 2021 Would Be Such a Boost for Bank Stocks,https://cdn.snapi.dev/images/v1/8/b/103334235-gettyimages-498338509.jpg,The Motley Fool,An effective vaccine in 2021 could get the economy churning at a more normal level and effectively help banks avoid some of the loan losses they are currently projecting.,https://www.fool.com/investing/2020/11/09/why-a-covid-19-vaccine-in-2021-would-be-such-a-boo/,0.4019,0.5859
PFE,2020-11-09,Pfizer's vaccine trial 'raises the bar' for other pharmaceutical companies: Jefferies' Jared Holz,https://cdn.snapi.dev/images/v1/x/j/pfizers-vaccine-trial-raises-the-bar-for-other-pharmaceutical-companies-jefferies-jared-holz.jpg,CNBC Television,"Jared Holz, Jefferies, healthcare equity strategist, joins 'Closing Bell' to talk about his thoughts on Pfizer's 90 percent effective vaccine trial that's driving the markets today. He says the result pushes other pharmaceutical companies to produce effective, low-cost vaccines.",https://www.youtube.com/watch?v=icdUkJkMEnw,0.0,0.7351
PFE,2020-11-09,"This is great news, but it's too soon to be certain: Fmr. CDC director on Pfizer's vaccine trial",https://cdn.snapi.dev/images/v1/d/n/this-is-great-news-but-its-too-soon-to-be-certain-fmr-cdc-director-on-pfizers-vaccine-trial.jpg,CNBC Television,"Dr. Tom Frieden, former CDC director under President Obama, says he is encouraged by the data from Pfizer's vaccine trials that showed it would be 90 percent effective. But he also warned it's too soon to tell if it will work for everyone.",https://www.youtube.com/watch?v=VkIBD6EnF4Y,0.6369,0.5423
PFE,2020-11-09,Pfizer vaccine is going to be great for the U.S. economy: Trian Partners CEO Nelson Peltz,https://cdn.snapi.dev/images/v1/t/b/pfizer-vaccine-is-going-to-be-great-for-the-us-economy-trian-partners-ceo-nelson-peltz.jpg,CNBC Television,"Nelson Peltz, Trian Partners CEO, joins 'Closing Bell' to discuss his take on the Pfizer vaccine and what it means for the U.S. economy. He also discusses the outcome of the 2020 presidential election and its impact on the market.",https://www.youtube.com/watch?v=yusQ-obBXb8,0.6249,0.0
PFE,2020-11-09,What Pfizer's Coronavirus Vaccine Data Means For Moderna,https://cdn.snapi.dev/images/v1/p/j/dna-24559-1280-21.png,Benzinga,"Moderna Inc (NASDAQ: MRNA) shares were advancing strongly Monday after a rival vaccine developed by Pfizer Inc. (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) showed efficacy in a late-stage study. High Bar For Moderna To Clear: The 90% vaccine efficacy demonstrated by Pfizer and BioNTech sets an extremely high bar for Moderna, SVB Leerink analyst Mani Foroohar said in a Monday note.",https://www.benzinga.com/analyst-ratings/analyst-color/20/11/18279366/what-pfizers-coronavirus-vaccine-data-means-for-moderna,0.0,0.7096
PFE,2020-11-09,"What You Need To Know In Options This Week: SPY, Disney, Cisco, Draft Kings, Pfizer And More",https://cdn.snapi.dev/images/v1/1/j/chart-5222700-1920-39.png,Benzinga,The DJIA and S&P 500 are soaring this morning following a promising Covid vaccine announcement from Pfizer (NYSE: PFE). The more tech heavy Nasdaq is mixed.,https://www.benzinga.com/markets/options/20/11/18283410/what-you-need-to-know-in-options-this-week-spy-disney-cisco-draft-kings-pfizer-and-more,0.0,0.4019
PFE,2020-11-09,Here's what to know about how Pfizer and BioNTech's Covid-19 vaccine will be transported,https://cdn.snapi.dev/images/v1/5/u/heres-what-to-know-about-how-pfizer-and-biontechs-covid-19-vaccine-will-be-transported.jpg,CNBC Television,"Pfizer and BioNTech have announced a Covid-19 vaccine that is more than 90 percent effective. Lori Ann LaRocco, CNBC senior editor, joins 'Power Lunch' to discuss how the vaccine will be transported and how quickly will there be mass production.",https://www.youtube.com/watch?v=V-a3D-bHLro,0.0,0.4767
PFE,2020-11-09,Travel companies cheer Pfizer Covid vaccine news as 'welcomed step' toward return in demand,https://cdn.snapi.dev/images/v1/p/u/106723726-1601478306430-gettyimages-1220515510-1006-08-fl200415019.jpeg,CNBC,"""Today's Pfizer news is a welcomed step in the right direction,"" TripAdvisor CEO Steve Kaufer told CNBC.",https://www.cnbc.com/2020/11/09/pfizer-covid-vaccine-travel-companies-see-it-as-welcomed-step-.html,0.6369,0.34
PFE,2020-11-09,ETF Edge: Impact of the election and Pfizer's vaccine news,https://cdn.snapi.dev/images/v1/y/b/etf-edge-impact-of-the-election-and-pfizers-vaccine-news.jpg,CNBC Television,"Matt Bartolini, State Stree; Nick Colas, DataTrek; and Brendan Ahern, KranShares, discuss the election results and Pfizer's big vaccine news, and what it means for the ETF market.",https://www.youtube.com/watch?v=DEINt6gLU7Q,0.0,0.0
PFE,2020-11-09,Jefferies analyst makes the case for Moderna after Pfizer and BioNTech rise on Covid-19 vaccine news,https://cdn.snapi.dev/images/v1/p/d/jefferies-analyst-makes-the-case-for-moderna-after-pfizer-and-biontech-rise-on-covid-19-vaccine-news.jpg,CNBC Television,"Michael Yee, Jefferies health care and biotech analyst, joins 'Power Lunch' to discuss the news that Pfizer and BioNtech have announced a Covid-19 vaccine is more than 90 percent effective and what it means for biotech sector.",https://www.youtube.com/watch?v=zf7fYIF-0X4,0.0,0.743
PFE,2020-11-09,"Pfizer vaccine is not a ‘slam dunk,' warns U.K. prime minister",https://cdn.snapi.dev/images/v1/v/n/im-257343width620size14988290398126465.jpg,Market Watch,"Boris Johnson said: “I just don't want to let people run away with the idea that this . . . is necessarily a home run, a slam dunk, a shot to the back of the net yet.",https://www.marketwatch.com/story/pfizer-vaccine-is-not-a-slam-dunk-warns-u-k-prime-minister-11604950947,0.0762,-0.4257
PFE,2020-11-09,Why These Fast Food Stocks Popped Monday Morning,https://cdn.snapi.dev/images/v1/p/r/sk22-2.jpg,The Motley Fool,Pfizer's vaccine data was welcome news for many restaurant stocks.,https://www.fool.com/investing/2020/11/09/why-these-fast-food-stocks-popped-monday-morning/,0.0,0.4588
PFE,2020-11-09,"Pfizer's promising COVID-19 vaccine trials is good news for Moderna's tests, Fauci says",https://cdn.snapi.dev/images/v1/k/n/200512-moderna-768x504.jpg,GeekWire,"Pharmaceutical giant Pfizer on Monday announced promising results from its COVID-19 vaccine trials, showing that it was more than 90% effective in preventing the disease.",https://www.geekwire.com/2020/pfizers-promising-covid-19-vaccine-trials-good-news-modernas-tests-fauci-says/,0.6808,0.7152
PFE,2020-11-09,Pfizer Vaccine News Pumps Up Oil Prices,https://cdn.snapi.dev/images/v1/v/1/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998682fstock-market-arrow-rising-above-a-stack-of-oil-barrelsjpgw700opresize.jpg,The Motley Fool,"Demand for oil could rise, and OPEC says it can meet the demand.",https://www.fool.com/investing/2020/11/09/pfizer-vaccine-news-pumps-up-oil-prices/,0.0,-0.25
PFE,2020-11-09,U.S. health officials 'very optimistic' Pfizer coronavirus vaccine and others 'could effectively end the pandemic',https://cdn.snapi.dev/images/v1/g/p/106588987-15929301292020-06-23t162754z-374314806-rc24fh98j533-rtrmadp-0-health-coronavirus-usa-congress.jpeg,CNBC,A senior administration official said Monday that U.S. health officials are “extremely encouraged” by the announcement that Pfizer's coronavirus vaccine is highly effective in preventing Covid-19.,https://www.cnbc.com/2020/11/09/pfizer-coronavirus-vaccine-us-officials-optimistic-pandemic-could-end.html,0.6697,0.4641
PFE,2020-11-09,How Pfizer's COVID-19 vaccine works: mRNA,https://cdn.snapi.dev/images/v1/d/i/p-1-90573488-mrna-vaccines.jpg,Fast Company,"The vaccine uses a new, innovative form of biotechnology to make the body produce antibodies to protect itself against the virus. In January, as cases of the new, mysterious coronavirus were growing in China—but two months before the World Health Organization declared the disease a pandemic—a handful of small biotech companies began scrambling to develop vaccines using an as-yet-unproven technology platform that relies on something called messenger RNA, usually shortened to mRNA.",https://www.fastcompany.com/90573488/how-pfizers-covid-19-vaccine-works-mrna,0.0,0.7351
PFE,2020-11-09,Pfizer CEO wants to be ‘among the first' to take COVID-19 vaccine,https://cdn.snapi.dev/images/v1/g/c/pfizer-ceo-covid-vaccinejpgquality90stripall.jpg,New York Post,"Pfizer will likely have millions of coronavirus vaccine doses ready by the end of 2020 — and the company's CEO is willing to be one of the first to take it. The Manhattan-based drugmaker expects to churn out up to 50 million doses of the shot globally this year and is in “a very, very.",https://nypost.com/2020/11/09/pfizer-covid-19-vaccine-nearly-50m-doses-will-be-ready-in-2020/,0.0,0.3612
PFE,2020-11-09,"Dow Jones Rockets 1,300 Points on Pfizer Vaccine News; Boeing Stock Soars; McDonald's Stock Drops Despite Earnings Beat",https://cdn.snapi.dev/images/v1/s/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5867412fgettyimages-1138898580jpgw700opresize.jpg,The Motley Fool,"An effective vaccine could start rolling out this year, marking the beginning of the end of the pandemic.",https://www.fool.com/investing/2020/11/09/dow-jones-rockets-1300-points-on-pfizer-vaccine-ne/,0.0,0.4767
PFE,2020-11-09,Pfizer COVID-19 vaccine news delivers hope around the globe,https://cdn.snapi.dev/images/v1/h/u/m02d20201109t2i1540583537w940fhfwllplsqrlynxmpega81mt.jpg,Reuters,"News that Pfizer Inc's experimental COVID-19 vaccine is more than 90% effective based on initial trial results renewed hope on Monday among world leaders, scientists and global investors that the battle against a pandemic that has killed over a million people could be won.",https://www.reuters.com/article/us-health-coronavirus-vaccine-highlights/pfizer-covid-19-vaccine-news-delivers-hope-around-the-globe-idUSKBN27P2MO,0.4404,0.4336
PFE,2020-11-09,PreMarket Prep Stock Of The Day: Pfizer,https://cdn.snapi.dev/images/v1/o/u/microscope-3184432-1920-109.jpg,Benzinga,"Benzinga's PreMarket Prep airs every morning from 8-9 a.m. ET. During that fast-paced, highly informative hour, traders and investors tune in to get the major news of the day, the catalysts behind those moves and the corresponding price action for the upcoming session.",https://www.benzinga.com/news/20/11/18280051/premarket-prep-stock-of-the-day-pfizer,0.0,0.0
PFE,2020-11-09,Why Casual-Dining Stocks Are Soaring Today,https://cdn.snapi.dev/images/v1/0/k/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998632fcasual-dining-restaurantjpgw700opresize.jpg,The Motley Fool,News that Pfizer has an effective vaccine sent the sector surging.,https://www.fool.com/investing/2020/11/09/why-casual-dining-stocks-are-soaring-today/,0.0,0.4767
PFE,2020-11-09,Trump Allies Are Rushing To Falsely Claim Government Credit For Pfizer Vaccine Success,https://cdn.snapi.dev/images/v1/w/0/trump-allies-are-rushing-to-falsely-claim-government-credit-for-pfizer-vaccine-success.jpg,Forbes,"Trump's Operation Warp Speed didn't fund the Pfizer drug, though the government did agree to buy the vaccine.",https://www.forbes.com/sites/roberthart/2020/11/09/trump-allies-are-rushing-to-falsely-claim-government-credit-for-pfizer-vaccine-success/,0.743,0.3612
PFE,2020-11-09,"Options Traders Swarm PFE, BNTX After Vaccine News",https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5820542fscientists-looking-through-microscopesjpgw700opresize.jpg,Schaeffers Research,"This morning, we covered two pharmaceutical stocks that exploded after announcing some more-than-optimistic coronavirus vaccine news.",https://www.schaeffersresearch.com/content/options/2020/11/09/options-traders-swarm-pfe-bntx-after-vaccine-news,0.0,0.0
PFE,2020-11-09,Pfizer CEO: Our vaccine timing had nothing to do with politics,https://cdn.snapi.dev/images/v1/4/t/201109095425-pfizer-covid-19-vaccine-clinical-trial-0909-restricted-super-169.jpg,CNN Business,Pfizer's encouraging news about the effectiveness of its Covid-19 vaccine came nearly a week after Election Day. But Pfizer CEO Albert Bourla says the timing had nothing to do with politics.,https://www.cnn.com/2020/11/09/business/pfizer-covid-vaccine/index.html,0.0,0.5267
PFE,2020-11-09,Pfizer Analyst: Coronavirus Vaccine Moving Closer To Emergency Use Authorization,https://cdn.snapi.dev/images/v1/w/6/medicine-5103043-1920-24.jpg,Benzinga,"Although the details of interim data from the Phase 3 trials of Pfizer Inc's (NYSE: PFE) COVID-19 vaccine study rea unclear, the results represent “a solid win” for the company, according to BofA Securities. The Pfizer Analyst: Geoff Meacham maintained a Neutral rating on Pfizer with an unchanged $39 price target.",https://www.benzinga.com/analyst-ratings/analyst-color/20/11/18275529/pfizer-analyst-coronavirus-vaccine-moving-closer-to-emergency-use-authorization,-0.3818,0.2023
PFE,2020-11-09,Pfizer Vaccine Prevents 90% of Infections in Large Study,https://cdn.snapi.dev/images/v1/0/8/pfizer-vaccine-prevents-90-of-infections-in-large-study.jpg,Bloomberg Markets and Finance,Nov.09 -- The Covid-19 vaccine under development by Pfizer Inc. and BioNTech SE prevented more than 90% of infections in a trial involving tens of thousands of volunteers. Bloomberg Intelligence's Sam Fazeli has the details on “Bloomberg Surveillance.,https://www.youtube.com/watch?v=41Yx96DOwrM,0.0772,0.0258
PFE,2020-11-09,Walter Isaacson on being a Pfizer vaccine trial participant,https://cdn.snapi.dev/images/v1/k/o/walter-isaacson-on-being-a-pfizer-vaccine-trial-participant.jpg,CNBC Television,"CNBC contributor Walter Isaacson and Dr. Purvi Parikh of NYU Langone join ""Squawk Alley"" to discuss Pfizer's developments on a coronavirus vaccine.",https://www.youtube.com/watch?v=x5WhwHuyJYg,0.0,0.296
PFE,2020-11-09,Potential approval of Pfizer vaccine still several weeks away: U.S. official,https://cdn.snapi.dev/images/v1/y/o/m02d20201109t2i1540567184w940fhfwllplsqrlynxmpega81f5.jpg,Reuters,U.S. Health and Human Services Secretary Alex Azar said on Monday it would take several weeks for U.S. regulators to receive and then process data on Pfizer Inc's vaccine for the coronavirus before the government could potentially approve it.,https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-az/potential-approval-of-pfizer-vaccine-still-several-weeks-away-u-s-official-idUSKBN27P2CF,0.4767,0.0
PFE,2020-11-09,Is the Stock Market Getting Ahead of Itself on COVID-19 Vaccine News?,https://cdn.snapi.dev/images/v1/o/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998782fcovid-19-vaccine-gettyjpgw700opresize.jpg,The Motley Fool,"The stock market soared Monday morning, but some wonder if it'll last.",https://www.fool.com/investing/2020/11/09/is-stock-market-ahead-of-itself-covid-19-vaccine/,0.0,0.0
PFE,2020-11-09,Pfizer Inc. (PFE) shares hit new 52-week high after positive results of Covid-19 vaccine,https://cdn.snapi.dev/images/v1/7/8/pfi1a.jpg,The Dog of Wall Street,Pfizer says its experimental coronavirus vaccine more than 90 percent effective in trials,https://thedogofwallstreet.com/bntx/pfizer-inc-pfe-shares-hit-new-52-week-high-after-positive-results-of-covid-19-vaccine,0.7003,0.4767
PFE,2020-11-09,Ivanka Trump Falsely Gives Credit To Government For Pfizer Vaccine Success,https://cdn.snapi.dev/images/v1/d/c/ivanka-trump-falsely-gives-credit-to-government-for-pfizer-vaccine-success.jpg,Forbes,"Trump praised Pfizer's partnership with Operation Warp Speed, despite the government scheme only agreeing to buy the vaccine, while it has not funded the vaccine's development.",https://www.forbes.com/sites/roberthart/2020/11/09/ivanka-trump-falsely-gives-credit-to-government-for-pfizer-vaccine-success/,0.743,0.6808
PFE,2020-11-09,Israel asks for U.S. help in getting potential Pfizer COVID-19 vaccine,https://cdn.snapi.dev/images/v1/q/a/m02d20201109t2i1540565445w940fhfwllplsqrlynxmpega81et.jpg,Reuters,Israel said it asked the U.S. government on Monday to help it get access to Pfizer's potential COVID-19 vaccine.,https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-is/israel-asks-for-u-s-help-in-getting-potential-pfizer-covid-19-vaccine-idUSKBN27P2C0,0.4019,0.4019
PFE,2020-11-09,"Zoom, Peloton, Netflix: Stay-At-Home Stocks Are Getting Smoked By Pfizer's Latest Vaccine Prospects",https://cdn.snapi.dev/images/v1/p/q/zoom-peloton-netflix-stay-at-home-stocks-are-getting-smoked-by-pfizers-latest-vaccine-prospects.jpg,Forbes,Stocks that have posted massive gains this year are among the few–and biggest–losers in Monday's rally.,https://www.forbes.com/sites/jonathanponciano/2020/11/09/zoom-peloton-netflix-stay-at-home-stocks-are-getting-smoked-by-pfizers-latest-vaccine-prospects/,0.296,0.34
PFE,2020-11-09,"Election, Pfizer vaccine give a lot more clarity: Matrix Asset Advisors CIO",https://cdn.snapi.dev/images/v1/f/i/election-pfizer-vaccine-give-a-lot-more-clarity-matrix-asset-advisors-cio.jpg,CNBC Television,"David Katz, CIO of Matrix Asset Advisors, and Tony Roth, CIO of Wilmington Trust, join ""Squawk Alley"" to discuss the markets and the coronavirus vaccine.",https://www.youtube.com/watch?v=_eJmOf0MPXw,0.6962,0.7906
PFE,2020-11-09,Restaurant Stocks Soar on Phenomenal Vaccine News,https://cdn.snapi.dev/images/v1/p/y/11abe1139b6397174ee3b87b18c83f55.png,The Motley Fool,Pfizer delivered an early holiday gift to restaurant investors Monday.,https://www.fool.com/investing/2020/11/09/restaurant-stocks-soar-on-phenomenal-vaccine-news/,0.0,0.6808
PFE,2020-11-09,"Walter Isaacson, a participant in Pfizer's Covid vaccine trial, describes what it's like",https://cdn.snapi.dev/images/v1/t/n/106717236-16010339452020-09-25t020718z-880456934-rc2e5j9xpzyt-rtrmadp-0-health-coronavirus-usa.jpeg,CNBC,"""I had zero worry"" going into the trial whether the vaccine was going to be safe, Isaacson told CNBC. But he does not know if he got the vaccine or the placebo.",https://www.cnbc.com/2020/11/09/walter-isaacson-part-of-the-pfizer-covid-vaccine-trial-describes-it.html,0.3612,0.0
PFE,2020-11-09,Coronavirus vaccine frontrunner Pfizer delivers key trial data – here's where the other vaccines stand,https://cdn.snapi.dev/images/v1/i/k/106600031-15936247142020-07-01t122821z-536695232-rc2ckh9zm6kb-rtrmadp-0-health-coronavirus-biontech-pfizer.jpeg,CNBC,A safe and effective Covid-19 vaccine is seen by investors and policymakers as a solution to get the global economy back on track.,https://www.cnbc.com/2020/11/09/coronavirus-vaccine-where-the-frontrunners-including-pfizer-stand.html,0.0,0.8074
PFE,2020-11-09,"WWE, Vail Resorts, MSG Among Soaring Sports Stocks After Pfizer Vaccine News",https://cdn.snapi.dev/images/v1/r/t/wwe-vail-resorts-msg-among-soaring-sports-stocks-after-pfizer-vaccine-news.jpg,Forbes,Global stock markets shot up Monday morning after Pfizer released early results from their promising vaccine trial. Publicly-traded sports companies were among the biggest winners.,https://www.forbes.com/sites/kurtbadenhausen/2020/11/09/wwe-vail-resorts-msg-among-soaring-sports-stocks-after-pfizer-vaccine-news/,0.0,0.7003
PFE,2020-11-09,"Dr. Siegel breaks down Pfizer coronavirus vaccine, distribution",https://cdn.snapi.dev/images/v1/e/o/dr-siegel-breaks-down-pfizer-coronavirus-vaccine-distribution.jpg,Fox Business,Fox News medical contributor Dr. Marc Siegel provides insight into Pfizer's coronavirus vaccine and vaccine distribution. Subscribe to Fox Business!,https://www.youtube.com/watch?v=UXkEHliT7X8,0.0,0.0
PFE,2020-11-09,Cramer on how investors should handle stay-at-home stock slump on Pfizer vaccine news,https://cdn.snapi.dev/images/v1/x/q/cramer-on-how-investors-should-handle-stay-at-home-stock-slump-on-pfizer-vaccine-news.jpg,CNBC Television,"Dow futures surged on the news that data from the coronavirus vaccine trial out of Pfizer and German biotech firm BioNTech shows the vaccine is more than 90% effective in preventing Covid-19 among those without evidence of prior infection. CNBC's Jim Cramer, Carl Quintanilla and David Faber discuss what this means for technology stocks that have risen during the pandemic.",https://www.youtube.com/watch?v=NQTrKyKiDwA,0.0,0.5046
PFE,2020-11-09,Homology Medicines News: 9 Things for FIXX Stock Investors to Know About the Pfizer Deal,https://cdn.snapi.dev/images/v1/o/r/biotech17.jpg,InvestorPlace,"Homology Medicines (FIXX) is making news on Monday after announcing a massive $60 million investment deal with Pfizer (PFE) The post Homology Medicines News: 9 Things for FIXX Stock Investors to Know About the Pfizer Deal appeared first on InvestorPlace. More From InvestorPlace Why Everyone Is Investing in 5G All WRONG Top Stock Picker Reveals His Next 1,000% Winner Radical New Battery Could Dismantle Oil Markets Revolutionary Tech Behind 5G Rollout Is Being Pioneered By This 1 Company Daily Picks: Stocks to Buy Ahead of the Election",https://investorplace.com/2020/11/homology-medicines-pfizer-news/,0.0,0.1943
PFE,2020-11-09,"Coronavirus: Pfizer, Biontech say COVID-19 vaccine is 90% effective",https://cdn.snapi.dev/images/v1/w/o/coronavirus-pfizer-biontech-say-covid-19-vaccine-is-90-effective.jpg,Yahoo Finance,"Yahoo Finance medical contributor Dr. Dara Kass breaks down the latest news on vaccine development and the spread of coronavirus. #coronavirus #COVID19 #coronavirusvaccine For 2020 election results please visit: Election results: https://www.yahoo.com/elections Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb About Yahoo Finance: At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.",https://www.youtube.com/watch?v=WcIelYWAHEg,0.4767,0.8074
PFE,2020-11-09,"Irrational Exuberance? Stocks Surging, Markets At All-Time Highs On Pfizer's COVID-19 Vaccine News",https://cdn.snapi.dev/images/v1/u/z/businessman-2365538-1920-3.jpg,Benzinga,"The S&P 500 skyrocketed 3.2% on Monday morning following news from Pfizer Inc. (NYSE: PFE) that its coronavirus vaccine candidate is more than 90% effective. While the news triggered a broad market rally, stocks that have been hit hardest during the pandemic were some of the market's biggest movers.",https://www.benzinga.com/analyst-ratings/analyst-color/20/11/18274798/irrational-exuberance-stocks-surging-markets-at-all-time-highs-on-pfizers-covid-19-,-0.34,0.5209
PFE,2020-11-09,Why BioNTech Stock Is Skyrocketing Today After Gaining 23% Last Month,https://cdn.snapi.dev/images/v1/v/g/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998182fbntx-stock-biontech-stock-why-bntx-stock-up-today-monday-covid-vaccinejpgw700opresize.jpg,The Motley Fool,"On Monday, the German biotech and its partner Pfizer announced that initial data shows their COVID-19 vaccine candidate is more than 90% effective.",https://www.fool.com/investing/2020/11/09/why-biontech-stock-is-skyrocketing-today-after-gai/,0.4215,0.5209
PFE,2020-11-09,Why Pfizer and BioNTech Stocks Are Soaring Today,https://cdn.snapi.dev/images/v1/m/e/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998292fscientist-holding-covid-vaccine-with-thumbs-upjpgw700opresize.jpg,The Motley Fool,The two companies reported great news for COVID-19 vaccine candidate BNT162b2.,https://www.fool.com/investing/2020/11/09/why-pfizer-and-biontech-stocks-are-soaring-today/,0.0,0.6249
PFE,2020-11-09,Stocks Surge Worldwide To New All-Time Highs After Pfizer Says Covid-19 Vaccine Candidate 90% Effective,https://cdn.snapi.dev/images/v1/w/4/stocks-surge-worldwide-to-new-all-time-highs-after-pfizer-says-covid-19-vaccine-candidate-90-effective.jpg,Forbes,Industries hardest hit by the pandemic are among those rallying the most on Monday morning.,https://www.forbes.com/sites/jonathanponciano/2020/11/09/stocks-surge-worldwide-to-new-all-time-highs-after-pfizer-says-covid-19-vaccine-candidate-90-effective/,0.4767,0.0
PFE,2020-11-09,"Trump Applauds Pfizer Vaccine News, While Biden Expresses Cautious Optimism",https://cdn.snapi.dev/images/v1/2/u/trump-applauds-pfizer-vaccine-news-while-biden-expresses-cautious-optimism.jpg,Forbes,It's a sign of the differing leadership approaches the two leaders have taken during the pandemic.,https://www.forbes.com/sites/jackbrewster/2020/11/09/trump-applauds-pfizer-vaccine-news-while-biden-expresses-cautious-optimism/,0.6705,0.0
PFE,2020-11-09,EU drug regulator says it is assessing early data from Pfizer COVID vaccine,https://cdn.snapi.dev/images/v1/a/w/m02d20201109t2i1540543723w940fhfwllplsqrlynxmpega8133.jpg,Reuters,The European Union drug regulator said on Monday it had not yet received results from large-scale trials on the COVID vaccines being developed by Pfizer and BioNTech and that it was currently assessing earlier data on the quality of the shot.,https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-em/eu-drug-regulator-says-it-is-assessing-early-data-from-pfizer-covid-vaccine-idUSKBN27P1X5,0.0,0.0
PFE,2020-11-09,Efficacy in Pfizer and BioNTech COVID-19 Study Rocks the Market,https://cdn.snapi.dev/images/v1/e/j/biotech13.jpg,24/7 Wall Street,Shares of both Pfizer Inc. (NYSE: PFE) and BioNTech S.E.,https://247wallst.com/healthcare-business/2020/11/09/efficacy-in-pfizer-and-biontech-covid-19-study-rocks-the-market/,0.0,0.296
PFE,2020-11-09,"Zoom Video Stock Plunges On Pfizer Vaccine News, Possible Business Travel Rebound",https://cdn.snapi.dev/images/v1/x/i/drugs31.jpg,Investors Business Daily,Zoom Video stock plunged on Monday amid positive coronavirus vaccine news from Pfizer. Shares in Zoom Video had soared some 635% in 2020 as businesses told employees to work from home.,https://www.investors.com/news/technology/zoom-video-stock-plunges-vaccine-news-pfizer/,0.0,0.7003
PFE,2020-11-09,Walter Isaacson on being part of the Pfizer coronavirus vaccine trial,https://cdn.snapi.dev/images/v1/o/v/walter-isaacson-on-being-part-of-the-pfizer-coronavirus-vaccine-trial.jpg,CNBC Television,"U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. Walter Isaacson, Tulane professor and an advisory partner at Perella Weinberg Partners, was part of the trial and he joins ""Squawk Box"" to discuss his experience as well as the promise of the mRNA technology the vaccine utilizes.",https://www.youtube.com/watch?v=XnDmIhY25nQ,0.0,0.7693
PFE,2020-11-09,BioNTech and Pfizer say their COVID-19 vaccine candidate is 90% effective,https://cdn.snapi.dev/images/v1/t/0/biotech5---mf19apak5n.jpg,Market Watch,BioNTech and Pfizer Inc.'s COVID-19 vaccine candidate is the first to demonstrate it can protect most people from contracting symptomatic infections with the virus in a Phase 3 clinical trial — an announcement that puts the companies in the lead to bring to market the first COVID-19 vaccine in the U.S.,https://www.marketwatch.com/story/biontech-and-pfizer-say-their-covid-19-vaccine-candidate-is-90-effective-2020-11-09,0.4767,0.3818
PFE,2020-11-09,Two Drugmakers Surging After COVID-19 Vaccine Announcement,https://cdn.snapi.dev/images/v1/9/-/9-pharmaceutical-companies-racing-for-a-covid-19-vaccine---scrdkjp0pt.jpg,Schaeffers Research,Two drug makers making waves on Wall Street this morning are Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX).,https://www.schaeffersresearch.com/content/news/2020/11/09/two-drugmakers-surging-after-covid-19-vaccine-announcement,0.0,0.0
PFE,2020-11-09,"Dow soars to first intaday record in 9 months on upbeat report on coronavirus Pfizer-BioNtech candidate, Biden presidency",https://cdn.snapi.dev/images/v1/6/a/biotech6---xfpkejkeyc.jpg,Market Watch,"U.S. stock benchmarks notched record highs early Monday after a Pfizer Inc. and BioNTech coronavirus vaccine candidate showed a 90% efficacy in Phase 3 trials. The news on the experimental drug comes as Democrat Joe Biden's electoral victory, projected on Saturday, laid the groundwork for a powerful rally.",https://www.marketwatch.com/story/dow-soars-to-first-intaday-record-in-9-months-on-upbeat-report-on-coronavirus-pfizer-biontech-candidate-biden-presidency-2020-11-09,0.0,0.4215
PFE,2020-11-09,"Dr. Scott Gottlieb, a Pfizer director and ex-FDA chief, says Covid vaccine won't help immediately",https://cdn.snapi.dev/images/v1/b/g/105764883-1551291628734gettyimages-664917690.jpeg,CNBC,"""I think we need to remember that we have perhaps a brief, but very hard stretch, ahead of us"" without a widely available Covid-19 vaccine, Gottlieb told CNBC.",https://www.cnbc.com/2020/11/09/dr-scott-gottlieb-pfizer-covid-vaccine-wont-help-immediately.html,-0.3089,-0.2592
PFE,2020-11-09,Pfizer board member Scott Gottlieb: States will manage distribution of coronavirus vaccine,https://cdn.snapi.dev/images/v1/9/r/pfizer-board-member-scott-gottlieb-states-will-manage-distribution-of-coronavirus-vaccine.jpg,CNBC Television,"U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins ""Squawk Box"" to discuss.",https://www.youtube.com/watch?v=IX9b7FUPxBw,0.0,0.5046
PFE,2020-11-09,EU about to sign supply deal for Pfizer COVID vaccine: lawmaker,https://cdn.snapi.dev/images/v1/4/v/m02d20201109t2i1540540985w940fhfwllplsqrlynxmpega811u.jpg,Reuters,"The European Union is about to sign a contract for millions of doses of the COVID-19 vaccine being developed by Pfizer and BioNTech , a prominent EU lawmaker said on Monday.",https://www.reuters.com/article/us-health-coronavirus-vaccine-pfizer-eu/eu-about-to-sign-supply-deal-for-pfizer-covid-vaccine-lawmaker-idUSKBN27P1VQ,0.0,0.3182
PFE,2020-11-09,Why BET founder says the Pfizer vaccine is particularly great for Black Americans,https://cdn.snapi.dev/images/v1/z/j/why-bet-founder-says-the-pfizer-vaccine-is-particularly-great-for-black-americans.jpg,CNBC Television,"Robert Johnson, founder of RLJ Companies and BET, joins CNBC's ""Squawk Box"" to discuss the impact of Pfizer's vaccine trial showing over 90% effectiveness and what it means for the U.S. economy.",https://www.youtube.com/watch?v=3ZFfBXLufKY,0.659,0.0
PFE,2020-11-09,Vaccine News: Pfizer Stock Soars 15% on Coronavirus Trial Results,https://cdn.snapi.dev/images/v1/5/e/m02d20201027t2i1538994505w940fhfwllplsqrlynxmpeg9q1fx.jpg,InvestorPlace,"Pfizer stock is rallying higher Monday on coronavirus vaccine results, and it's taking the rest of the stock market with it. The post Vaccine News: Pfizer Stock Soars 15% on Coronavirus Trial Results appeared first on InvestorPlace.",https://investorplace.com/2020/11/vaccine-news-pfizer-stock-soars-15-on-coronavirus-trial-results/,0.0,0.0
PFE,2020-11-09,"U.S. Futures Poised for Records on Joe Biden Victory, Positive Coronavius Vaccine News from Pfizer",https://cdn.snapi.dev/images/v1/8/m/us-futures-poised-for-records-on-joe-biden-victory-positive-coronavius-vaccine-news-from-pfizer.jpg,Cheddar,"U.S. futures were poised to open at record highs as investors react to a Biden victory in the presidential election, as well as positive coronavirus vaccine news from Pfizer and BioNTech. Chris Konstantinos, Chief Investment Strategist at RiverFront Investment Group, joined Wake Up With Cheddar for more on the markets.",https://www.youtube.com/watch?v=FKDL7ak_HrA,0.6808,0.7717
PFE,2020-11-09,Pfizer board member Scott Gottlieb: '2021 will look very different from 2020',https://cdn.snapi.dev/images/v1/b/5/pfizer-board-member-scott-gottlieb-2021-will-look-very-different-from-2020.jpg,CNBC Television,"U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins ""Squawk Box"" to discuss.",https://www.youtube.com/watch?v=lH4NiohKqho,0.0,0.5046
PFE,2020-11-09,Pfizer CEO says he wants to be among the first to take coronavirus vaccine to allay concerns,https://cdn.snapi.dev/images/v1/o/t/pfizer-ceo-says-he-wants-to-be-among-the-first-to-take-coronavirus-vaccine-to-allay-concerns.jpg,CNBC Television,"Pfizer CEO Albert Bourla said Monday that he would like to be among the first to take a coronavirus vaccine to ease public concerns about vaccine safety. But there are ethical considerations for that, Bourla said during an interview on CNBC's ""Squawk Box.",https://www.youtube.com/watch?v=-VHJiV8o63E,0.0,0.8779
PFE,2020-11-09,"Tech Stocks: Zoom, Peloton lead stay-home tech selloff after upbeat Pfizer vaccine announcement",https://cdn.snapi.dev/images/v1/1/z/im-243914width620size14780600461893765.jpg,Market Watch,Shares of technology stocks that saw big benefits from stay-at-home trends due to the pandemic are falling in premarket trading Monday given upbeat vaccine news from Pfizer Inc. and BioNTech SE.,https://www.marketwatch.com/story/zoom-peloton-lead-stay-home-tech-selloff-after-upbeat-pfizer-vaccine-announcement-11604931225,0.0,0.4939
PFE,2020-11-09,"Airline, hotel, and travel stocks poised for Monday rally on Pfizer vaccine news",https://cdn.snapi.dev/images/v1/t/d/poster-travel-stock-boost.jpg,Fast Company,"Everything's up in the air right now. Health experts have long warned us not to get too excited about vaccine trials before the full range of data can be examined, but investors in the travel industry are doing just that.",https://www.fastcompany.com/90573370/airline-hotel-and-travel-stocks-poised-for-monday-rally-on-pfizer-vaccine-news,0.25,0.0387
PFE,2020-11-09,Here are the winners and losers in Europe from the Pfizer vaccine news,https://cdn.snapi.dev/images/v1/t/x/im-257140width620size15005861664712778.jpg,Market Watch,"Here's the list of Stoxx Europe 600 components that have gained at least 20%. They are predominately in the travel sector, such as airlines and hotel operators.",https://www.marketwatch.com/story/here-are-the-winners-and-losers-in-europe-from-the-pfizer-vaccine-news-11604930298,-0.0772,0.3818
PFE,2020-11-09,Coronavirus Vaccine Candidate From Pfizer and BioNTech Leaps Over Efficacy Hurdle,https://cdn.snapi.dev/images/v1/o/1/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5998162fgettyimages-1236470093-5be3ipfjpgw700opresize.jpg,The Motley Fool,A phase 3 clinical trial found BNT162b2 more than 90% effective at preventing COVID-19 at the first interim analysis.,https://www.fool.com/investing/2020/11/09/coronavirus-vaccine-candidate-from-pfizer-and-bion/,0.0,0.5046
PFE,2020-11-09,Pfizer Stock Rockets As Coronavirus Vaccine Proves 90% Effective,https://cdn.snapi.dev/images/v1/j/o/drugs29.jpg,Investors Business Daily,Pfizer stock rocketed early Monday after the pharma giant said its coronavirus vaccine was more than 90% effective in a Phase 3 study. The post Pfizer Stock Rockets As Coronavirus Vaccine Proves 90% Effective appeared first on Investor's Business Daily.,https://www.investors.com/news/technology/coronavirus-vaccine-succeeds-phase-3-test-pfizer-stock-rockets/,0.4767,0.7553
PFE,2020-11-09,"Biden And Trump React To Pfizer's Vaccine Update, Stock Market Rally: 'Great News!'",https://cdn.snapi.dev/images/v1/p/y/the-white-house-1623005-1920-4.jpg,Benzinga,Pifzer Inc (NYSE: PFE) and partner BioTech SE (NASDAQ: BNTX) reported interim analysis of a Phase 3 study on coronavirus candidate BNT 162b2. The trial showed a 90% efficacy rate at the seven-day mark after a second dose of the vaccine was applied.,https://www.benzinga.com/news/20/11/18272147/biden-and-trump-react-to-pfizers-vaccine-update-stock-market-rally-great-news,0.6588,0.0
PFE,2020-11-09,Factbox: Development of Pfizer-BioNTech coronavirus vaccine,https://cdn.snapi.dev/images/v1/v/h/m02d20201109t2i1540533856w940fhfwllplsqrlynxmpega80yo.jpg,Reuters,U.S. drugmaker Pfizer and German partner BioNTech on Monday became the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine.,https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-fa/factbox-development-of-pfizer-biontech-coronavirus-vaccine-idUSKBN27P1QX,0.0,0.5859
PFE,2020-11-09,"Bond Report: 10-year Treasury yield pops above 0.90% on positive BioNTech, Pfizer vaccine news",https://cdn.snapi.dev/images/v1/7/o/biotech21---otnj8hkde0.jpg,Market Watch,U.S. Treasury yields surge higher early Monday after BioNTech and Pfizer said their COVID-19 vaccine candidate was 90% effective.,https://www.marketwatch.com/story/10-year-treasury-yield-pops-above-0-90-on-positive-biontech-pfizer-vaccine-news-11604929625,0.6597,0.5994
PFE,2020-11-09,American Express leads financial-sector rally in wake of Pfizer news,https://cdn.snapi.dev/images/v1/u/9/bank2.jpg,Market Watch,American Express leads financial-sector rally in wake of Pfizer news,https://www.marketwatch.com/story/financial-stocks-soar-led-by-american-express-after-upbeat-news-on-potential-covid-19-vaccine-2020-11-09,0.0,0.0
PFE,2020-11-09,Pfizer/BioNTech COVID-19 vaccine is effective in more than 90% of cases,https://cdn.snapi.dev/images/v1/l/o/104685035-m-740x416.jpg,Invezz,"In a statement on Monday, Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) said that their jointly developed COVID-19 vaccine is effective in more than 90% of the patients. The two drug manufacturers are the first ones to publish successful trial data, taking the world a step closer to winning the battle against the Coronavirus pandemic that has so far infected more than 50 million people worldwide and caused over 1.2 million deaths.",https://invezz.com/news/2020/11/09/pfizer-biontech-covid-19-vaccine-is-effective-in-more-than-90-of-cases/,0.4767,0.6395
PFE,2020-11-09,Pfizer CEO on manufacturing and distributing Covid-19 vaccine,https://cdn.snapi.dev/images/v1/m/g/pfizer-ceo-on-manufacturing-and-distributing-covid-19-vaccine.jpg,CNBC Television,"U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. Pfizer CEO Albert Bourla explains the company's plan to roll out the vaccine to meet the high demand.",https://www.youtube.com/watch?v=V2cntEzIAf0,0.0,0.4144
PFE,2020-11-09,Pfizer CEO says he would take coronavirus vaccine first to ease public concern,https://cdn.snapi.dev/images/v1/h/j/106787444-16049259982020-10-30t210259z-392434681-rc29tj9cenfb-rtrmadp-0-health-coronavirus-vaccine.jpeg,CNBC,Pfizer CEO Albert Bourla said Monday that he would like to be among the first to take a coronavirus vaccine to ease public concerns about vaccine safety.,https://www.cnbc.com/2020/11/09/coronavirus-vaccine-pfizer-ceo-says-he-would-take-it-first-to-ease-public-concern.html,0.3612,0.7783
PFE,2020-11-09,Pfizer CEO on formulating Covid-19 vaccine for younger and older populations,https://cdn.snapi.dev/images/v1/x/b/pfizer-ceo-on-formulating-covid-19-vaccine-for-younger-and-older-populations.jpg,CNBC Television,"U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. Pfizer CEO Albert Bourla joins ""Squawk Box"" to discuss.",https://www.youtube.com/watch?v=2gia2yGcSnk,0.0,0.5046
PFE,2020-11-09,"Biden welcomes Pfizer coronavirus vaccine news, says safety measures still needed",https://cdn.snapi.dev/images/v1/g/b/m02d20201109t2i1540529367w940fhfwllplsqrlynxmpega80x1.jpg,Reuters,"U.S. president-elect Joe Biden greeted Pfizer Inc's experimental COVID-19 vaccine as excellent news on Monday, but warned that widespread vaccination remains months away and Americans need to continue wearing masks and maintain social distancing.",https://www.reuters.com/article/us-health-coronavirus-vaccine-biden/biden-welcomes-pfizer-coronavirus-vaccine-news-says-safety-measures-still-needed-idUSKBN27P1OX,0.6705,0.0644
PFE,2020-11-09,Pfizer vaccine news is exactly what investors were craving,https://cdn.snapi.dev/images/v1/8/p/201109080717-pfizer-covid-19-vaccine-trial-restricted-super-169.jpg,CNN Business,"Markets spent weeks obsessing over the outcome of the US election. Now that it's clear Joe Biden will be the next president, Wall Street is moving on.",https://www.cnn.com/2020/11/09/investing/premarket-stocks-trading/index.html,0.0,0.0516
PFE,2020-11-09,UK says expects to receive 10 million doses of Pfizer/BioNTech vaccine this year,https://cdn.snapi.dev/images/v1/i/g/m02d20201109t2i1540528724w940fhfwllplsqrlynxmpega80ww.jpg,Reuters,"Britain expects to have 10 million doses of Pfizer/BioNTech's candidate COVID-19 vaccine available by the end of the year if regulators approve it, Prime Minister Boris Johnson's spokesman said on Monday, following positive clinical trial results.",https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-br/uk-says-expects-to-receive-10-million-doses-of-pfizer-biontech-vaccine-this-year-idUSKBN27P1OR,0.0,0.5574
PFE,2020-11-09,German health minister encouraged by Pfizer COVID-19 vaccine data,https://cdn.snapi.dev/images/v1/l/l/m02d20201109t2i1540528419w940fhfwllplsqrlynxmpega80vg.jpg,Reuters,"Data from Pfizer and its partner BioNTech on their experimental COVID-19 vaccine are encouraging, Germany's health minister said on Monday.",https://www.reuters.com/article/us-health-coronavirus-germany-spahn/german-health-minister-encouraged-by-pfizer-covid-19-vaccine-data-idUSKBN27P1LB,0.3612,0.5267
PFE,2020-11-09,"Behind Pfizer's vaccine, an understated husband-and-wife 'dream team'",https://cdn.snapi.dev/images/v1/9/a/m02d20201109t2i1540528152w940fhfwllplsqrlynxmpega80wq.jpg,Reuters,"Positive data on BioNTech and U.S. partner Pfizer Inc's COVID-19 vaccine is an unlikely success for the married couple behind the German biotech firm, who have devoted their lives to harnessing the immune system against cancer.Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study.",https://www.reuters.com/article/us-health-coronavirus-biontech-ceo-newsm/behind-pfizers-vaccine-an-understated-husband-and-wife-dream-team-idUSKBN27P1ON,0.25,0.9378
PFE,2020-11-09,"Cruise stocks charge up more than 20% after upbeat news on Pfizer, BioNTech COVID-9 vaccine candidate",https://cdn.snapi.dev/images/v1/e/u/biotech14.jpg,Market Watch,"Shares of cruise operators soared Monday, as investors cheered news that Pfizer Inc.'s and BioNTech Inc.'s COVID-19 vaccine candidate achieved ""success"" in an interim analysis from a Phase 3 study. Carnival Corp.'s stock rocketed 29.5% in active premarket trading, Royal Caribbean Group shares soared 21.1% and Norwegian Cruise Line Holdings Ltd.",https://www.marketwatch.com/story/cruise-stocks-charge-up-more-than-20-after-upbeat-news-on-pfizer-biontech-covid-9-vaccine-candidate-2020-11-09,0.0,0.8555
PFE,2020-11-09,Pfizer CEO on Covid vaccine efficacy: 'It is a great day for humanity',https://cdn.snapi.dev/images/v1/u/x/pfizer-ceo-on-covid-vaccine-efficacy-it-is-a-great-day-for-humanity.jpg,CNBC Television,"U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. ""It is a great day for science,"" Pfizer CEO Albert Bourla told CNBC's ""Squawk Box"" Monday morning.",https://www.youtube.com/watch?v=3yRsIL7s5eU,0.6249,0.8107
PFE,2020-11-09,"Dow futures soar 1,200 points after Pfizer says its Covid-19 vaccine is 90% effective",https://cdn.snapi.dev/images/v1/b/y/201109120517-02-covid-19-vaccine-trial-florida-file-super-169.jpg,CNN Business,US stock futures surged Monday morning after Pfizer said its Covid-19 vaccine is 90% effective.,https://www.cnn.com/2020/11/09/investing/dow-stock-market-today/index.html,0.4767,0.4767
PFE,2020-11-09,"Pfizer Says Covid-19 Vaccine Is 90% Effective, Although Trials Are Ongoing",https://cdn.snapi.dev/images/v1/j/n/pfizer-says-covid-19-vaccine-is-90-effective-although-trials-are-ongoing.jpg,Forbes,Early analysis of trial data suggests the vaccine Pfizer is producing with BioNTech could be 90% effective at preventing Covid-19 infection.,https://www.forbes.com/sites/roberthart/2020/11/09/pfizer-says-covid-19-vaccine-is-90-effective-although-trials-are-ongoing/,0.4767,0.4588
PFE,2020-11-09,"Cinema stock AMC soars 59% premarket, Live Nation up 14% as Pfizer vaccine news sparks rally in event stocks",https://cdn.snapi.dev/images/v1/x/y/entertainment-diversified6---zm014lleyu.jpg,Market Watch,"AMC Entertainment Holdings Inc.'s beaten-down shares soared a staggering 59% in premarket trade Monday, after Pfizer Inc. and BioNTech SE said their COVID-19 vaccine candidatewas found to be more than 90% effectiive in preventing the virus in trial participants without previous evidence of SARS-CoV-2 infection. The companies said they are planning to submit for Emergency Use Authorization (EUA) to the Food and Drug Administration soon after the safety milestones are met, which is currently expected in the third week of November.",https://www.marketwatch.com/story/cinema-stock-amc-soars-59-premarket-live-nation-up-14-as-pfizer-vaccine-news-sparks-rally-in-event-stocks-2020-11-09,0.0,0.6249
PFE,2020-11-09,Pfizer CEO calls Covid vaccine a 'great day for humanity' and a 'light at the end of the tunnel',https://cdn.snapi.dev/images/v1/n/y/106635982-1595948992117-gettyimages-1132313750-wm2-7799-20190226114402859.jpeg,CNBC,"""I think we can see light at the end of the tunnel"" on the pandemic, Pfizer's Albert Bourla told CNBC on Monday.",https://www.cnbc.com/2020/11/09/pfizer-ceo-albert-bourla-covid-vaccine-a-light-at-the-end-of-the-tunnel.html,0.6249,0.0
PFE,2020-11-09,"Trump celebrates Pfizer announcing a successful COVID-19 vaccine, days after he lost the US election",https://cdn.snapi.dev/images/v1/5/6/56848336-s-740x416-2.jpg,Business Insider,"President Donald Trump celebrated Pfizer announcing a successful COVID-19 vaccine, news which broke on the first business day after he lost the US presidential election. Trump tweeted on Monday morning: ""STOCK MARKET UP BIG, VACCINE COMING SOON. REPORT 90% EFFECTIVE. SUCH GREAT NEWS!""",https://www.businessinsider.com/trump-celebrates-pfizer-covid-19-vaccine-announcement-2020-11,0.7351,0.924
PFE,2020-11-09,"Pfizer's COVID-19 vaccine is more than 90 percent effective, company says",https://cdn.snapi.dev/images/v1/u/e/pfizer-63jpgquality90stripall.jpg,New York Post,"The coronavirus vaccine developed by Pfizer and BioNTech is more than 90 percent effective, the companies said Monday in a major milestone for the fight against the deadly global pandemic. The Manhattan-based drugmaker and the German biotech firm became the first pharmaceutical outfits to reveal successful data from a large, late-stage study of a COVID-19.",https://nypost.com/2020/11/09/pfizers-covid-19-vaccine-is-more-than-90-percent-effective-company/,0.4767,0.6486
PFE,2020-11-09,"European banks, airlines surge after Pfizer COVID-19 vaccine news",https://cdn.snapi.dev/images/v1/p/s/m02d20201109t2i1540522210w940fhfwllplsqrlynxmpega80um.jpg,Reuters,"Shares in European banks and in the travel and leisure industries surged about 10% on Monday after Pfizer announced that its experimental COVID-19 vaccine was more than 90% effective, which prompted a major rally across the continent's bourses.",https://www.reuters.com/article/us-health-coronavirus-vaccines-pfizer-st/european-banks-airlines-surge-after-pfizer-covid-19-vaccine-news-idUSKBN27P1JT,0.0,0.6771
PFE,2020-11-09,Cramer reacts to Dow futures soaring on news Pfizer vaccine is 90% effective,https://cdn.snapi.dev/images/v1/2/w/cramer-reacts-to-dow-futures-soaring-on-news-pfizer-vaccine-is-90-effective.jpg,CNBC Television,Stock futures surged after Pfizer and BioNTech said trial data indicated their Covid-19 vaccine is 90% effective in preventing Covid-19 among those without evidence of prior infection. CNBC's Jim Cramer discusses what this means for the markets.,https://www.youtube.com/watch?v=0iJ0BsXjwSQ,0.4767,0.4588
PFE,2020-11-09,"Treasury yields jump, gold suffers, tech stocks lag after Pfizer COVID-19 trial news",https://cdn.snapi.dev/images/v1/o/8/drugs23.jpg,Market Watch,"A Phase 3 trial showing the COVID-19 vaccine being developed by Pfizer and BioNTech was more than 90% effective hit several asset classes, as well as boosting stock futures . The yield on the 10-year Treasury jumped 9 basis points to 0.91%, and gold futures sunk $33 an ounce.",https://www.marketwatch.com/story/treasury-yields-jump-gold-suffers-tech-stocks-lag-after-pfizer-covid-19-trial-news-2020-11-09,-0.5719,0.8797
PFE,2020-11-09,"Dow futures surge 1,500 points on Pfizer's COVID-19 vaccine news",https://cdn.snapi.dev/images/v1/h/q/drugs24.jpg,Fox Business,Stock futures resumed their march higher on Monday on Pfizer's vaccine news and a Biden-Harris win.,https://www.foxbusiness.com/markets/us-stocks-november-9-2020,0.0,0.5859
PFE,2020-11-09,"Instant View: Global stocks soar on Pfizer, Biontech vaccine news",https://cdn.snapi.dev/images/v1/q/g/m02d20201109t2i1540520604w940fhfwllplsqrlynxmpega80tr.jpg,Reuters,"Global stocks surged to record highs after Pfizer on Monday said its experimental vaccine was more than 90% effective in preventing COVID-19, based on initial data from a large study.",https://www.reuters.com/article/us-health-coronavirus-global-markets/instant-view-global-stocks-soar-on-pfizer-biontech-vaccine-news-idUSKBN27P1IF,0.0,0.5046
PFE,2020-11-09,"Market Snapshot: Dow futures soar 1,500 points after Pfizer, BioNTech say coronavirus vaccine candidate 90% effective",https://cdn.snapi.dev/images/v1/m/g/im-257119width620size15005861664712778.jpg,Market Watch,"U.S. stock-index futures on Monday were soaring after Germany-based BioNTech SE and Pfizer Inc. said their COVID-19 vaccine candidate achieved ""success"" in the first interim analysis of from a Phase 3 study.",https://www.marketwatch.com/story/dow-futures-soar-1-500-points-after-pfizer-biontech-say-coronavirus-vaccine-candidate-90-effective-11604924582,0.4767,0.0
PFE,2020-11-09,Pfizer leaps 13% on news that its COVID-19 vaccine is over 90% effective in preventing illness,https://cdn.snapi.dev/images/v1/p/f/pfizer-leaps-13-on-news-that-its-covid-19-vaccine-is-over-90-effective-in-preventing-illness.jpg,Business Insider,"Pfizer leapt 13% in pre-market trading on Monday after the drugmaker announced that its experimental COVID-19 vaccine succeeded in late-stage trials. The US pharma firm said its vaccine, developed with German biotech partner BioNTech, is over 90% effective in preventing COVID-19 infection.",https://www.businessinsider.com/pfizer-stock-price-biontech-successful-covid-19-vaccine-emergency-approval-2020-11,0.0772,0.7003
PFE,2020-11-09,"Pfizer, BioNTech announce Covid-19 vaccine candidate is 90% effective",https://cdn.snapi.dev/images/v1/s/8/pfizer-biontech-announce-covid-19-vaccine-candidate-is-90-effective.jpg,CNBC Television,"U.S pharmaceutical giant Pfizer and German biotech firm BioNTech said their coronavirus vaccine was more than 90% effective in preventing Covid-19 among those without evidence of prior infection, according to data published Monday from their late-stage vaccine trial. CNBC's Meg Tirrell reports.",https://www.youtube.com/watch?v=mMrJSllDoPc,0.4767,0.5046
PFE,2020-11-09,Pfizer's COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial,https://cdn.snapi.dev/images/v1/i/q/gettyimages-1208040947jpgw600.jpg,TechCrunch,"The COVID-19 vaccine being developed by Pfizer and its partner BioNTech has shown to be effective blocking vaccine in 90 percent of participants in its Phase 3 clinical trial, the companies announced on Monday. That's based on data analyzed by an external, independent committee assigned to check the results of the trial, and reflects only […]",https://techcrunch.com/2020/11/09/pfizers-covid-19-vaccine-proves-90-effective-in-first-results-from-phase-3-clinical-trial/,0.4767,0.128
PFE,2020-11-09,COVID-19 vaccine found to be 90% effective in 'great day for science and humanity',https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5911572fgettyimages-1131003745jpgw700opresize.jpg,Skynews,"The coronavirus vaccine being developed by Pfizer and BioNTech has been found to be 90% effective in preventing people from getting the virus, it has been confirmed.",https://news.sky.com/story/coronavirus-pfizer-vaccine-found-to-be-90-effective-in-great-day-for-science-and-humanity-12128452,0.802,0.4588
PFE,2020-11-09,"BioNTech, Pfizer stocks soar after COVID-19 vaccine candidate achieves 'success' in first analysis",https://cdn.snapi.dev/images/v1/g/u/biotech8---mwxrayewnc.jpg,Market Watch,"Shares of Germany-based BioNTech SE shot up 17.9% and Pfizer Inc. jumped 8.6% in premarket trading Monday, after the company's said their COVID-19 vaccine candidate achieved ""success"" in the first interim analysis of from a Phase 3 study. The companies said BNT162b2 vaccine candidate was found to be more than 90% effective in preventing COVID-19 in trial participants without previous evidence of SARS-CoV-2 infection.",https://www.marketwatch.com/story/biontech-pfizer-stocks-soar-after-covid-19-vaccine-candidate-achieves-success-in-first-analysis-2020-11-09,0.0,0.6666
PFE,2020-11-09,"Stock futures surge, with Dow futures up 1100 points, after Pfizer vaccine news",https://cdn.snapi.dev/images/v1/h/r/drugs22.jpg,Market Watch,"U.S. stock futures extended what already were strong gains, following the news that the vaccine being developed by Pfizer and BioNTech was more than 90% effective in preventing COVID-19. Futures on the Dow Jones Industrial Average leapt 1,116 points, and those on the S&P 500 rose more than 3%.",https://www.marketwatch.com/story/stock-futures-surge-with-dow-futures-up-1100-points-after-pfizer-vaccine-news-2020-11-09,0.0,0.8387
PFE,2020-11-09,"Pfizer says its coronavirus vaccine helps prevent COVID-19, marking a milestone in the fight against the pandemic",https://cdn.snapi.dev/images/v1/p/f/pfizer-says-its-coronavirus-vaccine-helps-prevent-covid-19-marking-a-milestone-in-the-fight-against-the-pandemic.jpg,Business Insider,"A leading coronavirus vaccine candidate worked to prevent people from developing COVID-19, a milestone in society's war against the pandemic. The pharmaceutical company Pfizer said Monday that its vaccine succeeded in the final stage of clinical trials, which compared tens of thousands of volunteers who received two doses of the experimental vaccine against a group receiving a saltwater placebo.",https://www.businessinsider.com/pfizer-coronavirus-vaccine-success-plans-for-emergency-approval-fda-2020-9,0.0258,-0.25
PFE,2020-11-09,Pfizer trial: Vaccine more than 90% effective in preventing COVID-19,https://cdn.snapi.dev/images/v1/h/j/drugs21.jpg,Market Watch,Pfizer trial: Vaccine more than 90% effective in preventing COVID-19,https://www.marketwatch.com/investing/stock/PFE,0.5046,0.5046
PFE,2020-11-09,"Pfizer, BioNTech say late-stage trial data shows Covid vaccine is more than 90% effective in preventing infection",https://cdn.snapi.dev/images/v1/z/p/106599913-1593620338844ap-20183543531451.jpg,CNBC,"Albert Bourla, chairman and CEO of Pfizer, hailed the development as a ""great day for science and humanity.""",https://www.cnbc.com/2020/11/09/covid-vaccine-pfizer-drug-is-more-than-90percent-effective-in-preventing-infection.html,0.5046,0.7184
PFE,2020-11-09, Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study,https://cdn.snapi.dev/images/v1/d/7/press2---fa6niiwpg0.jpg,Business Wire,"NEW YORK & MAINZ, GERMANY--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection, based on the first interim efficacy analysis conducted on November 8, 2020 by an external, independent Data Monitoring Committee (DMC) from the Phase 3 clinical study. After discussion with the FDA, t",https://www.businesswire.com/news/home/20201109005539/en/%C2%A0Pfizer-and-BioNTech-Announce-Vaccine-Candidate-Against-COVID-19-Achieved-Success-in-First-Interim-Analysis-from-Phase-3-Study/,0.5719,0.0
PFE,2020-11-09,4 Strong Value Stocks for Savvy Investors Seeking 2021 Winners,https://cdn.snapi.dev/images/v1/q/c/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5901022fgettyimages-1170740969jpgw700opresize.jpg,InvestorPlace,"Take a look at four value stocks from sectors that have underperformed lately. In addition to valuations, these stocks have robust dividend yield.",https://investorplace.com/2020/11/4-strong-value-stocks-pfe-lmt-jpm-f-for-savvy-investors-seeking-2021-winners/,0.8316,0.5859
PFE,2020-11-09,Pfizer: SEC Foreign-Bribery Unit Has Formally Asked Company For Info,https://cdn.snapi.dev/images/v1/7/t/new-york-city-pfizer-world-headquarters-01-0.jpg,Benzinga,"Pfizer Inc. (NYSE: PFE) has disclosed in its earnings report that it received an official request for information from the US Securities and Exchange Commission, according to The Wall Street Journal. What Happened: The pharmaceutical company received formal requests regarding its operations in China and Russia from the SEC's foreign-bribery unit and the U.S. Justice Department in August and June.",https://www.benzinga.com/news/earnings/20/11/18264260/pfizer-sec-foreign-bribery-unit-has-formally-asked-company-for-info,0.0,0.6808
PFE,2020-11-09,Here's Why This Laggard in the Coronavirus Vaccine Race Could Still Win,https://cdn.snapi.dev/images/v1/v/b/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5989402fgettyimages-1210040522jpgw700opresize.jpg,The Motley Fool,The combination vaccine could save massive amounts of resources.,https://www.fool.com/investing/2020/11/08/heres-why-this-laggard-in-the-coronavirus-vaccine/,0.5859,0.4939
PFE,2020-11-09,November Is a Crucial Month for this Coronavirus Vaccine Stock,https://cdn.snapi.dev/images/v1/f/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5984402fgettyimages-1183175188jpgw700opresize.jpg,The Motley Fool,The fate of this company's late-stage trial is now in the hands of the FDA.,https://www.fool.com/investing/2020/11/08/november-is-a-crucial-month-for-this-coronvirus-va/,0.0,0.0
PFE,2020-11-09,Moderna and Pfizer: A Tale of Two mRNA Coronavirus Vaccine Stocks,https://cdn.snapi.dev/images/v1/t/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5988902fgettyimages-1210040522jpgw700opresize.jpg,The Motley Fool,These top players may reach the finish line first -- and offer the world a new kind of vaccine.,https://www.fool.com/investing/2020/11/08/moderna-and-pfizer-a-tale-of-two-mrna-coronavirus/,0.0,0.2263
PFE,2020-11-09,What Are Your Chances of Getting a Coronavirus Vaccine by Year-End?,https://cdn.snapi.dev/images/v1/p/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5981152fperson-getting-a-vaccine-shotjpgw700opresize.jpg,The Motley Fool,Hint: They're not great.,https://www.fool.com/investing/2020/11/08/what-are-chances-of-getting-a-coronavirus-vaccine-/,0.2023,-0.5096
PFE,2020-11-09,Better Coronavirus Stock: AstraZeneca vs. Pfizer,https://cdn.snapi.dev/images/v1/r/v/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5983032fcovid-vaccine-with-microscopejpgw700opresize.jpg,The Motley Fool,Both big drugmakers could have blockbuster COVID-19 vaccines on the way soon.,https://www.fool.com/investing/2020/11/07/better-coronavirus-stock-astrazeneca-vs-pfizer/,0.4404,0.5994
PFE,2020-11-06,3 Reasons Pfizer's Imminent Upjohn-Mylan Merger Is Great News for Investors,https://cdn.snapi.dev/images/v1/w/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5981132fpushing-giant-jigsaw-pieces-togetherjpgw700opresize.jpg,The Motley Fool,There really isn't a downside to this deal.,https://www.fool.com/investing/2020/11/06/3-reasons-pfizers-imminent-upjohn-mylan-merger-is/,0.6249,0.2543
PFE,2020-11-06,US Regulators Seek Information On Pfizer's China Operations,https://cdn.snapi.dev/images/v1/u/k/pfizer-finland-hq-february-13-2009.jpg,Benzinga,"Pfizer Inc (NYSE: PFE) in the SEC filing, disclosed that the U.S. stock market regulator and the Justice Department have informally sought information related to its operations in China. What Happened: The initial request for information was made in June by the U.S. Department of Justice's Foreign Corrupt Practices Act (FCPA) Unit.",https://www.benzinga.com/general/biotech/20/11/18244288/us-regulators-seek-information-on-pfizers-china-operations,0.0,0.5267
PFE,2020-11-05,U.S. government looking into Pfizer's operations in China,https://cdn.snapi.dev/images/v1/y/z/m02d20201106t2i1540189418w940fhfwllplsqrlynxmpega500i.jpg,Reuters,"Pfizer Inc received informal requests relating to its operations in China from the U.S. Department of Justice and the U.S. Securities and Exchange Commission (SEC) in June and August, respectively, its regulatory filing https://bit.ly/38geoz2 showed on Thursday.",https://www.reuters.com/article/us-pfizer-fcpa/u-s-government-looking-into-pfizers-operations-in-china-idUSKBN27M00Z,0.0,0.7906
PFE,2020-11-05,"Moderna, Novavax, Pfizer: How Are Coronavirus Vaccine Stocks Faring?",https://cdn.snapi.dev/images/v1/j/f/moderna-novavax-pfizer-how-are-coronavirus-vaccine-stocks-faring.jpg,Forbes,"Our indicative theme of Coronavirus Vaccine stocks – which includes a diverse set of U.S.-based pharma and biotech companies developing Covid vaccines – is up by about 560% year-to-date, on an equally weighted basis, compared to the S&P 500 which has gained just about 4% over the same period.",https://www.forbes.com/sites/greatspeculations/2020/11/05/moderna-novavax-pfizer-how-are-coronavirus-vaccine-stocks-faring/,0.0,0.3818
PFE,2020-11-05,"Need to Know: These 7 unloved stocks are for the long haul, says contrarian manager",https://cdn.snapi.dev/images/v1/e/t/etf28---gan7oyd3pn.jpg,Market Watch,"Our call of the day offers up several stocks that busy, distracted investors have been overlooking. Smead Capital Management's CIO says they are stocks to hold for the long run.",https://www.marketwatch.com/story/these-7-unloved-stocks-are-for-the-long-haul-says-contrarian-manager-11604579260,-0.4404,-0.34
PFE,2020-11-04,Australia signs two more COVID-19 vaccine deals,https://cdn.snapi.dev/images/v1/c/d/cdc-xlhdvfz0sum-unsplash-0.jpg,Reuters,"Australia has agreed to purchase another 50 million doses of two more COVID-19 vaccines, Prime Minister Scott Morrison said on Thursday, as Canberra aims to complete a mass inoculation programme within months.",https://www.reuters.com/article/us-health-coronavirus-australia/australia-signs-two-more-covid-19-vaccine-deals-idUSKBN27K2WI,0.0,0.2732
PFE,2020-11-04,Republican Hold On Senate Seen As Plus For Drug Companies,https://cdn.snapi.dev/images/v1/d/r/drugs30---bbzw9njnud.jpg,Investors Business Daily,"While the presidential race is undecided awaiting final results from key states, it appears Republicans could retain control of the Senate, and AbbVie stock and other biotech stocks rose. The post Republican Hold On Senate Seen As Plus For Drug Companies appeared first on Investor's Business Daily.",https://www.investors.com/news/technology/abbvie-stock-leasd-pack-biotech-stock-gains-republicans-could-retain-senate-majority/,0.0,-0.2263
PFE,2020-11-03,Ionis and Akcea announce that Pfizer has initiated a Phase 2b clinical study of vupanorsen (AKCEA-ANGPTL3-LRx),https://cdn.snapi.dev/images/v1/t/6/press6---grqyxwtjm9.jpg,PRNewsWire,"CARLSBAD, Calif. and BOSTON, Nov. 3, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) and its wholly owned subsidiary Akcea Therapeutics, Inc., today announced that Pfizer Inc. (NYSE: PFE) has initiated a Phase 2b study of vupanorsen (AKCEA-ANGPTL3-LRx) in statin-treated...",https://www.prnewswire.com/news-releases/ionis-and-akcea-announce-that-pfizer-has-initiated-a-phase-2b-clinical-study-of-vupanorsen-akcea-angptl3-lrx-301166067.html,0.0,0.0
PFE,2020-11-03,7 Top Stocks to Buy for November,https://cdn.snapi.dev/images/v1/p/o/software21.jpg,InvestorPlace,"As we near the end of 2020, it's time to safeguard your portfolio before we enter the new year. Here are the top stocks to buy in November.",https://investorplace.com/2020/11/7-top-stocks-to-buy-in-november/,0.2023,0.5267
PFE,2020-11-03,Which Biotech Stocks Are a Buy on Earnings?,https://cdn.snapi.dev/images/v1/q/n/medical19.jpg,InvestorPlace,"If you're interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip. The post Which Biotech Stocks Are a Buy on Earnings?",https://investorplace.com/2020/11/which-biotech-stocks-are-a-buy-on-earnings/,0.0,0.7351
PFE,2020-11-02,5 Industries Biden Would Destroy as President,https://cdn.snapi.dev/images/v1/s/w/swqdff---mi8uxzqxwn.jpg,InvestorPlace,"If Joe Biden wins on Election Day, election stocks in these five industries could hit bad times. Tread carefully as voters head to the polls.",https://investorplace.com/2020/11/election-stocks-sell-5-industries-threatened-biden-victory/,-0.5423,0.1779
PFE,2020-11-02,3 Biotech Stocks With Eye-Catching Pipelines,https://cdn.snapi.dev/images/v1/c/q/biotech1.jpg,InvestorPlace,"Investing in biotech stocks may feel daunting to many investors, but these three stocks deserve to be on your watchlist. The post 3 Biotech Stocks With Eye-Catching Pipelines appeared first on InvestorPlace.",https://investorplace.com/2020/11/3-biotech-stocks-with-eye-catching-pipelines/,0.0,0.0
PFE,2020-11-02,Week In Review: CStone Out-Licenses Ex-China Rights To 2 Immunotherapies In $1.3 Billion Deal,https://cdn.snapi.dev/images/v1/m/x/biotech7.jpg,Seeking Alpha,CStone Pharma out-licensed global rights (ex-China) for two immuno-oncology assets to US-based EQRx in a $1.3 billion agreement. CASI Pharma in-licensed China rights to a novel antibody checkpoint receptor inhibitor from Sweden's BioInvent in a $95 million deal.,https://seekingalpha.com/article/4383861-week-in-review-cstone-out-licenses-ex-china-rights-to-2-immunotherapies-in-1_3-billion-deal,0.0,0.7096
PFE,2020-11-02,3 Reasons Pfizer and BioNTech's Coronavirus Vaccine Might Fail Even If It Works,https://cdn.snapi.dev/images/v1/e/q/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5980812fvaccination-4jpgw700opresize.jpg,The Motley Fool,Clinical trials are tricky business.,https://www.fool.com/investing/2020/11/01/3-reasons-pfizer-and-biontechs-coronavirus-vaccine/,-0.5423,-0.1531
PFE,2020-10-30,Date Is Set for Merger Between Mylan and Pfizer's Upjohn Unit,https://cdn.snapi.dev/images/v1/s/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5978422facquisition-dealjpgw700opresize.jpg,The Motley Fool,The Federal Trade Commission has signed off on the deal.,https://www.fool.com/investing/2020/10/30/pfizer-and-mylan-set-merger-date/,0.0,0.0
PFE,2020-10-30,"Regulators are accelerating reviews of COVID-19 vaccines from Pfizer and AstraZeneca, according to a report",https://cdn.snapi.dev/images/v1/a/3/im-252333width620size15005861664712778.jpg,Market Watch,"The U.K. drug regulator is accelerating reviews of the coronavirus vaccines being developed by Pfizer and AstraZeneca, according to a report.",https://www.marketwatch.com/story/regulators-are-accelerating-reviews-of-covid-19-vaccines-from-pfizer-and-astrazeneca-according-to-a-report-11604084483,0.0,0.0
PFE,2020-10-30,Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn,https://cdn.snapi.dev/images/v1/4/0/press1---4piiqnf0mp.jpg,PRNewsWire,"HERTFORDSHIRE, England and PITTSBURGH and NEW YORK, Oct. 30, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Federal Trade Commission (the ""FTC"") accepted a proposed consent order, which concludes the FTC's review of the proposed...",https://www.prnewswire.com/news-releases/mylan-and-pfizer-receive-clearance-from-the-us-federal-trade-commission-for-proposed-combination-of-mylan-and-upjohn-301164021.html,0.0,0.4588
PFE,2020-10-30,Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn,https://cdn.snapi.dev/images/v1/j/5/press20.jpg,Business Wire,"HERTFORDSHIRE, England & PITTSBURGH & NEW YORK--(BUSINESS WIRE)--Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Federal Trade Commission (the “FTC”) accepted a proposed consent order, which concludes the FTC's review of the proposed combination of Mylan and Pfizer's Upjohn Business. The parties have now obtained all required antitrust clearances for the proposed transaction. The combination will be effected through a Reverse Morris Trust transaction, pursuant",https://www.businesswire.com/news/home/20201030005641/en/Mylan-and-Pfizer-Receive-Clearance-from-the-U.S.-Federal-Trade-Commission-for-Proposed-Combination-of-Mylan-and-Upjohn/,0.0,0.8402
PFE,2020-10-29,Vaccine expectations baked into Pfizer's stock price: Analyst,https://cdn.snapi.dev/images/v1/3/d/vaccine-expectations-baked-into-pfizers-stock-price-analyst.jpg,CNBC International TV,Vamil Divan of Mizuho Americas explains how much upside there is for Pfizer stock if the company becomes a front runner in the race for a coronavirus vaccine.,https://www.youtube.com/watch?v=NSb03kdONJI,0.0,0.0
PFE,2020-10-29,Judgement Day Approaches For COVID-19 Vaccine Names,https://cdn.snapi.dev/images/v1/f/r/drugs25.jpg,Seeking Alpha,"PFE/BNTX and MRNA remain the front-runners in the race to develop a COVID-19 vaccine. PFE has seen some delays but at least, we haven't passed an interim analysis without success.",https://seekingalpha.com/article/4382733-judgement-day-approaches-for-covidminus-19-vaccine-names,0.0,-0.612
PFE,2020-10-29,5 Best Stocks To Buy: Our Recent Dividend Stocks Purchases,https://cdn.snapi.dev/images/v1/5/r/data-internet21.jpg,Seeking Alpha,"Despite volatility, we continue to put our hard-earned cash to work. In total, we purchased 4 companies and one ETF over the last week. Three of the companies are Dividend Aristocrats, and one is an exchange-traded fund that invests in dividend growth stocks!",https://seekingalpha.com/article/4382466-5-best-stocks-to-buy-recent-dividend-stocks-purchases,0.6369,0.4389
PFE,2020-10-29,U.K. Government Expects Pfizer's Vaccine Verdict Before Christmas,https://cdn.snapi.dev/images/v1/w/n/syringe-417786-1920-6.jpg,Benzinga,"Reuters reports that senior sources in the British government expect a verdict on Pfizer Inc's (NYSE: PFE) COVID-19 vaccine results, before AstraZeneca Plc's (NASDAQ: AZN) trials, according to the Financial Times.  What Happened: Pfizer's vaccine is being developed in collaboration with German company BioNTech SE (NASDAQ: BNTX).",https://www.benzinga.com/general/biotech/20/10/18112056/u-k-government-expects-pfizers-vaccine-verdict-before-christmas,0.1531,0.1531
PFE,2020-10-29,"Got $1,000? These 2 Top Stocks Are Great Buys Right Now",https://cdn.snapi.dev/images/v1/w/p/e474f9657d2d7e1dcf6fe2d45822714c.png,The Motley Fool,These leaders in the coronavirus vaccine race have other things to offer investors.,https://www.fool.com/investing/2020/10/29/got-1000-these-2-top-stocks-are-great-buys-right-n/,0.7096,0.0
PFE,2020-10-29,Here's the Clear Leader in Developing a Coronavirus Vaccine for Kids,https://cdn.snapi.dev/images/v1/p/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5965132fboy-receiving-a-vaccinejpgw700opresize.jpg,The Motley Fool,"So far, only one late-stage study evaluating a COVID-19 vaccine candidate includes children.",https://www.fool.com/investing/2020/10/29/heres-the-clear-leader-in-developing-a-coronavirus/,0.3818,0.0
PFE,2020-10-28,Why Pfizer Stock Dropped Today,https://cdn.snapi.dev/images/v1/c/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5971602fgettyimages-1154450279jpgw700opresize.jpg,The Motley Fool,Investors are still waiting on data from Pfizer's ongoing clinical trial for its coronavirus vaccine candidate.,https://www.fool.com/investing/2020/10/28/why-pfizer-stock-dropped-today/,0.0,0.0
PFE,2020-10-27,Pfizer Vaccine Data Delayed; Fed Halts Clinical Trial,https://cdn.snapi.dev/images/v1/p/f/pfizer-covid-vaccine-457x274.jpg,PYMNTS,"Any remaining hope for an end to the coronavirus crisis within the next few months appears to be fading, with two more setbacks on the research front emerging on Tuesday (Oct. 27). Pfizer CEO Albert Bourla told investors on Tuesday that the pharma giant won't be releasing coronavirus vaccine data before the Nov. 3 election, […]",https://www.pymnts.com/coronavirus/2020/pfizer-vaccine-data-delayed-fed-halts-clinical-trial/,-0.2263,-0.296
PFE,2020-10-27,Don't Be Fazed by the Recent Market Volatility,https://cdn.snapi.dev/images/v1/g/a/drugs33.jpg,InvestorPlace,Don't be misled by worrisome headlines by the fearmongering media. The market should only get better from here.,https://investorplace.com/2020/10/why-im-not-fazed-by-the-recent-market-volatility/,0.0,0.0516
PFE,2020-10-27,Pfizer Inc. (PFE) CEO Albert Bourla on Q3 2020 Results - Earnings Call Transcript,https://cdn.snapi.dev/images/v1/u/o/transcript49.jpg,Seeking Alpha,Pfizer Inc. (PFE) CEO Albert Bourla on Q3 2020 Results - Earnings Call Transcript,https://seekingalpha.com/article/4381823-pfizer-inc-pfe-ceo-albert-bourla-on-q3-2020-results-earnings-call-transcript,0.0,0.0
PFE,2020-10-27,How Pfizer Missed an Opportunity With Its Q3 Results,https://cdn.snapi.dev/images/v1/v/s/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5967582fscientist-in-labjpgw700opresize.jpg,The Motley Fool,"The big drugmaker posted mixed third-quarter numbers. However, several key catalysts should be right around the corner.",https://www.fool.com/investing/2020/10/27/how-pfizer-missed-an-opportunity-in-q3/,0.1531,0.0
PFE,2020-10-27,Crucial Covid vaccine data expected from Pfizer this week now unlikely to come before U.S. election,https://cdn.snapi.dev/images/v1/t/a/106696363-1599690402216-gettyimages-1228428304-364547128-1-9.jpeg,CNBC,,https://www.cnbc.com/2020/10/27/crucial-covid-vaccine-data-expected-from-pfizer-this-week-now-unlikely-to-come-before-us-election.html,0.0,0.0
PFE,2020-10-27,"Pfizer CEO: may be a week between conclusive vaccine data, public notification",https://cdn.snapi.dev/images/v1/y/y/m02d20201027t2i1538994505w940fhfwllplsqrlynxmpeg9q1fx.jpg,Reuters,"Pfizer Inc's Chief Executive Albert Bourla said on Tuesday that once it knows whether the vaccine candidate it is developing with Germany's BioNTech SE works, it could be a week before it lets the public know, making it unlikely it will release data before the Nov. 3 presidential election.",https://www.reuters.com/article/us-pfizer-results-vaccine/pfizer-ceo-may-be-a-week-between-conclusive-vaccine-data-public-notification-idUSKBN27C27G,0.0,0.0
PFE,2020-10-27,Do Merck and Pfizer Earnings Signal a Pullback in Health Care?,https://cdn.snapi.dev/images/v1/a/c/drugs21---tiwmnwzmmh.jpg,24/7 Wall Street,Merck & Co. Inc. (NYSE: MRK) and Pfizer Inc.,https://247wallst.com/healthcare-business/2020/10/27/do-merck-and-pfizer-earnings-signal-a-pullback-in-health-care/,0.4939,0.0
PFE,2020-10-27,"Pfizer earnings report touts coronavirus vaccine progress in 42,000-participant clinical trial",https://cdn.snapi.dev/images/v1/c/y/health-coronavirus-pfizerjpgquality90stripall.jpg,Fox Business,Pfizer Inc. (PFE) on Tuesday reported third-quarter profit of $2.19 billion.,https://www.foxbusiness.com/markets/pfizer-earnings-share-price-stock-vaccine,0.4019,0.4404
PFE,2020-10-27,Could Some Coronavirus Vaccines Be Left Out in the Cold?,https://cdn.snapi.dev/images/v1/p/o/podc1---kjeo5ltffr.jpg,The Motley Fool,Some coronavirus vaccines must be stored at extremely low temperatures. Could this limit their market potential?,https://www.fool.com/investing/2020/10/27/could-some-coronavirus-vaccines-be-left-out-in-the/,0.0,-0.3384
PFE,2020-10-27,Pfizer Earnings Mixed; Drug Giant Steady,https://cdn.snapi.dev/images/v1/h/q/drugs12---6zvyie1tli.jpg,Investors Business Daily,Pfizer earnings narrowly beat third-quarter views but revenue came in short. PFE stock was little changed before Tuesday's open.,https://www.investors.com/news/technology/pfizer-earnings-pfe-stock/,0.0,0.0
PFE,2020-10-27,Pfizer posts light EPS beat but misses on revenue in Q3,https://cdn.snapi.dev/images/v1/i/5/pfizer-posts-light-eps-beat-but-misses-on-revenue-in-q3.jpg,CNBC Television,CNBC's Meg Tirrell breaks down Pfizer's quarterly earnings results as well as the latest developments out of the company's Phase 3 coronavirus vaccine trial.,https://www.youtube.com/watch?v=LoA9RlzPXS4,-0.3291,0.2732
PFE,2020-10-27,Investors Betting on a Coronavirus Vaccine Better Know Who Gets First Dibs in Global Pact,https://cdn.snapi.dev/images/v1/p/z/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5956622fgettyimages-1210040522jpgw700opresize.jpg,The Motley Fool,"The World Health Organization is managing a global vaccine program without U.S. participation, and it could have a big impact for investors.",https://www.fool.com/investing/2020/10/27/investors-betting-on-a-coronavirus-vaccine-better/,0.4404,0.0
PFE,2020-10-27,"Pfizer's late-stage coronavirus vaccine trial is near complete enrollment with 42,000 volunteers",https://cdn.snapi.dev/images/v1/t/u/106599913-1593620338844ap-20183543531451.jpg,CNBC,,https://www.cnbc.com/2020/10/27/pfizers-late-stage-coronavirus-vaccine-trial-is-near-complete-enrollment-with-42000-volunteers.html,0.0,0.0
PFE,2020-10-27,3 Dirt-Cheap Dividend Stocks to Buy Today,https://cdn.snapi.dev/images/v1/w/i/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5962152fsuitcase-full-of-cashjpgw700opresize.jpg,The Motley Fool,These giants show no signs of letting up on their regular payments to investors.,https://www.fool.com/investing/2020/10/27/3-dirt-cheap-dividend-stocks-to-buy-today/,0.0,-0.296
PFE,2020-10-27,Will the Coronavirus Vaccine Market Be Winner-Take-All?,https://cdn.snapi.dev/images/v1/r/v/syringe-1884779-1920-7.jpg,The Motley Fool,The answer boils down to simple math.,https://www.fool.com/investing/2020/10/27/will-the-coronavirus-vaccine-market-be-winner-take/,0.0,0.0
PFE,2020-10-26,This analyst has concerns about the Pfizer and BioNTech vaccine,https://cdn.snapi.dev/images/v1/p/3/this-analyst-has-concerns-about-the-pfizer-and-biontech-vaccine.jpg,CNBC Television,"CNBC's Kelly Evans discusses vaccine stocks, and why there are concerns about vaccine effectiveness, with Dr. Vincent Chen, biotech analyst at Bernstein. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic Turn to CNBC TV for the latest stock market news and analysis.",https://www.youtube.com/watch?v=3kej0uS5B1c,0.0,0.128
PFE,2020-10-26,What's the Best Way to Invest in Coronavirus Vaccine Stocks?,https://cdn.snapi.dev/images/v1/p/o/podc9---ajlptxtusp.jpg,The Motley Fool,Here are three potential strategies.,https://www.fool.com/investing/2020/10/26/whats-the-best-way-to-invest-in-coronavirus-vaccin/,0.6369,0.0
PFE,2020-10-26,Here's the Biggest Misconception About Coronavirus Vaccines,https://cdn.snapi.dev/images/v1/n/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5845132fgettyimages-1225481435jpgw700opresize.jpg,The Motley Fool,It could translate to good news for biotechs with COVID-19 therapies.,https://www.fool.com/investing/2020/10/25/heres-the-biggest-misconception-about-coronavirus/,0.0,0.4404
PFE,2020-10-26,Better Coronavirus Stock: Moderna vs. Pfizer,https://cdn.snapi.dev/images/v1/m/e/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5955472fvaccine-shotjpgw700opresize.jpg,The Motley Fool,Which stock wins between this up-and-coming biotech and a longtime pharma giant?,https://www.fool.com/investing/2020/10/25/better-coronavirus-stock-moderna-vs-pfizer/,0.4404,0.5719
PFE,2019-08-22,Pfizer's Xtandi Label Expansion Filing Gets Priority Review,https://cdn.snapi.dev/images/v1/b/g/drugs24.jpg,Zacks Investment Research,"If data from ARCHES study is approved to be included in the label of Pfizer's (PFE) Xtandi, it can treat a broader prostate cancer patient population.",https://www.zacks.com/stock/news/482846/pfizers-xtandi-label-expansion-filing-gets-priority-review,0.0,0.0258
PFE,2019-08-22,3 Dividend Stocks That Pay Better Than Coca-Cola.,https://cdn.snapi.dev/images/v1/n/4/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5373342f18-08-21-a-jar-of-coins-with-the-word-dividends-on-it-gettyimages-545379302jpgw700opresize.jpg,The Motley Fool,Coke's yield is a juicy 3% or so. But you can do better!,https://www.fool.com/investing/2019/08/22/3-dividend-stocks-that-pay-better-than-coca-cola.aspx,0.3612,0.4926
PFE,2019-08-21,"Pfizer Digs Deeper Into Gene Therapy, Rivaling These Biotech Stocks",https://cdn.snapi.dev/images/v1/f/w/drugs18.jpg,Investors Business Daily,Pfizer stock jumped Wednesday after the Dow Jones giant announced a big push into gene therapy manufacturing as it tackles Duchenne muscular dystrophy and hemophilia B.,https://www.investors.com/news/technology/pfizer-stock-rises-investment-gene-therapy-manufacturing/,0.0,0.0
PFE,2019-08-21,Trade of the Day: Pfizer Stock Is Flashing Attractive Buy Signals,https://cdn.snapi.dev/images/v1/r/v/pf9-3.jpg,InvestorPlace,"PFE stock recently dropped 20% following the company's latest earnings report. As a result, Pfizer has reached extreme oversold readings that could lead to a pop in the stock.",https://investorplace.com/2019/08/trade-of-the-day-pfizer-stock-is-flashing-attractive-buy-signals/,0.4404,0.1027
PFE,2019-08-20,"3 Healthcare Stocks to Trade: UNH, JNJ and PFE",https://cdn.snapi.dev/images/v1/a/l/etf24-51.jpg,InvestorPlace,"Even though they are prone to headlines during elections, here are 3 healthcare stocks to buy: PFE, UNH and JNJ.
The post 3 Healthcare Stocks to Trade: UNH, JNJ and PFE appeared first on InvestorPlace.",https://investorplace.com/2019/08/3-healthcare-stocks-to-trade-unh-jnj-and-pfe/,0.0,0.0
PFE,2019-08-15,Pfizer recalls two lots of migraine drug due to potential bacterial contamination,https://cdn.snapi.dev/images/v1/f/z/drugs9.jpg,Market Watch,"Pfizer Inc. PFE, +0.23% is recalling two lots of its migraine medication Relpax, the U.S. Food and Drug Administration said Thursday.",https://www.marketwatch.com/story/pfizer-recalls-two-lots-of-migraine-drug-due-to-potential-bacterial-contamination-2019-08-15,0.0,0.0
PFE,2019-08-13,"Tuesday’s Vital Data: Uber, Pfizer and Roku",https://cdn.snapi.dev/images/v1/5/c/stocks1600-768x432.jpg,InvestorPlace,"Options trading was buzzing in Uber, Pfizer and Roku on Monday. Here are the metrics that matter moving forward.",https://investorplace.com/2019/08/tuesdays-vital-data-uber-pfizer-and-roku/,0.296,0.0258
PFE,2019-08-13,5 Biggest New Drugs Approved in 2019 So Far,https://cdn.snapi.dev/images/v1/c/8/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5366262fwhite-pill-with-dollar-symboljpgw700opresize.jpg,The Motley Fool,And the one big pharma most likely to benefit the most.,https://www.fool.com/investing/2019/08/13/5-biggest-new-drugs-approved-in-2019-so-far.aspx,0.4215,0.5046
PFE,2019-08-12,"Pfizer's stock sinks again, toward 14-month low to pace 'Dow's' losers",https://cdn.snapi.dev/images/v1/p/v/drugs14.jpg,Market Watch,"Shares of Pfizer Inc. PFE, -3.52% dropped 3.6% in afternoon grading Monday, putting them on track to close at a 14-month low, as the drugmaker extends the rough patch in the wake of its second-quarter earnings report and announcement to merge its Upjohn business with Mylan Inc.",https://www.marketwatch.com/story/pfizers-stock-sinks-again-toward-14-month-low-to-pace-dows-losers-2019-08-12,-0.6705,0.1531
PFE,2019-08-12,Pfizer Once Again the Most Shorted Dow Stock,https://cdn.snapi.dev/images/v1/5/g/chemicals15.jpg,24/7 Wall Street,"It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.",https://247wallst.com/investing/2019/08/12/pfizer-once-again-the-most-shorted-dow-stock/,0.0,0.6486
PFE,2019-08-06,SNY vs. PFE: Which Stock Is the Better Value Option?,https://cdn.snapi.dev/images/v1/z/u/drugs10.jpg,Zacks Investment Research,SNY vs. PFE: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/459725/sny-vs-pfe-which-stock-is-the-better-value-option,0.6486,0.6486
PFE,2019-08-06,"3 Big Stock Charts for Tuesday: Pfizer, AES and Centurylink",https://cdn.snapi.dev/images/v1/i/o/etf13-35.jpg,InvestorPlace,"The stock charts of Pfizer, AES and Centurylink have emerged as enticing prospects within a sea of volatility.
The post 3 Big Stock Charts for Tuesday: Pfizer, AES and Centurylink appeared first on InvestorPlace.",https://investorplace.com/2019/08/3-big-stock-charts-for-tuesday-pfizer-aes-and-centurylink/,0.0,0.296
PFE,2019-08-05,These 5 Prescription Drugs Will Generate a Jaw-Dropping $62.3 Billion in 2024,https://cdn.snapi.dev/images/v1/s/9/385.jpg,The Motley Fool,"These five-star medicines should continue to push the industry higher in the next decade, despite the political blowback surrounding U.S. prescription drug prices.",https://www.fool.com/investing/2019/08/04/the-top-5-best-selling-prescription-drugs.aspx,0.0,0.0
PFE,2019-08-02,Fitch Ratings downgrades Pfizer to A vs. A-plus with negative outlook,https://cdn.snapi.dev/images/v1/n/7/drugs40.jpg,Market Watch,"Fitch Ratings downgraded Pfizer Inc.'s long-term issuer default rating by one notch to A from A-plus on Friday, after the closing of the acquisition of Array BioPharma earlier this week.",https://www.marketwatch.com/story/fitch-ratings-downgrades-pfizer-to-a-vs-a-plus-with-negative-outlook-2019-08-02-9913253,-0.5719,0.0
PFE,2019-08-02,The 'Dogs Of The Dow' For 2019 Stalled In July,https://cdn.snapi.dev/images/v1/e/t/etf48-33.jpg,Forbes,"The eight “Dogs of the Dow” have an aggregate year-to-date gain of 12.2%, lagging the Dow Jones Industrial Average, which is up 15.2%.",https://www.forbes.com/sites/investor/2019/08/02/the-dogs-of-the-dow-for-2019-stalled-in-july/,-0.2023,0.3182
PFE,2019-07-31,5 Stocks to Buy and Keep an Eye on Come Fall,https://cdn.snapi.dev/images/v1/e/t/etf13-59.jpg,InvestorPlace,Q2 earnings season rolls on and Wall Street tries to not act disappointed by the early end to the latest round of U.S.-China trade talks.,https://investorplace.com/2019/07/5-stocks-to-buy-and-keep-an-eye-on-come-fall/,0.0,0.3724
PFE,2019-07-31,"Square ahead of earnings, plus the Boeing trade in #AskHalftime",https://cdn.snapi.dev/images/v1/y/w/square-ahead-of-earnings-plus-the-boeing-trade-in-askhalftime.jpg,CNBC Television,"The ""Halftime Report"" traders answer viewer questions on Square, Boeing, Pfizer, & Nokia.",https://www.youtube.com/watch?v=dGUpSqSmCD4,0.0,0.0
PFE,2019-07-31,"Wednesday’s Vital Data: Pfizer, Advanced Micro Devices and Apple",https://cdn.snapi.dev/images/v1/r/q/4srj-7.jpg,InvestorPlace,"Options trading was buzzing in Pfizer, Advanced Micro Devices and Apple on Tuesday. Here are the metrics that matter moving forward.",https://investorplace.com/2019/07/wednesdays-vital-data-pfizer-advanced-micro-devices-and-apple/,0.4939,0.2732
PFE,2019-07-31,Here’s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal,https://cdn.snapi.dev/images/v1/k/p/drugs2.jpg,InvestorPlace,"The new company emerging from the Pfizer-Mylan deal gets former blockbusters like Lipitor and Celebrex, now generics, and the EpiPen business, which has been an object of scandal.
The post Here’s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal appeared first on InvestorPlace.",https://investorplace.com/2019/07/heres-how-pfizer-stock-and-pharma-stand-to-benefit-from-mylan-deal/,0.4588,0.3818
PFE,2019-07-30,"Why Beyond Meat, McDermott International, and Pfizer Slumped Today",https://cdn.snapi.dev/images/v1/e/l/sto2934.jpg,The Motley Fool,Sometimes even solid growth isn't enough to lift a stock's price.,https://www.fool.com/investing/2019/07/30/why-beyond-meat-mcdermott-international-and-pfizer.aspx,0.0,0.4939
PFE,2019-07-30,5 Top Stock Trades for Wednesday (July 31),https://cdn.snapi.dev/images/v1/8/b/8b-10.jpg,InvestorPlace,"Under Armour, PepsiCo, Invitae, Capital One and Pfizer are our top stock trades for Wednesday. Here's how to trade them.",https://investorplace.com/2019/07/5-top-stock-trades-for-wednesday-uaa-pep-nvta/,0.2023,0.2023
PFE,2019-07-30,Pfizer Becomes a Falling Knife After Monday's Earnings,https://cdn.snapi.dev/images/v1/d/n/pfizer5.jpg,Investopedia,"The pharma giant beat EPS estimates but missed on revenue, with sales suffering from major drugs that are now offered as generics.",https://www.investopedia.com/pfizer-became-a-falling-knife-after-mondays-earnings-4707595,-0.1531,-0.7876
PFE,2019-07-30,Morgan Stanley Downgrades Pfizer In Wake Of Upjohn-Mylan Merger,https://cdn.snapi.dev/images/v1/w/3/pfi88.jpg,Benzinga,"Morgan Stanley downgraded Pfizer Inc (NYSE: PFE) Tuesday after the drug company announced the spinoff of its Upjohn division on Monday, sending its stock downward.",https://www.benzinga.com/analyst-ratings/analyst-color/19/07/14160768/morgan-stanley-downgrades-pfizer-in-wake-of-upjohn-mylan-merger,0.0,0.0
PFE,2019-07-30,Pfizer's stock tumbles toward worst 2-day stretch in 10 1/2-years,https://cdn.snapi.dev/images/v1/l/w/pfi9.jpg,Market Watch,"Shares of Pfizer Inc. PFE, -5.30% tumbled 5.2% to pace the Dow Jones Industrial Average's DJIA, -0.18% decliners in morning trading Tuesday, after Bank of America Merrill Lynch analyst Jason Gerberry downgraded the drug maker in the wake of the deal in which the company's Upjohn business will merge with generic drugmaker Mylan N.V.",https://www.marketwatch.com/story/pfizers-stock-tumbles-toward-worst-2-day-stretch-in-10-12-years-2019-07-30,-0.6249,0.296
PFE,2019-07-30,"Morgan Stanley downgrades Pfizer, says Mylan sale this week revealed some bad news",https://cdn.snapi.dev/images/v1/n/c/103890274-gettyimages-537929536.jpg,CNBC,Morgan Stanley downgraded Pfizer to equal-weight from overweight and slashed it price target to $40 per share from $48 per share.,https://www.cnbc.com/2019/07/30/morgan-stanley-downgrades-pfizer-says-mylan-sale-this-week-revealed-some-bad-news.html,-0.5423,0.0
PFE,2019-07-30,3 Key Things to Know About How the Mylan-Upjohn Merger Affects Pfizer Shareholders,https://cdn.snapi.dev/images/v1/h/n/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5241922fpills-with-some-in-shape-of-dollar-dignjpgampw700ampopresize.jpg,The Motley Fool,"Pfizer's proposed deal with Mylan is complicated. But if you're a Pfizer shareholder, here's what you need to know.",https://www.fool.com/investing/2019/07/30/3-key-things-to-know-about-how-the-mylan-upjohn-me.aspx,0.0,0.0
PFE,2019-07-29,"Jefferies' Holz: Pfizer, Mylan deal not seen as defensive, both business in 'tight spaces'",https://cdn.snapi.dev/images/v1/s/x/jefferies-holz-pfizer-mylan-deal-not-seen-as-defensive-both-business-in-tight-spaces.jpg,CNBC Television,"Jared Holz, health care sector strategist at Jefferies, and Chris Meekins, research analyst at Raymond James, join CNBC's ""Closing Bell"" to discuss the new deal between Pfizer and Mylan, as well as presidential hopeful Sen.",https://www.youtube.com/watch?v=h-jMerEtae8,-0.0191,0.8689
PFE,2019-07-29,"Health-Care M&A Takes Center Stage With Mylan-Pfizer, Exact-Genomic Deals",https://cdn.snapi.dev/images/v1/t/4/health-care-ma-takes-center-stage-with-mylan-pfizer-exact-genomic-deals.jpg,Bloomberg Markets and Finance,"Bloomberg's Nabila Ahmed takes a look at the latest M&A activity in the health-care industry. She speaks on ""Bloomberg Markets: The Close.""",https://www.youtube.com/watch?v=IIJWnr20HFc,0.0,0.0
PFE,2019-07-29,Pfizer Inc. (PFE) CEO Albert Bourla on Q2 2019 Results - Earnings Call Transcript,https://cdn.snapi.dev/images/v1/m/n/transcript40.jpg,Seeking Alpha,Pfizer Inc. (PFE) CEO Albert Bourla on Q2 2019 Results - Earnings Call Transcript,https://seekingalpha.com/article/4278771-pfizer-inc-pfe-ceo-albert-bourla-q2-2019-results-earnings-call-transcript?source=feed_sector_transcripts,0.0,0.0
PFE,2019-07-29,How Big Is Pfizer's Generic Drugs Business That It Plans To Merge With Mylan?,https://cdn.snapi.dev/images/v1/1/g/drugs20.jpg,Forbes,"Pfizer (NYSE:PFE) today announced its plan to combine its generic drugs business with Mylan in a Reverse Morris Trust transaction. The combined entity could generate sales of over $20 billion by 2020, and Pfizer will hold a 57% stake in the new company, with Mylan holding the rest.",https://www.forbes.com/sites/greatspeculations/2019/07/29/how-big-is-pfizers-generic-drugs-business-that-it-plans-to-merge-with-mylan/,0.0,0.5106
PFE,2019-07-29,"Mylan, Pfizer combined could generate more than $19 billion in annual sales: Analyst",https://cdn.snapi.dev/images/v1/m/b/mylan-pfizer-combined-could-generate-more-than-19-billion-in-annual-sales-analyst.jpg,CNBC Television,"CNBC's ""Power Lunch"" team and Meg Tirrell discuss generic drug makers with Irina Koffler of Mizuho Securities.",https://www.youtube.com/watch?v=zZ_XFHmbFvc,0.0,0.296
PFE,2019-07-29,What You'll Want to Know About Pfizer's Q2 Earnings Results,https://cdn.snapi.dev/images/v1/0/u/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5331082fpills-with-some-in-shape-of-dollar-dignjpgw700opresize.jpg,The Motley Fool,No big surprises with Pfizer's Q2 earnings results. The big surprise was a major deal with Mylan that caused the results to be announced earlier than expected.,https://www.fool.com/investing/2019/07/29/what-youll-want-to-know-about-pfizers-q2-earnings.aspx,0.0772,0.2023
PFE,2019-07-29,Pfizer Inc to Combine Off-Patent Drug Business With Mylan NV,https://cdn.snapi.dev/images/v1/x/h/drugs15.jpg,GuruFocus,"Drugmaker Pfizer Inc. (NYSE:PFE) announced on Monday it is combining its off-patent drug business, which is called Upjohn, with Pittsburgh-based generic pharmaceutical giant Mylan NV (NASDAQ:MYL) in an all-stock deal, creating a new company.",https://www.gurufocus.com/news/917420/pfizer-to-combine-offpatent-drug-business-with-mylan,0.0,0.296
PFE,2019-07-29,Mylan-Pfizer Deal: MYL Stock Soars on Off-Patent Drug Merger,https://cdn.snapi.dev/images/v1/t/v/drugs13.jpg,InvestorPlace,"A new Mylan-Pfizer deal that will have the companies taking part in a merger agreement has MYL stock heading higher on Monday.
The post Mylan-Pfizer Deal: MYL Stock Soars on Off-Patent Drug Merger appeared first on InvestorPlace.",https://investorplace.com/2019/07/mylan-pfizer-deal-has-myl-stock-up/,0.0,0.4939
PFE,2019-07-29,Pfizer to merge off-patent drug business with Mylan,https://cdn.snapi.dev/images/v1/e/n/pfizer-to-merge-off-patent-drug-business-with-mylan.jpg,Yahoo Finance,Yahoo Finance's Anjalee Khemlani reports on the Pharmaceutical Giants Pfizer and Mylan have reached.,https://www.youtube.com/watch?v=86KbecWWBAg,0.0,0.1027
PFE,2019-07-29,"Pfizer to spinoff, merge off-patent drugs unit with Mylan",https://cdn.snapi.dev/images/v1/f/f/drugs16jpg.jpg,Reuters,"Pfizer Inc  has agreed to spin off its off-patent branded drugs business and combine it with generic drugmaker Mylan NV , a move that leaves Pfizer with its more profitable innovative drugs, including cancer treatment Ibrance and pneumonia vaccine Prevnar.",https://www.reuters.com/article/us-mylan-pfizer/pfizer-to-spinoff-merge-off-patent-drugs-unit-with-mylan-idUSKCN1UO185,0.0,0.4716
PFE,2019-07-29,What to Watch When Merck and Pfizer Report Early on Tuesday,https://cdn.snapi.dev/images/v1/f/j/drugs11.jpg,24/7 Wall Street,Pfizer Inc. (NYSE: PFE) and Merck & Co. Inc. (NYSE: MRK) are each scheduled to release their second-quarter financial results before the markets open on Tuesday.,https://247wallst.com/healthcare-business/2019/07/29/what-to-watch-when-merck-and-pfizer-report-early-on-tuesday/,0.0,0.0
PFE,2019-07-29,Pfizer in talks to transition EpiPen maker into generics spinoff: spokeswoman,https://cdn.snapi.dev/images/v1/p/f/pf9-5.jpg,Reuters,"Pfizer Inc. is in talks to merge its contract manufacturer that produces Mylan’s EpiPen emergency allergy treatment into the new generics business it is creating by combining its older off-patent medicines unit with Mylan NV (MYL.O), a Pfizer spokeswoman said.",https://www.reuters.com/article/us-mylan-pfizer-epipen/pfizer-in-talks-to-transition-epipen-maker-into-generics-spinoff-spokeswoman-idUSKCN1UO1SG,0.0,-0.1027
PFE,2019-07-29,Stock Market News: Pfizer and Mylan Make a Deal; Chipotle Looks Tasty,https://cdn.snapi.dev/images/v1/a/2/stocks1600-768x432.jpg,The Motley Fool,Stocks were mixed on Wall Street Monday morning.,https://www.fool.com/investing/2019/07/29/stock-market-news-pfizer-mylan-make-a-deal-chipotl.aspx,0.0,0.0
PFE,2019-07-29,Mylan CEO to depart as part of deal with Pfizer's off-patent drug business,https://cdn.snapi.dev/images/v1/o/o/ook92-1.jpg,CNBC Television,"CNBC's Meg Tirrell reports on Pfizer's move to combine its off-patent drug business with Mylan, whose CEO Heather Bresch will depart as part of the deal.",https://www.youtube.com/watch?v=Kp8vDagElNQ,0.0,0.0
PFE,2019-07-29,"Pfizer (PFE) Beats on Q2 Earnings, to Merge Upjohn With Mylan",https://cdn.snapi.dev/images/v1/k/s/drugs10.jpg,Zacks Investment Research,Pfizer (PFE) beats estimates for second-quarter earnings but misses on sales. The company also lowers 2019 earnings and sales guidance.,https://www.zacks.com/stock/news/452910/pfizer-pfe-beats-on-q2-earnings-to-merge-upjohn-with-mylan,0.0,-0.4767
PFE,2019-07-29,"It's Market Madness: Jim Cramer on Earnings Season, Pfizer and Mylan, Starbucks",https://cdn.snapi.dev/images/v1/r/z/its-market-madness-jim-cramer-on-earnings-season-pfizer-and-mylan-starbucks.jpg,The Street,"Jim weighs in on Pfizer and Mylan, Starbucks and, of course, the causes for a week of market madness.",https://www.youtube.com/watch?v=huoAr0MFBeE,-0.4404,-0.4404
PFE,2019-07-29,"Merger Fever Runs Hot In Pharma As Pfizer, Mylan Announce Matchup",https://cdn.snapi.dev/images/v1/m/y/mypf92-1.jpg,Investors Business Daily,"Pfizer announced an all-stock plan Monday to combine its off-patent and generic drugs unit, Upjohn, with pharmaceutical company Mylan — sending Mylan stock flying as Pfizer stock stumbled.
The post Merger Fever Runs Hot In Pharma As Pfizer, Mylan Announce Matchup appeared first on Investor's Business Daily.",https://www.investors.com/news/technology/pharmaceutical-companies-pfizer-upjohn-combine-mylan-generic-drugs/,0.0,0.0
PFE,2019-07-29,S&P downgrades Pfizer by one notch to AA-minus after Upjohn/Mylan deal,https://cdn.snapi.dev/images/v1/p/f/pfz-2.jpg,Market Watch,"S&P Global Ratings downgraded Pfizer Inc.'s ratings by one notch to AA-minus Monday, after the company said it is divesting its Upjohn generics business and merging it with Mylan Plc.",https://www.marketwatch.com/story/sp-downgrades-pfizer-by-one-notch-to-aa-minus-after-upjohnmylan-deal-2019-07-29,0.0,0.0
PFE,2019-07-29,What's in Store for Array BioPharma (ARRY) in Q4 Earnings?,https://cdn.snapi.dev/images/v1/e/8/biotech3.jpg,Zacks Investment Research,Array BioPharma's (ARRY) Braftovi-Mektovi combination therapy is likely to drive fourth-quarter sales.,https://www.zacks.com/stock/news/452742/whats-in-store-for-array-biopharma-arry-in-q4-earnings,0.0,0.0
PFE,2019-07-29,Pfizer to merge generics unit with Mylan; seeks to sharpen cancer focus,https://cdn.snapi.dev/images/v1/v/o/drugs29.jpg,Reuters,"Drugmaker Pfizer Inc  has agreed to spin off its generic drugs business and combine it with Mylan , a move that leaves Pfizer with more profitable innovative drugs, including cancer drug Ibrance and pneumonia vaccine Prevnar.",https://www.reuters.com/article/us-mylan-pfizer/pfizer-to-merge-generics-unit-with-mylan-seeks-to-sharpen-cancer-focus-idUSKCN1UO185,-0.6597,0.4716
PFE,2019-07-29,What This Mylan-Pfizer Pharma Juggernaut Will Look Like,https://cdn.snapi.dev/images/v1/l/n/drugs50.jpg,24/7 Wall Street,Mylan N.V. (NASDAQ: MYL) released its second-quarter financial results before the markets opened on Monday.,https://247wallst.com/healthcare-business/2019/07/29/what-this-mylan-pfizer-pharma-juggernaut-will-look-like/,0.3612,0.0
PFE,2019-07-29,Pfizer Closes in on a Major Spinoff,https://cdn.snapi.dev/images/v1/m/x/pfi88.jpg,The Motley Fool,The pharmaceutical giant will reportedly combine its legacy products business with generic drug major Mylan.,https://www.fool.com/investing/2019/07/29/pfizer-closes-in-on-a-major-spinoff.aspx,0.0,0.0
PFE,2019-07-29,"Pfizer stock down after revenue miss, merger announcement",https://cdn.snapi.dev/images/v1/4/o/pfi9.jpg,Market Watch,"Shares of Pfizer Inc. PFE, +0.98% fell 3% in premarket trade Monday after the company announced a deal to merge its Upjohn business with Mylan and reported second-quarter earnings that topped profit expectations, though the drugmaker fell short of revenue estimates.",https://www.marketwatch.com/story/pfizer-stock-down-after-revenue-miss-merger-announcement-2019-07-29,-0.1531,0.6249
PFE,2019-07-29,Pfizer to Merge Off-Patent Unit With Mylan in All-Stock Deal,https://cdn.snapi.dev/images/v1/x/z/pfizer-to-merge-off-patent-unit-with-mylan-in-all-stock-deal.jpg,Bloomberg Markets and Finance,"Pfizer Inc. will combine its business line of older blockbuster medicines in an all-stock deal with generic drugmaker Mylan NV. Bloomberg Intelligence's Sam Fazeli has the details on ""Bloomberg Daybreak: Americas.""",https://www.youtube.com/watch?v=OsfX0od-x4I,0.0,0.5994
PFE,2019-07-29,Pfizer (PFE) Q2 Earnings Top Estimates,https://cdn.snapi.dev/images/v1/e/q/drugs47.jpg,Zacks Investment Research,"Pfizer (PFE) delivered earnings and revenue surprises of 3.90% and -0.44%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?",https://www.zacks.com/stock/news/452520/pfizer-pfe-q2-earnings-top-estimates,0.2023,0.128
PFE,2019-07-29,"Mylan, Pfizer's Upjohn To Merge And Create New Company",https://cdn.snapi.dev/images/v1/c/p/medications-257336-1920-50.jpg,Benzinga,Mylan (NASDAQ: MYL) shares are trading higher after it announced the launch of a new company with Pfizer's (NYSE: PFE) Upjohn division.,https://www.benzinga.com/m-a/19/07/14149338/mylan-pfizers-upjohn-to-merge-and-create-new-company,0.2732,0.296
PFE,2019-07-29,"Pfizer Reports Mixed Q2 Earnings, Lowers Guidance",https://cdn.snapi.dev/images/v1/b/i/biotech23-10.jpg,Benzinga,"Pfizer (NYSE: PFE) reported quarterly earnings of 80 cents per share, which beat the analyst consensus estimate of 75 cents by 6.67%.",https://www.benzinga.com/news/earnings/19/07/14149282/pfizer-reports-mixed-q2-earnings-lowers-guidance,-0.128,0.296
PFE,2019-07-29,Buy Pfizer Stock Before this Week’s Earnings Report Gives It a Bump Up,https://cdn.snapi.dev/images/v1/s/7/drugs41.jpg,InvestorPlace,"As it prepares to report its second-quarter earnings, Pfizer Stock is set to make some big moves. Now is the time to get in.",https://investorplace.com/2019/07/buy-pfizer-stock-before-this-weeks-earnings-report-gives-it-a-bump-up/,0.0,0.0
PFE,2019-07-29,Mylan CEO Heather Bresch to retire after deal to merge with Pfizer's Upjohn closes,https://cdn.snapi.dev/images/v1/r/y/drugs40.jpg,Market Watch,"Mylan N.V. MYL, +0.11% said that in connection with the deal to merge with Pfizer Inc.",https://www.marketwatch.com/story/mylan-ceo-heather-bresch-to-retire-after-deal-to-merge-with-pfizers-upjohn-closes-2019-07-29,0.0,0.0
PFE,2019-07-29,Pfizer to combine off-patent drug business with Mylan,https://cdn.snapi.dev/images/v1/i/i/ii292-1.jpg,CNBC Television,CNBC's Meg Tirrell reports on a new Pharma deal between Pfizer and Mylan.,https://www.youtube.com/watch?v=BqzZYdPOI7g,0.0,0.0
PFE,2019-07-29,Pfizer posts 30% rise in quarterly profit,https://cdn.snapi.dev/images/v1/l/m/m02d20190729t2i1413211723rlynxnpef6s0ucw640.jpg,Reuters,"Pfizer Inc  on Monday reported a 30% rise in quarterly profit, helped by demand for its branded treatments such as Ibrance, Eliquis and Xeljanz.",https://www.reuters.com/article/us-pfizer-results/pfizer-posts-30-rise-in-quarterly-profit-idUSKCN1UO18S,0.4404,0.34
PFE,2019-07-29,Mylan to combine with Pfizer's off-patent medicines unit,https://cdn.snapi.dev/images/v1/l/y/my723-2.jpg,Reuters,Mylan NV  said on Monday it would combine with Pfizer Inc's  off-patent branded and generic established medicines business to form a global generic drugmaker.,https://www.reuters.com/article/us-mylan-pfizer/mylan-to-combine-with-pfizers-off-patent-medicines-unit-idUSKCN1UO185,0.0,0.0
PFE,2019-07-29,Mylan's stock soars after deal to merger with Pfizer's Upjohn,https://cdn.snapi.dev/images/v1/6/9/drugs38.jpg,Market Watch,"Shares of Mylan N.V. MYL, +0.11% soared 24% in premarket trading Monday, after the generic drug maker confirmed it was merging with Pfizer Inc.",https://www.marketwatch.com/story/mylans-stock-soars-after-deal-to-merger-with-pfizers-upjohn-2019-07-29,0.0,0.296
PFE,2019-07-29,3 Things to Look For in Pfizer's Q2 Earnings Update,https://cdn.snapi.dev/images/v1/8/k/pfizer5.jpg,The Motley Fool,The big drugmaker announces its Q2 results on July 30. Here's what you can expect.,https://www.fool.com/investing/2019/07/29/3-things-to-look-for-in-pfizers-q2-earnings-update.aspx,0.0,0.0
PFE,2019-07-29,Pfizer plans combination of off-patent drug business with Mylan,https://cdn.snapi.dev/images/v1/0/a/103606723-rtx2cq0n.jpg,CNBC,"The deal, expected to be announced Monday, will result in Pfizer shareholders owning most of the new company with Mylan's shareholders owning slightly more than 40%.",https://www.cnbc.com/2019/07/28/pfizer-plans-combination-of-off-patent-drug-business-with-mylan.html,0.0,0.0
PFE,2019-07-29,10 Biggest Cancer-Fighting Stocks,https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5193592fabt-earnings-41719.jpg,The Motley Fool,The fight against cancer is a big battle. And these 10 companies are among the biggest combatants you can invest in.,https://www.fool.com/investing/2019/07/27/10-biggest-cancer-fighting-stocks.aspx,0.0,-0.8625
PFE,2019-07-29,Pfizer in talks to merge off-patent drugs business with Mylan,https://cdn.snapi.dev/images/v1/j/z/m02d20190727t2i1412584697rlynxnpef6q0b3w640.jpg,Reuters,"Pfizer Inc  is in talks to merge its off-patent drugs business with Mylan NV  in a stock deal, the Wall Street Journal reported on Saturday, citing people familiar with the matter.",https://www.reuters.com/article/us-mylan-nl-m-a-pfizer/pfizer-in-talks-to-merge-off-patent-drugs-business-with-mylan-idUSKCN1UM0DP,0.0,0.0258
PFE,2019-07-25,Array BioPharma (ARRY) Moves to Buy: Rationale Behind the Upgrade,https://cdn.snapi.dev/images/v1/w/e/biotech5.jpg,Zacks Investment Research,"Array BioPharma (ARRY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.",https://www.zacks.com/stock/news/449331/array-biopharma-arry-moves-to-buy-rationale-behind-the-upgrade,0.0,0.7506
PFE,2019-07-25,Intel Overtakes Pfizer as Most Shorted Dow Stock,https://cdn.snapi.dev/images/v1/e/t/etf30-54.jpg,24/7 Wall Street,"It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.",https://247wallst.com/investing/2019/07/25/intel-overtakes-pfizer-as-most-shorted-dow-stock/,0.0,0.6486
PFE,2019-07-24,Can Pfizer's Q2 Earnings Help Boost PFE Stock in a Struggling Pharma Market?,https://cdn.snapi.dev/images/v1/t/c/drugs39.jpg,Zacks Investment Research,"Pfizer Inc. (PFE) is set to report its Q2 earnings results on Tuesday, July 30.",https://www.zacks.com/stock/news/448975/can-pfizers-q2-earnings-help-boost-pfe-stock-in-a-struggling-pharma-market,0.3818,0.0
PFE,2019-07-23,Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for,https://cdn.snapi.dev/images/v1/j/f/drugs3.jpg,Zacks Investment Research,Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://www.zacks.com/stock/news/447566/analysts-estimate-pfizer-pfe-to-report-a-decline-in-earnings-what-to-look-out-for,0.0,0.2263
PFE,2019-07-22,Better Buy:  Pfizer vs.  AbbVie,https://cdn.snapi.dev/images/v1/x/a/top23.jpg,The Motley Fool,Which stock wins in a head-to-head matchup between these two big drugmakers?,https://www.fool.com/investing/2019/07/21/better-buy-pfizer-vs-abbvie.aspx,0.4404,0.5719
PFE,2019-07-22,"3 Stocks to Build Your Portfolio Around: Google, Pfizer & W.P. Carey",https://cdn.snapi.dev/images/v1/l/w/sto23-3.jpg,The Motley Fool,"It needs a solid foundation, and Alphabet, Pfizer, and W.P. Carey have proven their worth over time.",https://www.fool.com/investing/2019/07/20/3-stocks-to-build-your-portfolio-around.aspx,0.0,0.3612
PFE,2019-07-16,Sangamo's Hemophilia A Results Light A Spark And Push Program Into Pfizer's Hands,https://cdn.snapi.dev/images/v1/b/l/drugs3.jpg,Seeking Alpha,Sangamo Therapeutics reports positive results from its phase 1/2 open-label study using SB-525 to treat patients with Hemophilia A.,https://seekingalpha.com/article/4275320-sangamos-hemophilia-results-light-spark-push-program-pfizers-hands?source=feed_tag_long_ideas,0.2263,0.743
PFE,2019-07-12,Drug Pricing Woes Linger on Repealing Drug Rebate Proposal,https://cdn.snapi.dev/images/v1/u/n/drugs41.jpg,Zacks Investment Research,"Investors' skepticism runs rife as Trump drops the drug rebate proposal, pushing drugmakers to take center stage with regard to the controversial drug pricing issue.",https://www.zacks.com/stock/news/441711/drug-pricing-woes-linger-on-repealing-drug-rebate-proposal,-0.4404,-0.4215
PFE,2019-07-12,SNY or PFE: Which Is the Better Value Stock Right Now?,https://cdn.snapi.dev/images/v1/r/a/drugs34.jpg,Zacks Investment Research,SNY vs. PFE: Which Stock Is the Better Value Option?,https://www.zacks.com/stock/news/441539/sny-or-pfe-which-is-the-better-value-stock-right-now,0.6486,0.6486
PFE,2019-07-11,"These are the stocks that have powered the Dow's rally to 27,000",https://cdn.snapi.dev/images/v1/1/0-3/105981729-15611309300202019-06-05t145625z-1590043122-rc11ed42bf00-rtrmadp-3-usa-stocks.jpg,CNBC,"The Dow Jones Industrial Average surged above 27,000 for the first time ever on Thursday, just a day after the S&P 500 topped 3,000. Here's a look at the stocks that drove the rally.",https://www.cnbc.com/2019/07/11/these-are-the-stocks-that-have-powered-the-dows-rally-to-27000.html,0.0,0.0
PFE,2019-07-11,4 Drug Stocks Getting Smashed,https://cdn.snapi.dev/images/v1/e/x/exv2-2.jpg,InvestorPlace,Drug stocks are falling on fears of President Trump's next move on drug prices. Here's a look at the charts.,https://investorplace.com/2019/07/4-drug-stocks-getting-smashed/,0.0,-0.5267
PFE,2019-07-11,Big Pharma Sees Rising Tide in Short Interest,https://cdn.snapi.dev/images/v1/1/1/11bpha-1.jpg,24/7 Wall Street,Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials.,https://247wallst.com/healthcare-business/2019/07/11/big-pharma-sees-rising-tide-in-short-interest/,0.4588,0.0
PFE,2019-07-11,The 5 Most Shorted Dow Stocks.,https://cdn.snapi.dev/images/v1/7/s/7shst-1.jpg,24/7 Wall Street,"It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.",https://247wallst.com/investing/2019/07/11/5-most-shorted-dow-stocks-microsoft-on-the-rise/,0.0,0.6486
PFE,2019-07-10,The 10 Biggest Healthcare Stocks,https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5301712fbusinessman-pointing-to-healthcare-iconsjpgw700opresize.jpg,The Motley Fool,How big does a company's market cap need to be to make the top 10 list of healthcare stocks? $111 billion.,https://www.fool.com/investing/2019/07/10/the-10-biggest-healthcare-stocks.aspx?source=iedfolrf0000001,0.0,0.2023
PFE,2019-07-10,Here's Why Array BioPharma Soared 75.4% in June,https://cdn.snapi.dev/images/v1/z/t/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5305882fprescription-drug-pills-stacked-on-hundred-dollar-bill-gettyjpgw700opresize.jpg,The Motley Fool,It looks like Novartis let a big one get away.,https://www.fool.com/investing/2019/07/10/heres-why-array-biopharma-soared-754-in-june.aspx?source=iedfolrf0000001,0.0,0.3612
PFE,2019-07-10,Megadeals Enter Biotech Realm — And 3 Other Trends To Watch In 2019,https://cdn.snapi.dev/images/v1/c/b/cbm-2.jpg,Investors Business Daily,"Biotech companies exploded with ""megadeals"" in the first half of 2019 as pharmaceutical companies Bristol-Myers Squibb and AbbVie announced acquisitions worth a combined $137 billion.
The post Megadeals Enter Biotech Realm — And 3 Other Trends To Watch In 2019 appeared first on Investor's Business Daily.",https://www.investors.com/news/technology/biotech-companies-megadeals-political-pressure-china-trends-2019/,0.0,0.2263
PFE,2019-07-10,Merrill Lynch Has 5 Stocks to Buy That Could Beat Q2 Earnings Estimates,https://cdn.snapi.dev/images/v1/e/t/etf25-30.jpg,24/7 Wall Street,The ongoing trade and tariff issues most likely will have the greatest impact when companies report second-quarter earnings.,https://247wallst.com/investing/2019/07/10/merrill-lynch-has-5-stocks-to-buy-that-could-beat-q2-earnings-estimates/,0.0,0.6369
PFE,2019-07-09,Many Top Pharma & Biotechs Rise As Drug Price Disclosure Thrown Out,https://cdn.snapi.dev/images/v1/e/t-2/etf14-52.jpg,24/7 Wall Street,"While the public wants more pharmaceuticals and biotech advancements to treat the endless number of ailments or to extend their lives, there is a simultaneous push to make drugs more affordable.",https://247wallst.com/healthcare-business/2019/07/09/many-top-pharma-biotechs-rise-as-drug-price-disclosure-thrown-out/,0.2023,0.5719
PFE,2019-07-08,Will Sangamo and Pfizer’s Hemophilia Gene Therapy Keep Building Momentum?,https://cdn.snapi.dev/images/v1/e/m/drugs31.jpg,24/7 Wall Street,"Sangamo Therapeutics, Inc. (NASDAQ: SGMO) made a handy gain to start out the week after the firm, in conjunction with Pfizer Inc.",https://247wallst.com/healthcare-business/2019/07/08/will-sangamo-and-pfizers-hemophilia-gene-therapy-keep-building-momentum/,0.0,0.5267
PFE,2019-07-08,Buy Pfizer or Merck?,https://cdn.snapi.dev/images/v1/p/f/pfi823-1.jpg,CNBC Television,"The ""Halftime Report"" traders answer viewer questions on Pfizer vs. Merck.",https://www.youtube.com/watch?v=ADrx5gbf-fY&t=111s,0.0,0.0
PFE,2019-07-08,Trump targets big pharma with new drug price executive order,https://cdn.snapi.dev/images/v1/g/o/gox9-1.jpg,Fox Business,Former Celgene CEO Bob Hugin on President Trump's efforts to rein in drug prices and reform the U.S. health-care system.,https://www.youtube.com/watch?v=iT1u1-19m5I,0.0,0.0
PFE,2019-07-08,Better Buy: Pfizer vs. Johnson & Johnson,https://cdn.snapi.dev/images/v1/9/i/jnj-1.jpg,The Motley Fool,Which of these pharmaceutical giants is best positioned to help your portfolio grow?,https://www.fool.com/investing/2019/07/07/better-buy-pfizer-vs-johnson-johnson.aspx?source=iedfolrf0000001,0.4404,0.7845
PFE,2019-07-05,Pfizer Remains A Strong Hold In Our Portfolio,https://cdn.snapi.dev/images/v1/5/r/drugs12.jpg,Seeking Alpha,Shares have had a strong few months.,https://seekingalpha.com/article/4273635-pfizer-remains-strong-hold-portfolio?source=feed_tag_long_ideas,0.5106,0.6705
PFE,2019-07-05,"The Top 10 Biotechnology Companies (JNJ, ROG.VX)",https://cdn.snapi.dev/images/v1/k/t/drugs11.jpg,Investopedia,Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational biotechnology corporations.,https://www.investopedia.com/articles/markets/122215/worlds-top-10-biotechnology-companies-jnj-rogvx.asp,0.2023,0.296
PFE,2019-07-05,"The ""Halftime Report"": Can Pfizer hold its gains?",https://cdn.snapi.dev/images/v1/p/f/pfi882-1.jpg,CNBC Television,"The ""Halftime Report"" traders answer viewer questions on Pfizer.",https://www.youtube.com/watch?v=W0ks4lUsGtU&t=155s,0.34,0.0
PFE,2019-07-05,Trump says administration preparing an executive order on drug prices,https://cdn.snapi.dev/images/v1/1/0-3/106004366-1562340818732gettyimages-1153940064.jpeg,CNBC,"""We're working on it right now a favored nations clause where we pay the lower nation's price is, like Canada,"" President Donald Trump tells reporters.",https://www.cnbc.com/2019/07/05/trump-administration-preparing-drug-price-executive-order.html,0.0,0.4019
PFE,2019-07-03,Bloomberg Turnaround: How to Take Advantage of a $117 Billion Takeover Bid,https://cdn.snapi.dev/images/v1/a/s/astra-03-07.jpg,Bloomberg Markets and Finance,"In 2014, Pfizer Inc. made four attempts to buy AstraZeneca Plc in less than six months. AstraZeneca Chief Executive Officer Pascal Soriot used the situation to galvanize his staff.",https://www.youtube.com/watch?v=hZzoC8dUw9s,0.25,0.0
PFE,2019-07-03,Will the Pharma Space Witness More Mega-Merger Deals in 2H?,https://cdn.snapi.dev/images/v1/3/8/385.jpg,Zacks Investment Research,"After two mega-mergers, Bristol-Myers/Celgene and AbbVie/Allergan, in first half of 2019, it remains to be seen if more such deals are in store for the second half.",https://www.zacks.com/stock/news/437588/will-the-pharma-space-witness-more-mega-merger-deals-in-2h,0.0,0.0
PFE,2019-07-03,"3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser",https://cdn.snapi.dev/images/v1/e/t/etf27-36.jpg,InvestorPlace,"The stock charts of CVS Health, Pfizer and Weyerhaeuser head into the midpoint of the week on the verge of major moves.",https://investorplace.com/2019/07/3-big-stock-charts-for-wednesday-cvs-pfe-wy/,0.0,0.0
PFE,2019-07-02,Pfizer's Eucrisa Proves Safety in Kids with Atopic Dermatitis,https://cdn.snapi.dev/images/v1/g/a/drugs47.jpg,Zacks Investment Research,Pfizer's (PFE) Eucrisa ointment is found safe in a late-stage label expansion study for treating mild to moderate atopic dermatitis in minors aged 3 months to 2 years.,https://www.zacks.com/stock/news/437327/pfizers-eucrisa-proves-safety-in-kids-with-atopic-dermatitis,0.4215,0.4404
PFE,2019-07-02,3 Dow Jones Stocks to Buy for the Second Half,https://cdn.snapi.dev/images/v1/e/t/etf35-47.jpg,InvestorPlace,"As we head into the second half of the year, here are three Dow Jones stocks to buy for a long-term portfolio.",https://investorplace.com/2019/07/3-dow-jones-stocks-to-buy-for-the-second-half/,0.0,0.0
PFE,2019-07-02,"Ex-FDA Chief Scott Gottlieb Defends Return To Private Sector, Warren Calls For Resignation",https://cdn.snapi.dev/images/v1/1/1/11-5.jpg,Benzinga,It didn't take long for ex-FDA Commissioner Scott Gottlieb to land a new gig: he joined Pfizer Inc.'s board of directors and signed on as a partner at the venture capital firm NEA.,https://www.benzinga.com/news/19/07/14020031/ex-fda-chief-scott-gottlieb-defends-return-to-private-sector-warren-calls-for-resignation,-0.296,0.0
PFE,2019-07-02,"Warren calls on ex-FDA chief Gottlieb to resign from Pfizer board, says it 'smacks of corruption'",https://cdn.snapi.dev/images/v1/f/u/105830370-1554293317973gettyimages-1134332168.jpeg,CNBC,"'This kind of revolving door influence-peddling smacks of corruption, and makes the American people rightly cynical and distrustful,' Warren said in a July 1 letter to Gottlieb.",https://www.cnbc.com/2019/07/02/sen-warren-calls-on-ex-fda-chief-gottlieb-to-resign-from-pfizer-board.html,-0.34,-0.3818
PFE,2019-07-02,Scott Gottlieb defends his decision to join Pfizer's board,https://cdn.snapi.dev/images/v1/p/f/pfi923.jpg,CNBC Television,Former FDA Commissioner Scott Gottlieb was recently elected to the board of Pfizer.,https://www.youtube.com/watch?v=nFERazuvc3k,0.296,0.0
PFE,2019-07-02,"Scott Gottlieb on joining Pfizer's board, drug prices, and 'Medicare for All'",https://cdn.snapi.dev/images/v1/w/n/scott-gottlieb-on-joining-pfizers-board-drug-prices-and-medicare-for-all.jpg,CNBC Television,Former FDA Commissioner Scott Gottlieb was recently elected to the board of Pfizer.,https://www.youtube.com/watch?v=gGqaYXJZJ4E,0.0,0.0
PFE,2019-07-02,Former FDA Commissioner Gottlieb defends decision to join Pfizer board,https://cdn.snapi.dev/images/v1/7/k/105050631-gettyimages-866274606.jpg,CNBC,"Pfizer last week announced Gottlieb would join its board of directors — a job that paid a minimum of $335,000 in stock and cash in 2018.",https://www.cnbc.com/2019/07/02/former-fda-commissioner-gottlieb-defends-decision-to-join-pfizer-board.html,0.296,0.296
PFE,2019-07-01,How Pfizer Is Looking to Expand Its Eczema Treatment,https://cdn.snapi.dev/images/v1/i/j/pfi9.jpg,24/7 Wall Street,"Pfizer Inc. (NYSE: PFE) has announced topline results from its most recent late-stage study in children aged 3 months to less than 24 months with mild to moderate atopic dermatitis (AD), also known as eczema, a chronic skin disease characterized by inflammation of the skin and skin barrier defects.",https://247wallst.com/healthcare-business/2019/07/01/how-pfizer-is-looking-to-expand-its-eczema-treatment/,0.3182,-0.4939
PFE,2019-07-01,Pfizer's (PFE) Avastin Biosimilar Zirabev Gets FDA Approval,https://cdn.snapi.dev/images/v1/f/c/drugs23.jpg,Zacks Investment Research,"Pfizer (PFE) gets FDA approval for biosimilar Avastin, Zirabev. This is Pfizer's second oncology biosimilar to be approved in United States.",https://www.zacks.com/stock/news/436385/pfizers-pfe-avastin-biosimilar-zirabev-gets-fda-approval,0.4767,0.8271
PFE,2019-07-01,Pfizer's DMD Gene Therapy Shows Severe Side Effects in Study,https://cdn.snapi.dev/images/v1/3/7/drugs25.jpg,Zacks Investment Research,"Pfizer (PFE) presents early data from a study on its investigational gene therapy for DMD. However, the study highlighted some serious side effects in two out of the six participants.",https://www.zacks.com/stock/news/436331/pfizers-dmd-gene-therapy-shows-severe-side-effects-in-study,-0.3818,-0.0772
PFE,2019-07-01,Pfizer stock up 1.2% premarket after drugmaker announces positive results from Phase 4 eczema study,https://cdn.snapi.dev/images/v1/w/g/drugs19.jpg,Market Watch,"Shares of Pfizer Inc. PFE, -0.25% ticked up 1.2% in premarket trade Monday after the drugmaker said a Phase 4 study showed that an eczema treatment was well-tolerated in babies between 3 months and two years of age when used over a period of four weeks.",https://www.marketwatch.com/story/pfizer-stock-up-12-premarket-after-drugmaker-announces-positive-results-from-phase-4-eczema-study-2019-07-01,0.5574,-0.1531
PFE,2019-07-01,Acquisition Improves the Outlook of Pfizer Stock,https://cdn.snapi.dev/images/v1/a/c/drugs17.jpg,InvestorPlace,"Array's cancer drug pipeline, which has many advanced, high-potential treatments, can boost Pfizer stock price over the long-term.",https://investorplace.com/2019/07/acquiring-array-biopharma-improves-pfizers-prospects/,0.4215,-0.1779
PFE,2019-07-01,Pfizer's About to Enter a Sales Slump -- Here's Why You Should Like the Stock Anyway,https://cdn.snapi.dev/images/v1/l/i/pfz.jpg,The Motley Fool,Don't ignore the fallout from Lyrica's loss of patent exclusivity. But do look beyond it.,https://www.fool.com/investing/2019/06/30/pfizers-about-to-enter-a-sales-slump-heres-why-you.aspx?source=iedfolrf0000001,0.3612,-0.049
PFE,2019-07-01,Pfizer’s Duchenne Muscular Dystrophy Pain Could Make Sarepta the DMD King,https://cdn.snapi.dev/images/v1/b/p/15pha.jpg,24/7 Wall Street,Pfizer Inc. (NYSE: PFE) has released initial clinical data from its Phase 1b gene therapy study for Duchenne muscular dystrophy (DMD).,https://247wallst.com/healthcare-business/2019/06/29/pfizers-duchenne-muscular-dystrophy-pain-could-make-sarepta-the-dmd-king/,-0.5106,0.0
PFE,2019-06-28,These Are The 5 Worst Dow Jones Stocks In The First Half Of 2019,https://cdn.snapi.dev/images/v1/d/o/dowdow2.jpg,Investors Business Daily,"Health-related stocks were among the worst-performing Dow Jones stocks during the first half of 2019, led by Walgreens Boots Alliance.",https://www.investors.com/news/dow-jones-stocks-walgreens-3m-unitedhealth-pfizer-verizon-worst-in-1h-2019/,-0.6249,0.0
PFE,2019-06-28,Former FDA Commissioner has joined the board of directors at Pfizer Inc.,https://cdn.snapi.dev/images/v1/d/j/drugs1.jpg,Market Watch,Former U.S. Food and Drug Administration Commissioner Scott Gottlieb has joined the board of directors at Pfizer Inc.,https://www.marketwatch.com/story/former-fda-commissioner-scott-gottlieb-joins-pfizers-board-of-directors-2019-06-28,0.0,0.0
PFE,2019-06-28,Pfizer says FDA has approved its oncology biosimilar Zirabev to treat 5 types of cancer,https://cdn.snapi.dev/images/v1/e/t-2/drugs46.jpg,Market Watch,"Pfizer Inc. PFE, +1.02% said Friday the U.S. Food and Drug Administration has approved its oncology biosimilar Zirabev for the treatment of five types of cancer.",https://www.marketwatch.com/story/pfizer-says-fda-has-approved-its-oncology-biosimilar-zirabev-to-treat-5-types-of-cancer-2019-06-28,0.0258,-0.3818
PFE,2019-06-27,Pfizer names former FDA chief Scott Gottlieb to its board,https://cdn.snapi.dev/images/v1/d/r/m02d20190627t2i1402189472rlynxnpef5q21jw640.jpg,Reuters,"Pfizer Inc  said on Thursday it has named former U.S. Food and Drug Administration Commissioner Scott Gottlieb to its board of directors, effective immediately.",https://www.reuters.com/article/us-pfizer-board/pfizer-names-former-fda-chief-scott-gottlieb-to-its-board-idUSKCN1TS36L,0.0,0.4767
PFE,2019-06-27,Former FDA Chief Scott Gottlieb joins Pfizer's board,https://cdn.snapi.dev/images/v1/o/g/former-fda-chief-scott-gottlieb-joins-pfizers-board.jpg,CNBC Television,CNBC's Seema Mody reports on news that Pfiezer has named former FDA Chief Scott Gottlieb to its board.,https://www.youtube.com/watch?v=Onie7VJnX2U,0.0,0.0
PFE,2019-06-27,Former FDA Commissioner Scott Gottlieb joins Pfizer's board of directors,https://cdn.snapi.dev/images/v1/6/3/105925105-1558449878026nup-187141-0485cr.jpg,CNBC,"Scott Gottlieb, who stepped down as Food and Drug Administration Commissioner in April, will join Pfizer's board of directors, the company announced Thursday.",https://www.cnbc.com/2019/06/27/former-fda-commissioner-scott-gottlieb-joins-pfizers-board.html,0.0,0.296
PFE,2019-06-27,The 7 Top Small-Cap Stocks Of 2019,https://cdn.snapi.dev/images/v1/e/t/etf33-27.jpg,InvestorPlace,"Small-cap stocks have under-performed their large cap peers in 2019, but these 7 small-cap stocks have each more than tripled this year.",https://investorplace.com/2019/06/the-7-top-small-cap-stocks-of-2019/,0.2023,0.0
PFE,2019-06-27,UnitedHealth and one other Dow stock could be on the cusp of a comeback,https://cdn.snapi.dev/images/v1/u/n/unip55.jpg,CNBC,"As the Dow closes in on records, just four stocks have been shut out of the rally. Some could be on the verge of a major breakout.",https://www.cnbc.com/2019/06/27/unitedhealth-and-pfizer-could-be-on-the-cusp-of-a-comeback.html,0.0,0.0
PFE,2019-06-25,3 Dividend Stocks That Could Pay You the Rest of Your Life,https://cdn.snapi.dev/images/v1/a/s/asset-management24-13.jpg,The Motley Fool,"This drug company, renewable power generator, and candymaker should provide investors with a steady stream of income in the decades to come.",https://www.fool.com/investing/2019/06/25/3-dividend-stocks-that-could-pay-you-the-rest-of-y.aspx?source=iedfolrf0000001,-0.1027,0.0
PFE,2019-06-25,Pfizer (PFE) Flat As Market Sinks: What You Should Know,https://cdn.snapi.dev/images/v1/q/x/drugs50.jpg,Zacks Investment Research,"In the latest trading session, Pfizer (PFE) closed at $43.76, marking no change from the previous day.",https://www.zacks.com/stock/news/434254/pfizer-pfe-flat-as-market-sinks-what-you-should-know,0.0,-0.296
PFE,2019-06-25,3 Healthcare Stocks to Buy With the Market Near All-Time Highs,https://cdn.snapi.dev/images/v1/h/e/healthcaremsn4-2.jpg,InvestorPlace,"PFE, JNJ and UNH are three healthcare stocks to buy even up near all-time market highs. Each for its own reasons.",https://investorplace.com/2019/06/3-healthcare-stocks-to-buy-with-the-market-near-all-time-highs/,0.0,0.0
PFE,2019-06-24,The 7 Best Acquisitions of 2019,https://cdn.snapi.dev/images/v1/m/e/mergermsn.jpg,InvestorPlace,The $28 billion acquisition is the eighth-largest bank deal of all time. It’s expected to close in the fourth quarter.,https://investorplace.com/2019/06/the-7-best-acquisitions-of-2019/,0.6369,0.0
PFE,2019-06-24,Read This Before You Buy Any New Cancer Drug Stocks,https://cdn.snapi.dev/images/v1/d/j/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5294672flaboratory-technician-pipeting-bloodjpgw700opresize.jpg,The Motley Fool,Around $36 billion worth of biopharma acquisitions over the past few years suggests smaller might be better.,https://www.fool.com/investing/2019/06/24/read-this-before-you-buy-any-new-cancer-drug-stock.aspx?source=iedfolrf0000001,-0.6597,0.5859
PFE,2019-06-24,Pfizer's Talzenna Gets Approval in Europe for Breast Cancer,https://cdn.snapi.dev/images/v1/0/y/drugs7.jpg,Zacks Investment Research,"Pfizer's (PFE) PARP inhibitor, Talzenna, receives approval in Europe for treating BRCA-mutated locally advanced or metastatic breast cancer.",https://www.zacks.com/stock/news/433383/pfizers-talzenna-gets-approval-in-europe-for-breast-cancer,-0.3182,-0.1531
PFE,2019-06-24,These 3 Biotech Stocks Skyrocketed Last Week -- Are They Buys Now?,https://cdn.snapi.dev/images/v1/z/q/biotech38-6.jpg,The Motley Fool,These stocks were huge winners last week. But can their momentum continue?,https://www.fool.com/investing/2019/06/23/these-3-biotech-stocks-skyrocketed-last-week-are-t.aspx?source=iedfolrf0000001,0.0,0.6597
PFE,2019-06-21,5 Dow Stocks Not Allowing the DJIA a Proper Rally,https://cdn.snapi.dev/images/v1/e/t/etf7-22.jpg,24/7 Wall Street,The markets have been on a wild ride in this year. The seasonal theme of “Sell in May and go away” passed and seemingly has turned into “Hold your nose and buy in June.,https://247wallst.com/investing/2019/06/21/5-dow-stocks-not-allowing-the-djia-a-proper-rally/,0.0,0.0
PFE,2019-06-21,Pfizer Receives European Commission Approval For Breast Cancer Drug TALZENNA,https://cdn.snapi.dev/images/v1/y/c/medic-563423-1920-1-2.jpg,Benzinga,Pfizer (NYSE:PFE) has received approval from the European Commission for its TALZENNA a breast cancer drug.,https://www.benzinga.com/news/19/06/13957440/pfizer-receives-european-commission-approval-for-breast-cancer-drug-talzenna,-0.3182,-0.3182
PFE,2019-06-20,GSK offers concessions to address EU concerns over Pfizer deal,https://cdn.snapi.dev/images/v1/i/k/m02d20190620t2i1399681607rlynxnpef5j0juw640.jpg,Reuters,"GlaxoSmithKline has offered concessions to address EU antitrust concerns over its planned joint venture with Pfizer's consumer health business, the European Commission said on Thursday.",https://www.reuters.com/article/us-pfizer-m-a-gsk-eu/gsk-offers-concessions-to-address-eu-concerns-over-pfizer-deal-idUSKCN1TL0R0,0.0,0.0
PFE,2019-06-19,Here's Pfizer's Motivation Behind Its Biggest Takeover In 3 Years,https://cdn.snapi.dev/images/v1/b/p/drugs4.jpg,Investors Business Daily,"Dow Jones component Pfizer could become a leader in colon cancer treatment with its looming $11.4 billion acquisition of biotech company Array BioPharma, an analyst said Wednesday.",https://www.investors.com/news/technology/cancer-treatment-pfizer-buying-biotech-company-array/,0.34,-0.7096
PFE,2019-06-19,Big Drugmakers That May Tread the M&A Path After Pfizer,https://cdn.snapi.dev/images/v1/3/8/383-3.jpg,Zacks Investment Research,"There has been a flurry of M&A deal announcements this year in the drug industry. Here we discuss three big drug/biotech companies, which may make the next M&A move.",https://www.zacks.com/stock/news/431504/big-drugmakers-that-may-tread-the-ma-path-after-pfizer,0.0,0.0
PFE,2019-06-19,"3 Big Stock Charts for Wednesday: Pfizer, FMC and McCormick & Company",https://cdn.snapi.dev/images/v1/e/t/etf26-39.jpg,InvestorPlace,"The stock charts of MKC, FMC and PFE are at major turning points here at the midpoint of the trading week.",https://investorplace.com/2019/06/3-big-stock-charts-for-wednesday-pfe-mkc-fmc/,0.0,0.0
PFE,2019-06-18,"Pfizer to Buy Array BioPharma, Broaden Cancer Portfolio",https://cdn.snapi.dev/images/v1/b/a/biotech23.jpg,Zacks Investment Research,Pfizer (PFE) offers $48 per share to buy Array BioPharma and strengthen its cancer portfolio.,https://www.zacks.com/stock/news/431106/pfizer-to-buy-array-biopharma-broaden-cancer-portfolio,-0.6597,-0.2263
PFE,2019-06-18,5 Dividend Leaders To Buy From Merrill Lynch’s Large Cap Defensive Portfolio,https://cdn.snapi.dev/images/v1/e/t/etf5-24.jpg,24/7 Wall Street,"With summer starting on Friday, we could be in for a hot three months in more ways than one.",https://247wallst.com/investing/2019/06/18/5-dividend-leaders-to-buy-from-merrill-lynchs-large-cap-defensive-portfolio/,0.0258,0.0
PFE,2019-06-17,Biotech M&A Boom: 4 trades,https://cdn.snapi.dev/images/v1/t/f/tfs72.jpg,CNBC Television,"The ""Fast Money"" traders give you 4 trades in Biotech as the deal space heats up in the sector.",https://www.youtube.com/watch?v=AfpX7f4Uy_Y,0.0,0.0
PFE,2019-06-17,Fmr. FDA commissioner on biotech,https://cdn.snapi.dev/images/v1/m/q-5/fmr-fda-commissioner-on-biotech.jpg,CNBC Television,Former FDA Commissioner Scott Gottlieb on biotech,https://www.youtube.com/watch?v=YqJDCmWU2Lg,0.0,0.0
PFE,2019-06-17,Pfizer strengthens its position in cancer,https://cdn.snapi.dev/images/v1/u/g/biotech3.jpg,The Motley Fool,"Acquisitions made headlines, with Pfizer buying Array BioPharma.",https://www.fool.com/investing/2019/06/17/what-happened-in-the-stock-market-today.aspx?source=iedfolrf0000001,-0.34,0.0
PFE,2019-06-17,Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon,https://cdn.snapi.dev/images/v1/e/s/esuq7.jpg,The Motley Fool,The big drugmaker is spending more than $11 billion for the cancer-drug specialist.,https://www.fool.com/investing/2019/06/17/why-pfizers-acquisition-of-array-biopharma-wont-pa.aspx?source=iedfolrf0000001,0.0762,0.0
PFE,2019-06-17,Five Top Stock Trades for Tuesday June 18,https://cdn.snapi.dev/images/v1/s/t/stoc99.jpg,InvestorPlace,"Gilead Sciences, Pfizer, Tesla, Netflx and Facebook are our top stock trades for Tuesday. Here's a look at the charts.",https://investorplace.com/2019/06/5-top-stock-trades-for-tuesday-fb-nflx-gild-tsla/,0.2023,0.2023
PFE,2019-06-17,Array BioPharma News: ARRY Stock Skyrockets on Pfizer Deal,https://cdn.snapi.dev/images/v1/q/i/biotech11.jpg,InvestorPlace,Array BioPharma news for Monday concerning a deal with Pfizer (PFE) that will have the two companies coming together has ARRY stock soaring.,https://investorplace.com/2019/06/array-biopharma-news-boosts-arry-stock/,0.0,0.0
PFE,2019-06-17,How Much Is Pfizer Overpaying For Array Bio?,https://cdn.snapi.dev/images/v1/g/o/pf9-3.jpg,24/7 Wall Street,Array BioPharma Inc. shares shot up on Monday after the firm announced that it would be acquired by Pfizer Inc. in an all cash transaction.,https://247wallst.com/healthcare-business/2019/06/17/how-much-is-pfizer-overpaying-for-array-bio/,0.0,0.296
PFE,2019-06-17,Stock Market News: Array Get Winning Bids on a Big Deal Day,https://cdn.snapi.dev/images/v1/4/6/biotech17.jpg,The Motley Fool,Wall Street was in an optimistic mood on Monday morning.,https://www.fool.com/investing/2019/06/17/stock-market-news-sothebys-array-get-winning-bids.aspx?source=iedfolrf0000001,0.5267,0.3182
PFE,2019-06-17,"""Merger Monday"" Returns: Pfizer Buying Array",https://cdn.snapi.dev/images/v1/o/8/biotech10.jpg,Zacks Investment Research,"News on two major mergers in their respective industries are taking headlines, along with a fresh regional economic read.",https://www.zacks.com/stock/news/430565/merger-monday-returns-pfizer-buying-array-t-mobile-sprint-on-ice,0.0,0.6249
PFE,2019-06-17,Pfizer will access Array's approved cancer drugs in $11 billion deal,https://cdn.snapi.dev/images/v1/y/2/pfizer-will-access-arrays-approved-cancer-drugs-in-11-billion-deal.jpg,CNBC Television,"Dow component Pfizer is buying Array Biopharma for $48 per share in cash, or $11.4 billion.",https://www.youtube.com/watch?v=0E2mWA269PQ,-0.3818,0.296
PFE,2019-06-17,Pfizer acquires array biopharma in $10.64B deal,https://cdn.snapi.dev/images/v1/f/p/pfizer-acquires-array-biopharma-in-1064b-deal.jpg,Yahoo Finance,Pfizer is buying Array BioPharma in a deal valued at $10.6 billion.,https://www.youtube.com/watch?v=pW7KVOjEILc,0.0,0.4404
PFE,2019-06-17,How An $11.4 Billion Takeover Will Deepen Pfizer's Efforts In Cancer,https://cdn.snapi.dev/images/v1/r/b/drugs9.jpg,Investors Business Daily,"Dow Jones component Pfizer announced Monday an $11.4 billion plan to acquire biotech company Array BioPharma, which is working on cancer treatments.",https://www.investors.com/news/technology/biotech-company-array-acquired-pfizer-deal-cancer-treatments/,-0.6597,-0.6597
PFE,2019-06-17,Why Array BioPharma Stock Is on Fire Today,https://cdn.snapi.dev/images/v1/b/i/biotech18-6.jpg,The Motley Fool,Pfizer moves to acquire the cancer specialist in a deal valued at $11.4 billion.,https://www.fool.com/investing/2019/06/17/why-array-biopharma-inc-is-on-fire-today.aspx?source=iedfolrf0000001,-0.34,-0.3612
PFE,2019-06-17,S&P places Pfizer ratings on CreditWatch negative after $11.4 billion Array deal,https://cdn.snapi.dev/images/v1/g/v/pf9.jpg,Market Watch,"S&P Global Ratings placed Pfizer Inc.'s ratings on CreditWatch negative on Monday, after the drug company announced that it is acquiring Array BioPharma Inc.",https://www.marketwatch.com/story/sp-places-pfizer-ratings-on-creditwatch-negative-after-114-billion-array-deal-2019-06-17,-0.5719,-0.5719
PFE,2019-06-17,Pfizer To Buy Array BioPharma For $48/Share,https://cdn.snapi.dev/images/v1/c/j/medicine-2520463-1920-20.jpg,Benzinga,Array BioPharma (NASDAQ: ARRY) shares are trading sharply higher after the company announced it will be acquired by Pfizer (NYSE: PFE) for $48 per share in cash for a total value of around $11.4 billion.,https://www.benzinga.com/general/biotech/19/06/13928334/pfizer-to-buy-array-biopharma-for-48share,0.0,0.7003
PFE,2019-06-17,Pfizer buys Array Biopharma for $48/share in cash,https://cdn.snapi.dev/images/v1/p/a/pah82.jpg,CNBC Television,"Dow component Pfizer is buying Array Biopharma for $48 per share in cash, or $11.4 billion.",https://www.youtube.com/watch?v=2wDGoXrrMPk,0.0,0.296
PFE,2019-06-17,Array BioPharma's stock rockets after $11.4 billion buyout deal with Pfizer,https://cdn.snapi.dev/images/v1/q/k/biotech4.jpg,Market Watch,"Shares of Array BioPharma Inc. ARRY, +0.58% rocketed 56% toward a record high in premarket trading Monday, after biopharmaceutical company developing cancer treatments agreed to be acquired by Pfizer Inc.",https://www.marketwatch.com/story/array-biopharmas-stock-rockets-after-114-billion-buyout-deal-with-pfizer-2019-06-17,0.0,-0.2732
PFE,2019-06-17,Pfizer to buy Array for $10.64 billion,https://cdn.snapi.dev/images/v1/4/c/m02d20190617t2i1398681146rlynxnpef5g0nmw640.jpg,Reuters,"Pfizer Inc said on Monday it had agreed to acquire Array Biopharma Inc for $10.64 billion, which will grant it access to its cancer drugs.",https://www.reuters.com/article/us-array-biopharma-m-a-pfizer/pfizer-to-buy-array-for-10-64-billion-idUSKCN1TI15T,0.0,-0.2023
PFE,2019-06-17,5 Biggest Blockbuster Drugs of the Future,https://cdn.snapi.dev/images/v1/d/r/drugs50.jpg,The Motley Fool,Each of these drugs is forecast to rake in at least $9.5 billion in 2024. Investors looking to profit should pay attention to the pharmaceutical giants that sell them.,https://www.fool.com/investing/2019/06/15/5-biggest-blockbuster-drugs-of-the-future.aspx?source=iedfolrf0000001,0.5994,0.3612
PFE,2019-06-14,7 Stocks Not Enjoying the Bull Market and Holding Down the Dow in 2019,https://cdn.snapi.dev/images/v1/e/t/etf16-38.jpg,24/7 Wall Street,It’s been a wild ride in 2019. The seasonal theme of “sell in May and go away” passed and seemingly has turned into “Hold your nose and buy in June.,https://247wallst.com/investing/2019/06/14/7-stocks-not-enjoying-the-bull-market-and-holding-down-the-dow-in-2019/,-0.4168,0.0
PFE,2019-06-13,Pfizer's (PFE) Xeljanz Effective As Monotherapy in RA Study,https://cdn.snapi.dev/images/v1/f/b/drugs33.jpg,Zacks Investment Research,Pfizer's (PFE) study on JAK inhibitor Xeljanz XR demonstrates the efficacy of the medicine when used as a monotherapy without methotrexate.,https://www.zacks.com/stock/news/428916/pfizers-pfe-xeljanz-effective-as-monotherapy-in-ra-study,0.4767,-0.0772
PFE,2019-06-12,6 Large-Cap Stocks Outperforming the Benchmark,https://cdn.snapi.dev/images/v1/e/t/etf45-15.jpg,GuruFocus,"According to the GuruFocus All-in-One Screener, the following stocks have outperformed the Standard & Poor's 500 Index over the last 12 months.",https://www.gurufocus.com/news/893322/6-largecap-stocks-outperforming-the-benchmark,0.0,0.0
PFE,2019-06-12,Top Ranked Income Stocks to Buy for June 12th 2019,https://cdn.snapi.dev/images/v1/e/t/etf20-24.jpg,Zacks Investment Research,Top Ranked Income Stocks to Buy for June 12th,https://www.zacks.com/commentary/428514/top-ranked-income-stocks-to-buy-for-june-12th,0.2023,0.2023
PFE,2019-06-12,Big Pharma Sees a Rising Tide in Short Interest,https://cdn.snapi.dev/images/v1/1/5/15pha.jpg,24/7 Wall Street,Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials.,https://247wallst.com/healthcare-business/2019/06/12/big-pharma-sees-a-rising-tide-in-short-interest/,0.4588,0.0
PFE,2019-06-12,Boost Your Portfolio's Health With These 3 Big Drug Stocks,https://cdn.snapi.dev/images/v1/2/8/287-4.jpg,Zacks Investment Research,The large-cap pharma industry is doing well in 2019. Here are three stocks from the space that investors may consider betting on.,https://www.zacks.com/stock/news/428332/boost-your-portfolios-health-with-these-3-big-drug-stocks,0.4019,0.2732
PFE,2019-06-12,4 Price Momentum Stocks Hedge Funds Love Could Be Big Summer Winners,https://cdn.snapi.dev/images/v1/8/h/8hed.jpg,24/7 Wall Street,"We have noted that hedge fund performance over the past couple of years, especially by some of the bigger funds, has trailed the overall market performance.",https://247wallst.com/investing/2019/06/12/4-price-momentum-stocks-hedge-funds-love-could-be-big-summer-winners/,0.8074,0.0
PFE,2019-06-12,6 Most Shorted Dow Stocks,https://cdn.snapi.dev/images/v1/7/s/7sho-1.jpg,24/7 Wall Street,"It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.",https://247wallst.com/investing/2019/06/12/6-most-shorted-dow-stocks-pfizer-still-on-top/,0.0,0.6486
PFE,2019-06-10,Five Health Care Stocks Gurus Are Buying,https://cdn.snapi.dev/images/v1/2/0/20heal.jpg,GuruFocus,"According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.",https://www.gurufocus.com/news/891970/5-health-care-stocks-gurus-are-buying,0.4939,0.7184
PFE,2019-06-10,These 3 Biotech Stocks Doubled in the First Half of 2019,https://cdn.snapi.dev/images/v1/e/t/etf24-23.jpg,The Motley Fool,Could the second half of the year be as much fun as the first?,https://www.fool.com/investing/2019/06/10/these-3-biotech-stocks-doubled-in-first-half-2019.aspx?source=iedfolrf0000001,0.0,0.5106
PFE,2019-06-07,Why I'm Sticking With My 3 Worst-Performing Stocks of 2019 So Far,https://cdn.snapi.dev/images/v1/u/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5178452fscientist-holding-a-test-tube.jpg,The Motley Fool,"They might be this year's Bad News Bears, but I think these three stocks will be long-term winners.",https://www.fool.com/investing/2019/06/07/why-im-sticking-with-my-3-worst-performing-stocks.aspx?source=iedfolrf0000001,0.0,0.4404
PFE,2019-06-06,Why Is Array BioPharma (ARRY) Up 27.1% Since Last Earnings Report?,https://cdn.snapi.dev/images/v1/b/n/biotech8.jpg,Zacks Investment Research,Array BioPharma (ARRY) reported earnings 30 days ago. What's next for the stock?,https://www.zacks.com/stock/news/425534/why-is-array-biopharma-arry-up-271-since-last-earnings-report,0.0,0.0
PFE,2019-06-06,5 Reasons Pfizer Sat on a Potential New Alzheimer's Drug,https://cdn.snapi.dev/images/v1/n/a/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5278612fhealthcare-provider-helping-a-patient-stand-gettyjpgw700opresize.jpg,The Motley Fool,America's largest pharmaceutical company had plenty of good reasons not to pursue a potential new Alzheimer's treatment.,https://www.fool.com/investing/2019/06/06/5-reasons-pfizer-sat-on-a-potential-new-alzheimers.aspx?source=iedfolrf0000001,0.0,0.4404
PFE,2019-06-06,"3 Big Stock Charts for Thursday: Pfizer, Walmart and FleetCor Technologies",https://cdn.snapi.dev/images/v1/e/t/etf14-30.jpg,InvestorPlace,"The stock charts of WMT, FLT and PFE are headed into the latter half of the week at inflection points. Here's what you can expect from each.",https://investorplace.com/2019/06/3-big-stock-charts-for-thursday-pfizer-walmart-and-fleetcor-technologies/,0.0,0.0
PFE,2019-06-05,Pfizer denies report it hid possible Alzheimer’s breakthrough,https://cdn.snapi.dev/images/v1/q/8/pfizer-alzheimers-reportjpgquality90stripall.jpg,New York Post,"Pfizer is fighting back against a report that it hid the potential of a blockbuster drug to prevent Alzheimer’s disease in order to avoid shelling out for a “costly clinical trial.” Researchers at Pfizer in 2015 found that Enbrel, an anti-inflammatory drug used to treat rheumatioid arthritis, seemed to reduce the risk of Alzheimer’s disease.",https://nypost.com/2019/06/05/pfizer-denies-report-it-hid-possible-alzheimers-breakthrough/,-0.4939,0.128
PFE,2019-06-05,Pfizer to Launch Several Drugs Despite Generic Headwinds,https://cdn.snapi.dev/images/v1/s/z/drugs16.jpg,Zacks Investment Research,Pfizer (PFE) looks well positioned to launch several breakthrough innovative medicines in the next five years amid loss of exclusivity headwinds.,https://www.zacks.com/stock/news/424912/pfizer-to-launch-several-drugs-despite-generic-headwinds,0.0,0.4019
PFE,2019-06-05,The Four Most Oversold Dow Stocks,https://cdn.snapi.dev/images/v1/1/1/11over.jpg,Forbes,"Many of the stocks in the Dow Industrial Average dropped sharply in May as fears over the deepening trade war made them less attractive to investors. In his regular monthly scan, Viper Report’s Tom Aspray discusses the four most oversold Dow stocks.",https://www.forbes.com/sites/tomaspray/2019/06/05/the-four-most-oversold-dow-stocks/,0.0,-0.624
PFE,2019-06-04,The 10 Best Stocks for 2019 — So Far,https://cdn.snapi.dev/images/v1/b/u/bul23.jpg,InvestorPlace,"Roku, Array Biopharma and Guardant Health are just some of the best stocks by returns for the first half of 2019. The post The 10 Best Stocks for 2019 — So Far appeared first on InvestorPlace.",https://investorplace.com/2019/06/the-10-best-stocks-for-2019-so-far/,0.6369,0.8555
PFE,2019-06-04,"Top Research Reports for Pfizer, Coca-Cola & VMware",https://cdn.snapi.dev/images/v1/r/l/asset-management19.jpg,Zacks Investment Research,"Top Research Reports for Pfizer, Coca-Cola & VMware",https://www.zacks.com/research-daily/424605/top-research-reports-for-pfizer-coca-cola-vmware,0.2023,0.2023
PFE,2019-06-04,3 Cancer Stocks Given a Lift by Amgen,https://cdn.snapi.dev/images/v1/n/o/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5183412fbiotech-stocks-to-own.jpg,The Motley Fool,Success with an experimental new oncology treatment that scratches a 35-year itch is good news for more than one biotech stock.,https://www.fool.com/investing/2019/06/04/3-cancer-stocks-given-a-lift-by-amgen.aspx?source=iedfolrf0000001,-0.6597,0.765
PFE,2019-06-03,6 High-Yield Stocks,https://cdn.snapi.dev/images/v1/e/t/etf14-29.jpg,GuruFocus,"According to the GuruFocus All-in-One Screener, the following companies have high dividend yields but performed poorly over the last 12 months.",https://www.gurufocus.com/news/888731/6-highyield-stocks,0.0,0.0
PFE,2019-06-03,"'Dogs Of The Dow' Slump, Here's How To Trade Them Now",https://cdn.snapi.dev/images/v1/1/4/14dow.jpg,Forbes,"The eight “Dogs of the Dow” for 2019 have an aggregate year-to-date gain of 5.5% at the end of May, down from 12.2% at the end of April. Here's how to buy and sell them now.",https://www.forbes.com/sites/investor/2019/06/03/dogs-of-the-dow-slump-heres-how-to-trade-them-now/,0.0,0.5267
PFE,2019-05-30,Only five Dow stocks have gained in May as trade war drags on,https://cdn.snapi.dev/images/v1/1/0-2/103310522-gettyimages-479184028.jpg,CNBC,"Just five Dow components were poised for May gains Thursday afternoon, a reflection of the effect the trade war is having on Wall Street.",https://www.cnbc.com/2019/05/30/only-five-dow-stocks-have-gained-in-may-as-trade-war-drags-on.html,-0.4588,-0.128
PFE,2019-05-30,2 Ultra-High-Growth Biotech Stocks to Buy Now,https://cdn.snapi.dev/images/v1/b/i/biotech38-6.jpg,The Motley Fool,Amicus Therapeutics and Array BioPharma are two top growth stocks to consider buying now.,https://www.fool.com/investing/2019/05/30/2-ultra-high-growth-biotech-stocks-to-buy-now.aspx?source=iedfolrf0000001,0.0,0.5267
PFE,2019-05-30,Pfizer (PFE) Up 2.3% Since Last Earnings Report: Can It Continue?,https://cdn.snapi.dev/images/v1/i/b/pfi92.jpg,Zacks Investment Research,Pfizer (PFE) reported earnings 30 days ago. What's next for the stock?,https://www.zacks.com/stock/news/422183/pfizer-pfe-up-23-since-last-earnings-report-can-it-continue,0.0,0.0
PFE,2019-05-29,Array's Positive Phase 3 Results Make The Case For Revenue Growth For BRAFTOVI And METKOVI,https://cdn.snapi.dev/images/v1/d/m/biotech27.jpg,Seeking Alpha,"Array obtained positive results for its phase 3 BEACON CRC study using BRAFTOVI, METKOVI, and ERBITUX to treat patients with BRAF mutant metastatic colorectal cancer.",https://seekingalpha.com/article/4267182-arrays-positive-phase-3-results-make-case-revenue-growth-braftovi-metkovi?source=feed_tag_long_ideas,0.7351,0.2263
PFE,2019-05-28,This Just In: Goldman Sachs Picks 4 Big Pharma Stocks to Buy,https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5270562fdrugs-pharmaceuticals-pill-box-pills-2018-05-10-12-39-51-utcjpgw700opresize.jpg,The Motley Fool,And the analyst really likes one in particular.,https://www.fool.com/investing/2019/05/28/this-just-in-goldman-sachs-picks-4-big-pharma-stoc.aspx?source=iedfolrf0000001,0.0,0.4754
PFE,2019-05-28,4 Drug and Health Stocks Pushing Higher  ,https://cdn.snapi.dev/images/v1/b/i/biotechmsn-compressed.jpg,InvestorPlace,"U.S. equities are mostly higher in post-holiday trading on Tuesday, as investors are looking for stocks to buy.",https://feedproxy.google.com/~r/InvestorPlace/~3/71FlC3SQO_c/,0.0,0.0
PFE,2019-05-27,Pfizer's (PFE) Epilepsy Drug Lyrica Fails in Phase III Study,https://cdn.snapi.dev/images/v1/l/s/pf9-3.jpg,Zacks Investment Research,"Pfizer (PFE) announces failure of a phase III study evaluating Lyrica in patients with primary generalized tonic-clonic seizures, a form of epilepsy.",https://www.zacks.com/stock/news/420063/pfizers-pfe-epilepsy-drug-lyrica-fails-in-phase-iii-study,-0.4215,-0.5106
PFE,2019-05-24,Pfizer's Lyrica doesn't meet endpoint in epilepsy study,https://cdn.snapi.dev/images/v1/l/y/ly7dr.jpg,Market Watch,Pfizer Inc. said late Friday one of its drugs did not meet set goals for the treatment of epilepsy in a late stage clinical trial.,https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/gmEaZnwq7Fw/story.aspx,0.0,0.0
PFE,2019-05-23,Pfizer Has Limited Downside,https://cdn.snapi.dev/images/v1/o/s/11-2.jpg,Seeking Alpha,10-year chart shows strong support for shares.,https://seekingalpha.com/article/4266229-pfizer-limited-downside?source=feed_tag_long_ideas,-0.4404,0.802
PFE,2019-05-23,Pfizer or Johnson & Johnson? The viewers #AskHalftime,https://cdn.snapi.dev/images/v1/p/f/pfzj7.jpg,CNBC Television,"The ""Halftime Report"" traders answer viewer questions on Pfizer & J&J.",https://www.youtube.com/watch?v=RtaOeJqeP8c&t=36s,0.0,0.0
PFE,2019-05-23,Mr. Wonderful's Top 10 Dividend Stocks,https://cdn.snapi.dev/images/v1/0/x/0x600-149.jpg,Forbes,"Kevin O’Leary is Chairman of O’Shares Investments, but you probably know him as “Mr. Wonderful” from Shark Tank, assertsBen Reynolds, editor ofSure Dividendand contributor toMoneyShow.comin a special report that analyzes some of the shark’s top high quality, dividend paying ideas.",https://www.forbes.com/sites/moneyshow/2019/05/23/mr-wonderfuls-top-10-dividend-stocks/,0.2023,0.6956
PFE,2019-05-23,"Array BioPharma Inc. (ARRY) Shares March Higher, Can It Continue?",https://cdn.snapi.dev/images/v1/j/i/biotech6.jpg,Zacks Investment Research,"As of late, it has definitely been a great time to be an investor in Array BioPharma Inc. (ARRY).",https://www.zacks.com/stock/news/418486/array-biopharma-inc-arry-shares-march-higher-can-it-continue,0.296,0.7783
PFE,2019-05-21,Better Buy: AbbVie vs. Pfizer,https://cdn.snapi.dev/images/v1/k/5/hcs2.jpg,The Motley Fool,AbbVie and Pfizer are both undergoing a radical makeover. Which company should investors trust to come out even stronger?,https://www.fool.com/investing/2019/05/21/better-buy-abbvie-vs-pfizer.aspx?source=iedfolrf0000001,0.4404,0.7096
PFE,2019-05-20,Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock,https://cdn.snapi.dev/images/v1/p/f/pfemsn-300x165.jpg,InvestorPlace,Buy Pfizer stock on this current round of weakness. The underpinnings are bullish for 2020 and beyond.,https://feedproxy.google.com/~r/InvestorPlace/~3/30572ZveJNQ/,0.3818,-0.4215
PFE,2019-05-15,Pfizer Stock Is The Biggest Pharma — But Should You Buy It?,https://cdn.snapi.dev/images/v1/d/a/drugs11.jpg,Investors Business Daily,"Pfizer stock has fallen 7.1% this year, behind pharma stocks. Recent news has been upbeat with a drug approval and earnings beat.",https://feedproxy.google.com/~r/InternetTechnologyRss/~3/ciWE76f27MY/,0.0,0.1531
PFE,2019-05-14,Shark Tank's Kevin O'Leary: Keep your stock picks boring during trade turmoil,https://cdn.snapi.dev/images/v1/m/q-4/shark-tanks-kevin-oleary-keep-your-stock-picks-boring-during-trade-turmoil.jpg,CNBC Television,"Guest Host Kevin O'Leary of Shark Tank joins ""Squawk Box"" to give his top stock picks amid the market sell-off and what he thinks investors should do about Boeing.",https://www.youtube.com/watch?v=7DoVpIJT2qQ,-0.5859,0.2023
PFE,2019-05-13,Top vaccine makers Merck and Pfizer target China and older adults next,https://cdn.snapi.dev/images/v1/p/f/pfi22.jpg,CNBC,"The four companies that now dominate global vaccine sales are Merck, Pfizer, Sanofi Pasteur and GlaxoSmithKline.",https://www.cnbc.com/2019/05/10/merck-pfizer-sanofi-pasteur-and-glaxosmithkline-make-billions-from-shingrix-and-gardasil-vaccines.html,0.2023,-0.128
PFE,2019-05-10,All You Need to Know About Array BioPharma (ARRY) Rating Upgrade to Buy,https://cdn.snapi.dev/images/v1/r/e/biotech3.jpg,Zacks Investment Research,"Array BioPharma (ARRY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).",https://www.zacks.com/stock/news/412542/all-you-need-to-know-about-array-biopharma-arry-rating-upgrade-to-buy,0.0,0.7506
PFE,2019-05-09,2 Pharma Giants Shine as Wall Street Brings Strong IPOs for Cortexyme and NextCure,https://cdn.snapi.dev/images/v1/6/e/6el.jpg,24/7 Wall Street,Thursday market saw two very successful IPOs in the emerging biotech sector.,https://feedproxy.google.com/~r/typepad/RyNm/~3/viMU8PpZeNU/,0.5106,0.624
PFE,2019-05-08,Pfizer Buys Rare Disease Biotech Therachon For $340M,https://cdn.snapi.dev/images/v1/s/9/syringe-1884758-1920-7-4.jpg,Benzinga,"Pfizer Inc. (NYSE: PFE) said Wednesday that it reached a definitive agreement to acquire all the shares of Therachon Holding AG, a privately held clinical-stage biotech focused on rare diseases.",https://feeds.benzinga.com/~r/benzinga/~3/WV6qRuusYTc/pfizer-buys-rare-disease-biotech-therachon-for-340m,0.0,0.8126
PFE,2019-05-08,Array BioPharma (ARRY) Q3 Earnings and Sales Beat Estimates,https://cdn.snapi.dev/images/v1/y/c/biotech17.jpg,Zacks Investment Research,Array BioPharma's (ARRY) top and bottom lines beat estimates in the third quarter of fiscal 2019. Momentum in uptake of Braftovi-Mektovi combination therapy continues.,https://www.zacks.com/stock/news/411124/array-biopharma-arry-q3-earnings-and-sales-beat-estimates,0.0,0.2023
PFE,2019-05-07,Can Pfizer Leap Over the Competition With This Potential Blockbuster?,https://cdn.snapi.dev/images/v1/p/t/pt-25-193063-ojpg.jpg,The Motley Fool,"It's been nearly seven years since the FDA refused to approve tafamidis's first new drug application, and the field is a lot more crowded now.",https://www.fool.com/investing/2019/05/07/can-pfizer-leap-over-competition-with-tafamidis.aspx?source=iedfolrf0000001,0.5994,-0.296
PFE,2019-05-07,Array BioPharma Inc. (ARRY) CEO Ron Squarer on Q3 2019 Results - Earnings Call Transcript,https://cdn.snapi.dev/images/v1/n/s/transcript6jpg.jpg,Seeking Alpha,Array BioPharma Inc. (ARRY) CEO Ron Squarer on Q3 2019 Results - Earnings Call Transcript,https://seekingalpha.com/article/4261149-array-biopharma-inc-arry-ceo-ron-squarer-q3-2019-results-earnings-call-transcript?source=feed_sector_transcripts,0.0,0.0
PFE,2019-05-07,"Array BioPharma (ARRY) Reports Q3 Loss, Tops Revenue Estimates",https://cdn.snapi.dev/images/v1/o/z/biotech2jpg.jpg,Zacks Investment Research,"Array BioPharma (ARRY) delivered earnings and revenue surprises of 19.05% and 25.59%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?",https://www.zacks.com/stock/news/410143/array-biopharma-arry-reports-q3-loss-tops-revenue-estimates,0.25,0.128
PFE,2019-05-06,How Dow Jones' Pfizer Could Take On New Drugs From 2 Biotech Stocks,https://cdn.snapi.dev/images/v1/e/l/pfz.jpg,Investors Business Daily,Dow Jones component Pfizer gained approval Monday for a drug that treats a rare heart disease — potentially rivaling new drugs from Alnylam Pharmaceuticals and Ionis Pharmaceuticals.,https://feedproxy.google.com/~r/BusinessRss/~3/dVL5agWqXzw/,0.0,0.6908
PFE,2019-05-06,5 Reasons Why Pfizer Is a Great Stock to Buy and Hold for the Long Term,https://cdn.snapi.dev/images/v1/a/h/pd2.jpg,The Motley Fool,"A few bumps in the road might be on the way, but this big pharma stock should have pretty smooth sailing over the next decade.",https://www.fool.com/investing/2019/05/05/5-reasons-why-pfizer-is-a-great-stock-to-buy-and-h.aspx?source=iedfolrf0000001,0.6249,0.6486
PFE,2019-05-03,Pfizer Beats In Q1 But Lyrica Headwinds Will Likely Weigh On Near Term Growth,https://cdn.snapi.dev/images/v1/l/o/pf9.jpg,Forbes,"Pfizer recently reported its Q1 2019 results, which were above our estimates. This note details the company’s Q1 performance, and Trefis’ forecast for the full year 2019.",https://www.forbes.com/sites/greatspeculations/2019/05/03/pfizer-beats-in-q1-but-lyrica-headwinds-will-likely-weigh-on-near-term-growth/,0.3818,0.0
PFE,2019-05-02,Pfizer Stock Rebounds Under Cloud of Negative Charts,https://cdn.snapi.dev/images/v1/2/b/drugs48jpg.jpg,Investopedia,"Pfizer reported better-then-expected earnings on April 30, but the stock is under a ""death cross"" and a negative weekly chart.",https://www.investopedia.com/pfizer-stock-rebounds-under-cloud-of-negative-charts-4686156,-0.5719,-0.9081
PFE,2019-05-01,The top 2 health care names to play for a catch-up: Technician,https://cdn.snapi.dev/images/v1/h/e/he2l3.jpg,CNBC Television,"Mark Newton, Newton Advisors, on playing catch-up with health care stocks.",https://www.youtube.com/watch?v=20YklDG_jUo,0.7506,0.6124
PFE,2019-05-01,How Viagra Made Pfizer Billions Despite Generics,https://cdn.snapi.dev/images/v1/a/q/how-viagra-made-pfizer-billions-despite-generics.jpg,CNBC,Pfizer still holds the lead in the erectile dysfunction market even as Viagra sales falter.,https://www.youtube.com/watch?v=8f8ldl8-3AQ,0.0,-0.4215
PFE,2019-04-30,Pfizer Inc. (PFE) CEO Albert Bourla on Q1 2019 Results - Earnings Call Transcript,https://cdn.snapi.dev/images/v1/j/v/transcript46.jpg,Seeking Alpha,Pfizer Inc. (PFE) CEO Albert Bourla on Q1 2019 Results - Earnings Call Transcript,https://seekingalpha.com/article/4258082-pfizer-inc-pfe-ceo-albert-bourla-q1-2019-results-earnings-call-transcript?source=feed_sector_transcripts,0.0,0.0
PFE,2019-04-30,Pfizer CEO: Drug prices will not be a growth driver,https://cdn.snapi.dev/images/v1/m/q-3/pfizer-ceo-drug-prices-will-not-be-a-growth-driver.jpg,CNBC Television,"CNBC's Meg Tirrell reports on Pfizer's CEO claiming drug volume will drive growth for the company, not drug prices.",https://www.youtube.com/watch?v=An2kHegfIb8,-0.2924,0.3818
PFE,2019-04-30,What You Need to Know About Pfizer's Q1 Earnings Beat,https://cdn.snapi.dev/images/v1/a/w/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5217742fpfizer-earnings-04302019.jpg,The Motley Fool,The big drugmaker exceeded expectations in Q1 on both the top and bottom lines.,https://www.fool.com/investing/2019/04/30/what-you-need-to-know-about-pfizers-q1-earnings-be.aspx?source=iedfolrf0000001,0.0,0.2023
PFE,2019-04-30,Why Pfizer Shareholders Are Smiling After Earnings,https://cdn.snapi.dev/images/v1/p/f/pf9-4.jpg,24/7 Wall Street,"When Pfizer Inc. reported first-quarter 2019 results before markets opened Tuesday, the drugmaker posted adjusted diluted earnings per share (EPS) of $0.85 on revenues of $13.12 billion.",https://feedproxy.google.com/~r/typepad/RyNm/~3/mvJQvAx9tVk/,0.4588,0.296
PFE,2019-04-30,"Pfizer (PFE) Beats on Q1 Earnings & Sales, Raises EPS View",https://cdn.snapi.dev/images/v1/p/f/pfi92.jpg,Zacks Investment Research,Pfizer (PFE) beat estimates for first-quarter earnings and sales and raised the mid-point of its earnings expectations for 2019 by a penny and confirmed its previous outlook for full-year sales.,https://www.zacks.com/stock/news/405867/pfizer-pfe-beats-on-q1-earnings-sales-raises-eps-view,0.0,0.0
PFE,2019-04-30,Pfizer stock up 1.7% after earnings and revenue beat,https://cdn.snapi.dev/images/v1/p/f/pfizer5-2.jpg,Market Watch,"Shares of Pfizer rose 1.7% in premarket trade Tuesday after the company reported first-quarter earnings and revenue that beat expectations, while raising its full-year guidance.",https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/ubFp54YYhLU/story.aspx,0.0,0.296
PFE,2019-04-30,"Here's a breakdown of Big Pharma earnings from Merck, Pfizer, Eli Lilly",https://cdn.snapi.dev/images/v1/m/q-3/heres-a-breakdown-of-big-pharma-earnings-from-merck-pfizer-eli-lilly.jpg,CNBC Television,"CNBC's Meg Tirrell joins ""Squawk Box"" to discuss how earnings results from Pfizer, Merck and Eli Lilly compare.",https://www.youtube.com/watch?v=Fb9sFhR7yXE,0.0,0.0
PFE,2019-04-30,Three major pharmaceutical companies just reported earnings — here’s how they did,https://cdn.snapi.dev/images/v1/m/j/mjb6-2.jpg,CNBC,Shares of Pfizer and Merck rose after reporting financial results that beat expectations.,https://www.cnbc.com/2019/04/30/3-major-pharma-companies-just-reported-earning-heres-how-they-did.html,0.0,0.296
PFE,2019-04-30,"Pfizer, Merck both post earnings beats",https://cdn.snapi.dev/images/v1/m/q-3/pfizer-merck-both-post-earnings-beats.jpg,CNBC Television,"""Squawk Box"" reports on Pfizer's and Merck's earnings results and 2019 outlook.",https://www.youtube.com/watch?v=zwMShmxlZts,0.0,0.0
PFE,2019-04-30,Why This Could Be the Most Dangerous Time Ever to Invest in Healthcare Stocks,https://cdn.snapi.dev/images/v1/4/h/4hc.jpg,The Motley Fool,There's a clear and present danger to many healthcare stocks that's more serious than anything ever before.,https://www.fool.com/investing/2019/04/30/why-this-could-be-the-most-dangerous-time-ever-for.aspx?source=iedfolrf0000001,-0.5256,-0.3384
PFE,2019-04-29,AbbVie vs. Pfizer,https://cdn.snapi.dev/images/v1/i/c/391.jpg,The Motley Fool,Which big pharma stock is more likely to be the bigger winner over the long run?,https://www.fool.com/investing/2019/04/28/better-buy-pfizer-vs-abbvie.aspx?source=iedfolrf0000001,0.0,0.5859
PFE,2019-04-26,Pfizer & Apple: The Most Shorted Dow Stocks in April,https://cdn.snapi.dev/images/v1/p/a/pa22.jpg,24/7 Wall Street,"It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components. Short sellers are betting on these companies to fail, or at least for their share prices to fall handily.",https://feedproxy.google.com/~r/typepad/RyNm/~3/cGKNLHWlzrg/,0.0,0.4588
PFE,2019-04-24,Merck Maintains Status In Front-Line Cancer Space,https://cdn.snapi.dev/images/v1/f/d/fda3.jpg,Seeking Alpha,Merck announced FDA approval for Keytruda given in combination with Pfizer's Inlyta to treat front-line advanced kidney cancer patients.,https://seekingalpha.com/article/4256488-merck-maintains-status-front-line-cancer-space?source=feed_tag_long_ideas,-0.6597,0.34
PFE,2019-04-24,Pfizer to Report Q1 Earnings: Will It Beat Estimates?,https://cdn.snapi.dev/images/v1/r/d/pfi88.jpg,Zacks Investment Research,"While Pfizer's (PFE) key drugs like Ibrance and Xeljanz are likely to drive Q1 sales, genericization of key drugs and weak sales in the EH segment will hurt.",https://www.zacks.com/stock/news/398971/pfizer-pfe-to-report-q1-earnings-will-it-beat-estimates,0.0,-0.5859
PFE,2019-04-23,"Kidney-Cancer Market: Good for Patients, Hard for Investors",https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5201622fdoctor-patient-2.jpg,The Motley Fool,Drugmakers battle for patients.,https://www.fool.com/investing/2019/04/23/kidney-cancer-market-good-for-patients-hard-for-in.aspx?source=iedfolrf0000001,0.3612,-0.3818
PFE,2019-04-23,Pfizer (PFE) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release,https://cdn.snapi.dev/images/v1/v/3/pf9.jpg,Zacks Investment Research,Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,https://www.zacks.com/stock/news/391530/pfizer-pfe-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q1-release,0.0,0.2263
PFE,2019-04-22,Exact Sciences Is Near an All-Time High: Here's Why It Could Go Even Higher,https://cdn.snapi.dev/images/v1/e/x/exv2.jpg,The Motley Fool,Here's why Cologuard's popularity will continue to climb for a long time.,https://www.fool.com/investing/2019/04/22/exact-sciences-is-near-an-all-time-high-heres-why.aspx?source=iedfolrf0000001,0.0,0.4767
PFE,2019-04-22,"Eli Lilly-Pfizer's Non-Opioid Painkiller Faces Safety, Efficacy Concerns",https://cdn.snapi.dev/images/v1/t/j/syringe-1884758-1920-7-2.jpg,Benzinga,Eli Lilly And Co (NYSE: LLY) faced a setback following the  release of top-line results from a late-stage study of its pain medication candidate.,https://feeds.benzinga.com/~r/benzinga/~3/2Mn0g6Uelic/eli-lilly-pfizers-non-opioid-painkiller-faces-safety-efficacy-concerns,0.4215,-0.5106
PFE,2019-04-19,5 Top Pharmaceutical Stocks to Buy in 2019,https://cdn.snapi.dev/images/v1/u/r-2/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5178452fscientist-holding-a-test-tube.jpg,The Motley Fool,"Some are really big, while others are relatively small. But all these pharmaceutical stocks look like promising picks for 2019.",https://www.fool.com/investing/2019/04/19/5-top-pharmaceutical-stocks-to-buy-in-2019.aspx?source=iedfolrf0000001,0.2023,0.6369
PFE,2019-04-18,"Pfizer, Lilly shares decline as osteoarthritis drug misses goals in study",https://cdn.snapi.dev/images/v1/b/i/biotech33-2.jpg,Market Watch,Shares of drug makers Pfizer Inc. and Eli Lilly & Co. declined in the extended session Thursday after the companies said a clinical study of an osteoarthritis drug didn't meet certain goals.,https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/kLsbz4SWgaE/story.aspx,0.0772,0.0992
PFE,2019-04-15,The 3 Greatest Risks Pfizer Faces,https://cdn.snapi.dev/images/v1/p/d/pd2.jpg,The Motley Fool,Here's what could get in the way of the big pharma company's future success.,https://www.fool.com/investing/2019/04/14/the-3-greatest-risks-pfizer-faces.aspx?source=iedfolrf0000001,0.4767,0.5719
PFE,2019-04-11,Pfizer: A Better Prospect,https://cdn.snapi.dev/images/v1/p/t/pt-25-193063-o-2.jpg,Seeking Alpha,"Historical and projected rates of return for Johnson & Johnson are compared to similar data for Pfizer - with Pfizer, perhaps surprisingly, coming out a clear winner.",https://seekingalpha.com/article/4253889-johnson-and-johnson-solid-stable-returns-pfizer-better-prospect?source=feed_tag_long_ideas,0.6249,0.8225
PFE,2019-04-10,Pfizer Stock Sinks As Market Gains: What You Should Know,https://cdn.snapi.dev/images/v1/p/f/pfi9.jpg,Zacks Investment Research,"Pfizer closed the most recent trading day at $42.73, moving -0.26% from the previous trading session.",https://www.zacks.com/stock/news/378063/pfizer-pfe-stock-sinks-as-market-gains-what-you-should-know,0.34,0.0
PFE,2019-04-10,"Pfizer: Solid, Stable Returns",https://cdn.snapi.dev/images/v1/1/1/11-2.jpg,Seeking Alpha,"Supported by large share repurchases, Pfizer share price has shown steady growth, from ~$25 in 2012 to the current level.",https://seekingalpha.com/article/4253754-pfizer-solid-stable-returns?source=feed_tag_long_ideas,0.4215,0.8074
PFE,2019-04-10,The 5 Most Shorted Dow Stocks: Pfizer,https://cdn.snapi.dev/images/v1/p/f/pf9-3.jpg,24/7 Wall Street,"It takes a certain kind of courage to short sell blue chips, such as the Dow Jones industrial average components.",https://feedproxy.google.com/~r/typepad/RyNm/~3/vPJVvbrTkfI/,0.0,0.6486
PFE,2019-04-09,Brand-name drugs cost 18 times more than generics: AARP,https://cdn.snapi.dev/images/v1/m/q-2/brand-name-drugs-cost-18-times-more-than-generics-aarp.jpg,Fox Business,AARP Health Services Research Director Leigh Purvis discusses why drug prices are so high.,https://www.youtube.com/watch?v=5QOl-0NeTBM,0.0,0.0
PFE,2019-04-05,Pfizer's Ibrance Gets FDA Approval for Breast Cancer in Men,https://cdn.snapi.dev/images/v1/5/4/547-3.jpg,Zacks Investment Research,Pfizer's (PFE) blockbuster breast cancer medicine gets FDA approval to treat men. The approval for the expanded indication is based predominately on real-world data.,https://www.zacks.com/stock/news/371728/pfizers-ibrance-gets-fda-approval-for-breast-cancer-in-men,-0.3182,0.8126
PFE,2019-04-02,Gene-Editing Biotechs Pop After Pfizer Partner Scores In Hemophilia A,https://cdn.snapi.dev/images/v1/b/i/biotech39.jpg,Investors Business Daily,Sangamo Therapeutics popped to a five-month high Tuesday after its gene-editing therapy showed promise as a hemophilia A treatment. Sangamo stock jumped by double digits in high volume.,https://feedproxy.google.com/~r/BusinessRss/~3/tAUmjaSwIZ0/,0.0,0.3182
PFE,2019-04-01,"Bank Of America Hikes Pfizer Price Target, Estimates Citing Orphan Drug Catalysts",https://cdn.snapi.dev/images/v1/p/f/pf9.jpg,Benzinga,"Large-cap pharma stocks have seen a mixed performance in year to date, and among this group, Pfizer Inc.  is poised to benefit from some key second-half catalysts, according to an analyst at Bank of America Merrill Lynch.",https://feeds.benzinga.com/~r/benzinga/~3/IXoj1Kd4e9w/bank-of-america-hikes-pfizer-price-target-estimates-cit,0.0,0.6124
PFE,2019-03-29,This Dow stock could be a way to play catch-up to the rally,https://cdn.snapi.dev/images/v1/p/f/pfi2.jpg,CNBC,"The Dow is having its best start to the year since 2013. Now, two market watchers agree that one of the Dow components is a compelling name to own if you want to play catch-up: Pfizer.",https://www.cnbc.com/2019/03/29/pfizer-is-the-name-to-buy-to-catch-up-to-the-dows-rally-say-two-experts.html,0.34,0.8834
PFE,2019-03-27,Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck,https://cdn.snapi.dev/images/v1/p/f/pfi88.jpg,24/7 Wall Street,"Shares of drug giant Pfizer Inc.have been lagging rival Merck & Co., Inc.. The gain of 23% for Pfizer from this time a year ago is an impressive 23% return, but Merck’s gain has been 55% in the same period",https://feedproxy.google.com/~r/typepad/RyNm/~3/w-hVpgWnnBI/,-0.3182,0.8402
PFE,2019-03-25,5 Must-Own Merrill Lynch Income Portfolio High-Dividend Stocks,https://cdn.snapi.dev/images/v1/d/i/dividend1.jpg,24/7 Wall Street,24/7 Wall St. screened the portfolio looking for the highest yielding Buy rated companies and found five from different sectors that are solid plays now.,https://feedproxy.google.com/~r/typepad/RyNm/~3/Bzzb1JK-r4w/,0.0,0.3818
PFE,2019-03-22,"Final Trades: Verizon, XPO, Pfizer, Alphabet and BB&T",https://cdn.snapi.dev/images/v1/m/q/final-trades-verizon-xpo-pfizer-alphabet-and-bbt.jpg,CNBC Television,"The ""Halftime Report"" traders give their top stocks to watch for the second half.",https://www.youtube.com/watch?v=GOzdkOjGEqw,0.0,0.2023
PFE,2019-03-21,Diving for Dividends: PFIZER,https://cdn.snapi.dev/images/v1/p/f/pfe-21-03.png,CNBC Television,"Robert Sluymer, Fundstrat Technician, outlines his top stock to buy for investors searching for yield.",https://www.youtube.com/watch?v=PXUF2FmSj68&t=132s,0.0772,0.2023
PFE,2019-03-20,Pfizer acquires option to buy Vivet Therapeutics for equivalent of $635.8 million,https://cdn.snapi.dev/images/v1/p/f/pfz.jpg,Market Watch,"Pfizer Inc. said Wednesday it has paid 45 million euro, or the equivalent of $51 million to acquire a 15% equity stake in privately held gene therapy company Vivet Therapeutics.",https://feeds.marketwatch.com/~r/marketwatch/marketpulse/~3/MJC6DQPgwmw/story.aspx,0.0,0.0
PFE,2019-03-20,Pfizer buys stake in French gene therapy firm Vivet,https://cdn.snapi.dev/images/v1/1/0/105761925-1551198899700gettyimages-1127566854530x298.jpeg,CNBC,"Pfizer Inc said on Wednesday it has acquired a 15 percent stake in Vivet Therapeutics, and has an exclusive option to fully acquire the privately held French company that develops gene therapies for liver disorders.",https://www.cnbc.com/2019/03/20/pfizer-buys-stake-in-french-gene-therapy-firm-vivet.html,0.0,0.128
PFE,2019-03-19,Stocks to Build Your Portfolio Around,https://cdn.snapi.dev/images/v1/u/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5164712ftrust.jpg,The Motley Fool,The first stock you ever buy could be the most important. These three names won't disappoint.,https://www.fool.com/investing/2019/03/19/3-stocks-to-build-your-portfolio-around.aspx?source=iedfolrf0000001,0.0,0.5189
PFE,2019-03-18,How Important Is Oncology For Pfizer?,https://cdn.snapi.dev/images/v1/p/t/pt-25-193063-o.jpg,Forbes,"Pfizer’s oncology business contributes more than 10% to its overall top line. This can be attributed to its breast cancer drug ~ Ibrance ~ which has been doing well of late, and it has a large addressable market.",https://www.forbes.com/sites/greatspeculations/2019/03/18/how-important-is-oncology-for-pfizer/,0.2023,-0.3612
PFE,2019-03-13,"Forget About Dogs Of The Dow In 2019, Upgrade To Dobermans",https://cdn.snapi.dev/images/v1/d/o/doberman-1177935-1280-1200x800.jpg,Forbes,"A year ago, I introduced to Forbes readers my Dobermans of the Dow screen. It's simple to employ, and the historical returns far exceed the traditional Dogs of the Dow.",https://www.forbes.com/sites/michaelcannivet/2019/01/03/forget-about-dogs-of-the-dow-in-2019-upgrade-to-dobermans/,-0.2263,0.0
PFE,2019-03-12,Option trading opportunities in Pfizer,https://cdn.snapi.dev/images/v1/p/f/pfizer.jpg,CNBC Television,"""Halftime Report"" trader Jon Najarian spots unusual options activity in shares of Pfizer.",https://www.youtube.com/watch?v=TCpC0dl0wI0&t=0s,0.3818,0.296
PFE,2019-03-12,"Final trades: Array Biopharma, Alphabet, KKR & XLK tech",https://cdn.snapi.dev/images/v1/f/i/finaltrades-4.jpg,CNBC Television,"The ""Halftime Report"" traders give their top stocks to watch for the second half.",https://www.youtube.com/watch?v=Y9NBB_L2Kd0,0.0,0.2023
PFE,2019-03-11,"2 Undervalued Stocks With Strong, Secure Dividends",https://cdn.snapi.dev/images/v1/q/p/qpdvzfgckcw.jpg,Morningstar,Both Bristol-Myers Squibb and Pfizer are well-positioned for growth.,https://www.youtube.com/watch?v=QPdvzfgckcw,0.6908,0.3818
PFE,2019-02-27,Top technician says charts point to healthy gains ahead for this stock,https://cdn.snapi.dev/images/v1/c/j/cj7s4ylolgq.jpg,CNBC Television,"Robert Sluymer, Fundstrat, looks at the best stocks in health care space. With CNBC's Dominic Chu and Melissa Lee, and the Fast Money traders, Tim Seymour, Steve Grasso, Dan Nathan and Guy Adami.",https://www.youtube.com/watch?v=cj7s4yLoLgQ,0.7096,0.8126
PFE,2019-02-26,High U.S. drug prices fuel outrage,https://cdn.snapi.dev/images/v1/d/r/drugprices.jpg,Bloomberg Markets and Finance,"Lara Rhame, FS Investments chief U.S. economist, and Mike Liss, American Century portfolio manager, discuss drug pricing on ""Bloomberg Daybreak: Americas.""",https://www.bloomberg.com/news/videos/2019-02-27/high-u-s-drug-prices-fuel-outrage-video,-0.5106,0.0
PFE,2019-02-25,"We need more drug price transparency, says Senator Chuck Grassley",https://cdn.snapi.dev/images/v1/m/y/mysh5f9wirm.jpg,CNBC Television,"Senator Chuck Grassley (R-IA), head of the Senate Finance Committee, joins ""Squawk Box"" before the committee hears testimony from seven major pharmaceutical CEOs about drug pricing.",https://www.youtube.com/watch?v=MYSh5F9WIrM,0.0,0.0
PFE,2019-02-25,"There will be continued interest in gene therapy, says biotech analyst",https://cdn.snapi.dev/images/v1/r/o/roche-1.jpg,CNBC Television,"CNBC's ""Power Lunch"" team discusses whether there's more biotech buyouts ahead with Michael Yee of Jefferies.",https://www.youtube.com/watch?v=g4Wg0qvTJ0I,0.4588,0.0
PFE,2019-02-11,"Even if there's no trade deal, here's what traders think is still safe to buy",https://cdn.snapi.dev/images/v1/1/0/10jaziai56m.jpg,CNBC Television,"Are all the market risks priced in? The biggest risks to the New Year rally. With CNBC's Brian Sullivan and the Fast Money traders, Pete Najarian, Tim Seymour, Dan Nathan and Guy Adami.",https://www.youtube.com/watch?v=10jAziAI56M,0.1779,-0.4939
PFE,2019-02-05,Final Trades: Array BioPharma,https://cdn.snapi.dev/images/v1/t/2/t23uhmjw51ev-1.jpg,CNBC Television,"The ""Fast Money"" traders share their final trades of the day including Advanced Micro, Array Biopharma & more.",https://www.youtube.com/watch?v=T23UhMjW51E&t=0s,0.0,0.4939
PFE,2019-02-04,Trade Update: Array BioPharma,https://cdn.snapi.dev/images/v1/l/0/l0384w3hvzcv-4.jpg,CNBC Television,"""Halftime Report"" traders Jon and Pete Najarian spots unusual options activity in Square and Cars.com. Plus: trade updates on Intel and Array BioPharma.",https://www.youtube.com/watch?v=l0384W3hVzc&t=128s,0.0,0.0
PFE,2019-02-04,The traders answer your questions about: Pfizer,https://cdn.snapi.dev/images/v1/a/b/abf4ziklvq4.jpg,CNBC Television,"The ""Halftime Report"" traders answer viewer questions on Boeing, Paypal, Pfizer, Verizon, Visa & Gilead.",https://www.youtube.com/watch?v=abf4ZIKlVq4&t=68s,0.0,0.0
PFE,2019-01-29,What Boeing's Report Means for U.S. Companies With China Exposure,https://cdn.snapi.dev/images/v1/u/1/u13kumvf7pi.jpg,The Street,"Kate Warne, investment strategist at Edward Jones, spoke to TheStreet about what the Boeing earnings mean for companies with exposure to China, how the tech sector is doing after Apple's AAPLearnings and how healthcare is looking now that Amgen, Pfizer and Allergan have reported.",https://www.youtube.com/watch?v=u13kUMVf7pI,0.0,0.0
PFE,2019-01-28,"Stocks Mixed: Apple Earnings Due, Pfizer Reports, Pinduoduo Strong",https://cdn.snapi.dev/images/v1/w/8/w8mkcxl9dnc.jpg,Investors Business Daily,"Investor's Business Daily's MARKET UPDATE, with Alissa Coram and Ken Shreve.",https://www.youtube.com/watch?v=W8mKcXL9Dnc,0.5106,0.0
PFE,2019-01-24,Earnings Thirteen: 4 buys,https://cdn.snapi.dev/images/v1/1/c/1cqx0bznin8.jpg,CNBC Television,"The ""Fast Money"" traders give you 4 buys ahead of the big 13 Dow stocks reporting next week.",https://www.youtube.com/watch?v=1CQx0BZnin8,0.0,0.0
PFE,2019-01-17,"Bulls bet on this biopharma company. Plus, the update on Freeport-McMoRan",https://cdn.snapi.dev/images/v1/q/4/q4dbuoj6xfy.jpg,CNBC Television,"""Halftime Report"" traders Jon and Pete Najarian spot unusual options activity in shares of Macy's and Pfizer.",https://www.youtube.com/watch?v=Q4dBUoJ6XfY,0.0,0.296
PFE,2019-01-02,Is now a good time to buy tech? Is 3M poised to move higher? What about Fortinet? Your questions ans,https://cdn.snapi.dev/images/v1/v/o/vo4hb-ts9dg.jpg,CNBC Television,"The ""Halftime Report"" traders answer viewer questions on 3M, Fortinet, Pfizer, Weatherford International, and if now's the time to buy tech.",https://www.youtube.com/watch?v=VO4hb_Ts9dg,0.6641,0.0
PFE,2019-01-01,"Final Trades: FDX, PFE, & Bitcoin",https://cdn.snapi.dev/images/v1/o/i/oivdoec0swc.jpg,CNBC Television,"The “Fast Money” traders discuss how to trade FedEx, Pfizer and Bitcoin.",https://www.youtube.com/watch?v=OiVDoeC0swc,0.0,0.0
PFE,2018-12-27,Tech stock picks from two investing experts,https://cdn.snapi.dev/images/v1/v/i/viu4uxkd-qc.jpg,CNBC Television,"CNBC's ""Power Lunch"" team talks about the state of the markets with Ernesto Ramos of BMO and Kim Forrest of Fort Pitt Capital.",https://www.youtube.com/watch?v=vIU4uXKd_qc,0.0,0.0
PFE,2018-12-10,"Clients trust Apple stock despite its recent dip, says TD Ameritrade's JJ Kinahan",https://cdn.snapi.dev/images/v1/g/d/gdonwdlosok.jpg,CNBC Television,"JJ Kinahan, chief market strategist at TD Ameritrade, breaks down his clients' stock picks.",https://www.youtube.com/watch?v=gDONwDlosOk,0.7213,0.4084
PFE,2018-11-29,"Bulls shop for TJX. Plus, the trade on Pfizer",https://cdn.snapi.dev/images/v1/b/8/b8pkzdn8xwm.jpg,CNBC Television,"""Halftime Report"" trader Jon Najarian spots bullish option buying in TJX Companies and Pfizer.",https://www.youtube.com/watch?v=B8pkZdn8xWM,0.0,0.0
PFE,2018-11-20,BMO portfolio manager breaks down top dividend picks,https://cdn.snapi.dev/images/v1/i/a/iajx4j2hhw0.jpg,CNBC Television,"Ernesto Ramos, portfolio manager with BMO Global Asset Management, discusses his top dividend choices.",https://www.youtube.com/watch?v=iAJx4J2hHw0,0.2023,0.5106
PFE,2018-11-19,Pfizer to raise drug prices despite Trump's complaints,https://cdn.snapi.dev/images/v1/s/o/soc8igt3vca.jpg,Fox Business,Association for Accessible Medicines CEO Chip Davis discusses the Trump administration's fight to lower prescription drug prices.,https://www.youtube.com/watch?v=SOC8Igt3vCA,0.3089,-0.5859
PFE,2018-11-15,"Final Trades: Virtu, JPMorgan & Pfizer",https://cdn.snapi.dev/images/v1/i/v/ivyeaofonea.jpg,CNBC Television,"The ""Halftime Report"" traders give their top stocks to watch for the second half.",https://www.youtube.com/watch?v=IvyeAoFOneA,0.0,0.2023
PFE,2018-11-09,"Final Trades: CSCO, PFE & more",https://cdn.snapi.dev/images/v1/b/m/bmcip-ysegy.jpg,CNBC Television,"The ""Fast Money"" traders share their final trades of the day, including Cisco, Pfizer, Tesla and General Electric.",https://www.youtube.com/watch?v=bMciP-YseGY,0.0,0.296
PFE,2018-11-07,The future of the health-care industry,https://cdn.snapi.dev/images/v1/u/6/u6rlgkkgeoe.jpg,CNBC Television,"Fred Hassan, former Shering-Plough CEO, and Bill George, former Medtronic CEO, join 'Squawk on the Street' to discuss the impact on health-care stocks after news that the sector was the top issue for midterm voters.",https://www.youtube.com/watch?v=U6rLgKKgeOE,0.0,0.4588
PFE,2018-11-06,"Elections is more about the health care sector, and less drug prices, says pro",https://cdn.snapi.dev/images/v1/q/h/qhp0-wnd4ci.jpg,CNBC Television,Ipsita Smolinski of Capitol Street and Jared Holz of Jefferies join 'Closing Bell' to discuss the health care sector and how drug pricing could be changed following the midterm elections.,https://www.youtube.com/watch?v=qhp0_wnd4cI,0.4939,0.6597
PFE,2018-11-05,How health care could be impacted by the midterms,https://cdn.snapi.dev/images/v1/n/f/nfjcujynh9s.jpg,CNBC Television,"Umer Raffat of Evercore ISI, Institutional Investors number one biotech analyst, joins 'Power Lunch' to discuss how health care stocks could be impacted by the midterm elections.",https://www.youtube.com/watch?v=NfJcujyNH9s,0.4939,0.5423
PFE,2018-10-31,Pfizer and Coca-Cola Earnings Help Safer Income Stocks Shine,https://cdn.snapi.dev/images/v1/r/f/rflx3ewmkyc.jpg,Zacks Investment Research,"After a volatile October, Ryan McQueeney highlights two income companies that fared better than the broader markets during the selloff—Pfizer and Coca-Cola—and explains why earnings and defensive posturing might have helped the stocks.",https://www.youtube.com/watch?v=rFlX3eWmKyc,0.6705,0.4588
PFE,2018-10-29,Pfizer posts mixed quarter,https://cdn.snapi.dev/images/v1/f/j/fjfpdkzpity.jpg,CNBC Television,"Pfizer reports quarterly earnings of $0.78 per share, revenues of $13.298 billion.",https://www.youtube.com/watch?v=fjFPDKzPITY,0.0,0.296
PFE,2018-10-29,Where should investors go to sit out the sell-off? Traders give their picks,https://cdn.snapi.dev/images/v1/u/g/ug74bftptak.jpg,CNBC Television,"Sitting out the sell-off. Where investors are running to for cover. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Karen Finerman, Steve Grasso and Guy Adami.",https://www.youtube.com/watch?v=Ug74BftPTak,0.0,0.0
PFE,2018-10-23,Pfizer & Eli Lilly's Opioid Alternative Shows Promise,https://cdn.snapi.dev/images/v1/b/n/bn-c0aexou.jpg,Zacks Investment Research,"In a large clinical trial, Pfizer (PFE) and Eli Lilly (LLY) have been testing a pain medication, tanezumab, for the treatment of osteoarthritis.",https://www.youtube.com/watch?v=-bn_c0aexOU,0.3182,-0.5106
PFE,2018-10-17,Will Pfizer hit $50? Is Cleveland-Cliffs a safe bet ahead of earnings? The desk takes viewer quest,https://cdn.snapi.dev/images/v1/1/u/1uvohfmupuw.jpg,CNBC Television,"The ""Halftime Report"" traders take viewer questions on Pfizer, Mosaic and Cleveland-Cliffs",https://www.youtube.com/watch?v=1UvOHFMupUw,0.504,0.0
PFE,2018-10-11,"Final Trades: HD, DIS & more",https://cdn.snapi.dev/images/v1/r/q/rqxrhtskl7g.jpg,CNBC Television,"The ""Fast Money"" traders share their final trades of the day, including Home Depot, Disney, Pfizer and JPMorgan.",https://www.youtube.com/watch?v=rQxRhTSkL7g,0.0,0.296
PFE,2018-10-10,S&P 500 having worst month since September 2011,https://cdn.snapi.dev/images/v1/y/k/ykpndjxdlku.jpg,CNBC Television,CNBC's Bob Pisani breaks down Thursday's market sell-off after the closing bell.,https://www.youtube.com/watch?v=YKPNDJxDlkU,-0.6249,0.0
PFE,2018-10-02,"Stocks and rates are stuck in a game of chicken, so which will blink first",https://cdn.snapi.dev/images/v1/l/n/lnb08d4n-pi.jpg,CNBC Television,"The Dow closes at a record high. Will rates derail the rally? With CNBC's Melissa Lee and the Fast Money traders, Pete Najarian, Tim Seymour, Karen Finerman and Guy Adami.",https://www.youtube.com/watch?v=LNB08D4n_PI,-0.25,-0.296
PFE,2018-10-01,Pfizer says CEO Ian Read will retire at the end of the year,https://cdn.snapi.dev/images/v1/k/w/kwv92li02ao.jpg,Fox Business,Pfizer announced that CEO Ian Read will step-down by the end of the year and be replaced by the company's current chief operating officer Albert Bourla.,https://www.youtube.com/watch?v=KwV92lI02Ao,0.0,0.0
PFE,2018-09-28,"Final Trades: T, DIS & more",https://cdn.snapi.dev/images/v1/1/w/1ww7jldtru.jpg,CNBC Television,"The ""Fast Money"" traders share their final trades of the day, including AT&T, Disney, Pfizer and Celgene.",https://www.youtube.com/watch?v=_1wW7jlDTRU,0.0,0.296
PFE,2018-09-05,"The Final Call: STZ, PFE & more",https://cdn.snapi.dev/images/v1/x/9/x9uknhmxqgg.jpg,CNBC Television,"The ""Fast Money"" traders share their final trades of the day, including Constellation Brands, Pfizer, Taiwan Semiconductor and CBS.",https://www.youtube.com/watch?v=X9uKNHMxqgg,0.0,0.296
PFE,2018-08-28,Must own stocks: 5 buys,https://cdn.snapi.dev/images/v1/p/i/pira-eli9ha.jpg,CNBC Television,"The ""Fast Money"" traders give you their 5 picks for must own stocks.",https://www.youtube.com/watch?v=PirA_ELI9hA,0.0,0.0
PFE,2018-08-27,Stocks rally following US-Mexico trade deal,https://cdn.snapi.dev/images/v1/s/j/sjohopkl400.jpg,CNBC Television,"Traders Joe Terranova, Jim Lebenthal, Stephen Weiss and Josh Brown discuss that the U.S.-Mexico trade deal is good news for certain sectors of the economy and that the surging stocks signal that the market sees an eventual trade resolution with China.",https://www.youtube.com/watch?v=sJOhoPkl400,0.0,0.6124
PFE,2018-08-22,Exact Sciences CEO: Pfizer partnership | Mad Money | CNBC,https://cdn.snapi.dev/images/v1/f/n/fn2h0ndnhl4.jpg,CNBC Television,"Jim Cramer sits down with Exact Sciences CEO Kevin Conroy to find out what's next for the company, including its partnership with Pfizer.",https://www.youtube.com/watch?v=FN2H0NDnhL4,-0.4939,0.0
PFE,2018-08-21,"Jim Cramer on Target, Lowe's, Toll Brothers and Tariffs",https://cdn.snapi.dev/images/v1/t/o/to1oq-l2yog.jpg,Zacks Investment Research,"heStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Wednesday's trending stocks from the floor of the New York Stock Exchange including Target, Lowe's, Toll Brother's, and tariffs.",https://www.youtube.com/watch?v=tO1OQ_l2Yog,0.0,0.0
PFE,2018-08-15,Trading a huge rally: 6 picks,https://cdn.snapi.dev/images/v1/c/m/cmtp78cvfww.jpg,CNBC Television,"The ""Fast Money"" traders give you 6 ways to trade a big up day in the market.",https://www.youtube.com/watch?v=CMTp78cvFWw,0.3182,0.0
PFE,2018-08-07,Stocks to buy at market highs: 5 picks,https://cdn.snapi.dev/images/v1/7/t/7tpdnpsrhgm.jpg,CNBC Television,"The ""Fast Money"" traders give you 5 stocks to buy as the S&P 500 hits its highest level since January.",https://www.youtube.com/watch?v=7tPDNPsRHgM,0.0,0.0
PFE,2018-08-02,Trade it or fade it: This week's winners,https://cdn.snapi.dev/images/v1/m/-/m-3mbnyhb84.jpg,CNBC Television,"Trading this week's winners. Should investors keep betting on them? With CNBC's Michelle Caruso-Cabrera and the Fast Money traders, Tim Seymour, Steve Grasso, Brian Kelly and Dan Nathan.",https://www.youtube.com/watch?v=M-3MbNyhb84,0.4767,0.4767
